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ABSTRACT 
Effects of oxidative stress, exercise and cardiac rehabilitation on telomerase in T-
lymphocytes 
 
Myocardial infarction (MI) remains the primary cause of death worldwide, despite 
significant medical advances. Lymphocytes play a key role in both the pathogenesis 
of atherosclerosis and also the healing process following MI. It has been found 
however, that decreased lymphocyte telomere length correlates with greater risk of 
MI and worse outcomes. Atherosclerosis is causally linked with MI and can be 
triggered by myeloid and lymphoid cells, which destabilise and rupture lipid-rich 
plaques on the arterial wall. Atherosclerosis is also linked with elevated oxidative 
stress, increasing the risk of cardiovascular disease. Experiments in-vitro have shown 
that even mild oxidative stress caused telomere shortening and inhibits cell 
proliferation. Oxidative stress in-vivo can be caused by physical inactivity, which can 
contribute to atherosclerosis. Telomere length can be maintained by regular physical 
activity. 
 
My results show that hyperoxia enhanced IFN-γ mRNA transcription in T-
lymphocytes, whereas hypoxia significantly reduced inflammation. Oxidative stress 
suppressed a) in-vitro T-cell proliferation in a TERT-dependent way, b) telomerase 
activity and c) TERT expression in mTert-GFP+ mice by 5-fold (P<0.01) compared to 
hypoxia. MAPK inhibition (MAPKi) down-regulated IFN-γ mRNA transcription and 
enhanced splenocyte proliferation equally under both hypoxia and hyperoxia. MAPKi 
enhanced telomerase activity under hyperoxia by day 10 in culture and significantly 
increased telomerase activity by day 14 compared to hypoxia. The effect of MAPKi 
seems to require the presence of TERT and interaction between cells. Voluntary 
wheel running led to increased telomerase activity in ApoE-/-mTert-GFP+ mice on a 
high fat diet (HFD) compared to the no exercise group. HFD enhanced both 
telomerase activity and B-cell numbers under exercise compared to the same mice on 
a normal diet (ND). In humans, regulatory T-cells were elevated in the acute stage of 
MI and decreased by 7-fold (P<0.001) following cardiac rehabilitation. However, no 
significant effect was observed on telomerase activity. 
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CHAPTER 1. INTRODUCTION 
1.1 Functions of the immune system 
1.1.1 Different cell types in the immune system 	
The acquired, or adaptive, immune system is a subsystem of the immune system. It is the 
second of two immunity protection strategies, the other being the innate immune system 
(Rimer et al., 2014). The importance of the acquired immune system is due to its high 
specificity to pathogens and the long lasting protection it confers against different diseases. It 
is acquired over the lifetime of an organism through contact with specific pathogens, and is 
non-existent at birth (Nielsen et al., 2010). 
 
Each type of antigen, whether a virus, bacteria or any foreign body, has unique molecular 
markers, in addition to lymphocytes with their own clearly recognizable proteins. Mitotic 
activity in lymphocytes (T and B cells) is stimulated when foreign proteins are discovered in 
an organism. The second generation of lymphocytes (T and B cells), produced after mitosis 
then becomes subdivided into effector cells and memory cells. Effector cells are fully 
differentiated, and they seek and destroy foreign cells. Memory cells are dormant, but respond 
rapidly into defence mode if a pathogen is re-encountered. On recognition of the specific 
antigen, memory T-cells produce a huge lymphocyte population after repeated mitosis. 
Memory T-cells have shorter telomere length than naïve T-cells, which is most likely a 
consequence of continuous proliferation compared to naïve T-cells (Akbar and Vukmanovic-
Stejic, 2007).  
 
1.1.2 Acquired immunity 
 
1.1.2.1 T-cells 
T-cells originate from stem cells (Figure 1.1) in the bone marrow hematopoietic stem cells 
(HSCs). They then travel to the thymus to mature and differentiate; it is from this location that 
the name ‘T-cell’ originates. Subsequently, having developed their own receptors, the T-cells 
are released into the bloodstream. Interleukins secreted by effector helper T cells (CD4+) lead 
to division and differentiation of both T and B-cells. Effector (CD8+) cytotoxic T-cells 
destroy the infected cells with pathogen inside the organism by secreting enzymes, which 
penetrate the infected cell, such that the cytoplasm leaks out. Finally the DNA and organelles 
are attacked by CD8+ cytotoxicity, resulting in apoptosis. 
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CD4+ T-cells 
Cluster of differentiation 4 (CD4) is a glycoprotein found on the surface of T helper cells (Th-
cells). CD4 T-cells play an essential role in the immune system and can be classified into 
three main functional roles: memory, inflammatory and helper cells, depending on their 
cytokine production (Killar et al., 1987). Naïve CD4 T-cells differentiate into 4 sub-
populations: Th1, Th2, Th17 and regulatory T-cells (Tregs) after stimulus and activation in 
the bloodstream (Zhu et al., 2006; Mosmann et al., 2009).  
CD4 T-cells are mainly referred to as helper cells, as they primarily send signals to other 
types of immune cells, whereas CD8 T-cells are mainly known as killer cells since they 
actually destroy the infectious cells (Killar et al., 1987; Zhong et al., 2008). 
CD8+ T-cells 
Cluster of differentiation 8 (CD8) is a transmembrane glycoprotein found on the surface of T 
cytotoxic cells (Tc-cells). These cells play a crucial role in the immune system by producing 
and releasing cytotoxins (Perforin, granzymes and granulysin), into the cytoplasm of infected 
cells, leading to apoptosis (Zhong et al., 2008). 
1.1.2.2 B-cells 
B-cells (named after the avian ‘bursa of Fabricius’) are produced and developed in the bone 
marrow from HSCs (Figure 1.1). They are covered by B-cell receptors (BCRs) and produce a 
single specific antibody, which targets and adheres to the surface of infected cells. When a 
specific antigen comes into contact with cells, or if an interleukin signal is sent by a helper T-
cell, the B-cell will initiate replication. New B-cells differentiate into effector or memory 
cells. Effector B-cells produce vast quantities of free-floating antibodies, which travel through 
the bloodstream until they encounter a corresponding antigen, which is then ‘tagged for 
destruction’ by phagocytes. 
1.1.2.3 Monocytes 
Monocytes differentiate from hematopoietic stem cells after being produced in the bone 
marrow from precursor monoblasts (Figure 1.1). Monocytes play an important role in the 
immune system; using intermediary proteins (antibodies or complements) monocytes can coat 
the pathogen and destroy it by phagocytosis. They can also destroy the pathogen by antigen 
presentation or cytokine production (TNF, IL-1 and IL-12). 
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Altogether, CD4+ (helper) T-cells produce memory and effector cells via the production and 
secretion of cytokines. CD8+ (cytotoxic) T-cells play a role in the eradication of infected cells. 
Antibodies are produced by B-cells which stick to cell surfaces or are secreted into the blood. 
Monocytes use phagocytosis to engulf pathogens and secrete cytokines that attract T-
lymphocytes to the affected site using specific antigens. 
 
 
 
Figure 1.1. Illustration of the immune cells from origin to differentiation. 
 
All lymphoid and myeloid blood cells arise from bone marrow-based hematopoietic 
stem cells (HSCs). Myeloid progenitors differentiate into monocytes and granulocytes 
within the bone marrow before travelling into the peripheral bloodstream where they 
exist for a few hours or days. Conversely, after differentiating in the bone marrow, 
lymphoid progenitors migrate to the thymus, where they mature into T-cells.  
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1.1.3 Regulation of the adaptive immune response 
For adaptive immunity to develop, specific antigens must first be identified as non-self, which 
delays the process. The adaptive immune system relies entirely on the ability to differentiate 
between individual antigens (Bonilla and Oettgen, 2010). Over time, this produced the pool of 
clonal diversity, allowing dormant cells to remain inactive until such a time that they 
encounter any antigen for which they have a memory and can recognize. This ability is more 
effective in antigen removal than targeted immune responses. 
 
The adaptive immune system is predominantly made up of T and B-cells, as well as 
antibodies. Within the T-cell population, various subtypes are present, including regulatory, 
cytotoxic, and pro- and anti-inflammatory helper (Th) T-cells. Pathogens which show 
resistance to neutrophils and macrophages are usually cleared by T-lymphocytes. 
 
Following maturation in the thymus, both CD4 and CD8 are expressed by naïve T-cells, 
which are referred to as ‘double positive’ (DP). These cells reconfigure their TCRα chain, 
resulting in mature TCRαβ expression. In its ability to distinguish between self- and non-self 
Major Histocompatibility Complexes (MHCs), the T-cell is rendered receptive to survival 
signals and positive selection (Naito and Taniuchi, 2010). The preference for MHC I or MHC 
II, as distinguished by the reconfigured TCR causes the T-cell to cease CD4 or CD8 
expression accordingly, i.e. they become single positive. The Ras-Mek1 signalling pathway 
magnifies this process of positive selection (Alberola-Ila et al, 1996). 
 
Following this positive selection process, the final stage in T-cell maturation involves 
negative selection, which is also governed by Ras signalling. Thymocytes are screened and 
those which express a TCR with a preference for self-MHC/peptide complexes are deleted 
(Robey, 1999). ERK1/2 is not required for negative selection, but Ras activated MAPK c-Jun 
kinase (JNK) is, which implies that Ras signalling plays a specific role in T-cell maturation 
(Robey, 1999). TCR interaction causes variations both quantitatively and temporally in TCR 
signaling, which can induce an instructional bias on CD4/CD8 lineage commitment, as well 
as kinase-assisted (Lck and ZAP70) downstream signal transduction events (Yasutomo et al, 
2000).  
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CD3 and ζ-chains are phosphorylated by the Src kinase Lck when antigen presenting cells 
(APCs) are proximal to the TCR complex. This is due to an antigen/MHC complex bound to 
the surface of the APC. A conformational change is facilitated, which allows the TCR 
complex to bind with cytoplasmic tyrosine kinase Zap70, allowing Lck phosphorylation to 
take place (Smith-Garvin et al., 2009). 
 
Consequently, one co-receptor is activated and the other is terminated, as required by the 
lineage commitment of that cell (Laky et al., 2006). CD8 is expressed when TCR activation is 
inhibited, in spite of any MHC II complex specificity, or if MHC I specific cells respond in 
the opposite way to TCR signalling. CD4 expression is intrinsic, although the nature of the 
TCR signalling, with regard to magnitude, frequency and duration, influences this lineage 
commitment. The role of Notch, a transmembrane receptor, has been implicated in the 
signalling within developing T-cells (Robey, 1999). The absence of Notch has been 
associated with increased CD8+ thymocyte generation and decreased CD4+ thymocyte 
generation (Xiong et al., 2011). A CD8+ phenotype commitment is therefore likely to be 
caused by Notch, since although MHC-mediated positive selection would not be affected, it is 
believed that Notch activation may cause diversion of MHCII dependent thymocytes from a 
CD4 to a CD8 lineage (Suzuki et al, 1997; Laky et al, 2006). 
 
T-cell activation 
Activation of naïve CD4+ and CD8+ T-cells is a two-stage process. When an APC yields an 
MHC/antigen complex, the T-cell’s TCR is ligated with adjuvant co-stimulation (Smith-
Garvin et al, 2009). Cytokines and adhesins, particularly in relation to the immune response, 
are critical to this process. 
T-cell Receptor (TCR) 
TCR comprises two immunoglobulin chains (thus rendering it a heterodimer), as well as other 
nuclear signalling-related proteins (Janeway, 1992). Pathogens are recognized and cleared by 
TCR via MHC-bound antigens, which stimulate intracellular signalling cascades (Figure 1.2). 
However, further stimuli are required due to the low affinity of TCR binding (Stone et al., 
2009). TCRs comprise an α-chain, which is highly variable, and a more stable β-chain. These 
bond with invariant CD3 molecules via disulphide links. Being anchored to the membrane of 
the T-cell, stimulation by CD3 causes TCR signalling to the cells. 95% of T-cells express αβ 
TCRs; the rest express γδ TCR (Stone et al., 2009). 
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MHC/antigen complexes bind to the variable (V) region of the TCR chain, whilst the TCR is 
anchored to the cell membrane via the constant (C) region of the TCR chain (Rudolph et al., 
2006). Three hyper-variable regions, or complementary determining regions (CDRs), make 
up the V domain of a TCR chain. In thymocyte development, activated RAG 1 and 2 
recombination events cause stochastic rearrangement of CDRs, creating a vast range of TCR 
tertiary structures. The ability to achieve this wide variability is critical to recognizing and 
apprehending the broad array of antigens that will be encountered over an entire life span 
(Nikolich-Zugich et al, 2004). Recognition of processed antigens is generally mediated by 
CDR3, although some studies have demonstrated CDR1 and antigenic peptide also play a 
role. 
 
Figure 1.2. TCR signalling pathway to T-cell activation. (modified from Zhong et 
al., 2008) 
Once the engagement of T-cell receptors (TCRs) has taken place, proximal tyrosine 
kinases and other adapter molecules trigger phospholipase C, gamma 1 (PLCγ1) 
activation. This critical event stimulates triphosphate (IP3) and diacylglycerol (DAG) 
production, which triggers a number of pathways, including: Ca++-calcineurin-NFAT 
activation; the protein kinase C-theta (PKCθ)-Carma1/Bcl10- nuclear factor kappa-
light-chain-enhancer of activated B cells (NFκB) pathway; the Ras guanyl-release 
protein (RasGPR1)-Ras-Erk1/2- activator protein 1 (AP1) pathway; and protein kinase 
D (PKD). T-cell anergy may be caused by nuclear factor alone (in activated T-cells), 
which enhances the production of molecules such as DGKα, which promote anergy. 
Combined with DAG-medicated pathways, this cascade activates T-cells. Following 
this, TCR signalling is made more robust by CD28, leading to the activaton of 
phosphoinositide 3-kinase (PI3K) and the downregulation of Diacylglycerol kinases 
alpha and zeta (DGKα and ζ) expression. Signalling mediated by DAG may be 
suppressed when DAG converts to phosphatidic acid (PA) via DGKs. 
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Antigen presenting cells and major histocompatibility complexes (MHCs) 
A number of stages are involved in antigen processing before a cellular or humoral immune 
response becomes active. Specific fragments of antigen are phagocytosed by macrophages 
and dendritic cells before being presented for processing. The MHC uses tetrameric 
molecules to facilitate antigen presentation and also to mediate the distinction between self- 
and non-self-antigens. This is determined in both central and peripheral immunity by the level 
of interaction between TCRs and APC peptides. 
MHC-I and MHC-II present processed antigens on the APC surface. The difference between 
class I and II MHC is in their constituent α and β chains. MHC-I molecules are characterized 
by small, endogenous antigens, primarily cytotoxic CD8+ T cells, whilst MHC-II are found on 
the membrane of specialized APCs and bind exogenous antigens via a small α-chain ‘pocket’. 
MHC-I and II are heterodimeric glycoproteins, which exist on all human cells (except 
erythrocytes). Technically, any cell which expresses MHC is considered an APC. However, 
the three most effective types of ‘professional’ APC are B-cells, dendritic cells (DCs) and 
macrophages. Where other cells may only express MHC-II and co-stimulatory molecules in 
response to an inflammatory immune response or other physiological stress, DCs are 
particularly effective in their constitutive expression without the need for stress (Nickoloff 
and Turka, 1994). Consequently, DCs are the dominant human APC, enabling the 
differentiation and proliferation of specific T-cells. 
The adaptive immune response is therefore highly dependent on the above activity in order to 
detect, capture and present antigens, migrate these to T-cell areas, then respond to external 
stimuli and differentiate accordingly. Although this does not constitute an innate immune 
response, it essentially provides the link between innate and adaptive immunity. 
T cells and antigen presenting cells (APCs) 
T-cell activation relies on interaction between MHC and TCR, as well as co-receptors for 
CD4 and CD8 (Rudolph et al., 2006). Evidence is emerging which suggests that CD4 and 
CD8 form a complex with the TCR, creating an antigen-bound MHC co-receptor (Rudolph et 
al., 2006). When TCR is not present, CD4 and CD8 ordinarily bind with the antigen 
presenting cell via its MHC I and II ligands. Downstream signal transduction in T-cell 
activation is also reliant on the presence of activated CD3 within the TCR complex (Smith-
Garvin et al., 2009). The relationship between CD4+ and CD8+ T-cells is also critical: CD4 T-
cells, as well as pro-inflammatory cytokines and increased numbers of co-stimulatory 
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molecules, all have a modulating effect on dendritic cells, leading to CD8+ T-cell activation. 
In some cases, activation is the result of direct interaction; in others, it is the consequence of 
naïve CD8 precursor recruitment in lymphoid tissues. 
Co-stimulation of T-cells 
Co-stimulation is necessary for full T-cell activation. This is primarily achieved through TNF 
receptor (e.g. CD27 or CD40) and CD28 ligation (Acuto and Michel, 2003). When co-
stimulation is not possible, TCR ligation causes T-cell anergy (Smith-Garvin et al., 2009; 
Valenzuela and Effros, 2002). Of interest to this study, T-cell proliferation relies heavily on 
CD80/86, which becomes bound by CD28. In the laboratory, monoclonal antibodies will be 
used to co-stimulate and bind CD3 on the TCR complex. The process of co-stimulation will 
also cause src kinase activation. In turn, ITAMs on the CD3 complex are phosphorylated, 
recruiting ZAP-70, causing integrin activation and cytoskeletal rearrangement (Acuto and 
Michel, 2003; Van der Merwe and Dushek, 2011). 
Cytokines 
Eukaryotic cells secrete autocrine, endocrine and paracrine regulators, including cytokines, 
during a normal immune response. Intercellular signalling cascades are triggered by ligation 
of each cytokine’s corresponding cell-surface receptor. This causes the cell’s phenotype and 
transcription factors to be altered, thus promoting an adaptation response to the cell’s 
microenvironment. Monokines, lymphokines and interleukins express cytokine mRNA when 
their transcriptional activator is present and when an environmental change is detected in 
circulating cells. This is particularly true when subtle antagonistic or synergistic changes 
occur in the presence of cytokines. 
Interleukin- 2 (IL-2) 
IL-2 is produced via a CD28 canonical co-stimulatory signal (signal 2). TCR/CD3 
engagement with MHC/antigen (signal 1) has lower affinity of signal to stimulate the T-cell 
reseptor (Gaffen and Liu, 2004). IL-2 is mostly produced by CD4+ T-cells. Non-specific 
activation also leads to about 60% of CD4+ T-cells producing this cytokine. In pro-
inflammatory T-cell responses, IL-2 is produced by Th1, and TCR ligation causes CD8+ T-
cells to produce IL-2 (Ho et al., 1999). When MHC/antigen complexes are presented to naïve 
cell TCRs, B-cells and dendritic cells also secrete IL-2 (Granucci et al., 2001; Gaffen and Liu, 
2004). 
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Activated T-cells secrete a tiny α-helical cytokine (15kDa) with significant pleiotropic effects. 
The receptor of IL-2 is synthesized via TCR ligation, enabling effector T-cells to proliferate 
quickly. In humans and mice, the signalling role of IL-2 is significant; murine IL-2 is highly 
specific to its corresponding murine IL-2Rα subunit, whereas human IL-2 can induce T-cells 
across the species (Liu, 1999; Mosmann et al., 2009). IL2-R production plays a critical role in 
the expansion of CD4+ and CD8+ T-cells which respond to specific antigens (Miyazaki et al., 
1995; Gaffen and Liu, 2004). Both c-myc and c-fos signalling enable proliferation of 
activated T-cells, as well as anti-apoptotic signalling through Bcl. Both processes are reliant 
on IL-2 (Miyazaki et al, 1995). 
Janus Kinase (JNK) signalling, and signal transducers and activators of transcription (STATs) 
are also activated through the action of IL-2 on cellular metabolism. This is more of a long-
term T-cell proliferation effect, resulting in MAPK and ERK-Akt signalling pathways 
becoming activated. Nuclear factor of activated T-cells (NFAT) and the activator protein-1 
(AP-1) transcription factor are also activated by IL-2 (Gaffen et al., 1996; Garrity et al., 
1994). The presence of CD28 co-stimulatory signals supports this process, leading to robust 
T-cell activation through nuclear translocation of NFκβ (Kane et al, 2001). 
Interferon Gamma (IFN-γ) 
IFN-γ is produced by both Th1 CD4+ cells and cytotoxic CD8+ T-cells and, to a lesser degree, 
by NK cells. It is a soluble cytokine dimer and has critical importance to both innate and 
adaptive immunity. Not only are macrophages, NK cells and inducible nitric oxide synthase 
enzyme (iNOS) activated in the presence of IFN-γ, but it is also required for transcription 
factor activation, which, via a positive feedback loop, induces the Th1 lineage and suppresses 
Th2 differentiation. IFN-γ production is mediated by the APC cytokines IL-12 and IL-18 
(Fukao et al, 2000; Otani et al, 1999) and suppressed by IL-4, IL-10 and TGFβ, which are 
anti-inflammatory, whilst IFN-γ is a pro-inflammatory cytokine (Frostegård et al., 1999). It 
performs a number of other vital roles, including the facilitation of: leukocyte growth, 
maturation and differentiation (Young and Hardy, 1995; Boehm et al., 1997; Perussia et al., 
2001); NK cell activity (Carnaud et al., 1990); and Ig class switching (Carnaud et al., 1990; 
Finkelman et al., 1988). 
1.1.4 Role of T-lymphocytes in atherosclerosis 
The role of T-cells in regulating the immune response is critical. Th-cells differentiate in 
response to antigens present at inflammation sites. Four lineages may develop: Th1 and Th2 
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eliminate pathogens, both within and outside of cells; Th17 cells promote inflammation and 
eliminate pathogens through neutrophil recruitment in peripheral tissues; and Treg-cells 
regulate immune hyperactivity through inflammation inhibition (Beyer and Schultz, 2006; Yu 
and Gaffen, 2008). 
Healthy arteries attract T-cells into the aortic wall partly via L-selectin. In the aortic wall they 
localize primarily within the outermost connective tissue (Maffia et al., 2007). Of these T-
cells, most are activated phenotype TCRαβ+ CD4+ cells. Heat shock protein (HSP) is found in 
atherosclerotic plaques, alongside oxidized lipoprotein-specific T-cells. It is thought that 
lesion formation therefore causes local activation and clonal expansion (Rossmann et al., 
2008) and the expression of Vβ6 TCR, as opposed to Vβ and Vα segments. Some studies 
have noted that oxidized LDL also yields T-cell responses dependent on CD80-, CD86- and 
CD40-CD154 (Robertson and Hansson, 2006). 
A number of phases are implicated in atherosclerotic inflammation. In the early stages, IFN-γ, 
IL-6 and IgG2a antibodies are produced by Th1 cells. T-bet is a transcription factor, which 
allows differentiation of Th1 and also plays a role in Th1 and Th2 regulation in response to 
inflammatory diseases. T-bet deficiency may reduce atherosclerosis, as well as altered T-cell 
dependent oxidized LDL-specific antibodies, increased B1-derived antibodies, reduced 
lesional SMCs and an HSP-60 response to Th2 (Zhou et al., 1998). Increased 
proinflammatory cytokines, increased antibodies, and B-cell function regulation indicate that 
atherosclerosis is at least in part caused by Th1. Indeed, atherosclerotic lesions in Apoe-/- mice 
with increased blood cholesterol exhibit a switch to a Th2 response and IL-4 production, but 
further atherosclerosis is not inhibited (Zhou et al., 1998).  
Adoptive transfer into scid/scid Apoe-/- mice of CD4+ T-cells supports the proatherogenic role 
theory (Robertson and Hansson, 2006). There is evidence to suggest however, that CD4+ T-
cell atheroprotection may occur following immunization against MDA-LDL, although the 
presence of an adjuvant negates this effect. Both local arterial and systemic actions, via 
secondary lymphoid organs, may be implicated in this effect. Lymphocyte proliferation and 
IFN-γ are both inhibited by FTY720, a sphingosine-1-phosphate (S1P) analogue. FTY720 
also inhibits IL-6, IL-12 and CCL5 plasma levels and causes macrophages to switch to the 
M2 phenotype. Apoe is also inhibited in the presence of an adjuvant in Ldlr-/- and Apoe-/- mice 
(Nofer et al., 2007; Keul et al., 2007). 
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1.1.5 Regulatory T-cells (Tregs) 
T-cells are initially double-negative CD4-CD8-TCR-cells, becoming double-positive for these 
2 surface markers on reception of the appropriate signal. At this point, they become activated 
and proliferate into CD4+ and CD8+ T-cells. It has been suggested that atherosclerosis may be 
a form of autoimmune disease (Galkina and Ley, 2009; Foks et al., 2011). Tregs, which are 
critical to immunological tolerance, inhibit atherosclerosis development through avoiding 
inflammatory responses. 
Th1 and Th2 responses are controlled by Tregs, which themselves respond to HSP-60 and 
LDL. This provides further support for the theory that atherosclerosis is an autoimmune 
disease (Sakaguchi et al., 2006). Consequently, if Tregs are either damaged or absent, this 
may promote the atherosclerotic proinflammatory response. Passive transfer of cognate 
peptide-specific Tregs (Tr1) inhibits the production of Th1 cytokine, IFN-γ and IgG2a in 
ApoE-/- mice (Mallat et al., 2003). Indeed, recipient mice had less atherosclerosis and more 
IL-10. Adoptive transfer of CD4+CD25+Treg deficient bone marrow was found to increase 
lesion size in irradiated low-density lipoprotein receptor-deficient (Ldlr-/-) donors (Ait-Oufella 
et al., 2006). Furthermore, in recombinase activating gene-2-deficent apolipoprotein E-
deficient (Rag2-/-ApoE-/-) mice, lesion size doubled in response to the transfer of 
CD4+CD25+Treg deficient splenocytes, compared with wild-type splenocytes. This evidence 
implicates naturally occurring Tregs in playing a critical role in atheroprevention. 
Inducible costimulatory molecule (Icos) affects Treg response. Indeed, Tregs found in 
inducible costimulatory molecule knockout (Icos-/-) mice had far lower TGF-β-dependent 
suppression than their wild-type counterparts (Gotsman et al., 2006). CD31 also plays a role 
in Treg response, although the mechanism for this is not known (Groyer et al., 2007). Treg 
number and functioning is increased by obesity, and Th1 polarisation is suppressed in low 
density lipoprotein knockout (Ldlr-/-) mice with leptin deficiency (Taleb et al., 2007), 
resulting in improved Treg functioning and inhibited lesion development in atherosclerosis. 
Therefore, the immune response to atherosclerosis is also critically dependent on the 
leptin/leptin receptor pathway. IL-10 and TGF-β have also been implicated in the immune 
response to antigens in atherosclerosis (Van Puijvelde et al., 2007). 
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1.2 Atherosclerosis as an inflammatory disease 
 
1.2.1 Pathobiology of atherosclerosis 
Plaques, made up of blood substances including cholesterol, calcium and fats, may build up 
on arterial walls, causing atherosclerosis. Leukocytes, endothelial and smooth muscle cells 
may become inflamed, which can also lead to this arterial blood disease (Galkina and Ley, 
2009). All arteries, including coronary arteries and the aorta are prone to atherosclerosis, and 
blood clots caused by plaques may cause partial or complete blockages. If blood flow to the 
heart muscles is prevented or reduced, this can result in angina pectoris or myocardial 
infarction (a heart attack). Elsewhere in the body, a stroke or the inflammatory disease 
ischemic gangrene may result. Despite its causes not being fully understood, risk factors have 
been identified: smoking, bad diet and lack of exercise – these factors are controllable; and 
age and genetic predisposition – these are uncontrollable. Atherosclerosis is particularly 
insidious, due to a lack of any physical signs or symptoms until the point of a stroke or heart 
attack. 
Research into leukocyte recruitment mechanisms has shed some light on the causes of 
atherosclerosis. It has been observed that under an atherogenic (i.e. high fat) diet, leukocyte-
binding selective adhesion molecules such as VCAM-1 are expressed in some areas of arterial 
endothelium, attracting white blood cells which do not ordinarily bind with endothelial cells. 
VCAM-1 also binds monocytes and T-lymphocytes (Li et al., 1993). Mice that had been 
modified to express defective VCAM-1 exhibited interrupted lesion formation (Cybulsky et 
al., 2001). 
1.2.2 Mediators of inflammation 
When tissue is injured, damaged or destroyed in some way, a localized inflammatory 
response is triggered, preventing further damage by attacking, diluting or otherwise 
blockading both the damaged area and the agent which caused the injury. In atherosclerosis, 
inflammation can cause blockages in the blood flow, leading to a heart attack. Studies have 
shown that inflammation in atherosclerosis indicates a heightened risk of cardiovascular 
complications. One study found multiple connections between atherosclerotic inflammation 
and other processes related to the cellular immune response, endothelium activation and 
altering of metabolic parameters (Galkina and Ley, 2009). It had been demonstrated that 
CD4+ T-cells play a vital role in the development of atherosclerosis (Galkina and Ley, 2009). 
It was later found that patients with coronary artery disease (CAD) exhibited reduced 
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inflammation after engaging in physical exercise (Swandfager et al., 2012) and that tissue 
damage is inhibited by control of the inflammatory response by T-regs (Gol-Ara et al., 2012). 
Increased adhesion molecule expression in specific arterial sites tends to indicate a 
susceptibility to atheroma. Where blood flow is disrupted, particularly at branch points, 
atheroprotective mechanisms have been found to be damaged (Topper et al., 1996). It has 
been suggested that areas of decreased laminar stress produce less Nitric Oxide (NO), which 
would ordinarily have a dilatory and anti-inflammatory effect. NO also inhibits vascular cell 
adhesion molecule-1 (VCAM-1) expression on endothelial-leukocyte adhesion molecules (De 
Caterina et al., 1995). Other leukocyte adhesion molecules, e.g. intercellular adhesion 
molecule-1 (ICAM-1) and proteoglycans, cause inflammation by promoting oxidative 
modification of lipoproteins. These are also increased when blood flow is inhibited (Nagel et 
al., 1994). 
1.2.3 Role of the immune system in inflammation and atherosclerosis 
Chemoattractant molecules, including monocyte chemoattractant protein-1 (MCP-1) draw 
leukocytes from the endothelium into the intima. It has been suggested that this action is 
increased at lesion sites (Gu et al., 1998; Lee et al., 2001). Here, blood-derived inflammatory 
cells instigate an inflammatory response. Macrophages then produce scavenger receptors, 
which convert to foam cells through lipid ingestion. Inflammatory cytokines, IFN-γ and 
tumour necrosis factor (TNF–β), a lymphotoxin, are produced by macrophage colony 
stimulating factor (M-CSF) and T-cells, to stimulate smooth muscle cells (SMCs), 
macrophages, and vascular endothelial cells. Peptide growth factors and other fibrogenic 
mediators are secreted by arterial cells and activated leukocytes, causing SMCs to be 
replicated, leading to a dense extracellular matrix, or lesion (Smith et al., 1995). 
Inflammatory responses as described above are implicated in both atheroma and other 
thrombotic complications. Most fatal heart attacks are caused by atherosclerotic plaque 
disruption (Mach et al., 1999). Plaques have a fibrous cap, which may be disrupted by 
proteolytic enzymes attacking its collagen and making it more vulnerable to rupture. IFN-γ 
inside the plaque may be released by T-lymphocytes to suppress collagen synthesis, which 
also weakens the structure (Libby et al., 1996). Finally, one major link between inflammation 
and thrombosis is a procoagulant tissue factor, secreted by macrophages and regulated by 
inflammatory mediators (Libby, 2001). 
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Atherosclerotic lesions exhibit components of adaptive immunity. Antigen-specific adaptive 
immune responses have been implicated in atherogenesis (Andersson et al., 2010). ApoE-/- 
and Ldlr-/- mice, combined with B- and T-cell deficient mice, exhibit significant adaptive 
immunity in response to atherosclerosis. Progeny from ApoE-/- mice and lymphocyte deficient 
mice (also deficient in recombination activating gene (RAG) 1 or 2), or mice with severe 
combined immunodeficiency (SCID) exhibited significantly decreased atherosclerosis 
(Reardon et al., 2001; Zhou et al., 2000). 
These results confirm the role of proinflammatory T-cells, but B-cells have also demonstrated 
a protective role. ApoE-/- mice that have had their spleens removed exhibit aggravated 
atherosclerosis, but a protective effect was observed when these mice received splenetic B-
cells from their aged counterparts (Caligiuri et al., 2002). B-cells have also been shown to 
have a protective effect when bone marrow was transferred to Ldlr-/- mice from B-cell 
deficient mMT mice (Major et al., 2002). When the cytokine IL-5 is missing in bone marrow-
chimeric Ldlr-/- mice, lower amounts of immunoglobulin M (IgM) antibodies to 
phospocholine are found, resulting in higher atherosclerosis (Binder et al., 2004). Other 
studies, by Ait-Oufella et al. (2010) and Kyaw et al. (2010) have suggested that varying 
effects on atherosclerosis are produced by different subsets of B-cells. Notably, anti-CD20, 
and B220loIgM+ B cells do not inhibit plasma cell production, and IgG-producing B cells are 
more significantly affected than IgM production is. 
Atherosclerotic T-cells are memory-effectors and are αβ T-cell antigen receptor (TCR and 
CD4+ positive. Notwithstanding this, both TCRγδ and CD8+ cells have also been found 
(Hansson and Libby, 2006). Lesions in both humans and ApoE-/- mice have also exhibited T-
cell clonal expansion (Paulsson et al., 2000; Liuzzo et al., 2000), suggesting the possibility 
that within lesions, antigen-specific reactions take place. Furthermore, interrupted CD40 
ligation in Ldlr-/- mice is associated with smaller lesions (Mach et al., 1998). CD4+ T-cells 
from atherosclerotic ApoE-/- mice introduced to immunodeficient mice caused T-cells to be 
attracted to the lesion and increased atherosclerosis (Zhou et al., 2000). When an agonist to 
the tumour necrosis factor-like surface protein CD137 was injected into ApoE-/- mice, CD8+ 
T-cells were stimulated. The same effect was observed when smooth muscle cells (SMCs) 
expressed an artificial antigen, increasing atherosclerosis (Olofsson et al., 2008; Ludewig et 
al., 2000). Programmed death-ligand 1 (PD-L1) and programmed death-ligand 2 (PD-L2) are 
inhibitory molecules, deficiency of which resulted in larger plaques and of CD8+ T-cells 
infiltrating the lesion and supporting the theory that programmed death-1 (PD-1) may play a 
role in controlling CD8+ T-cells (Gotsman et al., 2007; Hoffmann and Spyridopoulos, 2015). 
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1.2.4 Oxidative stress 
Imbalances between the generation of Reactive Oxygen Species (ROS) in a living cell and 
that cell’s ability to detoxify reactive intermediaries (or repair the damage they cause) results 
in oxidative stress. When a cell’s redox state is disturbed, the resulting peroxides and free 
radicals produced can damage proteins, lipids and DNA, as well as other cell components. 
Oxidative stress, caused by oxidative metabolism can cause DNA strands to break as well as 
indirect damage to bases, for example in the form of the lesion 8-oxo-7,8-dihydro-2' -
deoxyguanosine (8-oxodG) (Valavanidis et al., 2009). ROS include O2− (superoxide radical), 
OH (hydroxyl radical) and H2O2 (hydrogen peroxide) (Chandra et al., 2015), that are 
described below: 
Different ROS types: 
1. Singlet oxygen reacts strongly with double bond-containing organic compounds. Singlet 
oxygen causes the oxidization of β-carotene into products which behave as secondary 
messengers. These play a role either in reducing the toxicity caused by singlet oxygen, or in 
the initiation of senescence (Foote et al., 1985; Holt et al., 2005). 
2. Superoxide radical: Electrons that leak from the mitochondrial electron transport chain 
can join molecular oxygen (O2) to form the ROS, superoxide radical (O2-). This reaction is 
easily increased by the presence of exogenous components, such as redox cycling compounds. 
Superoxide radicals are initially produced in the internal mitochondrial membrane (by NADH 
ubiquinone reductase and ubiquinone cytochrome C reductase as complexes I and III of the 
electron transport chain (ETC)). Hydrogen peroxide (H2O2) is formed following reduction of 
this species by superoxide dismutase (SOD) (Sohal et al., 1995; Babcock, 1999). NADPH 
oxidases also generates superoxide radicals in the membranes of specialized cells such as 
macrophages and these are rapidly released in a respiratory (or oxidative) burst (Kotsias et al., 
2013). These have a bactericidal function in combination with the phagocytic functions of 
macrophages. Superoxide radicals are also generated out of hypoxanthine and oxygen by the 
cytosolic enzyme xanthine oxidase, a flavin found in most tissues and also in milkfat 
globules. These particular superoxide radicals are thought to be one of the root causes of 
vascular pathologies (Sohal et al., 1995; Fridovich, 1995). 
3. Hydroxyl radical, via the Fenton reaction (Fe2+ + H2O2 à Fe3+ + .OH + OH-), .OH, a very 
reactive ROS, can be generated from hydrogen peroxide. This is one of the most prevalent 
reactions in all-biological systems and is responsible for the generation of numerous 
damaging lipid peroxidation products (Halliwell and Gutteridge, 1990). 
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.OH can be generated in a number of ways: Peroxinitrite or peroxinitrous acid can decay into 
hydroxyl radicals and .NO2. In neutrophils, myeloperoxidase and Cl- ions are also able to 
produce .OH during phagocytosis (Halliwell and Gutteridge, 2006). 
4. Hydrogen peroxide, enzymatic reactions in microsomes, peroxysomes and mitochondria 
are the primary source of H2O2. This process is significant to a number of functions, even 
under conditions of normoxia and cellular H2O2 concentrations are maintained at between 10-9 
and 10-7 M (Fransen et al., 2012). 
H2O2 can be synthesized by O2.- dismutation (via superoxide dismutase) in both plant and 
animal cells. This inhibits oxidative reactions. Cellular membranes are particularly porous to 
H2O2. The presence of both dismutase and catalase acts as a true cellular antioxidant by 
removing H2O2 (Fransen et al., 2012). 
The term ROS can refer to any oxygen-containing chemically reactive chemical species. 
These are a normal byproducts of oxygen metabolism processes and are involved in cell 
signaling and homeostasis (Devasagayam et al., 2004). Environmental stressors, such as 
excessive heat, exposure to UV (Devasagayam et al., 2004), or exogenous sources such as 
ionizing radiation can cause ROS levels to significantly increase which in turn can result in 
cell damage (Sosa et al., 2015). 
Exogenous ROS can be caused by drugs, smoke, radiation or other pollutants. Interaction 
between water and ionizing radiation – a process known as radiolysis -  can result in 
damaging intermediaries. The probability of this happening in humans is high, due to the fact 
that the human body is 55-60% water. During radiolysis, water molecules lose an electron and 
become reactive. A three-step chain reaction follows, which involves water being sequentially 
converted to a hydroxyl radical (•OH), hydrogen peroxide (H2O2), a superoxide radical 
(•O−2) and finally oxygen (O2). Any molecules in the path of the hydroxyl radical are 
stripped of electrons to become a free radical. A chain reaction is thus propagated (Sosa et al., 
2015). 
 
Endogenous ROS can be produced intracellularly in numerous different ways, according to 
the cell type. (1) by ROS producers such as NADPH oxidase (NOX) complexes (7 distinct 
isoforms) in cell membranes, mitochondria, peroxisomes, and endoplasmic reticulum (Muller, 
2000; Han et al., 2001). (2) As a by-product of oxidative phosphorylation in the mitochondria. 
Adenosine triphosphate (ATP) is generated by mitochondria to provide useable energy for 
cells. The process through which ATP is produced, oxidative phosphorylation, uses an 
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electron transport chain to convey protons across the inner mitochondrial membrane, which 
involves a series of oxidation-reduction reactions. Each successive acceptor protein has a 
higher reduction potential and the final destination for the electron being an oxygen molecule. 
Ordinarily, this molecule would be reduced to produce water, although 0.1-2% of electrons 
(the exact rate in live organisms is yet to be determined) which pass through the chain, 
oxygen is prematurely and incompletely reduced, resulting in a superoxide radical (•O−2). In 
itself, •O−2 is not particularly reactive, but in its protonated form, hydroperoxyl (HO•2), it can 
interfere with certain enzymes or initiate lipid peroxidation. At physiological pH, 
hydroperoxyl (whose pKa is 4.8) mostly exists as a superoxide anion (Li et al., 2013). 
 
 
Figure 1.3. ROS formation and metabolism. Under normal conditions, superoxide (.O-2) is 
formed by the mitochondrial respiratory chain. This can be dismutated by superoxide 
dismutase (SOD) into hydrogen peroxide (H2O2) which, through further reactions catalysed 
by transition metal (Mn+) can form the highly reactive hydroxyl radical (.OH). Superoxide 
also reacts swiftly with nitric oxide (NO), generating peroxynitrite, which is also highly 
reactive (Modified from Sitte and von Zglinicki, 2003). 
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Antioxidants 
1. Enzymatic 
a) Superoxide dismutases (SOD) are a class of enzymes which play a critical role in the 
antioxidant defense of oxygen-exposed cells. These enzymes catalyze the dismutation of 
superoxide into O2 and H2O2 (Benzie, 2000). Three forms of SOD exist in mammals and most 
chordates: SOD1, which is a dimer (two units), is mainly found in the cytoplasm and contains 
copper and zinc ions; SOD2, which is a tetramer, is mitochondrial and contains a manganese 
ion; and SOD3, an extracellular tetramer with copper and zinc ions. The genes are located on 
chromosomes 21, 6, and 4, respectively (21q22.1, 6q25.3 and 4p15.3-p15.1) (Benzie, 2000; 
Fransen et al., 2012). 
b) Catalase, is an enzyme primarily located in the peroxisomes, but also, to a lesser extent, in 
mitochondria. The enzyme itself catalases the conversion of H2O2 into O2 and H2O (2H2O2 à 
2H2O + O2) and is a key player in the antioxidant defense mechanisms (Benzie, 2000). 
Glutathione peroxidase performs the same function and both enzymes reduce the toxicity of 
oxygen-reactive radicals through the catalysis of superoxide into H2O2. Catalase is found in 
high concentrations in the liver, kidneys and red blood cells (Benzie, 2000). 
c) Glutathione peroxidases, reactions involving glutathione and H2O2 and organic 
hydroperoxides are catalyzed by glutathione peroxidase. This enzyme can be either selenium 
dependent or selenium independent, and reduces peroxides, thereby protecting against free 
radical damage. The enzyme can be found within either the mitochondria or the cytosol of the 
cell, and is critical to the prevention of lipid peroxidation. This in turn maintains the integrity 
of biological membranes (Brigelius-Flohé and Maiorino, 2013). 
 
2. Non-enzymatic. A number of small-molecule antioxidants are involved in antioxidant 
defense, as well as the antioxidant enzymes. These mainly function in the extracellular areas, 
such as the blood system, where there is a lower concentration of antioxidant enzymes. Two 
types of small-molecule antioxidants exist: lipid-soluble, which reside in cell membranes and 
lipoproteins, and water-soluble, which are present in bodily fluids such as blood and 
intercellular fluids (Nimse and Dilipkumar, 2015). 
3. Vitamins. Vitamin E, tocopherol, is the most abundant natural antioxidant and is found in 
both plants and animals. At least eight structural isomers exist. Primary among these is alpha-
tocopherol, which has particularly efficacy as an antioxidant. In cellular membranes, it reacts 
directly with oxy-radicals, superoxides and singlet oxygen, and protects against lipid 
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peroxidation (Darr et al., 1996). Vitamin C, ascorbic acid, is water-soluble (unlike vitamin E) 
and therefore has more efficacy in aqueous contexts. Both vitamins C and E work together to 
neutralize free radicals and singlet oxygen. The reduced antioxidant form of vitamin E 
(oxidized vitamin E) can also be regenerated, or recycled, by vitamin C. In its capacity as a 
reducing and antioxidant agent, vitamin C is able to process superoxide and hydroxyl free 
radicals, as well as lipid hydroperoxides through direct contact (Darr et al., 1996). 
1.2.5 Role of the immune system in oxidative stress 
Oxidative stress is caused by a disparity between oxidising and reducing agents (Sies, 1997), 
and can cause macromolecular damage over time, including lipid peroxidation, protein 
carbonylation and DNA oxidation. Increasingly however, the importance of Reactive Oxygen 
Species (ROS) in signalling is being acknowledged (Suzuki et al., 1997). Various examples 
can be provided: an ‘oxidative burst’ of neutrophil-generated ROS can destroy pathogens and 
thus benefit the immune systems in terms of antimicrobial protection (Dahlgren and Karlsson, 
1999). Immune complexes with auto-antigens may result in overproduction of ROS, which 
can be damaging to macromolecules, can suppress T-cell proliferation and may cause 
apoptosis (Thoren et al., 2007). Reactive nitrogen species (RNS) peroxynitrite, when 
incubated with T-cells, has a similar effect that may lead to apoptosis after inhibiting the T-
cell proliferation (Kasic et al., 2011). T-cells may also become hyper-responsive as a result of 
the susceptibility of TCR signalling to oxidative stress-induced modification of certain 
molecules such as CD3-ε, TCR-αβ and TCR-ζ (Cemerski et al., 2003). Small amounts of ROS 
however, have been shown to be beneficial. Indeed, low levels of H2O2 induced nuclear factor 
kappa B (NFκB) transcription, IL-2 gene expression and the IL-2 receptor chain-alpha in T-
lymphoma cells (Los et al., 1995). It is proposed that changes in the cellular redox 
environment cause T-cells to react with ROS in different ways (Griffiths, 2005) and also to 
differentiate accordingly (King et al., 2006). When 2, 3-dimethoxy-1, 4-naphthoquinone, a 
ROS generator, was used to stimulate peripheral blood mononuclear cells (PBMC), Th2 
phenotypes were observed to increase and Th1 were inhibited (King et al., 2006). When ROS 
are present, reactive carbonyls, such as 4-hydroxy-2-nonenal and malondialdehyde are 
generated at random on lipids and proteins, and these also lead to differentiation in favour of a 
Th2 phenotype (Moghaddam et al., 2011). These studies underline the importance of delicate 
ROS level regulation in order to maintain bacterial protection, immune response, or T-cell 
signalling in the cell maturation process.  
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Oxidative Stress and Regulatory T Cells 
Tregs make up 5-10% of all CD4+ T-cells and their immunosuppressive function is dependent 
on oxidative stress (Zhu and Paul, 2008). The redox state between DC and naïve T-cells at the 
immune synapse is heavily influenced by Tregs, causing cysteine availability to naïve T-cells 
to be significantly reduced (Yan and Banerjee, 2010; Yan et al., 2010). Whilst not antigen-
specific, this reduction is antigen dependent. Treg CLTA-4 and dendritic CD80/86 come into 
contact, stimulating a signal which suppresses the synthesis of DC iGSH and consequently 
extracellular cysteine synthesis (Yan et al., 2010). Furthermore, there is competition between 
Tregs and effector T-cells for this cysteine, which is then catabolized into sulphate, further 
limiting the amount of cysteine available (Yan et al., 2010). Effector T-cells consequently 
exhibit reduced intracellular glutathione (iGSH) levels and therefore fewer T-cells are 
activated and proliferation is reduced (Yan et al., 2010). The redox state at the immunological 
synapse is therefore critical. It has also been shown that, in comparison to other CD4+ T-cell 
subsets, Tregs have a higher tolerance for oxidative stress (Mougiakakos et al., 2009), making 
them far more adapted to immune response regulation. It has been found that Tregs secrete 
increased thioredoxin (Trx) which is an antioxidant enzyme, a 12 kDa oxidoreductase enzyme 
substrate containing a dithiol–disulfide, allowing it to scavenge ROS and metabolise H2O2 
(Mougiakakos et al., 2011). Trx inhibition leads to decreased cell-surface thiols and, on 
addition of agent N-ethylmaleimide, a thiol depleting agent, Tregs became far more sensitive 
to H2O2 and died as a result (Mougiakakos et al., 2011). Furthermore, Trx was released when 
Tregs were exposed to tumour necrosis factor-α (TNFα) and the number of cell-surface thiols 
increased, resulting in greater H2O2 resistance. 
 
1.2.6 Myocardial infarction as a complication of atherosclerosis 
Restricted cardiac blood supply damages cardiomyocytes, causing myocardial infarction 
(MI). Clots, blockages, narrowing or arterial wall hardening may affect any cardiac or 
coronary artery, leading to poor blood supply. Heart function may be improved following MI 
by Tregs, which protect cardiomyocytes and reduce inflammation. A number of studies have 
been performed on animals with MI, investigating various inflammatory and/or vascular 
outcomes. One rat model study exhibited peak TNF-α, interleukin-1β, and interleukin-6 levels 
one week following an induced MI, followed by a decline. These cytokines continued to be 
expressed at high levels, even in the unaffected myocardium, for a further 20 weeks. 
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It has been shown that MI can influence remote vascular processes (Takaoka et al., 2009), 
with implications for coronary restenosis following angioplasty or stent. A mouse model was 
studied, in which a spring wire was used to induce a smooth muscle cell-rich lesion in the 
femoral artery, mirroring stent-related restenosis. Four weeks later, neointimal hyperplasia 
was measured. It was found that the neointimal hyperplastic response was heightened if MI 
was induced at the same time as the injury. Green fluorescent protein (GFP) expressing mice 
had their bone marrow transplanted into the above mice. It was found that although 
neointimal hyperplasia was caused in part by GFP+ cells, the marrow itself was not implicated 
in the lesion’s expanded area. Instead, in the injured arterial areas, a number of 
proinflammatory transcripts were found by cDNA arrays to have increased after the MI. Some 
of these were responsive to TNFα, so TNFα mRNA was measured and found to be augmented 
for up to 28 days after MI was induced. Back at the injury site, TNFR1 was found to be 
increased. The study team then successfully demonstrated that TNFα could be suppressed 
using pentoxifylline and consequently, the effects of the induced MI on neointima 
augmentation were significantly reduced. The paper therefore demonstrates a mechanism 
linking myocardial damage and the inflammatory pathways which increase the injury 
response at a remote vascular site. Studies of human MI patients with coronary stents have 
shown the monocyte subset (CD14+CD16+CX3CR1+) to be linked with restenosis (Liu et al., 
2010). Consequently, adverse vascular events after MI may be caused by variation in 
peripheral blood monocytes. 
In a more recent study, ApoE-/- mice exhibited 50% increased plaque size three weeks after 
induced MI. Increased lesion protease activity was observed and CD11b+ myeloid cells, 
expressing increased levels of inflammatory genes, were found to occupy a larger area of that 
lesion. Increased monocyte levels in both blood and spleen – but not in bone marrow – were 
exhibited up to three months after MI. Humans who had died after acute myocardial 
infarction (AMI) also exhibited the same changes. It has been inferred therefore that the 
spleen may be involved in post-MI leukocytosis. It was found that atherosclerosis after MI 
slowed down following a splenectomy, although the bone marrow continued to release 
hematopoietic stem and progenitor cells, which seemed to accelerate atherosclerosis and 
support monocytosis (Katayama et al., 2006). 
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1.2.7 Immune response to myocardial infarction 
Pathophysiology of acute myocardial infarction (AMI) is heavily influenced by the 
inflammatory response of the immune system. Previously I have described the adaptive 
immune system and its classification; below I am going to give some details about the 
response of the adaptive immune system subsequent to myocardial infarction. 
Response of lymphocytes to MI 
Inflammation is our most effective immune response. Threats are recognized, cells mobilized 
and instigators are removed from injury sites by the inflammatory response (Goronzy and 
Weyand, 2006). Lymphocytes (in comparison to neutrophils, whose existence is fleeting) 
survive for decades, and vary in accordance with the individual experience of the host. When 
an immune response is triggered, a clonal burst differentiates lymphocytes into a range of 
effector cells, which memorise the antigenic instigator (Hoffmann and Spyridopoulos, 2015; 
Caliguri and Nicoletti, 2006; Goronzy and Weyand, 2006; Ducloux et al., 2003) for future 
response. A range of factors, including age, gender, prior experience of infections, genetics 
and environment influence the repertoire of any given individual (Spyridopoulos et al., 2016; 
Hotchkiss and Karl, 2003). 
Diseases with lymphopenia-mediated immunosuppression have been associated with 
increased incidents of cardiovascular events. AIDS patients, atomic bomb survivors or post-
transplant immunosuppressed patients have all been observed to exhibit suppressed CD4 
cells, leading to faster onset of atherosclerosis (Ducloux et al., 2003). In terms of ischemic 
heart disease development and prognosis, lymphocyte loss is implicated by these observations 
(Shmeleva et al., 2015). 
AMI patients exhibit lymphopenia, but little is known of the implications of this. Low 
lymphocyte counts and high neutrophil to lymphocyte ratios were associated with increased 
cardiovascular events both in patients with AMI (Nuñez et al., 2008; Dragu et al., 2008) and 
without (Horne et al., 2005). A recent study of 1,037 AMI patients (68% ST-elevation AMI) 
found over a 23-month median follow up period that a low baseline lymphocyte count, 
adjusted for baseline characteristics, served as an independent mortality predictor (Dragu et 
al., 2008). Another study of 515 ST-elevation AMI patients found that acute phase AMI was 
associated with lymphopenia and furthermore, the higher ratio of neutrophils to lymphocytes 
also correlated with higher mortality (Nuñez et al., 2008). 
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It has not yet been proven whether this association is causative or simply correlational, but 
these studies certainly suggest that further understanding of alternative approaches to the 
pathophysiology of AMI is called for. These include novel therapies, such as those designed 
to prevent immune deregulation caused by an excess of proinflammatory T-cells and 
cytokines through mobilisation of Treg (Goronzy and Weyand, 2006; Caliguri and Nicoletti, 
2006). 
Effector T-cells response to MI 
AMI risk can be more accurately indicated though lymphocyte count, which is a relatively 
easy measure to take. Whilst quick and easy to obtain however, lymphocyte count sheds little 
light on more complex cellular interactions. A deeper understanding of lymphocyte 
interaction and subtypes is required to gain useful therapeutic and pathophysiological 
knowledge. 
CD4 lymphocytopenia is symptomatic of T-cell mediated immunodeficiency and is closely 
linked with atherosclerosis. Renal patients with higher CD4 cell counts (>663/ml) were found 
to be 1/10 as likely to suffer atherosclerotic events (Ducloux et al., 2003). AMI activates both 
CD4 (helper) and CD8 (cytotoxic) T-cells. The ratio between these is inverted on admission, 
and if this ratio is kept low over time, then the risk factor was observed to increase (Blum and 
Yeganeh, 2003). 
Th1 and Th2 subsets are formed when CD4+ cells are stimulated by an antigen and these 
produce specific cytokines. Pro-inflammatories, including INFγ, tumour necrosis factor-α, IL-
2, IL-12 and IL-18 are released by Th1, whereas anti-inflammatories including IL-4, IL-5, IL-
6, IL-9, IL-10 and IL-13 are produced by Th2. IL-10 in particular can suppress polarization of 
Th1 (Blum and Yeganeh, 2003; Steppich et al., 2007). 
Th1 cells contribute to atherosclerotic growth as well as its destabilization, and can also lead 
to AMI in angina patients (Steppich et al., 2007; Methe et al., 2005). Both apoptosis of 
smooth muscle cells and increased synthesis of metalloproteinases are brought about by Th1, 
causing damage to the fibrous caps which form over atherosclerotic plaques, leading to 
rupture and potentially to thrombosis (Libby, 2001; Hansson, 2005). Unstable angina patients 
consistently exhibit increased Th1 levels compared with control groups (Steppich et al., 2007; 
Cheng et al., 2005; Methe et al., 2005). 
Acute immune deregulation has been observed in AMI patients (Boag et al., 2015). A study 
involving 33 AMI patients found a proinflammatory imbalance between Th1 and Th2 
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compared to control groups. This was linked with left ventricular dilation, systolic 
dysfunction, and to a worse functional class (Cheng et al., 2005). Increased Th1 produces 
cytokines which activate endothelial cells and leukocytes, as well as inducing adhesion 
molecules (Cheng et al., 2005; Steppich et al., 2007). Furthermore, apoptosis of endothelial 
cells may be caused when blood supply returns, bringing with it various proinflammatory 
agents, causing a worsening of microvascular aggravation (Pasqui et al., 2003; Rössig et al., 
2004). Pro-Th1 imbalance is implicated in AMI pathophysiology. IL-10, derived from Th2 is 
able to inhibit Th1 (Blum and Yeganeh, 2003; Steppich et al., 2007). It has been shown that 
mice which had been genetically manipulated to not produce IL-10 exhibited greater 
inflammatory response, higher TNF-α, higher neutrophil infiltration, increased intercellular 
adhesion molecules, increased infarct size and a higher death rate (Yang et al., 2000). In 
humans, as the ratio between pro- and anti-inflammatory cytokines increases, so does the 
frequency of cardiac events (Kilic et al., 2006). 
Furthermore, AMI patients express a CD4 subset which lacks the marker for CD28. These 
CD4+CD28null cells are cytolytic, expressing killer immunoglobulin-like receptors (Liuzzo et 
al., 2007; Zal et al., 2004). In AMI, CD4+CD28null cells are very damaging; that they can be 
isolated from unstable plaques and also produce high levels of IFN-γ is a dangerous 
combination. These cells also recognize human HSP-60 (Zal et al., 2004), and are found in 
higher concentrations in patients with recurring acute coronary events (Liuzzo et al., 2007). 
Regulatory T-cells response to MI 
Physiological processes may become pathological if they are not effectively down-regulated, 
and immune responses are no exception (Caliguri and Nicoletti, 2006; Goronzy and Weyand, 
2006; Mallat et al., 2007; Beissert et al., 2006). The previous ten years has seen increased 
scrutiny of the causes of AMI-related lymphocyte response. Both AMI patients and those with 
chronic atherosclerosis exhibit the same target antigenic stimuli, which means that coronary 
disease-related lymphocyte imbalances are not explained by the specific repertoire of target 
antigens alone (Caliguri and Nicoletti, 2006).  
It has been suggested that defective T-lymphocyte compartment regulation may be 
responsible for a tolerance break, causing the pathological autoreactive immune response 
observed in AMI (Caliguri and Nicoletti, 2006; Goronzy and Weyand, 2006; Mallat et al., 
2007). The idea of suppressor T-cells was first introduced in the 1970s, although the lack of 
more detailed characterization drew criticism (Gershon et al., 1972). By the mid-1980s, 
significant enquiry was focused on CD4+CD25+ Treg (Sakaguchi, 2004), which use Foxp3 
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transcription factor and express cytotoxic T-lymphocyte antigen-4 (CTLA-4) and 
glucocorticoid-induced tumour necrosis factor family receptor (GITR).  
It is thought that these natural suppressor cells come from a separate thymic lineage (Goronzy 
and Weyand, 2006). Their suppression of T-cells is antigen non-specific, although cell 
membrane contact must occur for this to happen. IL-2 has been implicated in CD4+25+ T-cell 
levels (Caliguri and Nicoletti, 2006; Goronzy and Weyand, 2006; Mallat et al., 2007; Beissert 
et al., 2006). 
CD4+CD25+ T-cells have been shown to cause tryptophan deficiency by affecting dendritic 
cell metabolism in mice. Consequently, effector T-cells, which are stimulated by tryptophan, 
die off, potentially leading to lymphopenia (Beissert et al., 2006). Tregs function to protect 
against T-cell-derived proinflammatory cytokines being boosted in AMI. There appears to be 
a two-way relationship between dendritic and CD4+CD25+ T-cells. Tregs accumulate after 
being induced and expanded by dendritic cells, which present antigens in tissues (Beissert et 
al., 2006). In the presence of TGF-β and IL-10, CD4+CD25+ cells are also able to suppress 
CD4+ T effector cells on contact (Beissert et al., 2006). 
Other regulatory T-cells, including Tr1 and Th3 have been examined (Caliguri and Nicoletti, 
2006; Goronzy and Weyand, 2006; Beissert et al., 2006). Tr1 produces TGF-β and IL-10 to 
inhibit a range of antigens. Th3 on the other hand, are non-antigen specific, and use primarily 
TGF-β to effect ‘bystander inhibition’. Th3 can be induced by oral administration of antigen 
and could, through this method, inhibit both Th1 and Th2 clone activation (Beissert et al., 
2006). Treg activation is believed to be antigen-specific, but the suppressive effect of 
activated Tregs is non antigen-specific (Goronzy and Weyand, 2006; Beissert et al., 2006). 
Therefore, if deployed in therapy, these cells must be able to accurately target the affected 
organs in order to be used successfully (Beissert et al., 2006). Plaque inflammation and 
development also involves Tregs. CD4+CD25+ cells transfer into genetically modified mice 
prevented atherosclerosis induction and also inhibited plaque infiltration by T-cells and 
macrophages. The same study found that Treg depletion prevented collagen build up, making 
the plaque more vulnerable to infiltration, and also that lesion size increased (Mallat et al., 
2007).  
It has been suggested that AMI-related self-attacking lymphocyte behavior could be the result 
of a fault within the lymphocyte network itself. Despite sharing similar plaque structures and 
antigens, the distinction between stable and acute atherosclerosis might be explained by this 
fault within the regulatory lymphocyte network. Defective T-reg compartments were first 
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identified in AMI patients by Mor et al. (2006). It was found that patients with unstable 
angina exhibited oxidized LDL-specific T-lymphocytes, although this was not seen in chronic 
stable angina patients. The unstable angina patients exhibited fewer and less effective Tregs, 
and this has critical implications for potential therapeutic strategies (Mor et al., 2006). 
This faulty regulation results in deviant behavior and, despite the cause being unknown, it is 
acknowledged that CD4+CD25+ T-cells are vital to the accurate modulation of the immune 
system. This knowledge yields great therapeutic potential as well as a deeper understanding of 
AMI pathophysiology (Caliguri and Nicoletti, 2006; Goronzy and Weyand, 2006). 
Monocytes’ Response to MI 
Debris from damaged myocardial tissue is phagocytosed by neutrophils. Having been 
imported from the capillaries, monocytes then migrate to the extravascular space and become 
macrophages. 48-72 hours following the acute episode, the macrophages outnumber the 
neutrophils. They produce cytokines, which stimulate collagen production, and instigate 
monocytosis and fibroblast proliferation (Gibson and Gibson, 2006). The inflammatory 
marker CRP is produced in the liver, stimulated by macrophage and monocyte-secreted IL-6, 
and has undergone extensive investigation (Bodi et al., 2005; De Servi et al., 2005). 
A study involving 238 primary angioplasty patients following acute ST-segment AMI was 
carried out, which used echocardiography to quantify systolic function, both at day 0 and at 6-
months. White blood cell (WBC) subtypes were also measured. It was found that when 
reperfusion was inhibited, monocytosis was also reduced. Furthermore, these results 
correlated with decreased systolic recovery at 6 months (Mariani et al., 2006). These findings 
heavily implicate the role of monocytes in repair only after the hyperacute phase has passed. 
It is still unknown whether monocytosis and neutrophilia are causal markers of necrosis, or 
they play a more direct role in injury related to reperfusion. It has been suggested that the 
association with more adverse angiographic outcomes is actually a two-way relationship 
(Gibson and Gibson, 2006). Pharmaceutical interventions including anticomplement 
antibodies, corticoids and neutrophil-blockers, which are designed to interrupt the 
inflammatory process, have not been successful in human studies (Gibson and Gibson, 2006; 
Nuñez et al., 2006). The conclusion from this is that elevated WBC is not a causative agent, 
but rather is merely a marker of negative clinical outcomes. Of course, a specific targeted 
ligand may not be involved at all; further investigation is required to identify the causal 
direction of this relationship. 
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1.3 Telomeres and Telomerase 
 
Deoxyribonucleic acid (DNA) is a molecule whose coding determines most of the specific 
characteristics of living organisms. These long-chained molecules comprise proteins and 
ribonucleic acid and are folded into compact structures called chromosomes. In humans, 23 
pairs of chromosomes can be found in the nucleus of every cell, making a total of 46 
chromosomes. Each pair comprises one chromosome inherited from each parent and 
consitutes the means by which hereditary information is passed down each generation. Most 
cells have a limited life span and must replicate through cell division; this is known as the cell 
cycle. Each cell division requires the DNA to replicate in order to pass the same genetic code 
to each subsequent cell. This is critical for cells to share the same characteristics and therefore 
function correctly. 
Linear chromosomes are capped at each end by a molecular structure called a telomere, which 
plays a vital role in chromosomal stability by preventing fusion events as well as 
chromosomal degradation due to exonucleases and oxidative stress. Every time a cell divides, 
replicating its chromosomes, the telomeres become slightly shorter. This continues in cells 
without telomerase until the telomeres emanate a DNA damage signal which halts the cell 
cycle and the cell cannot replicate, resulting eventually in cellular senescence since telomere 
damage can not be efficiently repaired (Petersen et al., 1998). This phenomenon is thought to 
function as a tumour suppressor mechanism for preventing cancer. Telomerase is an enzyme 
which uses its own RNA component to add telomeric repeats to the telomere structures, 
maintaining their length and preventing cellular senescence. Telomerase and its functions will 
be discussed in the forthcoming subchapters. 
1.3.1 Biology of telomeres and telomerase 
 
1.3.1.1 Telomeres 
Telomeric DNA consists of repeating hexameric sequences ([TTAGGG] n) and is located at 
the ends of mammalian chromosomes (Figure 1.3). These specialised DNA structures are 
associated with the shelterin multiprotein complex, the human form of which contains six 
proteins: telomere repeat factors 1 and 2 (TRF1/TRF2), TRF1-interacting nuclear protein 2 
(TIN2), TPP1, protection of telomeres 1 (POT1), and repressor/activator protein 1 (RAP1) (de 
Lange, 2005). In humans, telomere length ranges between 2-15 kilobase pairs (kbp) (Martens 
et al., 1998), whereas telomere length in laboratory mice can reach 40-80kbp (Blasco et al., 
1997). 
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Telomeres and their associated proteins maintain chromosomal integrity in a number of ways. 
Chromosomal ends are protected by telomeres from enzymatic degradation, which prevents 
them from fusing with one another. This prevents chromosomal DNA from being recognised 
as a double-stranded break, which in turn inhibits the DNA damage response (de Lange, 
2002). 
T-loop and D-loop Structures 
Telomeres form both T- and D-loops (Figure 1.4). The duplex part of the telomere is invaded 
by the single-stranded TTAGGG repeat tail. T-loop formation is dependent on DNA 
remodelling by architectural shelterin proteins (de Lange and Petrini, 2000). 
T-loop formation with telomeric DNA substrates can be increased when TRF2 binds to tail-
loop junctions in vitro. However, it is not yet known if TRF2 is responsible for stimulating T-
loop formation. It may simply act as a stabilizing factor, for example, by preventing branch 
migration of T-loops, blocking their resolution. Irrespective of this, it is known that TRF2 
inhibition in vivo may cause the T-loop to open, unfolding the telomere and resulting in the 
DNA being perceived as damaged appe (de Lange, 2005). Since chromosome ends are 
primarily protected by T-loops, the dynamics of such structures requires precise regulation in 
order for telomerase to access the telomere end without unravelling the chromosome ends 
(Griffith et al., 1999). 
In a study on D-loops (displacement loops) of 100-200 base pairs, it has been shown that 
single-stranded DNA can invade homologous double-stranded regions and base pairs on one 
of the two strands. This indicates that a specific structure holds the D-loops in place, as 
opposed to simply random DNA looping. The TTAGGG G-strand telomere overhang in the 
D-loop is paired with internal CCCTAA tracts. This not only protects the DNA end, but is 
also structurally distinct from a broken DNA end (Griffith et al., 1999; Howard et al., 1991). 
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Figure 1.4. Telomere location and structure 
 
Telomeres are located at the end of each chromosome’s arm and shorten with each 
cell division. Protein complexes are linked to telomeres and are called telosome or 
shelterin (TRF1, TRF2, TIN2, POT1, TPP1 and RAP1). Heterodimer POT1/TPP is also 
linked to the G-strand (Modefied from Hoffmann and Spyridopoulos, 2011). 
 
 
 
 
Figure 1.5. Structure of T and D loops 
 
The T-loop as shown in A: is the big loop from double stranded telomere DNA and 
shelterin proteins. The invasion of the 3’ single stranded (ss) overhang is the D-loop. 
The ss overhang also binds POT1. B: A telomere protection complex is formed by the 
sheltering proteins TRF1, TRF2, TPP1, POT1, TIN2 and RAP1. Modified from 
(Greider, 1999; de Lange and Petrini, 2000). 
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Telomere shortening is the product of both oxidative stress and the end replication problem, 
which occurs when the chromosomal ends are not fully replicated by DNA polymerase. This 
is called the “end replication problem” (Olovnikov, 1996). Mammalian DNA is replicated 
with DNA polymerases, which are only able to synthesise DNA in a 5’-3’ direction. A 
template is required for polymerases to begin the DNA synthesis, and the starting primer for 
this is an 8-12 RNA base segment. During this process, synthesis of the leading strand is 
uninterrupted, but the lagging strand is in short RNA-primed DNA segments known as 
Okazaki fragments. After DNA extension, the gaps are filled in by DNA polymerase priming 
from upstream DNA 3’ ends and the RNA segments are removed. Following removal of the 
outer 5’-RNA primer, a 3’ gap opens up, resulting in a daughter strand that is shorter than the 
parent strand (Watson, 1972; Levy et al., 1992). 
Consequently, the terminal sequence – a short section of the telomere– is lost every time 
DNA replication occurs (Watson, 1972; Levy et al., 1992). Beyond a critical telomere length, 
the cell cycle is arrested due to the uncapped telomere ends signalling a DNA damage and 
replicative senescence is induced. The 3’-G-rich strand is recognised by telomerase and 
elongated with the TTAGGG telomeric repeats that are complementary to the RNA template 
on the TERC component (Blackburn, 2005). Oxidative stress significantly affects telomeric 
shortening (≈50-500bp) (von Zglinicki et al., 1995; Lorenz et al., 2001). 
A finite number of cell divisions are therefore possible, known as the Hayflick limit (Allsopp 
et al., 1992; von Zglinicki et al., 1995; Blasco et al., 1997). In most somatic cells, where 
telomerase is not present, each cell division results in decreased telomere length, up to a 
critical limit, at which point, a p53-dependent DNA damage response (DDR) becomes 
activated, leading to cell senescence or apoptosis (Saretzki et al., 1999). DDR is caused by the 
activation of cell cycle checkpoint proteins (Ck1 and Ck2), which are triggered by sensor 
kinases (e.g. ATM/ATR or DNA PK), or phosphorylation of γH2A.X. Ultimately, a p53/p21 
pathway is initiated, resulting in cell-cycle arrest (d'Adda di Fagagna et al., 2003). 
Telomere-independent DNA damage signalling (e.g. a non-telomeric DNA damage response, 
cyclin-dependent kinase inhibitor signalling, or altered mitogenic signalling) may also cause 
cellular senescence (Rodier and Campisi, 2011). 
It has been suggested that telomere length may be a biomarker of human ageing, and in 
particular that telomere length is affected by oxidative stress and cellular senescence (von 
Zglinicki et al., 1995; von Zglinicki et al., 2005; Spyridopoulos and von Zglinicki, 2014). 
Further research into this concept has involved measuring the average leukocyte telomere 
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length (LTL) in relation to ageing and disease (Cawthon et al., 2003; von Zglinicki et al., 
2000). A positive correlation was found between LTL and atherosclerosis and environmental 
factors linked with vascular ageing, such as smoking, high BMI, lack of exercise and insulin 
resistance (Samani et al., 2001). A recent longitudinal study by Huzen et al. (2014) found 
telomere attrition to be accelerated by smoking and metabolic syndrome variables including 
waist-hip ratio, cholesterol and blood glucose levels. Consequently, LTL may also indicate 
chronic immune activation, caused by oxidative stress and inflammation. 
Telomere dysfunction and the induction of cell senescence. 
Cellular senescence is defined as the “ultimate and irreversible loss of replicative capacity 
occurring in primary somatic cells” (Hayflick and Moorhead, 1961). It was found by these 
two authors that in a constant culture condition, after a reasonably specific number of 
population doublings (PDs), senescence was reached. This implies the concept of a 
‘biological clock’ or ‘replication counter’, which uses cell divisions as a measure of biological 
time (Hayflick, 2000). After a certain number of divisions has been reached, then senescence 
is triggered, blocking any further cell division. Cellular senescence has numerous causes, but 
one very likely mechanism is through shortening of telomeres (Harley et al., 1990) or damage 
to telomeres (Hewitt et al., 2012). 
Telomere shortening can be caused firstly by the end-replication problem, which occurs when 
the chromosomal ends are not fully replicated by DNA polymerase (Olovnikov, 1996). When 
the final RNA primer becomes detached from the OKASAKI fragment during telomere 
replication, a G-rich overhang is formed. Moreover, when telomeres are processed, C-rich 
strand degradation results in a single-stranded G-rich 3'-overhang at the end of each telomere 
(Wellinger et al., 1996; Makarov et al., 1997). Secondly, oxidative stress was found to 
accelerate senescence through increased telomere shortening (Von Zglinicki et al., 1995). It is 
thought that confluent cells, in spite of the fact that telomere length is maintained due to 
absence of cell division, may nevertheless exhibit telomere dysfunction due to accumulation 
of DNA damage such as single strand or double strand breaks (Sitte et al., 1998; Petersen et 
al., 1998; Hewitt et al., 2012). Thus, while telomere shortening requires cell division, DNA 
damage can also accumulate in telomeres of non-dividing cells and result in telomere 
dysfunction. 
Reactive Oxygen Species (ROS) can cause significant damage to telomeres, resulting in their 
erosion and consequent signaling for senescence (Passos et al., 2007, 2010; Hewitt et al., 
2012). 
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A DNA Damage Response (DDR) is induced via p53, p21, and ATM/ATR and Chk1/2 
activation, caused by damaged or short telomeres (von Zglinicki et al., 2005). Telomeric 
damage is irreversible, so this process can eventually lead to senescence (permanent cell cycle 
arrest) (Hewitt et al., 2012; Nelson and von Zglinicki, 2013). Early events in DDR include 
signaling (Shilo, 2003) and recruitment of signaling kinases including ATR, ATM and 
potentially DNA-PK, to the damage site. When activated, these kinases cause the 
phosphorylation of Ser-139 at histone H2AX molecules (γH2AX) proximal to the damage 
location. It has been suggested that histone H2AX phosphorylation assists in the focal 
assembly of MDC1/NFBD1, NBS1 and 53BP1, which are checkpoint and DNA repair 
factors. Further to this, histone H2AX phosphorylation plays a role in the activation of 
transducer kinases Chk1 and Chk2 via phosphorylation. These converge the signal onto p53. 
Studies have already demonstrated that growth arrest via ATM/ATR activation is caused by 
telomere dysfunction (Karlseder et al., 1999; Rouse and Jackson, 2002) and eventually 
through activation of p53 and p16 (observed in fibroblasts from humans, but not mice) 
(Smogorzewska and De Lange, 2002). Various groups have shown that senescence-associated 
DNA damage foci (SDFs) may be formed by uncapped telomeres, also called Telomere 
induced foci (TIF’s) (Takai et al., 2003; d'Adda di Fagagna et al., 2003). 
Mechanism of cellular senescence by dysfunctional telomeres 
Through which mechanism is senescence caused by telomere shortening and age and telomere 
dysfunction? Telomere dysfunction can be caused by a) shortening of telomeres (von 
Zglinicki et al., 1995), b) uncapping of telomeres, for example by inhibition of TRF2 
(Karlseder et al., 1999) and c) by DNA damage that occurs anywhere in the telomere (Hewitt 
et al., 2012). Von Zglinicki et al. (2005) describe that both telomere shortening and 
dysfunction induce senescence via the induction of a DNA damage response pathway. 
Telomere damage causes the DNA ends to become exposed, which may result in triggering of 
the DNA damage response. Telomeres have a 3’ overhang, which forms a circular structure (a 
t-loop) by invading the double-stranded telomeric DNA. Binding proteins, including TRF1, 
TRF2 and Pot1 stabilize the t-loops (Smogorzewska and de Lange, 2004). However, TRF2 
can become mutated and overexpression of mutated TRF2 results in t-loops becoming 
uncapped and eventually causing senescence or apoptosis (Karlseder et al., 1999). Mutant 
TRF2 overexpression has the interesting side effect of inducing γH2AX foci (Takai et al., 
2003), which are known to indicate DNA double strand breaks (DSBs). Increased γH2AX 
foci at telomeres (TIF’s or TAF’s) are also seen in cells entering replicative senescence and in 
aged mice (Sedelnikova et al., 2004; Herbig et al., 2004; Hewitt et al., 2012). In addition, a 
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number of DNA damage factors, including MDC1, phospho-ATM, NBS1, Rad17 and 53BP1 
are known to gather around mutant TRF2-induced foci (d'Adda di Fagagna et al., 2003). 
Consequently, it has been proposed that DNA damage responses are triggered by not only 
general DNA damage, but also by telomere shortening. 
Two main pathways were identified, involving either p53 or Rb, in relation to the induction of 
cellular senescence. Inhibition of p53 and Rb by viral proteins causes human diploid 
fibroblasts to become immortal (Werness et al., 1990; Ide et al., 1983; Dyson et al., 1989). Rb 
is maintained in a hypophosphorylated form by p16INK4a, which inhibits CDK4/6. E2F 
activity is blocked by hypophosphorylated Rb, thereby inducing senescence. Senescent cells 
exhibit amplified P16INK4a levels, which in turn induces cellular cycle arrest (Hara et al., 
1996; Alcorta et al., 1996). However, the DNA damage response pathway seems to play no 
role in regulating P16INK4a levels. Rather, P16INK4a can be upregulated by oncogenic 
signals, including overexpression of activated Ras. Conversely, the DNA damage response 
pathway includes p53 as one of its key downstream targets, therefore, when this pathway is 
triggered, p53 is stabilized and activated. P53 is activated by ATM through a number of 
routes (Kastan and Bartek, 2004) including: downstream activation of the kinases Chk1 and 
Chk2, causing p53 phosphorylation at Ser20, which stabilizes p53 by disrupting interaction 
between MDM2 and p53. MDM2 can also be phosphorylated directly by ATM, causing it to 
be downregulated. Lastly, p53 can be phosphorylated at Ser15 by ATM, triggering p53 
transcriptional activity. There are numerous studies that have found evidence supporting a 
connection between p53 activity and cell cycle arrest. For example, heterozygous p53 
truncation mutations are known to cause activation of abnormal p53, leading to premature 
senescence (Maier et al., 2004; Tyner et al., 2002). Similarly, there are several of ways to 
deactivate p53, including homozygous deletion of p53, dominant-negative p53 mutants, 
antisense oligonucleotide, anti-p53 antibodies and p53 peptide inhibitors, all of which cause 
DNA synthesis to reinitiate, preventing cellular senescence and thereby extending the cell’s 
life span (Herbig and Sedivy, 2006). The evidence above underlines the key role played by 
p53 in cellular senescence induction. 
P53 activation causes p53 target genes to be transcribed and upregulated. Within these, one 
major causal factor of p53-induced senescence is p21. p21 inhibits CDK’s (cyclin dependent 
kinases), as does p16INK4a, leading to cell cycle arrest and consequently senescence. As the 
cells progress further into senescence, p21 increases (Alcorta et al., 1996) and it has been 
found that deleting the p21 gene in a targeted manner causes human fibroblasts to avoid 
senescence (Brown et al., 1997). The evidence collectively points to a role for the ATM-
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Chk1/2- p53-p21 pathway in responding to DNA damage and telomere shortening by 
inducing senescence (Fig. 1.Q1). 
If cellular senescence is genuinely caused by the DNA damage response pathway, then it 
should be reversed by inactivating that pathway, in theory causing the return of that cell to its 
normal replicative cycle. It has been observed that ATM/ATR and/or Chk1/Chk2 inhibition 
caused a significant amount of cells to return to the DNA synthesis phase, however without 
any real cell division occurring confirming the irreversibility of senescence (Herbig et al., 
2004; d'Adda di Fagagna et al., 2003). Further to this, ATM and ATR inhibition by the 
protein kinase inhibitor 2-aminopurine (2-AP) was found to re-enable DNA replication in 
40% of all cells (Herbig et al., 2004). A causal relationship is therefore confirmed linking the 
DNA damage response pathway and cell cycle arrest and that signal transduction pathways 
play an active role in maintaining cellular senescence (Passos et al., 2010). 
Figure 1.6. Illustration of how the DNA damage response pathway leads to cellular 
senescence (Modified from Lou and Chen, 2006). 
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1.3.1.2 Telomerase 
Telomerase is a reverse transcriptase which in its canonical function extends telomere ends 
(Greider and Blackburn, 1989). It consists of the reverse transcriptase (TERT) catalytic 
subunit and the RNA part (TERC) containing the template, and is associated with various 
additional proteins (e.g. heat-shock protein hsp90 and dyskerin) (Lingner et al., 1997;  
Nakamura et al., 1997). TERT and TERC are both necessary and sufficient for the catalytic 
activity of telomere maintenance and elongation to take place (Lingner et al., 1997). 
Both humans and mice share a similar TERT/TERC structure. The human TERT gene is 
located on chromosome 5, whereas in mice, it is found on chromosome 13 (Greenberg et al., 
1998). TERT mRNA in mammals comprises 16 exons and 15 introns across 35kb (Cong et 
al., 1999), and both mouse and human TERT genes have comparable promoter regions in 
which its regulation differs (Pericuesta et al., 2006). In mammals, TERC comprises 451 
nucleotides, while its template part complements the telomeric sequence, which comprises 11 
nucleotides (5’-CUAACCCUAAC-3’) (Feng et al., 1995; Egan and Collins, 2012). Mouse 
and human telomerase are also functionally similar. TERC knockout (KO) mouse cells (i.e. 
those which are telomerase-activity-deficient) have been transfected with human telomerase 
genes, resulting in fully restored telomerase. This leads to the conclusion that human and 
mouse telomerase is both functionally interchangeable and structurally conserved (Martín-
Rivera et al., 1998). 
1.3.1.3 Telomerase expression 
Telomerase is expressed in a tissue-specific manner, and across their lifespan, telomerase 
activity is persistent in various mouse tissues, including lymphocytes, liver, muscles, testes 
and intestines (Breault et al., 2008). Telomerase is active in most human embryonic tissues 
until about week 20 of gestation, at which point its levels gradually decrease. Activity is still 
detectable in certain adult human cells, including lymphocytes, endothelial cells, stem cells 
and germ cells (Ulaner et al., 1998). In contrast, telomerase is active in most adult mouse 
somatic tissues (Martín-Rivera et al., 1998). Another important difference between telomerase 
activity in mouse and human cells is its different processivity which is much lower in mouse 
tissues (Chen and Greider, 2003). 
1.3.1.4 Telomerase functions 
Canonical as well as non-canonical functions have been described for telomerase (Figure 1.5). 
When functioning canonically, telomerase protects against chromosomal end fusion, 
	 36	
chromosomal instability and telomere erosion. Immortal cell proliferation requires an 
indefinite potential, such as that found in stem, germ, embryonic and cancer cells, and 
necessitates telomerase activity (Greenberg et al., 1998; Martín-Rivera et al., 1998). 
Non-canonical (non-telomeric) telomerase functions have also been demonstrated. For 
example, TERT is increasingly implicated in a number of telomere-independent effects, cell 
survival and proliferation, mitochondrial function, regulation of gene expression, stem cell 
biology, chromatin remodelling and cellular transformation as well as a protective function 
against apoptosis and oxidative stress (Cong and Shay, 2008; Saretzki, 2014; Ahmed et al., 
2008; Haendeler et al., 2009; Singhapol et al., 2013). 
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Figure 1.7. Telomerase functions as a reverse transcriptase 
Telomeres are elongated by telomerase in the following way: 1. The telomere is short 
and un-replicated. 2. Telomerase extends the un-replicated end by annealing its RNA 
template to the DNA overhang. 3. The RNA template directs sequential nucleotide 
additions and anneals to the added sequence. 4. New DNA polymerase attaches the 
complementary strand (Modified from Sadava, 2007). 
 
Regulation of telomerase 
Telomerase is a highly regulated enzyme that synthesises telomeric repeats and maintains 
telomeres during late S-phase (Blackburn, 2005). Its activity is observed in human in highly 
proliferative cells, such as germ line, self-renewing stem cells and embryonic tissues, as well 
as lymphocytes and endothelial cells. 
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Telomerase regulation is achieved at various levels, including regulation by binding to and 
accessing telomeres, regulation of hTERT transcription, regulation of hTR, TERT splicing, 
post translational modification (phosphorylation), telomerase regulation by subcellular 
localization and cytokine regulation of telomerase activity in T-cells. 
Telomerase regulation by binding to and accessing telomeres 
Telomere tracts are not always maintained in all cells, despite the presence of active 
telomerase. One reason can be inaccessibility of telomeres by telomerase which affects level 
of regulation (Counter et al., 1998). 
Telomerase accessibility is regulated by telomere-associated proteins (Evans and Lundblad, 
2000); the first of these to be identified were TRF1 and TRF2 (TTAGGG repeat binding 
factors 1 and 2). These play a role in t-loop formation after having bound specifically to 
duplex telomeric DNA (Griffith et al., 1999). In this capacity, TRF1&2 negatively regulate 
telomere length (Smogorzewska et al., 2000; van Steensel and de Lange, 1997). In 
telomerase-positive cells, telomere elongation is subdued by TRF1&2 overexpression 
(Smogorzewska et al., 2000). It has also been suggested that the DNA damage repair 
complex, Rad50/MRE11/NBS1, interacts with TRF1&2 (Karlseder et al., 1999), implying 
that telomere integrity and DNA repair pathways interact at a molecular level. In vitro studies 
have shown that parallel pairing of telomeric DNA is promoted by TRF1 (Griffith et al., 
1998). Furthermore, DNA polymerase-induced C-strand DNA synthesis is inhibited by TRF1 
binding to duplex telomeric DNA (Smucker and Turchi, 2001), an observation supported by 
the role of TRF1 in telomere elongation inhibition (Ancelin et al., 2002). Endogenous TRF1 
is removed by a dominant negative TRF1, causing telomeres to extend in telomerase-positive 
cells only (Karlseder et al., 2002). Telomerase is thought to be prevented from reaching the 
telomeres, because it is blocked by TRF1, which binds along the double-stranded telomeric 
DNA repeats. By this reasoning, more TRF1 is able to attach to longer telomeres, resulting in 
a negative feedback loop. This not only regulates telomere length, but also provides a 
potential explanation for why the shortest telomeres are preferentially elongated (Steinert et 
al., 2000). Two TRF1-associate partners have been identified: TIN2 (Kim et al., 1999) and 
tankyrase (Smith et al., 1998; Cook et al., 2002), which also both play roles in the negative 
feedback loop. PinX1, a TRF/Pin2-interacting protein that inhibits telomerase, has also been 
shown to directly interact with hTERT (Zhou and Lu, 2001). 
The binding between some shelterin proteins and telomeres prevents telomerase from 
interacting with the end of chromosomes. This may lead to telomerase regulation (Venteicher 
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and Artandi, 2009) by the association between protection of telomeres 1 (POT1) and TTP1 
(POT1 and TIN2 organizing protein 1) at the 3’ end of telomeres. This prevents telomerase 
from binding to the end of the chromosome (de Lange, 2005). One study suggested that the 
physical links between the shelterin complex and telomerase is secondary to the affinity of 
POT1 to telomeric sDNA and TPP1 with telomerase, which also prevents telomerase from 
binding with the chromosome end. This may be one type of telomerase regulation (Xin et al., 
2007; Chu et al., 2015).  
TPP1 plays a role in the recruitment of telomerase to telomeres (Abreu et al., 2010). Super-
telomerase HeLa cells (hTERT and hTR are overexpressed) have been used to investigate this 
phenomenon, using quantitative chromatin immunoprecipitation (ChIP) alongside 
immunofluorescence and fluorescence in situ hybridization (FISH). These methods are able to 
track hTR and hTERT relationships with telomeres. Reduced telomerase presence at 
telomeres has been found to be associated with the depletion of TPP1 and TIN2 on telomeres 
via the action of short hairpin RNA (shRNA). TPP1 binds to telomeres via TIN2 to regulate 
the presence of telomerase at the telomeres (Abreu et al., 2010). 
TPP1-POT1 was found to be a stimulator for telomerase activity (Wang et al., 2007; Wang 
and Lei, 2011; Schmidt et al., 2014). A tripartite model which explains telomere length 
regulation has been proposed (Wang et al., 2007). This also appears to reconcile the 
apparently contradictory roles of TPP1 and POT1. 
1) The 3'-terminus of the G-overhang is covered by POT1-TPP1, the telomere becomes 
occupied, preventing telomerase binding. 
2) An as-yet unknown mechanism breaks the bond between POT1-TPP1 and the above 
site. This mechanism could involve disruption of the shelterin complex or post-
translational modification. 
3) During telomere extension, the POT1-TPP1 complex functions as a telomerase 
processivity factor. 
The telomere then extends to a certain threshold, generating new repeats, to which shelterin 
complexes bind. Human telomeres could be maintained by one or more rounds of telomere 
extension per cell cycle. When POT1-TPP1 is present, telomerase processivity was in the 
region of four repeats, or 24 nucleotides. The new 3'-terminus then becomes rebound to 
POT1-TTP1, preventing further telomere extension (Wang et al., 2007; Nandakumar and 
Cech, 2013). 
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Regulation of hTERT transcription:  
c-Myc is an oncogene which promotes growth, proliferation and apoptosis. c-Myc and Max 
(basic-helix-loop-helix-zipper (bHLHZ) protein) both form a heterodimer which binds with 
the E-box sequence 5'-TTAGGG-3' in the regulatory region of a target gene. Studies 
involving sequence analysis of the hTERT promoter have shown that the core region -34 and 
-242 nucleotides contain E-boxes, both upstream of the ATG (Cong et al., 2002). 
The Sp1 transcription factor can potentially bind to one of five GC-boxes situated between 
two E-boxes on the hTERT core promoter (Kyo et al., 1997). Components within the general 
transcription mechanism, including TBP-associated factors and the TATA-box binding 
protein, interact with Sp1. Together, these associations assist in initiating the transcription of 
promoters lacking in TATA boxes (Emili et al., 1994; Hoey et al., 1993; Pugh and Tjian, 
1991). The promoter for hTERT lacks TATA box (Cong et al., 1999; Kyo et al., 2000). It has 
been found within the core promoter that Sp1 sites are vital to hTERT promoter activity. Site 
mutations were seen to completely inhibit promoter activity in luciferase reporter assays 
(Cong and Bacchetti, 2000; Kyo et al., 1997).  
Human papillomavirus (HPV) I6 E6 protein can induce telomerase activity in both mammary 
epithelial cells and primary human keratinocytes (Klingelhutz et al., 1996), mediated by 
hTERT transcription upregulation, itself the result of E6 and irrespective of p53 degradation 
and c-Myc induction (Gewin and Galloway, 2001; Oh et al., 2000; Veldman et al., 2001). 
Telomerase activity in the human endometrium has a positive correlation with endometrial 
cell proliferation and is detected during the menstrual cycle (Kyo et al., 1997; Tanaka et al., 
1998). This indicates a role for steroid sex hormones in telomerase activity regulation. Two 
possible oestrogen responses have been identified through hTERT promoter sequence 
analyses. The first contains a Sp1 site -950 bp upstream of the ATG. This is located in close 
proximity to an oestrogen response half-site that functions as an oestrogen response element. 
The second oestrogen response element is found at -2754 bp upstream of the ATG (Cong et 
al., 1999; Kyo et al., 1999). It has recently been shown that telomerase activation via 
oestrogen happens through direct transcriptional regulation of hTERT expression within 
tissues responsive to hormones (Kyo et al., 1999; Misiti et al., 2000). 
Within 3h of 17β-oestradiol treatment, human ovarian epithelial cells with oestrogen 
receptors exhibit telomerase activity running concurrently with hTERT induction and 
expression of mRNA and protein. In these cells, oestrogen activated hTERT transcription is 
	 41	
contingent on oestrogen receptor α, but not oestrogen receptor β. DNA footprinting has 
indicated that the -950 response element is modified in the oestrogen receptor. 17β-estradiol 
treatment indicates that this occurs in oestrogen receptor + cells, but not in oestrogen receptor 
– cells. Furthermore, the -950 response element has been shown via luciferase assays to cause 
hTERT transcription induction to be observed. Even when placed into the heterologous 
thymidine kinase promoter, the oestrogen response element maintains functionality (Misiti et 
al., 2000). 
In addition to a transcriptional activation, there are also negative regulators of hTERT 
transcription, for example Mad1. 
Normal cell growth and development depend on components of the c-Myc/Max/Mad 
transcription factors, which control various processes including differentiation, transformation 
and apoptosis (Grandori et al., 2000). These elements dimerize and, after binding to it, either 
activate or suppress E-box-containing promoter activity. Max is ubiquitous and dimerizes 
with both c-Myc and Mad. Gene expression is activated by E-box-bound c-Myc/Max 
heterodimers, whilst Mad/Max heterodimers act in competition for E-box-binding to repress 
transcription. Chromatin immunoprecipitation has shown hTERT promoter activity to have an 
antagonistic effect on HL60 cell differentiation (Xu et al., 2001). The hTERT promoter E-
boxes of HL60 cells which proliferate exponentially and express both telomerase and hTERT 
become occupied by c-Myc/Max heterodimers. Telomerase activity is downregulated and 
hTERT transcription repressed as a consequence of changing from c-Myc/Max to Mad1/Max. 
In other words, c-Myc and Mad1 have opposite effects on hTERT transcription – but 
telomerase positive cells, including immortal and tumour cells, often exhibit increased c-Myc 
expression, whilst Mad1 expression remains relatively low. Most human somatic cells, as 
well as hTERT gene-repressed differentiated cells exhibit reversed c-Myc and Mad1 
expression. 
Wilms’ tumour 1 (WT1) tumour suppressor 
hTERT transcription suppression can also be caused by WT1 tumour suppressor (Oh et al., 
1999). This works by interacting directly with the hTERT promoter, whose binding site can 
be found at -352 upstream of the ATG, in the core region. Mutation of this site causes 293 
cells to exhibit increased hTERT promoter activity, but not HeLa cells. Expression of mRNA 
for hTERT, as well as 293 cell telomerase activity, are reduced in proportion to WT1 
overexpression (Oh et al., 1999). WT1’s role in the inhibition of hTERT is cell specific, since 
the WT1 gene is only expressed by kidney, gonad and spleen cells. It therefore significantly 
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affects kidney and gonad cell growth and differentiation (Englert, 1998). While differentiation 
is in progress, hTERT gene expression may be suppressed by WT1. Furthermore, WT1 
inactivation may play a part in telomerase activation whilst tumours are forming in its target 
tissues. 
Regulation of hTR 
Telomerase is regulated in part by hTR levels, Sp1 and HIF-1 activate hTR transcription, 
while specificity protein 3 (Sp3) represses it by silencing the hTR promoter using MAPK 
signalling cues (reviewed in Cairney and Keith, 2008).  
Mitogen-activated protein kinase (MAPK) signalling cascades are critical in the triggering of 
stress signals and extracellular growth. These processes play a role in modulating gene 
promoter transcription via mechanisms such as direct Sp1 phosphorylation. Binding sites for 
transcription factors such as AP-1, c-myc and Ets are effective in the core promoter and are 
involved in hTERT transcription regulation. A link has been suggested between Sp1-related 
regulation of hTR promoter activity, as shown by reporter assays, and the involvement of 
MAPK pathways in hTR transcription regulation (Cong et al., 2002; Janknecht, 2004; Kyo 
and Inoue, 2002). 
Bilsland et al. (2006) recently reported that the mitogen-activated protein kinase kinase kinase 
1 (MEKK1)/c-jun-NH2-kinase (JNK) pathway plays a role in both Sp3 expression through 
binding and also hTR promoter activity repression. hTR promoter activity is induced by 
SP600125, the JNK inhibitor and this is dose-dependent. Having been shown in transient 
transfection assays as well as inducing endogenous levels of hTR at a concentration of 12.5 
mmol/L, this implies that hTR may be repressed by JNK. These findings were verified by co-
transfection of the constitutively active kinase domain MEKK1. Within the JNK pathway, 
MEKK1 is a significant MAP3K and this has been shown, in a panel of cancer cell lines, to 
strongly repress hTR promoter activity. It was also found that the repressive effect of MEKK1 
could be suppressed by 12.5mmol/L SP600125 or JNK overexpression. However, the 
phosphoacceptor site mutant JNK2APK had no effect (Bilsland et al., 2006). 
These findings inspired deeper investigation into the core promoter for JNK repression, 
particularly the role of the Sp1 binding sites. When these sites were mutated within the hTR 
core promoter, SP600125-induced promoter activity was slightly attenuated. This signposts 
the involvement of factors other than Sp1 binding in hTR induction via JNK inhibition. Sp3 is 
also bound at these sites and, as mentioned earlier, this can repress hTR promoter activity. 
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This effect can be achieved solely via Sp3 binding. However, it was found that when co-
transfected with MEKK1, the effect is increased; ovarian carcinoma cell line A2780 exhibited 
basal activity levels reduced to 9%. It can be inferred from this that hTR promoter activity is 
repressed through collaboration between Sp3 and MEKK1 (Bilsland et al., 2006). 
Regulation of TERT by alternative splicing  
Complex genomes have vastly increased coding capacity due to the fact that 95% of genes in 
multicellular eukaryotes are affected by alternative splicing. Indeed, the phenomenon enables 
around 20,000 protein coding sequences to generate more than 100,000 proteins (Nilsen and 
Graveley, 2010). It has long been known that atypical alternative splicing is partially 
responsible for the regulation of hTERT expression, which may be a consequence of 
hTERT’s low expression level (Ulaner and Giudice, 1997; Ulaner et al., 1998). 
RNA splicing involves the removal of non-coding intron sequences, which allows exon 
sequences to join together. This is a co-transcriptional event, involving recruitment and 
assembly of a ‘spliceosome’ around the site of the splice, while pre-mRNA is transcribed by 
polymerase II (Schmidt et al., 2011; Goldstrohm et al., 2001). The spliceosome, a complex 
‘molecular machine’ is a ribonucleoprotein made up of five small nuclear RNA (snRNA) 
particles (U1, U2, U4, U5, U6) in addition to around 300 other proteins (Jurica and Moore, 
2003). These components are assembled in a specific sequence at every 30 and 50 splice site, 
polypyrimidine tract and branch point. From here, introns are formed into a lariat arrangement 
and removed, enabling exons to ligate (Beyer and Osheim, 1988; Tennyson et al., 1995). 
Alternative splice variants are caused by the inclusion or exclusion of exons, which might 
always be present in a gene’s mRNA (constitutive), or may only sometimes be present 
(alternative). Proximity of a splice site to cis-regulatory sequences (exonic splicing enhancers 
(ESEs) or silencers (ESSs), or intronic splicing enhancers (ISEs) or silencers (ISSs)) 
determines whether usage of that site is enhanced or suppressed (Roca et al 2013). In turn, 
these cis-regulatory sequences are bound by transacting factors or one of over 500 splicing 
factors which are able to play a role in alternative splicing. 
Several unique elements are involved in the regulation of hTERT splicing. The hTERT gene 
is 42kb and is located in humans on chromosome 5p15.33. Numerous isoforms can be spliced 
from its 16 exons (Kilian et al., 1997), of which 22 have been identified so far (Hrdlickova et 
al., 2012). None of these isoforms however – with the exception of the full-length transcript, 
containing all 16 exons – are able to elongate telomeres, nor do they exhibit any reverse 
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transcriptase activity (Saeboe-Larssen et al., 2006; Yi et al., 2000). The reverse transcriptase 
domain of hTERT contains the following alternatively spliced isoforms: minus-alpha, minus-
beta or minus alpha-beta. Exon 6 contains a splice acceptor site, resulting in a 36bp deletion, 
which allows minus-alpha to form an in-frame transcript. This becomes translated into a 
dominant-negative protein that does not exhibit reverse transcriptase activity (Saeboe-Larssen 
et al., 2006; Colgin et al., 2000). 
Post-translational modification of TERT 
The correlation between TERT mRNA levels and telomerase activity is not consistent, which 
suggests post-translational TERT regulation (Ulaner et al., 2000; Rohde et al., 2000; Oguchi 
et al., 2004). 
Mammalian and plant TERT sequences exhibit sites for phosphorylation (Kang et al., 1999; 
Oguchi et al., 2004), which implicates at least two kinases in the phosphorylation of hTERT. 
C-Abl phosphorylates hTERT in the presence of ionizing radiation, resulting in telomerase 
being reduced to a third of its normal activity. An increase in telomerase activity has been 
observed in c-Abl deficient mice (Kharbanda et al., 2000). This result suggests that 
telomerase activity is negatively regulated by c-Abl. Conversely, hTERT phosphorylation by 
Akt increases telomerase activity. It is assumed that this is due to hTERT being translocated 
into the nucleus from the cytoplasm in lymphocytes (Kang et al., 1999; Minamino and 
Kourembanas, 2001). 
Nuclear translocation and phosphorylation of hTERT involves its phosphorylation by Akt 
kinase, and it has been suggested that this also enhances telomerase activity (Kimura et al., 
2004; Kawagoe et al., 2003). Serine residues 227 and 824 on the hTERT protein provide 
apparent sites for the phosphorylation of TERT by Akt (Kang et al., 1999). 
Arecent study has suggested that phosphorylation at serine 227 may cause nuclear localization 
of hTERT due to its location between two amino acid clusters in the bipartite nuclear 
localization signal (NLS) sequence. The study mutated serine residues at 227 and 824 to 
alanine (S227A, S824A, S227, 824A) – site-directed mutagenesis of hTERT. Following this, 
the 227 serine residue was replaced by glutamate (S227E), to create a mutant which would 
mimic phosphorylation. Mutant constructs, such as FLAG-hTERT were used to transfect 
H1299 cells, which were then analysed by immunofluorescence staining. The findings 
suggested that hTERT nuclear translocation is influenced by serine 227 (Chung et al., 2012). 
Findings by Plunkett et al. (2007) support the observation that hTERT expression is not the 
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only regulator of telomerase activity in human T-cells. The authors also detected hTERT in 
every CD8+ T-cell subset following T-lymphocyte activation and that furthermore, the 
addition of IL-2 only caused a slight increase. The study suggests that as hTERT is a substrate 
for Akt, and hTERT should be phosphorylated to enable telomerase activity (Kang et al., 
1999; Liu et al., 2001), then CD8+ T-cells might also have decreased hTERT phosphorylation. 
Consequently, it was found that a lack of Akt did not cause telomerase down-regulation in the 
CD8+CD28-CD27- T-cell subset. None of the CD8+ T-cell subsets exhibited any changes in 
total Akt. In order for activation of telomerase to occur, Akt must be phosphorylated at both 
the Ser473 and Thr308 sites. In the CD8+CD28-CD27- T-cell subset, a selective lack of Akt 
phosphorylation was found at the Ser473 site. Adding IL-2 did not reverse this (Plunkett et 
al., 2007). Data from this research indicates that when Akt fails to phosphorylate hTERT on 
the Ser227, there is a correlation with CD8+ T lymphocyte senescence.	
Telomerase regulation by subcellular localization 
It has been suggested that changes in subcellular localisation prevents the formation of new 
telomeres (Wong et al., 2002). TRF1, a component of human shelterin, interacts with PinX1, 
which has been implicated in telomerase regulation via sequestration (Lin et al., 2007). PinX1 
binds directly to both hTERT and hTR in the nucleolus (Banik and Counter, 2004), which has 
been shown in vitro to reduce telomerase activity (Zhou and Lu, 2001). Est2 (TERT) and 
PinX1 have been shown to interact within yeast cells, also leading to nucleolus sequestration 
(Lin and Blackburn, 2004). 
Nuclear exclusion mechanism 
The molecular mechanism for hTERT nuclear exclusion follows both exogenous and 
endogenous oxidative stress (Haendeler et al., 2003a). A study by Haendeler et al. (2003b) 
found that Src kinase phosphorylation of the TERT protein on tyrosine 707 was required for 
nuclear exclusion to occur. In this instance, TERT and Ran GTPase associate together, then 
leave the nucleus in a leptomycin-sensitive manner via the nuclear pores. An antioxidant (e.g. 
N-acetylcysteine) is required to prevent this shuttling (Haendeler et al., 2003b; Haendeler et 
al., 2004). Nuclear TERT exclusion is therefore triggered primarily by oxidative stress. Both 
nuclear and mitochondrial telomerase locations have been modelled using organelle-specific 
localization vectors developed initially in Haendler’s research team (Haendeler et al., 2009; 
Haendeler et al., 2003b). It was recently established that two G-quadruplex ligands used to 
treat cancer cell lines induced hTERT shuttling into mitochondria and decreased TERT 
protein as well as telomerase activity (Zhuang and Yao, 2013). 
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TERT shuttling between nucleus and cytoplasm 
It has been shown that a putative hTERT nuclear export signal (NES) is required to bind the 
14-3-3 protein in order for nuclear localisation and hTERT accumulation to occur (Seimiya et 
al., 2000). Conversely, hTERT would localise in the cytoplasm if both proteins and NES 
mutations were interrupted, although telomerase activity continued uninterrupted even if 14-
3-3 binding did not occur. Furthermore, hTERT-mediated apoptosis suppression may involve 
the 14-3-3 proteins (Zhang et al., 2003). 
TERT shuttling in lymphocytes 
In peripheral blood lymphocytes (PBL), telomerase is regulated through the PI3K/Akt/NF-κB 
signalling pathways (Akiyama et al., 2003). This was demonstrated by Akiyama et al. (2004), 
who showed that PBL cytoplasmic telomerase activity could be induced by TNFα, then 
hTERT was translocated to the nucleus in the following hour. A specific inhibitor of NF-κB 
translocation, SN-50, prevented TNFα-induced telomerase activity from translocating to the 
nucleus, but allowed it to continue in the cytoplasm. Instead, PBL cytoplasmic TNFα-induced 
telomerase activity was blocked by Wortmannin, a specific P13K suppressor, which also 
blocked TNFα-induced hTERT nuclear translocation (Akiyama et al., 2004). 
Unstimulated T-lymphocytes contain cytoplasmic telomerase, which proceeds to the nucleus 
once the cells are activated (Liu et al., 2001). Nuclear translocation of hTERT is made 
possible by AKT-mediated phosphorylation of the nuclear localisation signal (NLS) at serine 
227 of hTERT (amino acid residues 222-240) (Chung et al., 2012). Plunkett et al. (2007) have 
found that when Akt phosphorylation on serine 473, fails to happen telomerase is not 
activated and CD8+ T-cells proceeded to senescence. Telomerase activity is necessary for T-
cells to proliferate following activation. However, once the ability to upregulate telomerase is 
lost leading to telomere shortening they enter senescence (Effros et al., 2003).  
Mitochondrial localisation of hTERT 
Human, mouse and rat TERT has been found to contain a specific N-terminal mitochondrial 
localisation sequence (MLS) (Santos et al., 2004). It is suggested that this sequence developed 
late in the enzyme’s evolution, as it is not fully formed in plants and is lacking in yeast, 
ciliates and other simple organisms. TERT is directed towards the mitochondria by the 
mitochondrial localisation signal (MLS) and transported out of the nucleus via the nuclear 
exclusion signal (Seimiya et al., 2000). Following exposure to hydrogen peroxide and 
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etoposide, hTERT overexpressing human cells exhibited more mtDNA damage and higher 
apoptosis induction (Santos et al., 2004; Santos et al., 2006). However, other research has 
shown that when hTERT binds to mtDNA in vitro, or resides within mitochondria, then less 
mtDNA damage, ROS and apoptosis is observed (Ahmed et al., 2008, Haendeler et al., 2009). 
Furthermore, numerous other groups – including Santos’ – have established the benefits of 
mitochondrial TERT in various roles, including improved respiration, decreased 
mitochondrial superoxide, increased mitochondrial membrane potential and reduced apoptosis 
in both stressed and non-stressed conditions (Ahmed et al., 2008; Haendeler et al., 2009; 
Kovalenko et al., 2010). For hTERT shuttling between the nucleus and mitochondria, Src 
kinase phosphorylates tyrosine 707 in both the nucleus and in mitochondria, resulting in 
exclusion of hTERT from the nucleus and degradation of hTERT in mitochondria (Haendeler 
et al., 2003b; Buchner et al., 2010). 
Cytokines regulate telomerase activity in T-cells. 
Telomeres and telomerase regulation in T-lymphocytes have been examined from two 
perspectives. One study measured telomere length in different T-cell subpopulations and 
found longer telomeres in naïve T-cells compared with memory T-cells (Weng et al., 1995; 
Akbar and Vukmanovic-Stejic, 2007). Other studies establishe a correlation between 
replicative senescence and telomere length in a selective single subpopulations (Fletcher et 
al., 2005; Vukmanovic-Stejic et al., 2006).  
During absence of TCR signalling T-cell proliferation can be stimulated by specific 
cytokines. This process is called homeostatic proliferation (Surh and Sprent, 2005). 
Homeostatic cytokines induce proliferation of CD4 and CD8 lymphocytes (T-cells) without 
the need of antigen stimulation, i.e. infection. (Surh and Sprent, 2005; Wallace et al., 2006; 
Dunne et al., 2005; Weng et al., 2002). In this context, IL-7 is a homeostatic cytokine for CD4 
T-cells, while IL-15 regulates CD8 T-cell proliferation. T-cell proliferation was activated in 
vitro by IL-7 and IL-15 (Wallace et al., 2006) and was found to be associated with telomerase 
activity induction and the prevention of telomere erosion in T lymphocytes. On the other 
hand, telomerase activity was inhibited by cytokines such as IFN-α, which increased CD4+ T-
cell telomere loss in vivo (Reed et al., 2004). In vitro, CD4+ T-cell telomerase activity was 
inhibited by IFN-α secreted by cytomegalovirus (CMV) Ag-stimulated plasmacytoid dendritic 
cells (Fletcher et al., 2005). This means that cytokines may regulate T-cell telomerase 
activity. 
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IL-2 can stimulate hTERT localisation into the nucleus and telomerase activity activation. 
Furthermore, telomerase activity is regulated through the PI3K/Akt/Hsp90/mTOR/p70S6 
kinase (S6K) pathway at the posttranslational level of hTERT in the human NK cell line (NK-
92) when stimulated with IL-2 (Kawauchi et al., 2005). 
1.3.2 Role of telomerase and telomere length in cardiovascular disease 
 
A study of 25 coronary heart disease (CHD) patients aged 64±3.4 years compared PBMNC 
telomere lengths in two control groups; 13 elderly (65±2.1 year-old) and 14 young (26.7±1.8 
year-old) participants. The study found that patients with CHD had shorter telomere lengths in 
lymphoid and myeloid cells compared to control groups of the same age or younger 
(Spyridopoulos et al., 2009). Furthermore, coronary artery disease (CAD) patients were found 
to have shortened telomeres in bone marrow cells (BMCs), which was both age and CAD-
dependent and was also linked with BMC functionality (Spyridopoulos et al., 2008). 
Common carotid and internal carotid intima-media thickness were measured using ultrasound 
in the Cardiovascular Health Study (n = 419) (Fitzpatrick et al., 2007). In spite of the fact that 
leukocyte telomere length decreased as carotid stenosis increased, this was not significant (p 
= 0.07). Another study compared the incidence of carotid plaques against leukocyte telomere 
length among hypertensive patients (n = 163). 73 (44%) patients were found to have plaques 
(detected by ultrasound) as well as significantly shorter leukocyte telomere lengths (8.21kb 
vs. control 8.43kb, p=0.03). Mean lipid levels (high- and low-density lipids and total 
cholesterol) remained the same between groups, even after 55 patients on lipid reducing drugs 
were excluded (Benetos et al., 2004). These results indicate that shortened leukocyte 
telomeres may predict carotid plaques more accurately and may also play an as-yet 
undiscovered role in plaque development among hypertensive patients. A study of patients 
with type-2 diabetes (n = 30) and patients who did not exhibit either carotid or femoral 
plaques (n = 30) found that diabetics with plaques exhibited shorter telomere lengths (5.39, 
SEM 0.2kb) than those without (6.21, SEM 0.2kb). All patients were found to have shorter 
leukocyte telomeres than non-diabetics (8.7, SEM 0.5kb), although no distinction was made 
between femoral and carotid plaques (Adaikalakoteswari et al., 2007). 
A study involving peripheral blood lymphocytes in mTert-GFP+ mice found that GFP+ cells 
expressed about 50% less telomerase compared between the ages of 2 and 5 months, 
suggesting that age-related decline in telomerase activity can occur in vivo. The study also 
found that low-density lipoprotein (LDL) cholesterol can inhibit both T-cell proliferation and 
telomerase activity in vitro (Bennaceur et al., 2014). Another study on mice investigated the 
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effects of Pioglitazone, an anti-diabetic drug which improved vascular function and slowed 
atherosclerotic progression. This study found that, in the presence of TERT, Pioglitazone also 
down-regulated p53 and p16 proteins as well as checkpoint kinase (Chk2). TERT-/- mice did 
not exhibit this effect. The study also found that the drug up-regulated telomere-stabilising 
proteins, telomerase activity and therefore reduced vascular cell senescence (Werner et al., 
2011). 
Spyridopoulos et al. (2016) analysed PBMNCs from 749 85-year-olds. It was found that both 
CD4 and CD8 T-cell compartment senescence was a reliable predictor of cardiovascular 
mortality, myocardial infarction and stroke. A correlation has also been found between CD8 
cell telomere erosion and left ventricular function deterioration. These results therefore 
demonstrate a link between cardiovascular disease and immunosenescence (Boag et al., 2015; 
Hoffmann et al., 2015). 
Peripheral blood leukocytes from coronary heart disease (CHD) patients exhibit shorter 
telomere lengths (TL) than cells from age-matched healthy adults (Sakaguchi et al., 2014). It 
has also been demonstrated that CD8+ T-cell TL in chronic myocardial infarction (MI) 
patients is shorter compared to other myeloid and lymphoid leukocyte populations, as well 
those of age-matched seropositive non-MI individuals (Bentz and Yurochko, 2008; Hoffmann 
et al., 2015). It is therefore believed that the relationship between shortened TL in CD8+ T-
cells and left ventricular function – which shows an inverse correlation – demonstrates a link 
between predisposition to immunosenescence and cardiovascular desieases (reviewed in Boag 
et al., 2015) 
Apolipoprotein E-deficient (ApoE-/-) mice as a model for atherosclerosis.  
Apolipoprotein E-deficient (ApoE-/-) mice are considered to be a good model for 
hyperlipidemia and atherosclerosis (cardiovascular phenotypes). The first gene-targeted 
mouse model of atherosclerosis was generated 20 years ago by inactivating the ApoE gene 
through homologous recombination (Plump et al., 1992; Piedrahita et al., 1992). ApoE-/- mice 
are considered highly relevant to studies of atherosclerosis, due to their ability to develop 
spontaneous hypercholesterolemia and arterial lesions which resemble those found in humans 
(Plump et al., 1992; Piedrahita et al., 1992). 
Phenotypic properties of ApoE-/- mice: 
1. As ApoE-/- mice age, they develop hypercholesterolemia, as well as spontaneous 
atherosclerotic lesions, which can be found in both the carotid artery and the aortic 
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arch. In the plaque areas moderate lesions in the aortic arch of 4-month old ApoE-/- 
mice were found. By 13-months, these plaques had increased considerably. By 
comparison, wild-type mice exhibited no such lesions (Ross, 1999). 
2. ApoE-/- mice exhibit some distinct phenotypes, including endothelial dysfunction. A 
study of isolated aortic rings ex vivo found that in 13-month old ApoE-/- mice, 
endothelial nitric oxide (NO) dependent vasorelaxation was reduced when challenged 
with acetylcholine, although this was not observed in 4-month old mice, nor was it 
seen in wild-type mice at either age. The study concluded that endothelial dysfunction 
in ApoE-/- mice is age-dependent (Wang et al., 2000), implicating NO deficiency in 
atherosclerosis (Anderson et al., 1995). 
3. Atherosclerotic aged (18 months old) ApoE-/- mice were found to have aortal vascular 
senescence, whereas their non-atherosclerotic aged wild type C57BL6 counterparts 
did not (Pereira et al., 2010). This suggests a connection between aortal vascular 
senescence and the development of vascular disease during ageing. This may be 
responsible for the observed endothelial dysfunction in this mouse model. Research 
with ApoE-/- atherosclerotic mice may help to elucidate the interaction between 
vascular senescence and vascular endothelial dysfunction (Minamino et al., 2002; 
Matsushita et al., 2001).  
4. Coronary systolic afterload stress is absorbed by the elasticity of the aorta. Therefore, 
the more rigid the aorta, the more stress is directed to the heart. One study shows that 
ApoE-/- mice at 13-months were found to have increased heart weight, compared to 
their wild-type counterparts at the same age, although 7-month old mice exhibited no 
such difference (Wang, 2005). Using a non-invasive Doppler method to measure 
aortic flow velocity, also found that cardiac output increased significantly in 13-month 
old ApoE-/- mice, compared to wild-type controls (Wang, 2005). This was 
accompanied by cardiac hypertrophy. Again, this result was not observed in 7-month 
old mice (Hartley et al., 2000). Niebauer et al. (1999) found that ApoE-/- mice had 
reduced aerobic capacity in spite of an increased cardiac output during resting 
conditions. It was therefore concluded that these mice had compromised cardiac 
reserves. This may be caused by elevated cardiac hypertrophy due to an increase in 
cardiac afterload as a result of aortic stiffening in ApoE-/- mice (Wang, 2005). 
 
Why can ApoE knock out influence the regulation of telomerase? 
Nothing has been reported in the literature so far about the regulation of telomerase activity in 
tissues from ApoE-/- mice specifically. However, these ApoE-/- mice are a good model of 
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atherosclerosis, which is known to be associated with increased oxidative stress and 
inflammation which may decreased telomerase activity in T-cells. 
 
T-lymphocytes play a critical role in atherogenesis (Bennaceur et al., 2014). Our group has 
also shown that peripheral blood lymphocyte telomeres shorten faster than those in myeloid 
cells in coronary heart disease (CHD) patients (Spyridopoulos et al., 2008; Spyridopoulos et 
al., 2009). Given these two factors, it is thought that in T-cells, telomere length may be a 
factor influenced by atherosclerosis but it is also possible that it is causally involved in the 
disease formation by yet unknown mechanisms. Telomere length in T-cells is pre-dominantly 
maintained by telomerase (Plunkett et al., 2007). Therefore, interventions such as introducing 
the small molecule activator, TA-65, to restore telomerase activity (de Jesus et al., 2011; 
Harley et al., 2011), may prove extremely useful in slowing down telomere shortening in age-
related diseases including atherosclerosis. Atherosclerosis has been implicated in diminishing 
telomerase activity, causing telomeres to shorten (Bennaceur et al., 2014). Our previous study 
has shown that treatment of activated human lymphocytes with LDL-cholestrol for 5 days 
decreases telomerase activity significantly as well as cell proliferation (Bennaceur et al., 
2014). However, there are conflicting data around in the literature. Gizard et al. (2011) 
showed that in macrophages, atherosclerosis might increase telomerase activity via 
inflammation. This is due to the fact that the transcription factor NFκB activates the TERT 
promoter and TERT expression as well as telomerase activity in response to inflammatory 
stimuli such as oxidized LDL (Gizard et al., 2011). Oxidized LDL can be caused by oxidative 
stress resulting in lipid peroxidation and cell damage (Pashkow, 2011; Minamino and 
Komuro, 2007). The same group fed a high fat diet (HFD) to LDLR-/- mice and found a 13-
fold increase in vascular telomerase activity after 3 months of this diet compared to a normal 
diet (Gizard et al., 2011). 
Our study sought to establish a greater understanding of the cell-specific functions of 
telomerase in T-cells/splenocytes in regard to atherogenesis. Using the ApoE-/-mTert-GFP+ 
mouse model, we studied high fat diet (HFD)-fed ApoE-/- x mTert-GFP+ reporter mice.  
 
1.3.3 Role of telomerase and telomere length in T-lymphocytes 
 
Telomerase was not found to be particularly active in unstimulated peripheral blood T-cells 
(Akiyama et al. 2002; Kawauchi et al., 2005). However, telomerase plays a far greater role in 
T-cells after stimulation (Weng et al., 1998; Hathcock et al., 2005). All primary human 
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thymocyte subpopulations exhibit pronounced telomerase activity (Weng et al., 1996). CD4+ 
T-cells taken from chronic inflammation sites (for example, the tonsils) exhibit high 
telomerase activity levels, although not as high as that found in the thymus. High telomerase 
activity is also seen in antigen-specific T-cell stimulation in vivo. A study found that CD8+ T-
cells which had reacted to the naturally occurring Epstein-Barr virus (EBV) were telomerase 
positive (Weng et al., 1996; Maini et al., 1999; Plunkett et al., 2001). Murine studies have 
shown an antigen-specific CD4+ T-cell telomerase activity in response to antigen challenge in 
vivo (Hathcock et al., 1998). Mice infected with lymphocytic choriomeningitis caused viral-
peptide specific CD8+ T-cells and long-term memory cells to express telomerase. Combined, 
these studies and observations suggest that telomerase expression in response to acute 
immune response can be responsible for maintaining telomere lengths, replicative capacity 
and long-term memory in cells. 
Human T-cell studies carried out in vitro also shed light on telomere length regulation. When 
the T-cell receptors CD3 and CD28 were stimulated with specific antibodies, T-cell 
proliferation was induced. Subsequently, T-cells expressed telomerase equally well from both 
old and young donors (Son et al., 2000). On the other hand, a study on CD8+ T-cells from 
human PBMNCs concluded that telomere lengths in CD8+ T-cells were shorter and that 
telomerase activity was lower in the older group compared to the younger group. These 
results also demonstrated that CD8+ T cell expression (CD28/CD27) was higher in the 
younger group (Plunkett et al., 2007). Antigen stimulation (Adibzadeh et al., 1996) or anti-
receptor antibody stimulation (Weng et al., 1997) caused a proliferative response to be 
induced in T lymphocytes repeatedly, up to a point. At this point, the cells appeared senescent 
and no stimulus could induce further proliferation. Over the course of this long-term culture 
and repeated cell divisions, telomeres became progressively shorter. Critically, naïve T-cells 
have an increased potential for proliferation due to their longer telomeres than memory T-
cells, which have undergone more cell divisions (Weng et al., 1995). Activated T-cells 
initially exhibited high levels of telomerase on stimulation, although this decreased at every 
cell division point, until senescence was reached and telomerase levels were very low. A 
correlation was found between telomerase activity and telomere shortening; telomeres did not 
shorten after initial cell division, but as telomerase decreased, the telomeres became 
progressively shorter (Weng et al., 1997; Akbar and Vukmanovic-Stejic, 2007; Plunkett et al., 
2007). 
Telomerase is implicated in telomere length maintenance, and as its activity decreases, 
telomeres begin to shorten in T cells. Telomere length also seemed to be related to the 
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proliferative capacity of T-cells (Plunkett et al., 2007). Therefore, telomerase might have an 
effect on T-cell division and senescence. Closer examination of this relationship has been 
carried out: The cDNA that codes for the expression of human TERT (hTERT) has been 
transfected into CD8+ T-cells. In the control group, the cells which expressed the least 
endogenous telomerase reached senescence more quickly, while the hTERT over-expressing 
experimental group had higher telomerase activity and divided far more readily (Hooijberg et 
al., 2000; Rufer et al., 2001). 
 
1.3.4 Interaction between oxidative stress and telomeres 
 
Telomere loss and the deceleration of replication can be caused by oxidative stress. This has 
been shown both in studies of human ageing (von Zglinicki et al., 2000) and in vitro (von 
Zglinicki et al., 1995). Guanine, which is found in abundance in telomeres, is particularly 
prone to the effects of oxidative stress (Wang et al., 2010). It is not fully known if this is 
merely a side-characteristic of telomeres, or if it is part of a functional process. Oxidative 
stress is implicated in telomere shortening and also causes damage to DNA through double 
and single-stranded breaks and through oxidising bases (Petersen et al., 1998; von Zglinicki et 
al., 1995). Cells enter replicative senescence via the tumour suppressor p53 in response to 
double-stranded breaks, telomere shortening or telomere dysfunction/uncapping (Shiloh, 
2003, von Zglincki et al., 1995; Takai et al., 2003, Hewitt et al., 2012). The ‘camouflage’ 
structure is created by a shelterin complex and is known as ‘telomere capping’. A DNA loop 
is created on the telomere end, disguising it from signalling and it is thought that oxidative 
stress results in a dysfunction of this loop on the telomere end. Each time the DNA replicates, 
a greater amount of the telomere is lost (von Zglinicki et al., 1995; Sitte et al., 1998). In 
addition, damage to telomeres can not be repaired (Petersen et al., 1998; Henle et al., 1999). 
While DNA damage foci within genomic regions are often repaired, telomeric damage 
(telomere associated foci, TAFs) are not (Hewitt et al., 2012, Nelson and von Zglinicki, 
2013). However, the underlying mechanisms are not well understood yet. 
Telomerase activity which combats telomere shortening through a specific and regulated re-
elongation process might be also inhibited by oxidative stress (Saretzki, 2014). This has been 
observed in endothelial cells and is also implicated in the attrition of telomeres and 
consequent senescence. In addition, telomerase (TERT) shuttles out from the nucleus to the 
cytoplasm under oxidative stress, as shown by Ahmed et al (2008). There it enters the 
mitochondria, but is no longer able to extend telomeres (Saretzki, 2009). 
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1.4 Role of p38 MAP Kinase (MAPK) in inflammation and disease 
 
1.4.1 Expression and function of MAPK 
 
Mitogen-activated protein kinases (MAPK) are expressed in all eukaryotic cells and are 
activated in a number of ways, including cellular stress, neurotransmitters, hormones, growth 
factors and cytokines (Widmann et al., 1999). MAPK are serine-threonine protein kinases, 
whose sequential activation pathway is a three-component module conserved from yeast to 
humans. This is established through three kinases as follows: MAPK kinase kinase (MKKK), 
MAPK kinase (MKK), and MAPK. In mammalian cells, there are currently 14 MKKK, 7 
MKK and 12 MAPK known, the latter of which subdivides into five distinct families, each 
with its own biological function: MAPKerk1/2, MAPKp38, MAPKjnk, MAPKerk3/4, and 
MAPKerk5. In the yeast Saccharomyces cerevisiae, five MAPaK pathways are responsible 
for mating, cell wall remodelling, nutrient deprivation, and stress responses (osmolarity 
changes). In mammalian cells, MAPK pathways are activated via a range of stimuli, indicated 
by the diversity of MKKK in MAPK modules (Widmann et al., 1999).  
The MAPK signalling pathway in normal cells  
MAP kinases, or MAPK, originate from the mitogen activated protein kinase protein family 
(Figure 1.6). The MAPK pathway is invoked when a ligand (e.g. EGF) binds with the 
extracellular component of a receptor tyrosine kinase (RTK) membrane-bound receptor, 
leading to two RTK sub-units being dimerised at the inner side, and catalysing 
phosphorylation at both sub-units. Next, growth factor receptor-bound protein binds 
temporarily to the phosphorylated RTKs. Son of Sevenless (SOS) genes, named after their 
homologues in Drosophila, are capable of binding to Ras. When dormant, Ras binds to 
guanosine diphosphate (GDP), allowing SOS to take advantage of the exchange between Ras-
bound GDP and guanosine triphosphate (GTP), which causes Ras protein activation. Active 
Ras, bound to GTP can bind to a range of effector proteins. One critical effector is the kinase 
B-Raf, which phosphorylates, to activate the MEK 1 and 2 kinases. These go on to 
phosphorylate the ERK 1 and 2 kinases, ultimately leading to transcriptioj factor activation of 
the activator protein-1 (AP-1) family (Meloche and Pouyssegur, 2007; Whitmarsh and Davis, 
1996; Gille et al., 1995; Rouse et al., 1994; Widmann et al., 1999). 
The Jun and Fos transcription factors are among the most widely known. Following 
activation, these migrate to the nucleus to form heterodimers which bind with AP-1 motifs 
and these are modulated by DNA. This caused expression of numerous genes, including 
growth factors, cytokines and cyclins. Consequently, normal cells proliferate, causing 
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deactivation of the Ras-GTP complex. This allows for a MAPK signalling pathway to be 
permanently activated, therefore avoiding undesirable effects. The GTPase activating protein 
(GAP) deactivates Ras-GTP, by binding to it and increasing its GTPase activity by several 
orders of magnitude. This is achieved by enabling a domain that allows Ras protein to 
hydrolyse GTP into GDP. When the GTP-bound Ras becomes inactive, the B-Raf bond is 
broken and the MAPK signalling pathway ends (Widmann et al., 1999; Robbins et al., 1993; 
Roux et al., 2007; Karnoub and Weinberg, 2008). 
The MAPK signalling pathway in tumour cells with Ras mutation.  
Ras gene mutation drastically effects cells. Mutated Ras protein behaves similarly to non-
mutated Ras. It activates as normal and furthermore, active Ras-GTP complex, binds to and 
activates the B-Raf kinase. Critically however, the mutated Ras-GDP protein cannot be 
inactivated by GAP. While GAP still binds to Ras-GTP, the domain required for Ras GTPase 
is not available, so hydrolysis of GTP into GDP does not occur. Because of this, the mutated 
Ras-GDP is not deactivated and B-Raf kinase remains active and bound to Ras-GTP. MEK 1 
and 2 proteins continue to be activated through B-Raf phosphorylation, leading to increased 
activation of ERK 1 and 2, and increased active Jun and Fos. The kinase cascade continues 
unabated, causing continuous proliferation, which is the determining characteristic of a 
tumour cell (Widmann et al., 1999; Melloni et al., 2012). 
The MAPKp38 cascade can be found predominantly in endothelial, myocardial and renal 
cells, and is a key component in the initiation and progression of inflammatory diseases. 
Activating factors include: proinflammatory cytokines, pathogens, growth factors and 
environmental stimuli. LDL cholesterol, reactive oxygen species (e.g. peroxides), 
barotraumas and ischaemia are also implicated in MAPKp38 activation (Melloni et al., 2012). 
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Figure 1.8. MAPK signalling pathway in normal and tumour cells. 
 
The MAPK signalling pathway causes proliferation of normal cells. Following this, the 
active Ras-GTP complex becomes inactive, leading to the signalling pathway being 
deactivated. However, Ras-GTP remains active in tumour cells, consequently leaving 
the MAPK signalling pathway active and therefore leading to uncontrolled cell 
proliferation – the very definition of a tumour cell (Data from Widmann et al., 1999 and 
Melloni et al., 2012). 
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1.4.2 p38 MAPK Pathway 
 
In mammals, the p38 MAPK family is made up of four homologous proteins, MAPKp38α,β,γ 
and δ, which are activated by cellular stress (e.g. osmotic or heat shock, ultraviolet (UV) 
irradiation, protein synthesis inhibitors, lipopolysaccharides); certain cytokines; and G 
protein-coupled receptors (GPCR). Activation is via an ordered activation module of specific 
protein kinases, MKKK/MKK/MAPK. This is a similar mechanism to that found in the yeast 
MAPKhog1 (Singh et al., 2010). 
 
MAPKp38 has the ability to phosphorylate numerous substrates. Within the Thr-Gly-Tyr 
activation motif, MAPKp38 can be activated through dual phosphorylation of Thr and Tyr. 
When MAPKp38 activity is engaged, the protein kinase 2 and 3 phosphorylates small heat-
shock proteins such as 27-kDa (Widmann et al., 1999). As a substrate for MAPKp38, ATF2 
can be phosphorylated at Thr-69 and Thr-71 within its amidogen-terminal activation domain, 
which enables greater transcription. Similarly, Elk1 is phosphorylated within its carboxylic 
acid-terminal activation domain. The C/EPB group of transcription factors includes 
GADD153 (chop), which MAPKp38 will phosphorylate on serine residues 78 and 81. This 
also increases transcriptional activity (Singh et al., 2010). MAPK p38α includes a carboxylic 
acid-terminal truncated isoform, which binds with and phosphorylates the transcription factor 
Max. This forms a heterodimer with the MAPKerk substrate c-Myc, to increase potential for 
integration of MAPK Erk and MAPKp38 signalling pathways (Singh et al., 2010; Cargnello 
and Roux, 2011). 
 
This ability points towards MAPKp38’s involvement in a wide range of biological functions. 
The compound pyridinyl-imidazole [SmithKline Beecham (SB)-203580], a kinase inhibitor of 
MAPKp38, blocks production of cytokines (IL-1 and TNF-α) in stimulated monocytes. 
MAPKp38 appears to play a vital role in the production of cytokines in hematopoietic cells, 
since blocking MAPKp38 activity results in inhibited production of IL-2 in T cells. When 
MAPKp38 is inhibited by (SB)-203580, IL-2 and IL-7 driven proliferation is inhibited, which 
may indicate a vital role for MAPKp38 in cytokine stimulated cellular proliferation 
(Cargnello and Roux, 2011). 
 
1.4.3 Role of MAPK inhibition/inhibitors (MAPKi) in cell death 
 
Apoptosis, through cellular stress (e.g. UV irradiation, osmotic shock), can stimulate 
MAPKp38 kinase activity, as well as ligation of Fas and TNF receptors. This process is 
impaired by MAPKp38 activation blockage by pyridinyl-imidazole compounds. MAPKp38 
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and JNK MAPK activity induced by overexpression of MKKKask1 leads to apoptosis, 
whereas kinase dead MKKK Ask1 blocks TNF-induced apoptosis. Furthermore, 
administration of (SB)-203580 prevents sodium salicylate induced apoptosis and MAPKp38 
activity. MAPKp38 may also be activated without apoptosis, inferring that its involvement in 
cell death is dependent on the induction method and cell type. MAPKp38’s involvement in 
survival versus death responses can therefore be integrated into the sum of metabolic 
processes that determine caspase activation and by extension, committment – or not – to 
apoptosis. (Deacon et al., 2003). 
 
1.4.4 Role of MAPKi in inflammation 
 
MAPKp38 signalling upregulates inflammation and, during chronic obstructive pulmonary 
disease (COPD), is increased. Administration of (SB)-239063, identified earlier as an 
inhibitor of MAPKp38 signalling, suppressed production of TNF. However, this effect was 
not observed with prednisolone, a corticosteroid. This implies a benefit for use alongside 
therapies which include inhaled corticosteroids, although long-term trials are required 
(Underwood et al., 2000). 
 
A study by Ranjbaran et al. (2007) concluded that IL-12 plasma levels regulate an 
inflammatory pathway and this is associated with Th1 cell responses. Circulating IL-18 
levels, which are linked with Th1 immune response may facilitate this. It is therefore 
suggested that the systemic IFN-γ axis may be involved in coronary atherosclerosis 
development. This has echoes of – although is not connected with – the IL-6/CRP cytokine 
cascade, which has already been studied extensively. Artery infiltration with T-cells and/or 
exacerbated Ag-driven T-cell responses may activate IFN-γ production through coronary 
arterial inflammatory stimuli. Consequently, IL-12 and IL-18 in circulation may be involved 
in atherosclerosis development by stimulating bystander activation of T-cells. Furthermore, 
IFN-γ secretion was decreased by p38 MAPKi in vitro when coronary artery segments were 
cultured.  
 
1.4.5 Role of MAPKi in myocardial infarction 
 
In mammalian cells, MAPKp38 inhibition has been observed to not only limit infarct cells, 
but also the atherogenic process itself (Melloni et al., 2012). Some studies demonstrated 
MAPKp38 inhibition as a key potential therapeutic approach in acute coronary syndrome 
(ACS). Its presence in the coronary vessel wall and myocardium enable MAPKp38 to mediate 
the breakdown of atherosclerotic plaque, attract platelets and release vasoregulatory 
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cytokines. As previously noted, physical trauma to the coronary arterial wall (e.g. stent 
implantation), would amplify the MAPKp38 mediated cascade involved with IL-6/cytokine 
signalling for secondary production of C-reactive protein (CRP) from the liver, which peaks 
48 hours after percutaneous coronary intervention (PCI) (Melloni et al., 2012). It is also 
thought that MAPKp38 inhibition could potentially mediate vascular stabilization, due to the 
role of microvascular circulation in myocardial preservation during ACS. Furthermore, 
MAPKp38 is prominently involved in cardiomyocyte apoptosis. It is thus expected that 
losmapimod, a MAPKp38 inhibitor, may prevent remodelling after ACS (Melloni et al., 
2012; Cheriyan et al., 2011). 
In cases of myocardial injury, MAPKp38 can mediate cardiac fibroblast-based TGF signal 
transduction and therefore may have a critical involvement in cardiac fibrosis. Its inhibition 
can reduce interstitial and perivascular fibrosis. As such, losmapimod may promote cardiac 
relaxation, thus preventing detrimental remodelling. There is also evidence to suggest that 
MAPKp38 enables tropomyosin dephosphorylation, reducing cardiac contractility. The 
contractile element’s calcium sensitivity is altered, rather than ATP use, which increases 
energy efficiency (Singh et al., 2010; Melloni et al., 2012). 
 
1.4.6 p38 MAPK knockout mice 
 
p38α knockout mice 
Defects in placental angiogenesis caused oxygen deprivation, malnutrition and death in utero 
for a number of p38α null mice from a range of different backgrounds. Following E11.5, mice 
were backcrossed from (129/Sv X 129/J)F1 X C57BL/6 into a C57BL/6 background and this 
led to a reduction in the number of knockout embryos  detected. Of the survivors, the 
homozygous offspring were infertile, whereas the heterozygous mice remained fertile. Foetal 
livers in the TG mice appeared underdeveloped and were paler. The mice overall also 
appeared paler. Their yolk sac appeared normal and only a small number of circulating 
erythrocytes were detected. The study used markers for hematopoietic cell types and stages of 
development, and found that CFU-E progenitors had reduced differentiation and expansion, 
although it was possible to correct this. These findings suggest that p38α is required for both 
erythroid differentiation and Epo expression (Tamura et al. 2000; Adams et al. 2000; Mudgett 
et al. 2000). 
The involvement of p38α in cardiac function has been the subject of a number of studies. One 
study, of mice specifically generated with both p38α alleles deleted, found reduced cardiac 
function at 6-8 weeks. This effect appeared to be more pronounced in mice from a C57BL/6 
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background than those with a FVB/N background (Kaiser et al., 2004). A different study, of 
heterozygous p38α and p38β mice at 6-8 weeks old found similar results to the previous 
study, but also noted that p38α mice exhibited higher resistance to myocardial infarction. The 
study detected no changes in blood pressure (diastolic or systolic), heart weight or 
architecture, or LV pressures (Otsu et al. 2003; Braz et al. 2003). Cardiac-specific p38αΔ40-83 
floxed mice with a C57BL/6 background were generated to study cardiac ischaemia and 
specifically the effect of p38α on hypertrophy and fibrosis. Externally, these KO mice 
appeared identical to WT mice. Cardiac structure and function appeared the same (detected 
via echocardiography and cardiac cauterization), but biomechanical stress (pressure overload) 
caused a different response to that exhibited by WT mice. These findings have been 
interpreted to indicate that survival is dependent on the kinase, but that this is not essential to 
hypertrophic heart growth (Nishida et al. 2004). 
p38β knockout mice 
p38β KO mice were generated and were found to exhibit normal birth frequency, fertility, 
thymocyte development and size. In fact, no health problems or phenotype were observed. 
These were crossbred with TNFDARE mice, which are susceptible to the development of 
inflammatory diseases. The offspring were found to be identical to the controls, indicating no 
significant involvement of p38β in inflammatory diseases (Beardmore et al. 2005). A 
different study found that the lack of p38β had no effect on either basal or insulin-mediated 
glucose uptake, suggesting that hormonal activated glucose transport also does not involve 
p38β (Turban et al. 2005). 
Heart function studies have also studied the involvement of p38β. These found no increase in 
the survival of, or resistance to, myocardial infarction for heterozygous p38β+/– mice 
compared with p38α+/– mice (Braz et al. 2003; Otsu et al. 2003). p38β was found to play a 
more significant role in cardiomyocyte survival in response to biomechanical stress. TG mice 
were generated by crossbreeding dn14-3-3 with cardiac-specific forms of dnp38α or dnp38β. 
Mice with dn14-3-3 alone were unable to withstand cardiac pressure overload and died. 
However, dn14-3-3/dnp38β mice all survived, and p38α/dn14-3-3 mice exhibited a 60% 
survival rate (Zhang et al. 2003b). 
p38γ and p38δ knockout mice. p38γ and p38δ mouse models have been generated in both 
single and double KO varieties. All appeared normal and were both viable and fertile 
(Beardmore et al. 2005; Sabio et al. 2005; Aouadi et al. 2006). 
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1.5 Exercise and cardiac rehabilitation 
 
1.5.1 Effects of exercise on the immune system 
 
Physical exercise has an important role to play in general health and wellbeing (Figure 1.7). 
The development and evolution of atherosclerosis is affected significantly by the activity of 
the immune system (Libby et al., 2009). Vascular endothelial cell signals recruit monocytes 
which, when activated, produce nitric oxide (NO), metalloproteinases, tumor necrosis factor α 
(TNF-α) and interferon-γ (Janeway et al., 2002). Proinflammatory cytokines are produced by 
T-lymphocytes activated by oxidised LDL cholesterol within the intima. It has been shown 
that exercise can affect these functions to lower rates of inflammation and thus slow down 
atherosclerotic progression. (Pynn et al., 2004 and Fukao et al., 2010) 
 
C-reactive protein (CRP) is an acute-phase reactive protein, used as an inflammatory 
biomarker to predict cardiovascular disease and mortality (Kaptoge et al., 2010). Similarly, 
fibrinogen has been used to predict mortality in CAD patients (Danesh et al., 2005). Through 
use of these biomarkers, there is evidence to suggest that interleukin (IL) 6 and VCAM-1 aid 
more precise medical decision making (Lindmark et al., 2001). In elderly CAD patients, there 
is also an association with TNF-α, whereas increased concentration of IL-10 has been linked 
with cardiovascular risk reduction. It cannot be consistently shown that physical activity 
lowers CRP concentrations in all adults, although changes in CRP and other inflammatory 
biomarker concentrations have been found in CAD patients. (Oemrawsingh et al., 2011; 
Kelley and Kelley, 2006; Lavie et al., 2011). 
 
The peripheral T cell compartment is susceptible to many changes as a result of the ageing 
process. Whilst the numbers of T-cells are similar between the elderly and the young, older 
people tend to display more late stage differentiation phenotypes 
(KLRG1+/CD28−/CD27−/CD57+) and specificity to antigenic determinants of specific viruses, 
including EBV and CMV. Healthy adults have a greater number of CD4+ T cells than CD8+ T 
cells (Agrawal et al., 2009). When this trend is found to be inverted, it is presumed that 
excessive clonal expansions of apoptosis resistant CD8+ T cells have resulted in memory 
CD8+ T cell inflation. Ageing causes a higher rate of defects in adaptive immune responses, 
which can significantly impair T cells’ ability to secrete IL-2 and to proliferate in response to 
various stimuli. (Appay et al., 2008) 
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Many studies have demonstrated that physical exercise improves the body’s functioning in all 
parameters and can lead to decreased risk of developing diseases, including infectious 
illnesses, age-related impairments and cardiovascular diseases. This in turn leads to increased 
longevity (Kodama, 2009). Spielmann et al. (2011) performed a study of 102 healthy men 
ages 18 to 61 years, and found that the training group showed an increased proportion of 
naïve CD8+ T-cells, and decreasing proportions of senescent/exhausted CD4+ and CD8+ T-
cells. Nieman et al. (1993) undertook a study of 30 trained women, ages 72.3 to 74.7 years, 
which demonstrated increasing NK-cell cytotoxicity, increasing T-cell proliferation, constant 
lymphocyte counts, and decreasing frequency of URTI symptoms compared to a group of 
women with an untrained status.  Ludlow and co-authors (2008) conducted a study on 69 men 
and women, ages 55.4 to 65.2 years, and the results showed increasing leukocyte telomere 
length in moderate exercisers. Ogawa et al. (2003) studied 62 to 64 year old subjects, 
including 9 trained and 12 untrained women; the trained women were members of a walking 
group, whilst the untrained women were sedentary. They concluded that IL-2+/CD8+ IL-
4+/CD8+ and IL-4+/CD4+ T-cell numbers are increased and that IFN-γ:IL-4 ratio is constant.  
 
In comparison to less physically active older people, those who exercise demonstrated greater 
T cell proliferative response to mitogens and depleted memory T cells and senescent T cells. 
Both Nieman et al. (1993) and Shinkai et al. (1995) found greater mitogen-induced T cell 
proliferation in aerobically conditioned older people. When adjusted for the indication that 
age may be of less importance than aerobic fitness change in terms of influencing T cell 
phenotypic shifts, the relationship between age and naïve or senescent T cells was not 
maintained. 
 
When multiple doses of the mitogens concanavalin (Con A) and phorbol myristate acetate 
(PMA) were used, Woods et al. (1999) found that a 6-month supervised aerobic training 
programme increased T cell proliferation in previously sedentary elderly subjects on the same 
medication. The same group (Woods et al., 2003) then conducted a follow up study, which 
showed that age-related memory and naïve T cell ratio increase in mice, which may simply 
indicate a response to exercise training in mice; they suggested that the experiment needs 
further reestablishment and refinement with human subjects. Initial immune status may have a 
greater effect than previously thought. De Waard et al., (2007) conducted a study on mice 
with a large myocardial infarction, to investigate effect of early exercise training on 
myofilament function and effects on pump dysfunction in the left ventricle. They concluded 
that there was no clear effect in terms of left ventricular remodelling, but did however find 
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that early exercise after a large myocardial infarction can decrease dysfunction of the left 
ventricle. They explained this as a result of improvement in myofilament function via exercise 
training. 
 
Furthermore, Fairey et al. (2005) found a positive correlation between aerobic exercise and T 
cell generation in postmenopausal women who had survived breast cancer. Shimizu et al. 
(2008) performed a 6-month aerobic exercise intervention on males and females between 61 
and 76 years old, which resulted in increased numbers and percentages of CD4+ T-cells 
expressing CD28. 
 
 
Figure 1.9. Interaction between exercise, cardiovascular system and the immune 
system. 
Physical activity causes the capillaries to open by about 100% (compared to 20-25% 
at rest), leading to increased blood flow. This increase in blood flow interacts with 
cardiac input/output and the immune system organs. 
 
 
1.5.2 Exercise and atherosclerosis 
Animal models have been used to investigate the anti-atherogenic effect of exercise, which 
was shown to prevent and improve the outcome of cardiovascular diseases (Froelicher, 1972; 
Kramsch et al., 1981). ApoE-/- mice were used to provide evidence of experimental 
atherosclerosis by induced fibro-fatty accumulation at the arterial walls. After forced mild to 
moderate exercise treatment, the development of atherosclerosis was suppressed in these mice 
(Okabe et al., 2006). It is therefore thought that in HFD-fed ApoE-/- mice, a higher number of 
fatty acids are plasma oxidized and that nitric oxide synthase (eNOS), an endothelial isoform, 
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may be increasingly upregulated. Indeed, eNOS expression is stimulated in endothelial cells 
in response to HFD, and this is thought to be associated with plasma lipid peroxides 
(Ramasamy et al., 1998).  
Many studies concluded that atherosclerosis progression was reduced by medium-term 
exercise over 6-9 weeks (Laufs et al., 2005; Okabe et al., 2007; Pellegrin et al., 2007). Mice 
who underwent long-term exercise developed a more stable plaque phenotype shown by 
decreased macrophage levels (Pellegrin et al., 2009). 
Numerous atherosclerotic risk factors exist, including: obesity, intolerance to glucose, 
resistance to insulin, high blood pressure, low HDL-C and elevated triglyceride concentration. 
Physical exercise and weight loss can have a positive effect on many of these factors. For 
example, reduced LDL-C may lead to reduced HDL-C to a similar degree, which is associated 
with a reduction in ingested saturated fat (Stefanick et al., 1998). Exercise in humans can 
modify IL-6 and TNFalpha, both adipocytokine products, which regulate intercellular 
adhesion molecule-1 and vascular adhesion molecule-1 (Ziccardi et al., 2002). 52 exercise 
studies, lasting under 12 weeks and including 4700 participants underwent meta-analysis, and 
results demonstrated an average increase of 4.6% in HDL-C levels. LDL-C reduced by 5% 
and triglyceride by 3.7% (Leon and Sanchez, 2001). The HEalth, RIsk factors, exercise 
Training And GEnetics (HERITAGE) study is the largest of its type, involving 299 male and 
376 female normolipidemic participants over a 5-month exercise training period (Leon et al., 
2000). Male participants exhibited a 1.1mg/dl (3%) increase in HDL-C, a 0.9mg/dl (0.8%) 
decrease in LDL-C and a 5.9mg/dl (2.7%) decrease in triglycerides. Female participants 
showed a 1.4mg/dL (3%) increase in HDL-C, a 4.4mg/dL (4%) decrease in LDL-C and a 
0.6mg/dL (0.6%) decrease in triglycerides. Subjects with baseline hypertriglyceridemia may 
be prone to greater HDL-C increases (Couillard et al., 2001). 
1.5.3 Effects of exercise on telomerase activity and telomere length 
Oxidative and psychological stresses have been shown to play a significant role in telomerase 
activity and to affect telomere length (Demissie et al., 2006; Epel et al., 2004; Epel et al., 
2006). It has been suggested that low telomerase levels in leukocytes – and therefore 
shortened telomeres - may be a predictor of CVD risk (Epel et al., 2006). Many studies 
provide evidence of a positive link between exercise and telomerase activity and telomere 
lengths (Melk et al., 2014; Cherkas et al., 2008; Werner et al., 2009 and Kadi and Ponsot, 
2010). 
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In a human study there was an overall positive correlation between leukocyte telomere length 
and maximal oxygen consumption (r = 0.44, P < 0.01) (LaRocca et al., 2010). Human 
leukocytes had longer telomeres in the healthy older exercise group compared to the 
sedentary group of the same age, while there was no effect of exercise on telomere length in 
the healthy younger group compared to young sedentary people (LaRocca et al., 2010). Other 
lifestyle factors, including BMI, smoking status and levels of physical exercise were 
correlated with telomere length (Song et al., 2010) and some studies have shown that negative 
lifestyle factors cause telomeres to shorten, resulting in damage to DNA. Moreover, exercise 
is associated with reduced oxidative DNA damage, whereas smoking increases this damage 
(Tamae et al., 2009). Athletes exhibit a noticeable increase in telomerase activity in 
mononuclear cells after exercise; in young people this was 2.5-fold and in middle-aged 
people, it was 1.8-fold. Moreover, peripheral blood mononuclear cell cultures (PBMNCs) had 
longer telomeres in older athletes compared to older people with sedentary lifestyles (Werner 
et al., 2009). Shorter telomeres are also associated with increased subjective psychological 
stress (Epel et al., 2004; Epel et al., 2006). Physical exercise was shown to enable a buffer 
between psychological stress and telomere length (Werner et al., 2009), and people 
experiencing low psychological stress were found to have longer telomeres and higher 
telomerase activity (Epel et al., 2004; Epel et al., 2006; Puterman et al., 2010). The level of 
exercise has a positive effect on telomere length. Moderate exercise levels lead to 
significantly increased telomere length in human PBMNCs compared with the lowest or 
highest levels of exercise, based on each subject’s exercise energy expenditure (EEE). It is not 
thought that telomere length can be influenced by acute or short term exercise, as this does 
not provide strong enough stimulation (Ludlow et al., 2008). Telomerase has been shown to 
play a central role in telomere regulation and on survival proteins after exercise; the voluntary 
running exercise had no effect on TERT-/- mice (Werner et al., 2009). 
1.5.4 Cardiac rehabilitation and its phases 
 
Cardiac rehabilitation is critically important, in view of the high mortality rate associated with 
cardiovascular diseases. About 1.8 million lives are put at risk annually from cardiac diseases 
in Europe alone (British Heart Foundation: European cardiovascular disease statistics 2012). 
In the UK, approximately 170,000 patients are diagnosed with acute myocardial infarction 
every year, and around 2.3 million people are living with cardiovascular disease in the UK 
(British Heart Foundation 2012). Based on this, a cardiac exercise program, either as a 
preventative or rehabilitative measure, is of great importance. Cardiac rehabilitation is part of 
a comprehensive care package for cardiovascular patients (Wenger et al., 1995; Leon et al., 
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2005). Such rehabilitation is a long-term program, tailored to both the patient’s physiological 
and psychological needs, and requires a combination of daily exercise and education to 
modify the risk factors (Balady et al., 2000). 
Numerous studies and associations increasingly agree that patients with ST elevation MI, 
non-ST elevation MI and all patients undergoing reperfusion will benefit from cardiac 
rehabilitation (British Association for Cardiovascular Prevention and Rehabilitation, 2012; 
National Institute for Health and Care Excellence (NICE), 2010a, 2010b, 2013; Piepoli et al., 
2014; and Department of Health (DH) Cardiac rehabilitation commissioning pack, 2010). 
Bethell et al. (2009) and Mampuya (2012) show that cardiac rehabilitation programs vary in 
frequency, intensity and duration between patients. Most cardiac exercise rehabilitation 
programs involve 2-3 sessions weekly for approximately 8 weeks (British Heart 
Foundation, 2014), whereas some may last for 3-6 months depending on the patient’s 
condition, assessed during sessions medically supervised by a physical therapist (Mampuya, 
2012; Menezes et al., 2014). 
Cardiac exercise rehabilitation is able to decrease mortality. A systematic review of over 6000 
MI patients found that patients involved in cardiac exercise rehabilitation showed a lower risk 
of all mortality causes, compared with patients who were not involved (Lawler et al., 2011). 
Another review over 10,000 patients concluded that cardiac exercise rehabilitation reduced 
overall mortality and cardiovascular mortality (Heran et al., 2011). In addition, cardiac 
exercise rehabilitation led to reduced hospital admissions. A review study conducted on 33 
randomised controlled trials and involving over 4700 heart failure patients summarised that 
the cardiac exercise rehabilitation program reduced the risk of overall hospitalisation and its 
duration (Sagar et al., 2015). Furthermore, cardiac exercise rehabilitation improved quality of 
life and physiological wellbeing in general. A randomised controlled trial on over 3100 
cardiac patients from 23 studies concluded that after cardiac exercise rehabilitation, 
psychological distress was greatly decreased, and serum cholesterol and systolic blood 
pressure both improved (Linden et al., 1996). Cardiac patients also reported lower rates of 
anxiety and depression after cardiac rehabilitation (Lavie and Milani, 2006). Cardiac patients 
with depression after cardiac exercise rehabilitation still had 59% lower mortality compared to 
those who did not participate in exercise rehabilitation (Milani et al., 2011). 
Rehabilitation programs consist of three phases (British Heart Foundation, 2014; Bethell et 
al., 2009; Mampuya, 2012), the first of which begins in hospital as soon as the patient has 
reached a stable condition. This is known as Phase I (acute) and involves educating the patient 
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about their cardiac condition and how it can be managed though physical exercise. Very mild 
breathing and range-of-motion exercises are introduced to the patient in their bed, before 
moving on to walking and stair climbing at an appropriate time. This partly also serves as 
psychological preparation for increased exercise in general. 
Following discharge from the hospital, the recovery stage (Phase II) is instigated. A range of 
interventions are brought about, including a structured exercise program under supervision, as 
well as further education with regard to weight loss and nutrition, smoking cessation, stress 
management and any other lifestyle changes. This phase lasts for three months and involves 
between 24 and 36 sessions of 60-90 minutes. These involve 20-30 minutes of exercise 
designed according to the patient’s ECG responses, as well as supervisory observation. An 
instructor also delivers guided warm up and cool down exercise instructions. The activity 
level is gradually increased and the patient observed until they are able to undertake the 
exercise sessions safely and without supervision.  
At this point, the patient will be familiar with the exercises and will have developed their own 
regime, based on their education and self-observations. This is the long-term maintenance 
stage (Phase III), which continues for the rest of the patient’s life. Any issues are reported to 
the rehabilitation team, who provide counselling and further information as necessary. 
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1.6 Aims and hypothesis 
 
Aim and hypothesis 1: 
 
Aim 
To develop an in-vitro model that determines lymphocyte proliferation as well as telomerase 
activity under chronic inflammation, and thus reflects the response of immune cells during 
atherosclerosis. 
 
Hypothesis 
I hypothesized that hyperoxia (40% oxygen saturation) would lead to enhanced oxidative 
stress and inflammation, which would in turn suppress telomerase activity and cell 
proliferation. 
 
Aim and hypothesis 2: 
 
Aim 
The aim of this part of the project was to test in vitro whether the effect of p38 MAPK 
inhibition on T cells, important mediators of atherosclerosis, was a) dependent on telomerase, 
and b) would exert a beneficial effect even under oxidative stress. 
 
Hypothesis 
I hypothesized that inhibition of MAPK promotes T-cell proliferation dependent on 
telomerase activity under oxidative stress. 
 
Aim and hypothesis 3: 
 
Aim 
It is well known that aerobic exercise has anti-atherogenic effects. Additionally, exercise in 
mice has been shown to induce telomere-stabilizing proteins in the arterial wall (Werner et al., 
2008). Consequently, this chapter aims to: 
a) Study the effect of voluntary exercise on mice splenocytes. 
b) Establish the regulation of telomerase activity in atherosclerosis using an mTert-GFP+ 
x ApoE-/- mouse model. 
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Hypothesis 
I had hypothesized that the anti-atherogenic effects of exercise are co-dependent on 
telomerase and the immune system.			
Aim and hypothesis 4: 
 
Aim 
This part of the project aims to identify the effect of cardiac rehabilitation on T-lymphocytes, 
regulatory T-cells, telomere length and telomerase activity in patients diagnosed with acute 
myocardial infarction (AMI). 
Hypothesis 
I hypothesized that the effects of cardiac exercise rehabilitation might be co-dependent on 
telomerase and the immune system.		
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CHAPTER 2. MATERIAL AND METHODS 
2.1 Materials 
2.1.1 Plasticware 
• 96-, 24-, 6-well plates; 25cm2-flask (VWR European). 
• PCR plates (VWR European). 
• Tissue culture dishes (Thermo Fisher Scientific, Korea)  
• Cell strainer 100µm (Nylon, USA) 
• FACS tubes (FALCON a Corning brand, 352054, Mexico)	
• Magnetic beads (Miltenyi Biotec)	
2.1.2 Media, antibodies and chemicals 
Fetal Bovine Serum (FBS) (Lonza) was brought up to 37°C then activated by heat via a 1h 
immersion in a water bath at 56°C. This was then aliquoted in sterile conditions for 50ml and 
frozen at -20°C. 
Penicillin and streptomycin, under sterile conditions, 10,000 units/mL penicillin and 10 
mg/mL streptomycin solution (Sigma-Aldrich). 
 
Media RPMI 1640 (Gibco 21875-034) supplemented with 0.5 mM 2-mercaptoethanol (Sigma 
M7522), 25 mM Hepes Buffer (Gibco 15630-080), 10% FBS (PAA A15 151) and 30µg/ml of 
penicillin-streptomycin (Gibco 15070-063). Culture media were pre-warmed in a 37ºC water 
bath (Grant Instruments, Jencons PLS, UK). 
 
IL-2 (AE5212101, RD, USA) was prepared from frozen stock (-20ºC) of 100µM/ml and 
added to a working concentration of 1.5µg/ml. 
 
MAPK inhibitor BIRB 796 Doramapimod (Axon 1358) was prepared in DMSO (Sigma 
472301) to working dilutions of 500nM. 
 
Phosphate Buffered Saline (PBS) (Gibco 18912-014). 
 
Dimethyl sulfoxide (DMSO) (472301 Sigma, USA). 
 
Equipments were described in relevant chapter. 
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2.2 Methods 
2.2.1 Mouse lines and Ethics statements 
 
Ethical approval for the use of all mice was granted by Newcastle University’s Local Ethical 
Review Committee and it was licensed by the UK Home Office (PPL 60/3864) for TERT 
mice, (PPL/60-3876) for mTert-GFP+ mice and (PPL/60/4553) for ApoE-/-mTert-GFP+. All 
mice were housed in a single room with sawdust, paper bedding and ad libitum water access. 
They were kept at 20±2°C under a 12/12h light/dark photoperiod. All guiding principles for 
the care and use of laboratory animals were complied with. 
 
2.2.1.1 TERT+/+ (C57BL/6), TERT-/- and TERT+/- mice 
The TERT knockout (Figure 2.1) mouse line was purchased from Jackson Laboratory. TERT-
/- mice lines, strain: B6.129S-Tert, tm1Yjc/J (Chiang et al., 2004), on a C57BL/6 background 
were used. Breeding produced wild-type, first-generation (G1) knockout as well as 
heterozygote mice for the TERT genotypes. TERT-/- mice and their wild type and 
heterozygote littermates were all purchased from Jackson Laboratory (USA). 
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Figure 2.1. Illustration of wild type TERT gene and the TERT knockout construct 
(modified from Chiang 2004) 
 
A. Comparison of wild type TERT DNA and B. the TERT-/- constructs in mice. Wild 
type TERT+/+ contains 16 exons. The knockout described by Chiang et al (2004) 
contains a GFP and a neomycin-resistant gene (neo) inserted into exon 1. Chiang et 
al. (2004) performed a two-step construction process on TERT-deficient mice.  
Step 1) A 6kb-mTERT genomic DNA fragment derived from strain 129 and containing 
exons 1 and 2 of the mTERT gene was used as the basis of a targeting vector, which 
was inserted into the pBluescript-KS vector at the EcoRI site (KS-tert). A BamHI-Xbal 
fragment excised from KS-tert was sub-cloned into pBluescript-KS vector (KS-BX). A 
unique enzyme restriction site (Xhol) in KS-BX using PCR. This was proximal to an 
ATG corresponding to the translation initiation code of the mTERT mRNA. Neomycin 
resistance and green fluorescent protein (GFP) genes were then inserted in the Xhol 
site to create a BamHI-Xbal DNA fragment with neomycin and GFP-resistant genes. 
This replaced the BamHI-Xbal fragment of KS-tert. An mTERT gene-targeting 
construct was created by inserting the thymidine kinase gene at a Not1 site outside of 
the genomic DNA fragment. Step 2) This was linearized using SaII, then 
electroporated into embryonic stem cells. Colonies that were resistant to G418 were 
isolated. A BmHI-Xbal fragment from KS-tert was used as a probe in the Southern blot 
analysis to identify embryonic stem cell colonies with homologous recombination 
events. Mutant mice were generated from these. 
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2.2.1.2 mTert+/+GFP+ mice 
mTert-GFP+ mice were generated (Figure 2.2) as a model in 2008 by Breault et al. to 
determine the expression of TERT in mice at the single-cell level (Briault et al., 2008). These 
transgenic were generated by integrating a GFP gene behind the mTERT promotor with the 
aim of getting an easier read-out of mTERT transcription in this mouse model. The 
construction of the mouse model is shown in figure 2.1. 
 
 
Figure 2.2. Illustration of the mTert-GFP+ construct (Breault et al., 2008)  
 
Genomic DNA fragments were digested from A.victoria cells, at the same time cut 
vectors applied on pGFP plasmid vectors. One strap of DNA was placed on the cutting 
part of the pGFP plasmid vectors to recombinant. This was then excised from the 
recombinant (E. Coli) DNA by electroporation to produce GFP+ cells. The mTert-GFP 
plasmid was created and a linearised mTerT GFP transgene was electroporated into 
mouse (J1) embryonic stem cells. This was selected using G418 and screened for 
GFP expression. The transgene was created using the 4471 bp fragment of the mTert 
gene promoter (accession number AF 121949). The fragment was amplified by PCR 
from genomic DNA, then digested using BamHI and HindIII. Part of the promoterless 
GFP vector was also digested. The remaining part was recombined with purified PCR 
fragment, then removed from the new recombinant DNA in (Excherichia coli) E. Coli by 
electroporation. A pure 129S1/SvIMJ background of mTert-GFP was used because 
embryonic stem (ES) cells normally tend to express high telomerase activity (Breault 
et al., 2008 and Armstrong et al., 2000). In light of this, ES transgenesis (as opposed 
to pronuclear oocyte injection) was used to enable maximal transgene expression and 
to exclude transgene silenced clones following genomic integration. 
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Advantages and limitations of a GFP reporter mouse for measuring gene expression. 
Principle and definition of a reporter system: Gene promoter activity (e.g. the TERT 
promoter) determines the level of gene expression. A reporter system is able to substitute 
gene coding sequences using that gene’s promoter with a detectable reporter. One commonly 
used reporter is the fluorescence gene, GFP (other genes can also be used, such as luciferase 
or galactosidase). In this case, GFP intensity indicates the expression level of that promoter’s 
gene. In my study (Nayef AL Zhrany, thesis, Chapters 3, 4 and 5) for example, I used the 
mTERT promoter with a GFP reporter gene behind it in order to determine the gene 
expression levels of the mTERT gene in mTERT reporter mice (Breault et al., 2008). The 
gene expression levels or transcriptional activity of a promoter is determined by the binding 
of various transcription factors. These can be activating or repressing. Examples for activating 
transcription factors for the TERT gene are Sp1, c-myc while inhibiting factors are mad and 
others. 
 
Figure 2.3. A diagram illustrating the principle of a reporter gene (modified from 
Wikipedia). 
 
 
Advantages. The GFP reporter of gene expression has two advantages: i) direct observation 
of protein accumulation in single living cells is possible, prior to quantitative analysis and ii) 
It can be measured on a ‘per-cell’ basis. 
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i. Direct observation of protein accumulation in living cells prior to quantitative 
analysis 
This is a significant advantage, as it enables the quantitative results to be reasonably 
approximated prior to flow cytometric analysis of the cells. Furthermore, this ability for direct 
observation of GFP accumulation enables the observer to empirically assess that GFP 
expression has occurred prior to the tasks involved in preparing the cells for analysis 
(Soboleski et al., 2005). 
ii. Measurement of GFP expression on a cell-by-cell basis 
This enables greater accuracy in assessing promoter activity in the cell population than 
alternative measurement techniques, which simply take an average value across the entire cell 
population for example when using RNA isolation and RT-PCR. Consequently, a more 
accurate picture is produced with the reporter assay. Flow cytometry then allows for mean 
and SD values to be quickly determined in different cell populations (for example, positive 
and negative for GFP). GFP fluorescence, measured by flow cytometry is especially powerful 
in comparing the expression of reporter genes across different cell populations (Soboleski et 
al., 2005). 
Limitations of GFP as a reporter of gene expression 
i. One significant limitation of this method is that high intensity auto-fluorescence may 
be exhibited by tissues. This can result in unusually high background readings, which 
can confound the data interpretation. 
ii. Assessing gene expression events in real time may be affected also by GFP instability 
and degradation. 
iii. Cultured cells have to be transfected with the reporter system (usually plasmids) 
which is an overexpression and the expression levels of the gene also might vary 
depending on the integration site of the plasmid. For mouse model a transgenic mouse 
has to be generated which is time consuming and labourious. 
 
2.2.1.3 ApoE-/-mTert-GFP+ mice 
 
ApoE null male and female mice (Piedrahita et al., 1992) were bred in order to maintain an 
ApoE-/- mouse colony. Mice from this colony were crossed with mTert-GFP+/+ (Breault et al., 
2008) mice, resulting in ApoE+/-mTert-GFP+/- mice. These were subsequently inbred to create 
ApoE-/-, -/+ and +/+ mice. Of these, approximately 50% were mTert-GFP+ (Figure 2.3). 
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Figure 2.4. ApoE-/-mTert-GFP+ mouse generation 
Step A: Cross of ApoE-/- mice with mTert-GFP+. Step B: Cross male ApoE+/-mTert-
GFP+ female with ApoE+/-mTert-GFP+. Step C: Select appropriate mice (ApoE-/-mTert-
GFP+) for the experiment. 
 
 
2.2.1.4 Mouse diet 
 
All mouse groups in my PhD thesis were on a normal diet (ND) (Harlan, Teklad Global 19% 
Protein Extruded Rodent Diet) of 19% crude protein, 9% crude fat and 5% crude fibre. 
However some groups from ApoE-/-mTert-GFP+ or ApoE+/+mTert-GFP+ (assigned to the 
exercise programme or its control groups) received an adjusted calorie, high fat diet (HFD) 
containing 42% fat (Harlan, Rx:1591957, TD.88137). 
2.2.2 Mouse dissection and isolation of spleen and thymus 
 
After being euthanized (cervical dislocation), mouse bodies were dissected inside the tissue 
culture hood, under sterile conditions. Each body was placed on its back, a midline incision 
was made and the skin was retracted between the head and the thighs. A one-inch incision 
was made left of the peritoneal wall to reveal the spleen. This was gently separated from the 
body by tearing the connective tissue which lay behind it. An incision was made from the 
xiphoid to the neck and the ribs were gently cracked to enable retraction. This exposed the 
thymus, which sits just above the heart. Both lobes were excised as one part using curved 
forceps. 
 
Both organs were macerated through a 100µm cell strainer (BD352360), then suspended in 
10ml complete MACS buffer rinsing solution (phosphate buffered saline (pH 7.2), 2mM 
EDTA, and 0.5% MACS BSA stock solution). The suspension was pipetted at an angle and 
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layered over 5ml Ficoll Biochrom in a 15ml falcon tube by pipetting it with the tubes held at 
an angle. This was placed in a centrifuge at 800xg for 20 minutes at 20°C. Acceleration was 
set at full (9) and stopped without any deceleration. The suspension was separated and the 
Peripheral Blood Mononuclear Cell (PBMNCs) layer was removed to another 15ml tube and 
washed again in complete MACS buffer rinsing solution. This was spun down again for 10 
minutes under the same conditions but this time with full deceleration (9), and the resulting 
pellet was re-suspended in fresh buffer solution. The process was repeated and the pellet was 
re-suspended once more, this time in complete RPMI medium for counting. 
 
10µl of this suspension was diluted in 1:10 buffer (Figure 2.4), then mixed with 1:1 0.4% 
Trypan blue solution. 10µl of this mixture was loaded on to the edge of the cover glass of a 
Neubauer hemocytometer until capillary action ensured that the counting area was filled 
entirely. After 30 seconds had elapsed, the cells were counted. Now, the cells were ready for 
further use, either for culture, staining, or cryopreservation, as described later. 
 
	
Figure 2.5. Cell counting steps:  
10µl from cell suspension was diluted 1:10 in buffer, then mixed 1:1 with 0.4% Trypan 
blue solution. 10µl from this mixture was loaded at the edge of the cover glass. 
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2.2.3 Cryopreservation of cells 
Cryopreservation at -80°C was used to maintain either human PBMNCs or mouse splenocytes 
as live cells. In the case of freezing live cells, RPMI 1640 [R0883 Sigma, USA] with 10% 
FBS and 10% DMSO, was used as freezing medium. To do this, cells were sedimented by 
centrifugation (800g for 10 minutes) and the supernatant was discarded. The media were then 
added at 100µl per million cells. After mixing, the cells were transferred to a cryovial and 
stored in a cryo-container (Thermo Scientific, USA) to cool slowly at 1 degree per minute 
overnight at -80°. Afterwards, the cryovial was removed from the cryo-container and stored at 
-80°. 
2.2.4 TCR stimulation  
Activation of T-cell receptors of splenocytes was achieved in two ways (Figure 2.5), 
achieving either strong or moderate activation of the T-cell receptor. Coating wells with 
antibody results in less frequent contact of cells with the antibodies (moderate activation), 
while mixing micro-beads with cells leads to a 1:1 ratio between cells and antibodies.   
1) Strong TCR activation. A micro-beads CD3e/CD28-Biotin T-cell expansion kit (Miltenyi 
Biotec, 130-093-627) was used at ratio of 1:1 (cells to beads) in RPMI 1640 medium. 
Anti-Biotin MACSiBead particles were loaded with 100µl of vortexed CD3e-Biotin and 
100µl CD28-Biotin in a 2ml tube. 300µl of cold (4°C) complete Auto MACS rinsing 
solution (Phosphate buffered saline (pH 7.2), with 2mM EDTA and 0.5% MACS BSA 
stock solution) was mixed with the antibody mixture. Anti-Biotin MACSiBead particles 
were homogenously resuspended and 500µl was added to the antibody mixture, then 
incubated at 4°C for 2 hours before use with cells. 
2) Moderate TCR activation. Plates were coated overnight with anti-CD3 (BD 553238) and 
anti-CD28 (BD 553295) antibodies at 1µl/ml PBS at 4°C. 
	
Figure 2.6. Two modes of splenocytes T-cell receptor activation in splenocytes 
A: Moderate activation. As antibodies coated the well floor, the layer of cells which lay 
on the antibodies were activated, whilst the other cells had less frequent contact with 
the antibodies to activate.  
B: Severe activation. As antibodies floated with the cells in the medium, this gave a 
high frequent contact between antibodies and cells to activate. 
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2.2.5 Mouse PBMNCs culture  
 
A Ficoll-hypaque density gradient (using Biochrom AG Biocoll L 6113/5) was used to isolate 
PBMNCs from mouse spleens. Cells (2x106/ml) were cultured in complete RPMI 1640 
medium (Gibco 21875-034) supplemented with 0.5 mM 2-mercaptoethanol (Sigma M7522), 
25 mM Hepes Buffer (Gibco 15630-080) and 10% fetal bovine serum (FBS) (PAA, A15 
151). Different cell plates were incubated under different oxygen saturations (2.2.8) and 
activated using two stimulation types, as specified in each experiment description. All 
procedures were carried out in a sterile environment and under a cell culture hood. 
 
2.2.5.1 Cell culture in 96-well plates 
96-well plates were used only with pure CD4+ T-cell expansion under strong activation. CD4+ 
T-cells from either TERT+/+ or TERT-/- mice were seeded at 2x105 cells/well (volume = 
200µl/well) in a 96-well plate. CD4+ T-cells were generated by immunomagnetic bead-
isolation from splenocytes, which were cultured at 2x106/ml in a 24-well plate for 14 days (as 
described in 2.2.5.2) with anti-CD3 (BD 553238) and anti-CD28 (BD 553295) antibodies 
(prepared at 1µl/ml PBS). The medium was changed and 1.5µg/ml IL-2 was added every 2-3 
days for all experiments. CD4+ T-cells were re-activated every 7 days (days 0, 7, 14, and 21) 
by adding CD3e/CD28-Biotin micro-beads at a 1:1 ratio (Miltenyi T-cell expansion kit). Cells 
were incubated under appropriate oxygen saturation (described in the experiment). For the 
control group, 1µl/ml DMSO was added, and 500nM/ml mitogen-activated protein kinases 
inhibitor (MAPKi, BIRB 796 Doramapimod, Axon 1358) was added to the treated group. 
CD4+ T-cells were split to a new well when they reached double their starting number. This 
continued until they reached 2x106 cells, after which cells were collected and transferred to 
24-well plates. 
2.2.5.2 Cell culture in 24-well plates 
Cells were isolated from the spleen by Ficoll-hypaque density gradient. Splenocytes from any 
mouse independently of their genotype were then seeded at 2x106/ml in a 24-well plate for 
different times, specified at each experiment. There were two types of activation: the first is 
called ‘moderate activation’, because the antibodies stick to the well bottom. The layer of 
cells which lies on top of the antibodies will activate, whilst the other cells get less frequent 
contact with the antibodies. In moderate activation, plates were coated overnight before the 
day of the experiment with anti-CD3 (BD 553238) and anti-CD28 (BD 553295) antibodies 
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(prepared at 1µl/ml PBS) at 4°C.  The medium was changed and 1.5µg/ml and IL-2 was 
added every 2-3 days. For the control group, 1µg/ml of DMSO was added, whilst 500nM/ml 
MAPKi was added for treated group. Cells were incubated under the oxygen saturation 
described at each experiment. 
The second type of activation is called strong activation, because the micro-antibodies were 
floated with the cells in the medium, giving cells high frequent contact with the antibodies for 
activation. In this type of activation, cells were seeded at 2x106/well/2ml; 1ml for cells and 
1ml for CD3e/CD28-Biotin micro-beads at a 1:1 ratio (Miltenyi T-cell expansion kit). T-
lymphocytes were activated every 7 days (days 0, 7, 14, and 21). The medium was changed 
and 1.5µg/ml of IL-2 was added every 2-3 days. For the control group, 1µl/ml DMSO was 
added and 500nM/ml MAPKi was added to the treated group. In strong activation, cells were 
split to a new well when they reached double the starting number. This continues until they 
reached 10x106 cells, then cells were collected and transferred to 6-well plates. 
 
2.2.5.3 Cell culture in 6-well plates 
6-well plates were used after cell expansion in 24-well plates under strong activation. All 
10x106 cells were collected and mixed in one well of a 6-well plate. 50% of the suspension 
was spun down for 10 minutes at 800g. The medium was changed and 1.5µg/ml of IL-2 was 
added every 2-3 days. For the control group, 1µl/ml DMSO was added and 500nM/ml 
MAPKi was added to the treated group. Cells were split to a new well when their number 
doubled; this was done without spinning down, just adding new medium. This continued until 
cell numbers reached 24x106, after which they were transferred to a 25 cm2 flask (50ml). 
 
2.2.5.4 Cell culture in 25cm2 flask 
25cm2 flasks were used after cell expansion in 6-well under strong activation. Cells were 
collected and mixed when they reached up to 24x106 cells in one 25cm2 flask. 50% of the 
suspension was spun down for 10 minutes at 800g. The medium was changed and 1.5µg/ml of 
IL-2 was added every 2-3 days. For the control group, 1µl/ml DMSO was added, and 
500nM/ml MAPKi was added to the treated group. Cells were split into a new 25cm2 flask 
when their number doubled without centrifugation. 
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2.2.6 Immunomagnetic sorting of mouse CD4+ T-cells 
 
Mouse splenocytes derived from either a) the process described above at 2.2.2 or b) 
splenocytes were expanded for 14 days in coated 24-well plates overnight at 4°C with anti-
CD3 (BD555338) and anti-CD28 (BD555727) antibodies; cells were seeded as 2x106/well in 
1ml of complete mouse medium RPMI 1640 (Gibco 21875-034) supplemented with 0.5 mM 
2-mercaptoethanol (Sigma M7522), 25 mM Hepes Buffer (Gibco 15630-080), 10% FBS 
(PAA A15 151). DMSO (1µl/ml) was added at the zero time point, then every 2-3 days, along 
with a change of medium. Splenocytes were expanded under hypoxic conditions 3% O2 
saturation, 5% CO2, and humidified air, at 37°C.  
 
When the CD4+ purification stage was reached, cells were passed through a sterilized 30µm 
pre-separation filter (120-002-220) and counted. The splenocytes were pelleted again (300xg, 
10minutes) and the supernatant completely discarded. The pellets were then re-suspended in 
cold complete Auto MACS rinsing solution (phosphate buffered saline (pH 7.2), 2mM 
EDTA, and 0.5% MACS BSA stock solution) at 90µl/107 cells. Then CD4 (L3T4, 130-049-
201) MicroBeads (10µl/107 cells) were added and the mixture vortexed. Following incubation 
for 15 minutes at 4°C, the cells were rinsed again with the same solution, re-pelleted (300xg, 
10minutes), then re-suspended in the Auto MACS solution, this time at 500µl/108 cells. 
A pre-prepared MS column (130-042-201), placed on a MiniMACS magnetic separator, was 
washed with 1ml of 4°C complete Auto MACS rinsing solution and cells were passed 
through. This process enabled the separation of unlabelled (CD4-) cells, which passed straight 
through, and CD4+ cells, which remained inside the column. The column was washed three 
times with 500µl of the Auto MACS solution, then removed from the magnetic separator. A 
further rinse with 1ml Auto MACS solution and plunging forced the remaining CD4+ T-cells 
into a pre-cooled collection tube. The process was then repeated to increase the sample’s 
purity. 
The CD4+ T-cells’ purity was assessed by transferring 200µl of the final suspension to a fresh 
FACS tube for staining with CD4-PE-Cy (552775). This was then incubated for 20 minutes in 
zero light conditions and washed using the BD FACS Lyse/Wash Assistant (337146, USA). A 
compensated FACS Canto II, running FACS Diva software for 50,000 live events was used to 
analyse purification against negative controls. Dead cells were excluded as far as possible, 
based on scatter signals. All processes were carried out under sterile and ice-cold conditions. 
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Figure 2.7. CD4+ T-cell purification after expansion 
 
Splenocytes from both TERT+/+ and TERT-/- mice were expanded for 2 weeks in 24-
plates coated with CD3+/CD28+ antibodies (moderate activation), then CD4+ cells were 
sorted using immunomagnetic separation (microbeads bind specifically to a CD4+ cell 
antigen and are retained in a magnetic field, whilst unlabelled cells pass through with 
buffer washes. Labelled cells are removed from the magnetic field and flushed out). 
Pure CD4+ cells are then ready to be used and activated with CD3+/CD28+ microbeads 
(strong activation) for 3 weeks to obtain the growth curve.  
 
 
2.2.7 Long-term culture of splenocytes and CD4+ T-lymphocytes 
Splenocytes were cultured in a 24-well plate (2x106 cells/2ml/well) and CD4+ T-cells were 
cultured in a 96-well plate (2x105 cells/200µl/well). Both sets of cultured cells were expanded 
using (50% volume) complete medium RPMI 1640. MACSibead mouse T-cell expansion 
beads (Miltenyi 130-093-627) were added to the remaining medium at a ratio of 1:1 beads per 
cell (i.e. 4x106 cells and 4x106 beads/2ml). 
 
50% of the volume of each sample was transferred to a new well every 2-3 days and 50% 
fresh medium added, to maintain T-cell activation beads, without centrifugation. Cells were 
counted under a microscope, using the Neubauer chamber (hemocytometer) as described 
previously. 1.5µg/ml IL-2 and 500nM/ml MAPKi (Di Mitri et al., 2011) was added and cells 
were re-activated on a seven-day cycle. When the cell count reached 10x106 cells, the 
suspensions were collected, mixed and transferred to a 6-well plate. These were centrifuged to 
50% volume and the supernatant aspirated. The cells were then re-suspended in fresh 
medium. When the cell count reached 24x106 in the 6-well plate, they were transferred to a 
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50ml (25cm2) culture flask and re-suspended in 50ml complete mouse medium for further cell 
culture expansion.  
CD4+ T-cells underwent a similar process. When the cell count reached 2x106, they were 
transferred to a 24-well plate (2x106/2ml/well). Following this, the same process was used as 
for the splenocytes expansion. 
 
2.2.8 Hypoxia, normoxia and hyperoxia  
 
Hypoxia (3% O2), normoxia (atmospheric 20% O2) and hyperoxia (40% O2) conditions were 
maintained throughout experiments using a Heraeus Hera Cell 150 incubator. A constant 5% 
CO2 in humidified air at 37ºC was maintained. Cell behaviour under oxidative stress was 
explored under hyperoxic conditions by introducing industrial O2 to produce 40% oxygen 
saturation. 
 
2.2.9 Quantification of TERT+/+ and mTert-GFP+ (cells) splenocytes, thymocytes and T-
lymphocytes 
 
Cells were harvested from the spleens and thymuses of both Tert+/+ and mTert-GFP+ mice. 
These were strained via a cell strainer (100µm, BD Falcon 50734-0004) and rinsed in 
complete Auto MACS rinsing solution (described above). Lymphocytes were isolated using 
Ficoll-Hypaque density gradient and washed twice, diluted to 2x106/ml in complete RPMI 
1640 mouse medium. 2x106 cells from each genotype were transferred to FACS tubes and 
rinsed with 1ml of Auto MACS rinsing solution at time point zero. These were then 
centrifuged at 800xg for five minutes, and the supernatant discarded. 
 
Fc (Fragment-crystallizable) receptor-mediated binding of unspecific epitopes was blocked 
using purified rat anti-mouse CD16/CD32 (Mouse BD Fc Blocking solution 553141). The 
pellets were then suspended in 100µl of the rinsing solution and 2µg mouse BD Fc Blocking 
solution purified anti-mouse CD16/CD32 per 2x106 cells was added to the suspension, which 
was then incubated for 5 minutes at 4°C. The cells were then directly stained in the presence 
of Fc blocker using CD4-PE-Cy, CD8a-Pacific-Blue, CD11b-APC and CD45R (B220) PerCP 
antibodies. GFP expression in GFP mice was determined with no need for labelling because it 
is endogenously expressed. A compensated FACSCanto II, running FACSDiva software for 
50,000 live events was used to measure the cell expression against negative controls (wild-
type cells). 
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The remaining Tert+/+ and mTert-GFP+ cells were cultured for 3, 5, 7, 10 and 14 days to 2x106 
cells per well. 24-well plates were coated overnight, before the day of the experiment, with 
anti-CD3 (BD555338) and anti-CD28 (BD555727) antibodies at 4°C. MAPKi (500nM) and 
1.5µg/ml IL-2 were added to cells at 0h, then at each medium change, every 2-3 days. Cells 
were then incubated under hypoxic conditions (3% O2) and hyperoxic conditions (40% O2). 
Cells were rinsed and counted at regular intervals (3, 5, 7, 10 and 14 days). 0.1% DMSO was 
added for control wells. 
 
1ml of each mixture was spun down at 800xg for 5 minutes. Following aspiration of the 
supernatant, the pellet was stained with Fc blocking solution (Mouse BD Fc Block purified 
anti-mouse CD16/CD32, BD 553141) as described previously. Cells were then labelled with 
CD4-PE-Cy, CD8a-Pacific-Blue, CD11b-APC and CD45R (B220) PerCP antibodies for flow 
cytometric analysis. GFP expression was determined by endogenous expression, and other 
expressed antigen markers were measured as described previously (2.2.9). 
 
2.2.9.1 Flow cytometry (FACS) 
 
Flow cytometry was developed in the 1970s to enable quantitative analysis of single cells and 
is now widely used in research and industrial contexts. The technique is able to define 
phenotype expression, intracellular DNA/RNA measurements and other cell functions, 
including apoptosis. Flow cytometry involves a process of fluorescence-activated cell sorting 
(FACS) analysis, which was developed by BD Biosciences. Flow cytometry is able to 
distinguish individual particles according to internal complexity, size or granularity. 
Three primary systems, optics, electronics and fluidics, make up the flow cytometer (Figure 
2.7). Optics involves the use of lasers, lenses and a range of sensors to analyse samples; 
electronics converts these light signals to digital data for computational analysis; and fluidics 
uses hydrodynamic focusing of the sheath fluid to enable the optical analysis. 
To explain this further; laser beams aimed at individual cells are either scattered or absorbed. 
When light at an appropriate wavelength is absorbed by the cell, it can then be re-emitted 
(fluorescence) if that cell contains naturally fluorescent particles. Another way for this to 
happen is if intracellular antigens become bound to fluorochrome antibodies. The detected 
data is then comprised of either forward-scattered (FSC, collected at an angle <10°) or side-
scattered (SSC, = 90°) light, which is contingent on both the cell’s internal complexity and its 
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size, as shown in (Figure 2.8). The data yielded by this technique reveals a large amount of 
information with regard to cells’ physical properties. 
Fluorochromes (fluorescent probes) may also be measured using flow cytometry, and a wide 
choice of (primarily monoclonal) antibodies is available on the market for use with a range of 
specific antigens. Peridinin Chlorophyll Protein (PerCP), Allophycocyanin (APC), 
Phycoerythrin with Cyanine (PE-Cy) and Pacific Blue are all popular choices for targeting 
cell content, e.g. DNA (Hoechst 33342 or propidium iodide (PI)). When light is absorbed by 
fluorochromes, this energises the electrons, making them unstable. Light of a longer 
wavelength is then emitted. That ‘emission wavelength’ reveals specific characteristics about 
the emitting molecule. Spectral overlaps may occur when more than one fluorochrome is 
used, and this must be taken into account when interpreting the results. The emitted photons 
are detected by a photomultiplier tube (PMT), which uses a photocathode to generate a 
corresponding voltage and consequently, a pulse. This pulse is then converted into a digital 
signal for data analysis by the computer, which records fluorescence quantity and intensity 
and can report this data in various graphical ways (Scheffold and Kern, 2000; Stewart, 2000; 
Bakke, 2001; Givan, 2001). 
Table 2.1. Antibodies used in immunophenotyping of mouse splenocytes and 
thymocytes 
Laser Bandpas
s filter 
Fluorochromes Antibodies Source Catalogue 
number 
Quantity 
(µl) 
Blue 
488nm 
780/60 PE-Cy7 CD4 BD 552775 5µl 
Blue 
488nm 
530/30 GFP ………... Genetically 
modified 
Genetically 
modified 
……….. 
Violet 
405nm 
450/50 Pacific Blue CD8a BD 558108 5µl 
Red 
633nm 
660/20 APC CD11b MACS 130-091-241 5µl 
Blue 
488nm 
682/33 PerCP CD45R 
(B220) 
MACS 130-102-213 5µl 
 
Splenocyte and thymocyte populations were prepared (at each time point for FACS) by 
addition of 5µl CD4 (PE-Cy7), 5µl CD8a (APC), 5µl CD11b (APC) and 5µl CD45R-B220 
(PerCP) to 2x106 cells after the cells were washed by centrifugation. Cells were then 
incubated in the dark at room temperature for 10 minutes before being washed using BD 
FACS lyse/wash assistant, and analysed in FACSCanto II 424 (BD, USA). The same steps 
were applied for mTert-GFP+ cells, but 5 colours were detected by FACS, as GFP was the 
extra one.  
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Figure 2.8. Flow cytometer principle 
Laser analysis of cells in sheath fluid is carried out to identify different physical and 
fluorescent properties, using a range of lenses and sensors. The signal is transmitted 
via a photomultiplier tube (PMT) to a computer, where it is digitised and converted to 
data. 
 
 
 
 
 
Figure 2.9. Flow cytometry analysis on single cell level: modified from (Dimmick, 
2009) 
Laser beams become diverted when they hit a cell. Relative directions of the forward 
scatter detector and side scatter detector and fluorescence of the fluorochromes. 
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2.2.9.2 Strategy for FACS gating of wild-type cells 
Dying and dead cells were gated as accurately as possible from the main population of P1 
events. B-cells (CD45R(B220)) and monocytes (CD11b) were discounted from the negative 
B-cell population. CD4+, CD8+, DP and DN cells were then determined and gated from 
negative monocytes. Fluorochromes of CD4+, CD8+, CD11b and CD45R(B220) were 
recorded and compared with negative controls from the same cell populations, with all other 
conditions remaining the same. In total, 50,000 live events were recorded using FACSCanto 
II, running FACSDiva software. These were then scored and analysed (Figure 2.9). 
 
Figure 2.10. FACS gating strategy for wild-type cells 
CD45R(B220) positive (B-cells) were gated from the main lymphocyte population (P1). 
CD11b positive (monocytes) were then gated from the CD45R(B220) negative (B-cell) 
population. Finally, CD4+, CD8+, DP and DN T-lymphocytes were gated from the 
CD11b negative (monocytes) population. 
 
2.2.9.3 Strategy of FACS gating of mTert-GFP+ cells 
The cells were gated in the main lymphocyte population as P1 events, excluding dying and 
dead cells as far as possible. Having excluded B-cells (CD45R(B200)) from lymphocyte (P1), 
monocytes (CD11b) were similarly discounted from the population of negative B-cells. GFP+ 
cells were gated from negative monocytes. Then, CD4+, CD8+, DP and DN cells were 
determined and gated from both GFP positive and GFP negative cells. Furthermore, GFP+ 
cells were gated in a positive population of B-cells and monocytes. GFP expression was 
measured against non-transgenic cell controls, and the remaining fluorochromes were 
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compared with negative controls from the same cell populations, with all other conditions 
remaining the same. In total, 50,000 live events were recorded using FACSCanto II, running 
FACSDiva software, which were then scored and analysed (Figure 2.10). 
Figure 2.11. FACS gating strategy for mTert-GFP+ mice cells 
Step 1: After gating and determining the lymphocyte population (P1), B-cells were 
excluded.  Step 2.1: Monocytes were excluded from negative B-cells. Step 2.2: B-
cell+GFP+ cells were determined from B-cells+. Step 3.1: GFP+ cells were excluded 
from negative monocytes. Step 3.2: Monocyte+GFP+ cells were determined from 
monocytes+. Step 4.1: T-cells (CD4+, CD8+, DP and DN cells) were determined and 
gated from negative GFP cells. Step 4.2: GFP+T-cells+ (CD4+, CD8+, DP and DN 
cells) were determined and gated from GFP positive cells. 
 
2.2.10 Quantification of oxidative stress and mitochondrial membrane potential 
 
These techniques were performed together with Dr. G. Saretzki at the Campus for Ageing and 
Vitality at Newcastle University, using splenocytes that I had prepared. 
DHE staining 
Dihydroethidium was purchased from Molecular Probes (Life Sciences). A working solution 
of 1:500 dilution was produced by adding 2µl of stock solution (5mM in DMSO) to 1ml of 
DMEM medium without serum. Mitochondrial superoxide levels were measured by staining 
n≈2x105 cells with 10µM DHE. This was left in total darkness at 37°C for 30 minutes, then 
incubated and spun for three minutes at 1800rpm. After discarding the supernatant, the cells 
were re-suspended in 3ml of DMEM. FL3 median fluorescence intensity was measured using 
Step2.1	
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Step4.1	
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flow cytometry (Partec, Germany). Those cells that remained unstained were re-suspended in 
DMEM with FCS and measured at FL3. The resulting value was then subtracted from that of 
the stained cells. 
 
Measurement of the mitochondrial permeability transition using JC-1 probe: 
(5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide, Molecular Probes, 
T3168) 
Approximately 2x105 cells were pelleted and re-suspended in 300µl RPMI 1640. 200µl of JC-
1 (1µl/ml in phenol red and supplement-free RPMI) was prepared, then mixed vigorously by 
pipette with the suspension, giving a JC-1 concentration of 1ug/ml. 
 
Following incubation and centrifugation as above, the cells were then washed in cold PBS 
and re-suspended in 3ml PBS at room temperature. Cells were then measured for FL1 and 
FL3 fluorescence using flow cytometry. The amount of FL3 fluorescence of unstained cells 
was subtracted from FL1 and the ratio between FL3 and FL1 provided a measure for the 
membrane potential. 
 
At low membrane potential or at concentrations below 0.1µM, the green fluorescent JC-1 
probe exists as a monomer. At higher concentrations or higher membrane potentials, red JC-1 
aggregates are formed by JC-1. These exhibit a broad excitation spectrum with a maximum 
emission at 590nm. The green fluorescent monomer emissions (absorption/emission maxima 
510/527nm in water) can therefore be combined with the aggregate to yield various ratio 
measurements. In the case of flow cytometry, JC-1 can be excited at 488nm and detected in 
bivariate mode, using the green channel for the monomer and the red channel for the J-
aggregate. Both measurements were performed in a Partec Flow cytometer (Partec, Muenster, 
Germany). 
 
2.2.11 Quantification of telomerase activity by TRAP-PCR ELISA 
(Roche, Switzerland) 
Photometric enzyme immunoassay for determination of telomerase activity, using the 
Telomeric Repeat Amplification Protocol (TRAP):  
This assay was performed by Dr. G. Saretzki (Institute for Cell and Molecular Biosciences at 
the Campus for ageing and Vitality at Newcastle University), using splenocytes that I had 
prepared. 
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Cultured cells were added to 1ml cryopreservation medium, then cooled to -80°C. The 
samples were later removed and thawed quickly by rubbing the tubes. These were then 
centrifuged for 5 minutes at 800xg (SİGMA 1-14, 134744, Germany) and the supernatant 
removed. The cells were washed in 1ml PBS, then pelleted at 800xg for 5 minutes. 
 
Following re-suspension in 20µl pre-cooled Lysis reagent, the cells were retropipetted three 
times, then incubated on ice for 30 minutes. Protein content was measured using a Bradford 
assay and 500ng of protein was removed from each sample for the PCR reaction (using 2x 
PCR mix provided with the kit). The TRAP reaction was carried out using a thermal cycler 
(Hybaid) to perform a combined primer elongation/amplification reaction. 
 
Table 2.2. TRAP reaction protocol 
 Time Temp Cycles 
Primer elongation 30min 25°C 1 
Telomerase inactivation 5min 94°C 1 
Amplification: 
Denaturation 
Annealing 
Polymerization 
 
30s 
30s 
90s 
 
94°C 
50°C 
72°C 
30 
 10min 72°C 1 
Hold  4°C  
 
Hybridisation and ELISA procedure: 
5µl of the amplification product was added to 20µl of denaturation reagent per sample in an 
Eppendorf tube, and incubated at 15-25°C for 10 minutes. 225µl of hybridization buffer was 
added and mixed by vortex in each tube. 100µl from each tube was then transferred to pre-
coated MP modules (Roche), and covered with a self-adhesive foil to prevent evaporation. 
Following incubation on a 300rpm shaker at 37°C for 2 hours, the hybridization solution was 
removed and the wells were rinsed in 200µl (per well) of washing buffer. The process was 
repeated 4 times before completely removing the washing buffer. 
 
100µl of Anti-DIG-POD working solution was added to each well. Once again, the MP was 
covered with foil and incubated on a 300rpm shaker at 18-22°C for 30 minutes. The wells 
were washed 5 times x 30s with 200µl of the same washing buffer. 100µl room temperature 
TMB substrate solution was added to each well. These were incubated for colour 
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development, shaking very slowly either manually or on a shaker at 50 rpm at 15°C - 25°C 
for around 15 minutes. 100µl of stop reagent was added to each well immediately after 
incubation, causing the reacted POD substrate to change colour from blue to yellow, 
maximizing sensitivity. Each sample’s absorbance level was measured within the following 
30 minutes using the Omega spectrophotometer microplate reader (BMG Labtech) at 450nm. 
 
2.2.12 Total RNA isolation and cDNA synthesis 
 
Total RNA isolation 
 
Cultured cells were added to 1ml cryopreservation medium, then cooled to -80°C. The 
samples were later removed and thawed quickly by rubbing the tubes. These were then 
centrifuged for 5 minutes at 800xg (SİGMA 1-14, 134744, Germany) and the supernatant 
removed. The cells were washed in 1ml PBS, then pelleted at 800xg for 5 minutes. The 
pellets were thoroughly mixed with 1ml of TRIzol (155966026, Life Technologies, USA) and 
incubated at room temperature for 5 minutes. 250µl chloroform was added to the TRIzol 
mixture and the tubes were shaken vigorously for 15 seconds, then incubated for a further 5 
minutes at room temperature. The samples were spun down at 10,000 rpm for 5 minutes and 
three layers were formed as follows: top layer: clear-aqueous, interphase layer: white 
precipitated DNA and bottom layer: pink organic phase. 
 
The top of clear-aqueous layer was carefully extracted to a fresh 1.5ml eppendorf tube using a 
200µl pipette (leaving about ≥ 1mm behind to avoid DNA contamination). Top layer 
containing RNA was mixed gently with 550µl isopropanol and incubated for 5 minutes at 
room temperature. The cells were pelleted at 14,800 rpm for 30 minutes and the isopropanol 
removed by pipette. The pellets were then washed over ice with 1ml of 75% ethanol (Sigma, 
7023, USA) in distilled water (Gibco, DNase/RNase Free, 10977-035, UK) 
 
This mixture was centrifuged for 5 minutes at 9500 rpm and the ethanol was aspirated. The 
samples were then returned to ice, and any remaining ethanol was evaporated by keeping 
tubes open. To accelerate the process, the RNA pellets were centrifuged again at high speed 
(14,800 rpm) for 30 seconds and a 10µl pipette was used to carefully aspirate the remaining 
ethanol. 20µl of distilled water was added and gently mixed with the RNA pellet. The total 
RNA concentration was determined using a Thermo Scientific NanoDrop spectrophotometer 
(8-sample spectrophotometer, ND-8000 UV/Vis, 0319, USA). 
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One drop (3µl) of distilled water was pipetted on to the 8-sample pedestal and this was 
cleaned using Whatman paper after the sampling arm was closed for few seconds. ND-8000-
V2.2.1 was operated, then nucleic-acid standard method was chosen following preparation 
and a blank measurement. One drop of (the same buffer that was used to dilute the RNA 
pellet) distilled water (Gibco, DNase/RNase free, 10977-035, UK) was loaded to lower 
sample pedestal. The sample type was then switched from DNA-50 to RNA-40 after the 
sampling arm was closed. The blank was measured and stored with DNase/RNase free 
distilled water. Both sample pedestals were cleaned again using Whatman paper. The lower 
sample pedestals were loaded with 2µl RNA samples and were then activated from the 
computer program. RNA concentration measurement was chosen and result was recorded as 
ng/µl. 
 
The quality of the RNA concentration at ratio of 260/280 was determined using the RNA 
wavelength (260nm) and protein wavelength (280nm). Following this measurement, the 
sampling arm was opened and both pedestals were cleaned with distilled water and Whatman 
paper. The RNA samples were cryopreserved at -80°C for further use.  
 
cDNA synthesis 
 
A High Capacity cDNA Reverse Transcription kit (Applied Biosystems AB, 4368814, USA) 
was used to synthesise the first strand of cDNA. Kit reagents and RNA samples were thawed 
on ice separately. 500ng of RNA was diluted in cold distilled water in individual PCR tubes at 
up to 10µl/reaction. This was followed by adding 10µl/reaction of 2X reverse transcription 
(RT) master mix to the same PCR tube. 
 
The master mix was prepared as 2µl of 10X RT reverse transcription buffer (4319981); 0.8µl 
of 25X dNTP Mix (100mM, 4367381, AB, UK); 2µl of 10X RT reverse transcription random 
primers (4319979, AB, USA); and 1µl of MultiScribe Reverse Transcriptase (1312125, AB, 
USA), mixed with 4.2µl of cold distilled water. The mixture was placed on ice and mixed via 
pipette. The mixture was then centrifuged (Eppendorf, centrifuge 5810R, Germany) at 
maximum speed for 1 minute to spin down the mixture and expel air bubbles. It was then 
either placed on ice until needed or loaded directly onto a thermal cycler (SENSOQUEST, 
Labcycler, Germany), which was programed for 4 steps as follows: 10 minutes at 25°C; 120 
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minutes at 37°C; 5 minutes at 85°C; then incubated at 4°C, using infinity as a time unit. The 
first strand of cDNA was stored at -20°C until required for further use. 	
2.2.13 Quantitative Polymerase Chain Reaction (q-PCR) 
 
TaqMan Gene expression (Applied Biosystems 4369016, US) approaches was used to test 
gene expression of synthesised cDNA. First strand cDNA was synthesised from total RNA. 
This was isolated, then stored at -80°C. cDNA tubes were thawed on ice and separated 
completely from the Master Mix primers, using TaqMan to avoid any contamination. 
 
TaqMan procedure 
1µl 20X TaqMan gene expression assay was mixed with 10µl 2X TaqMan gene expression 
master mix to create the TaqMan Master Mix, which was used for a single reaction and 
diluted in 5µl of DNase/RNase-free water (gibco, DNase/RNase free, 10977-035, UK). Each 
single reaction was triplicated and aliquoted to either 96- or 384-well reaction plates. 4µl 
cDNA was then pipetted per single reaction, after cDNA was diluted with DNase/RNase-free 
water to 30ng for each sample. Each plate was loaded to an appropriate Real-Time PCR 
machine (the 96-well plate was run at Applied Biosystems 7500 fast real-time PCR system 
and 384-well plate was run at Applied Biosystems QuantStudio 7 flex) and both machines 
applied a standard run. Three stages of thermal cycling were conducted as follows: 
1) Hold for 2 minutes at 50°C 
2) Hold for 10 minutes at 95°C 
3) 40 cycles of 95°C for 15 seconds followed by 1 minute at 60°C 
Rn18s was used as housekeeping gene primer and gene expression was quantified against the 
no activation cell group as control for activation group. The activation group was used as a 
control for the treated group.   
 
Table 2.3. Different specificities of studied primers 
Primers (TaqMan)	 Sequence 5’-3’ 
Forward – Reverse 
“Information is not released by the company”  
Annealing 
temperatur
e (˚C)	Rn18s	 Mm03928990_g1,	1341105	 72	IL-2	 Mm00434256_M1,	1328535	 72	IFN-gamma	 Mm01168134_M1,	1340467	 72					
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2.2.14 Quantification of mouse regulatory T-cells  	
1x106 splenocytes were centrifuged at 300g for 10 minutes and the supernatant was aspirated. 
Cells were then resuspended in 1x106/90µl of buffer. 10µl of CD4-FITC and CD25 antibody 
was added to the suspension and mixed well (FoxP3-APC, 130-094-164, MACS). Cells were 
incubated at 4°C for 10 minutes in the dark, then washed in 1ml of buffer per 1x106 cells and 
centrifuged at 300g for 5 minutes at 4°C and the supernatant aspirated. 1x106 cells were 
resuspended in cold, fresh Fixation/Permeabilization Solution then mixed well. Cells were 
incubated for 30 min in the dark at 4°C. Cells were washed in 1ml of cold buffer per 1x106, 
then centrifuged at 300g for 5 min at 4°C and the supernatant aspirated. Cells were washed in 
1x Permeabilization Buffer per 1x106 cells, then centrifuged at 300g for 5 min at 4°C and the 
supernatant aspirated. Cells were then resuspended in 80µl of cold 1x Permeabilization 
buffer, mixed well and incubated for 5 min at 4°C. 10µl of Anti-FoxP3 antibody was added to 
the cells, which were mixed well and incubated for 30 min in the dark at 4°C. Cells were then 
washed in 1ml of cold 1x Permeabilization buffer and centrifuged at 300g for 5 min at 4°C 
and the supernatant aspirated. A wash-only programme was then used, involving BD FACS 
Lyse/Wash Assistant (337146, USA). T-cell surface marker expression was measured and 
scored against negative controls. 50,000 live events were scored and analysed using 
compensated FACSCanto II using FACSDiva software. 	
2.2.15 Voluntary wheel running of mice and quantification of running parameters 
with Spike2 (7.12) software 
 
The computer system of voluntary wheel running mice and the facilities combined with it 
were created by Dr. Bill Chaudhry and modified from the University of Oxford (De Bono et 
al., 2006). Each exercise cage was provided with a 37.8 cm diameter angled rotating running 
track (Lillico, Surry, UK), fixed to a greased steel axle attached to a plank. The running 
wheels were angled to allow them to fit inside the smaller cages. Two magnets were affixed 
to the wheel and there a sensor was fixed to the cage. This sensor connected to the Transducer 
(MICRO3, 1401, CED, Cambridge, UK) which simultaneously monitored the individual 
rotations of up to 44 wheels. This transducer was connected to the computer (Figure2 2.11). 
Each magnetic detection was recorded as a ‘tick’ on the computer system and was analysed 
by Spike 2 Cambridge Electronic Design (CED) software, version 7.12 (072866). This system 
recorded and saved each 24 hour cycle in a separate file. From the baseline activity data, the 
running parameters can be calculated as the duration of time continuously spent running, with 
maximum 5 second intervals between recorded wheel rotations. The distance was calculated 
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from the total number of wheel rotations multiplied by the wheel diameter (37.8 cm). The 
average speed in each 24-hour cycle is calculated by dividing the total distance travelled by 
the total duration of running time. Maximum speed was calculated as the fastest upper 99th 
percentile of all wheel rotations during a 24-hour period. Mice, food, water and the recording 
computer system were observed and monitored daily. The steel axle was greased once/twice a 
week if necessary. Mice and food were weighed weekly, and the mice ran voluntarily on the 
running wheel. Some mouse groups on HFD, another group on ND as described at 2.2.1.4. 
 
 
 
 
 
 
Figure 2.12. Illustration of the computer system for the mouse voluntary wheel 
running exercise 
 
Step1: Affix magnet to the outer wheel surface and the sensor on the outside of the 
cage, ensuring both are aligned for detection of the activity. Step 2: connect cages to 
the transducer, with each cage on a separate channel. Step 3: connect the transducer 
to the computer system. Step 4: computer system records the activity and analyses it 
using Spike 2 Cambridge Electronic Design (CED) software, version 7.12 (072866).    
 
 
 
 
 
 
 
Cage1	 Cage2	 Cage3	 Cage4	
Step	1	
Step	2	
Step	3	
Step	4	
Magne,c	Sensor	at	cage		
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2.2.16 Patient recruitment, inclusion and exclusion criteria. 
 
Ethical approval was granted by the National Research Ethics Service (NRES) North East 
Ethics Committee. NHS permissions were granted by the Newcastle University Hospitals 
NHS Trust (REC no: 15/EM/0072). 
19 acute STEMI patients being treated with PPCI at the Freeman Hospital in Newcastle upon 
Tyne gave informed consent to take part in this study. Inclusion criteria were as follows: 
patients must be over 50 years old; they must have acute coronary syndrome (STEMI); they 
must be undergoing percutaneous coronary intervention (PPCI) treatment; they must have 
blood samples taken within 24h of the PPCI following the cardiac rehabilitation programme. 
Additionally, the coronary artery under investigation must be >3mm in diameter, and must be 
proximally occluded (TIMI flow grade 0-1) on admission, then reperfused (TIMI flow grade 
2-3). 
Exclusion criteria were as follows: 
1) Immunological dysfunction (e.g. positive serology for HIV or hepatitis; acute or chronic 
inflammatory or neoplastic co-existing disease). 
2) Haemodynamic instability, cardiogenic shock, unconsciousness. 
3) Open (TIMI >1) culprit coronary artery during angiography. 
4) Any other studies involving investigatory drugs within 30 days prior to this study. 
5) Incapacity to consent verbally. 
6) Non-cardiac condition resulting in life expectancy <1 year. 
 
2.2.17 Accelerometer and GENEActive software for the analysis of daily activity in 
patients with myocardial infarction (MI) 
 
An accelerometer (GENEActive) was used to objectively monitor cardiac each patient’s daily 
physical activity. The device is waterproof, has a sampling frequency of 85.7Hz and measures 
in three dimensions (x, y and z axes), with a dynamic range of ±8g. The data are retained 
onboard, unfiltered on the MEMS chip. Acceleration is expressed in mg (where g = 
acceleration due to gravity = 9.81 m/s2). The GENEActive and Actigraph accelerometers used 
in the NHANES survey (Troiano et al., 2014) were recently validated and strong agreement 
was found between the two devices measuring vector magnitude of wrist acceleration. Intra-
class correlation was >0.95. Oxygen consumption variance was explained (>70%) across a 
range of activities and intensities (Hildebrand et al., 2014). 
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Each patient (with no contraindications, i.e. allergies to plastic or metal) was given the 
accelerometer (GeneActiv; Activinsights Ltd., Kimbolton, Cambs, UK) twice; once at 24h 
after cardiac stent percutaneous coronary intervention (PCI) for 7 days (24-hour periods) 
consecutively, and once after 3 months of cardiac rehabilitation for the same amount of time. 
Accelerometers were fixed in the non-dominant hand and all accelerometers were sent back 
via pre-paid mail at the end of 7 days. Data was expressed in m/s2 and the sample rate was 
75Hz. Static periods were accounted for and corrected accordingly (Lukowics et al., 2004). 
The three raw signals (x, y, z) were used to calculate the Euclidian norm, or magnitude (-1g, 
negative numbers rounded to 0), which gave rise to the movement-related acceleration, 
expressed in milligrams (van Hees et al., 2013) 
 
2.2.17.1 Accelerometer data processing and analysis 
 
After the GENEActive software and accelerometer systems were set up, R-package (R Core 
Team, Vienna, Austria) was used to analyse the binary data, using GGIR software 
[http:/cran.r-project.org] (van Hees et al., 2013) and was sent for further analysis at 
MOVELab (Newcastle University, Newcastle Upon Tyne, UK). 
The average wrist acceleration magnitude (overall volume), time distribution across 
acceleration, and estimated time spent in 5 minute and 10 minute bouts of MVPA were used 
as summary measures. Detailed signal processing adhered to the following: verification of 
sensor calibration error using local gravity as a reference (van Hees et al., 2014) detection of 
sustained abnormally high values; non-wear detection; calculation of the vector magnitude of 
activity-related acceleration using the Euclidian Norm minus 1 g (ENMO: 𝑥! + 𝑦! + 𝑧! - 
1g) with any negative values rounded up to zero; exclusion of the first 10h and last 20h of the 
measurement (van Hees et al., 2013).  
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Figure 2.13. GENEActiv devices 
A. GENEActiv accelerometer: given to participants to record and store daily physical 
activity. B. Charger cradle: used to connect the accelerometer to the computer 
system, C. The accelerometer is inserted into the cradle until a firm click is heard and 
the light flashes. D. GENEActiv software setup page, providing participant 
information (participant code, age, BMI, etc.), measurement frequency, time and 
recording start mode, etc. E. GENEActiv software data extraction page which shows 
a preview of the first few minutes of data collected and allows data to be downloaded 
to a chosen file location. 
 
2.2.18 Cardiac rehabilitation programme 
At the Freeman Hospital (Newcastle Upon Tyne, UK) all cardiac patients (15/EM/0072) went 
for cardiac rehabilitation, which was tailored according to the severity of each patient’s 
condition and their need for recovery to normal daily activity and a productive life, to prevent 
further complications as per National Health Service (NHS) UK recommendations. Patients 
who participated in this study were diagnosed by a cardiologist with acute coronary syndrome 
(STEMI) and underwent percutaneous coronary intervention (PPCI). In accordance with NHS 
regulations, these patients underwent cardiac rehabilitation one week after myocardial 
infarction. In this study, we accepted any type of aerobic exercise as cardiac rehabilitation, 
but not as a strengthening exercise. There was variation in aerobic exercise between patients 
(table 2.4) and the exercise location differed between patients depending on where they live. 
The main goal here was to discover whether aerobic cardiac rehabilitation (for 3 months) had 
Charger	cradle	
GENEAc/v	accelerometer	
A	
B	
C	D
E
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an effect on telomerase activity, telomerase length and lymphocytes (immune cells), 
regardless of the type of aerobic exercise, duration of the session, location (place) of the 
exercise, and of the medical team who care for and observe the patient. The primary aim was 
to find out the potential benefit, and changes in clinical condition, after cardiac exercise 
rehabilitation vs. before cardiac exercise rehabilitation. 
Table 2.4. Aerobic exercise types Patient	number	 Type	of	Aerobic	exercise	 Rehabilitation	centre	2	 Walk	and	general	activity	 No	1	 Walk	and	running	 Yes	1	 Walk	and	steps	exercise	 Yes	1	 Stationary	cycling	 Yes	3	 Aerobics	classes	 Yes			
2.2.19 Human regulatory T-cells quantification 
 
Whole fresh blood from patients with acute myocardial infarction (MI) was collected in 10ml 
heparinized vacutainer tubes 24-hours post-STEMI and 3 months post-heart attack. 100µl was 
transferred to a FACS tube (FALCON, 352054, Mexico) with two controls (Isotype control-
PE and FMO-CD25 control, BD). All samples were incubated in the dark at room temperature 
for 20 minutes with 5µl anti-CD4-V500, 20µl anti-CD3-PerCP, BD. The test tube and isotype 
control tubes used 20µl anti-CD25-APC, whilst the control tube did not. Lysing solution: 
Pharm Lyse (BD, Pharm Lyse, 555899) was diluted 1:10 with water (Sigma, 7732-18-5), then 
1ml of the diluted lyses reagent was added to all tubes. This was incubated for 15 minutes at 
room temperature in the dark. Lysing mixture was washed with 2ml/tube of 5% FBS (PAA, 
A15 151) in PBS, pH 7.4, then centrifuged at 500xg for 5 minutes and the supernatant was 
removed. The washing step was repeated and the pellet was gently resuspended in residual 
wash buffer. 2ml of human FoxP3 buffer A (BD, 560098), diluted 1:10 with (room 
temperature) water (Sigma, 7732-18-5),	was added to cells and vortexed and then incubated 
for 10 minutes at room temperature in the dark. This was centrifuged at 500xg for 5 minutes 
and the fixative was removed gently by pipette. The pellet was then rinsed in 2ml 5% FBS in 
PBS and centrifuged for a further 5 minutes at 500xg. The supernatant was aspirated and the 
pellet was gently resuspended in residual wash buffer. Diluted Human FoxP3 buffer B (BD, 
51-9005450) was mixed with diluted Human FoxP3 buffer A at ratio of 1:50 to create Human 
FoxP3 buffer C. 0.5ml of this was added to the cells to permeabilise them. This mixture was 
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incubated for 30 minutes at room temperature in the dark. The permeabilising mixture was 
washed with 2ml/tube of 5% FBS/PBS, pH 7.4, then centrifuged at 500xg for 5 minutes and 
the supernatant removed. The washing step was repeated. 
	
20µl FoxP3-PE (BD, 560046) was added to test tube and FMO-CD25 control, whilst 20µl PE 
Mouse IgG1k Isotype Control (BD, 556027) was added to the Isotype control-PE tube. All 
tubes were gently shaken by vortex and incubated for 30 minutes at room temperature in the 
dark. Cells were then washed, using a wash only programme, using BD FACS Lyse/Wash 
Assistant (337146, USA). Expression of regulatory T-cell surface markers was scored against 
two negative controls. One tube was stained without CD25-APC and another tube stained 
with PE Mouse IgG1k Isotype Control instead of FoxP3. Compensated FACSCanto II 
utilising FACSDiva software was used. 30,000 CD3+/CD4+ live events were scored for 
analysis. 
 
 
Table 2.5. Antibodies and reagents used with human regulatory T-cells 
Reagent Source Quantity (µl) 
CD3-PerCP BD, 345766 20 
CD4-V500 BD, 560768 20 
CD25-APC BD, 555434 5 
FoxP3-PE BD, 560046 20 
PE Mouse IgG1k Isotype Control BD, 556027 20 
Human FoxP3 Buffer Set BD, 560098 See above description 
Lysing Buffer BD, 555899 See above description 
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Figure 2.14. FACS gating strategy for human regulatory T-cells quantification 
Step 1: After gating and determining the lymphocyte population (cells), CD4+ T-
lymphocytes (CD3+/CD4+) was gated. Step 2: CD4+CD25+ cells were determined from 
CD4+ population. Step 3: CD25+FoxP3+ cells were determined from CD4+CD25+ 
population. Step 4: CD4+CD25+highFoxP3+ cells were determined from CD4+CD25+high 
population. Step 5: CD25-FoxP3+ cells were determined from CD4+CD25- population. 
Two controls (-CD25 and –FoxP3) were used to quantify the Tregs. 
 
2.2.20 Human whole blood TruCount 
50µl of complete blood was placed in the centre of the TruCount tube by electronic reversal 
pipette. 10µl of BD Multitest 6-color (TBNK, 337166, BD) was added to a blood sample and 
mixed well by gently vortexing. The mixture was incubated at room temperature for 25 
minutes in the dark. 1ml of (1:10) lysing buffer (555899, BD) was added to the blood mixture 
and incubated for 15 minutes at room temperature in the dark. The tube was then placed on a 
roller (SRT6, Stuart, UK) at room temperature in the dark for 5 minutes. The BD FACSCanto 
II software for TruCount was set up, using 7-color setup beads (BD, 335775). 500µl of Bead 
Step1	
Step2	
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ep
3	
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ep
4	
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ep
5	
Control	(-CD25)	 Control	(-FoxP3)	
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diluent (BD FACS 7-colour setup B, Bead Diluent, 336565) was added to the 7-colour setup 
beads tube and mixed well by gentle vortex. This tube was run in FACSCanto II software to 
setup the system. When the setting passed, the sample tube was run and TruCount cells were 
calculated by software system. 
2.2.21 Telomere length determination in human PBMNCs 
The assay was performed by the Biomarker lab of the Institute of Neurosciences at the 
Campus for Ageing and Vitality, Newcastle University, using splenocytes that I had prepared. 
The QiaAmp DNA mini Kit (QIAGEN, Hilden, Germany) was used to extract DNA from the 
PBMC. Quality and concentration was established using NanoDrop (ThermoScientific). 
Using a modified method, similar to that described by Martin-Ruiz et al., 2005, based on the 
abundance of telomeric template, telomere length was compared to a single copy gene 
(36B4), using the following primers: TelA (5’ CGG TTT GTT TGG GTT TGG GTT TGG 
GTT TGG GTT TGG GTT 3’); TelB (5’ GGC TTG CCT TAC CCT TAC CCT TAC CCT 
TAC CCT TAC CCT 3’); 36B4F (5’ CAG CAA GTG GGA AGG TGT AAT CC 3’) and 
36B4R (5’ CCC ATT CTA TCA TCA ACG GGT ACA A 3’). Plate-to-plate variation was 
accounted for by using three internal control DNA samples, whose telomere length was 
already known (10.4 kb, 3.9 kb and 2 kb), and each measurement was carried out three times, 
using an Applied Biosystems 7900HT Fast Real Time PCR system with 384-well capacity. 
The intra-assay variation coefficient was 2.7% (Martin-Ruiz et al., 2005). 
2.2.22 Statistical analysis 
Graphs from all test results were produced using GraphPad Prism version 6.0. All data are 
displayed as mean ± standard error of the mean (sem) except where otherwise stated. A p-
value of < 0.05 was considered statistically significant. The paired T-test and nonparametric 
tests (two-tailed), followed by the Wilcoxon matched-pairs signed rank test (confidence level 
of 95%) were used to compare two matching groups with one different parameter. An 
unpaired T-test and nonparametric test (two-tailed), followed by the Mann-Whitney test were 
used to compare two non-matching groups with one different parameter at a confidence level 
of 95%. Multiple groups, differing in just one parameter were compared using one-way 
ANOVA and Dunnett’s test as post-hoc test. Multiple groups with two different parameters, 
represented at different time points, were compared using the two-way ANOVA, multiple 
comparisons, followed by a Tukey test. All n-numbers indicated for the different experiments 
(in vitro or in vivo) are independent biological repeats, either mice or cells derived from 
independent mice.   
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CHAPTER 3. Effect of mild chronic oxidative stress on 
proliferation and regulation of telomerase in splenocytes and 
CD4+ T-lymphocytes 
 
3.1 Introduction 
 
Atherosclerosis is a cardiovascular disease characterized by chronic inflammation and 
oxidative stress. Chronic oxidative stress has been implicated in atherosclerotic plaques and 
endothelial dysfunction that contributes to vascular inflammation (Guzik et al., 2006; Heitzer 
et al., 2001). Oxidative stress was found to enhance atherogenesis in the vascular wall, which 
may lead to inflammation or myocardial infarction (Sorescu et al., 2002).  
 
Lymphocytes play an important role in atherosclerosis but its mechanisms are complicated, as 
some subsets accelerate atherosclerosis, whilst others are atheroprotective. Th1, Th2, Th17 
and Tregs are the subset of CD4+ cells. CD4+ with CD8+ are components of T lymphocytes. 
From a population of T lymphocytes, CD4+ cells have a contradictory role with 
atherosclerosis, as Th1 secretes IFN-γ cytokines, which are proatherogenic (Frostegård et al., 
1999). Th2 cells are associated with recovery from myocardial infarction (Frostegård et al., 
1999; Engelbertsen et al., 2013). Recently, the study of B cells has identified a controversial 
role with atherosclerosis. B cells are of two main types: B1 and B2 (Ait-Oufella et al., 2010). 
B1 cells were classified as atheroprotective, secondary to the natural IgM antibodies produced 
(Perry et al., 2013; Chou et al., 2008). Some studies indicate that B2 cells are also 
atheroprotective (Caligiuri et al., 2002; Doran et al., 2012), whilst others argue that B2 cells 
are proatherogenic (Ait-Oufella et al., 2010; Kyaw et al., 2010). 
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3.2 Results 
 
3.2.1 Hyperoxia induces oxidative stress and inflammation in lymphocytes 
 
3.2.1.1 Hyperoxia induces oxidative stress in splenocytes and CD4+ T-cells 
 
 
To study the effect of oxidative stress on cells, a 40% O2 saturation level (hyperoxia) was 
chosen to create an oxidative stress environment in the culture. In order to analyse the level of 
ROS, oxidative stress was measured using dihydroethidium (DHE). DHE is cell-permeable 
and reacts with O2- to create ethidium, which exhibits red fluorescence when it binds to 
nuclear DNA (Benov et al., 1998; Zhao et al., 2003). Cells were cultured (tert+/+ and tert-/- 
splenocytes for ≥ 20 days and CD4+ T-cells for 10 days), then stained with DHE as described 
at (2.2.10).  
 
40% oxygen saturation (hyperoxia) produced significant (P<0.01) oxidative stress in both 
genotypes, Tert+/+ and Tert-/- (figure 3.1A), compared to Tert+/+ hypoxia (3% O2). There were 
no significant changes between 3% O2 Tert+/+ vs. 3% O2 Tert-/-. The cell genotype also has no 
effect on oxidative stress. 40% O2 produced significantly (P<0.05) greater oxidative stress 
with Tert+/+ CD4+ T-cell (figure 3.1B), compared to Tert+/+ 3% O2. Finally, Hyperoxia (40% 
O2) saturation is an in-vitro model to increase oxidative stress. 
 
3.2.1.2 The effect of hyperoxia on mitochondrial membrane potential levels in 
splenocytes and CD4+ T-cells 
 
As found in the previous experiment, hyperoxia (40% O2 saturation) increased oxidative 
stress in vitro, highlighting the importance of mitochondria as its dysfunction leads to 
increased oxidative stress (Dexter et al., 1989; Zhang et al., 1999). Mitochondria are 
ordinarily associated with cellular energy production, but also serve functions beyond this 
role. Mitochondrial membrane potential measurements have indicated a role in both normal 
cell function and cell death (Škárka and Oštádal, 2002; Adams et al., 2000). Oxidative stress 
can be controlled in vitro. In human fibroblasts, increasing oxidative stress accelerates 
telomere shortening in replicating DNA, whereas decreasing oxidative stress has the opposite 
effect, resulting in an increased cell lifespan (von Zglinicki et al., 1995; Saretzki et al., 2003). 
Induction of telomere damage results in mitochondrial dysfunction and consequently 
senescence within a dividing cellular population (Passos et al., 2007; Saretzki, 2009).  
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This experiment was therefore designed to establish the extent to which mitochondrial 
function under ROS production may affect cell proliferation. The JC-1 fluorescence ratio was 
used to measure the mitochondrial membrane potential levels as described at (2.2.10). These 
properties are important because the physiological function of the respiratory chain ATP 
relies on mitochondrial membrane potential (Joshi and Bakowska, 2011). 
Splenocytes from either wild-type Tert+/+ or Tert-/- mice were cultured for ≥ 20 days and CD4+ 
T cells from Tert+/+ (wild-type) mice were cultured for 10 days. Figure 3.2A shows no 
significant effect of the increased oxidative stress in this experiment on mitochondrial 
membrane potential levels for both genotypes. The same result was found with tert+/+ CD4+ T-
cells (figure 3.2B). In conclusion, oxidative stress produced secondary to 40% oxygen 
saturation does not seem to be associated with mitochondrial membrane potential levels in 
splenocytes and CD4+ T lymphocytes.  
 
3.2.1.3 Oxidative stress produces inflammation in mice splenocytes 		
An imbalance between free radical production, reactive metabolites, oxidants and antioxidants 
is known as ‘oxidative stress’, which may cause damage to biomolecules, cells, and 
potentially an entire organism (Duracková, 2008). Oxidative stress, among other factors, 
including biological, chemical and physical, may cause chronic inflammation (Bartsch and 
Nair, 2006). IFN-γ is a key proatherogenic cytokine, expressed in arterial plaques during 
inflammation (Frostegård et al., 1999). 
 
The goal for this experiment was to establish whether oxidative stress caused by hyperoxia 
(40% O2 saturation) leads to inflammation, by measuring transcription of IFN-γ. Splenocytes 
were cultured for 3 days, then IFN-γ transcription was measured by RT-PCR at day 1, 2 and 
3, as described at (2.2.13). 
Figure 3.3 shows that the IFN-γ mRNA transcription declined between day one and day three 
under hypoxia (3% O2 saturation), whereas it increased under hyperoxia (40% O2 saturation). 
At day 3, there was a significant (P<0.05) difference in the level of IFN-γ mRNA 
transcription between 3% and 40% O2 saturation, with the hyperoxic condition yielding a 
15.3-fold increase. From this we can conclude that the oxidative stress produced under 
hyperoxia also induces inflammation. 40% oxygen saturation (hyperoxia) provides a suitable 
in vitro model to produce inflammation. Furthermore, it seems that 3% oxygen saturation also 
initially induces inflammation, but it is reduced by day 3, while under 40% oxygen saturation 
the inflammation response seems to remain constant. 
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Figure 3.1. Oxidative stress levels as measured by dihydroethidium (DHE) 
fluorescence.  
 
A-B. Plates were coated with anti-CD3 and anti-CD28 antibodies (prepared at 1µl/ml 
PBS). Medium was changed and 1.5µg/ml IL-2 was added every 2-3 days for all 
experiments. Cells were cultured under 3% and 40% oxygen saturation. A. 
Splenocytes from either Tert+/+ or Tert-/- mice were seeded at 2x106/ml in a 24-well 
plate. Splenocytes were cultured for ≥ 20 days (n=4). B. CD4+ T cells from wild-type 
(Tert+/+) mice were seeded at 2x105 cells/well (volume = 200µl/well) in a 96-well 
plate. CD4+ T-cells were generated by immunomagnetic bead-isolation from 
splenocytes and cultured for 10 days (n=3). TERT+/+ under 3% O2 was used as 
100%. All values are displayed as mean±sem. *P<0.05, **P<0.01 for comparison 
between oxygen saturation levels using 2-way ANOVA for A, and two-tailed unpaired 
t test for B. 	
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Figure 3.2. Mitochondrial membrane potential levels as measured by JC-1 
fluorescence ratio.  
 
A-B. Plates were coated with anti-CD3 and anti-CD28 antibodies (prepared at 1µl/ml 
PBS).  Medium was changed and 1.5µg/ml IL-2 was added every 2-3 days for all 
experiments. Cells were cultured under 3% and 40% oxygen saturation.  
A. Splenocytes from either wild-type Tert+/+ or Tert-/- mice were seeded at 2x106/ml in 
a 24-well plate. Splenocytes were cultured for ≥ 20 days (n=4). B. CD4+ T cells from 
wild-type (Tert+/+) mice were seeded at 2x105 cells/well (volume = 200µl/well) in a 96-
well plate. CD4+ T-cells were generated by immunomagnetic bead-isolation from 
splenocytes and cultured for 10 days (n=3). All values are displayed as mean±sem. 
(ns) no significant for comparison between oxygen saturation levels using 2-way 
ANOVA for A, and two-tailed unpaired t test for B.  				
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Figure 3.3. Oxidative stress enhances transcription of IFN-gamma mRNA.  
 
Splenocytes from wild-type (Tert+/+) mice were seeded at 2x106/ml in a 24-well plate. 
Splenocytes were cultured for 3 days. Plates were coated with anti-CD3 and anti-
CD28 antibodies. Control cells grew on uncoated wells. Cells were cultured under 3% 
(hypoxia) and 40% (hyperoxia) oxygen saturation. All values are displayed as 
mean±sem (n=3). *P<0.05 for comparison between oxygen saturation levels using 
two-tailed unpaired t test.  																	
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3.2.2 Hyperoxia suppresses splenocyte proliferation by a telomerase dependent 
mechanism 
 
3.2.2.1 Effects of telomerase and oxidative stress on splenocyte proliferation 
 
Having confirmed that hyperoxia leads to increased oxidative stress (Figure 3.1) and 
inflammation, I next sought to investigate how this affects the proliferation of lymphocytes. 
In order to test this I used a hyperoxic 40% oxygen saturation and compared this to 3% 
oxygen saturation. Mouse splenocytes were cultured and T-cells specifically activated with 
anti-CD3e/anti-CD28 micro-beads. As shown in figure 3.4, splenocytes proliferated under 3% 
oxygen saturation from 2x106/well on day zero to 55.7±4.6x106/well after 28 days. 
Interestingly, under hyperoxic conditions cell proliferation was diminished significantly, 
resulting in 38.4±0.73x106/well after 28 days (P<0.0001). 	
Telomerase has been shown play a crucial role in cell proliferation (Martin-Rivera et al., 
1998), especially in lymphocytes (Buchkovich and Greider, 1996).  To investigate the role of 
telomerase in oxygen dependent inhibition of proliferation, I isolated splenocytes from 
telomerase deficient mice (TERT-/-). As expected, TERT-/- cells proliferated almost 2.4-fold 
less under 3% oxygen saturation compared to TERT+/+ cells (22.9x±4.2x106/well vs. 
55.7±4.6x106/well, respectively, P<0.0001) (Figure 3.4). Surprisingly, there was no further 
decrease in proliferation under 40% oxygen saturation in the TERT-/- cells, as present in 
TERT+/+ cells, suggesting that the effect of hyperoxia and oxidative stress on T-cell 
proliferation is dependent on telomerase. 	
Altogether, TERT+/+ splenocytes showed maximal proliferation under 3% O2 culture 
condition, expanding about 30-fold over 28 days. TERT-/- splenocytes only expanded 10-fold 
over the same time period. Surprisingly, this was independent of oxygen conditions, 
suggesting that the effect of hyperoxia on cell growth is telomerase or at least TERT-
dependent. This experiment also confirmed that T-lymphocytes can proliferate without the 
presence of telomerase. 
 
3.2.2.2 Effect of telomerase and oxidative stress on proliferation of different 
splenocyte subsets 	
Splenocytes consist of a range of different cell populations with different roles and immune 
functions. These include T-cells, B-cells and monocytes. In the previous experiment (Figure 
3.4), splenocytes were expanded in culture and their proliferation monitored. Now I aimed to 
find out whether there are differences in proliferation between cell types, especially when 
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only T-cells (CD4+ and CD8+ cells) were activated. This experiment was designed to study 
the proliferation behaviour of a subpopulation of T-cells and also to discover the effect of T-
cell activation on other splenocyte subsets. 	
Although the previous experiment (Figure. 3.4) showed that hyperoxia had a suppressive 
effect on activated splenocytes, I wanted to know whether this effect was directed at a specific 
subpopulation of splenocytes. Since mouse splenocytes consist mainly of B-lymphocytes, T-
lymphocytes and monocytes, I used specific antibodies and flow cytometry to identify which 
population was affected. Activation of splenocytes with anti-CD3/CD28 antibody leads 
primarily to proliferation of CD4+ T-lymphocytes (from 0.08±0.004x106/well to 
20.5±2.4x106/well, a 267-fold increase over 2 weeks (P<0.0001), under 3% oxygen saturation 
and to 11.75±1.4x106/well under hyperoxia (40% oxygen saturation), P<0.01, (Figure 3.5A). 
A significant increase in cell number was observed from day 7 (P<0.05) 3% O2 = 
5.5±0.72x106/well vs. 40% O2 = 2.3±0.12x106/well and again at day 10, 11.6±1.3x106/well 
under 3% O2 vs. 5.8±1.3x106/well under 40% O2 (P<0.001). Furthermore, there was a trend 
for increase – although this did not reach statistical significance (ns) - between 3% and 40% 
oxygen saturation which started from day 5 (2.5±0.72x106/well vs. 0.98±0.36x106/well). 
From this, we can conclude that with time, an interaction between cells presumably by 
secreted cytokines leads to an increase in cell proliferation. CD8+ T-cells (Figure 3.5B) 
proliferate less than CD4+ T-cells, also without significant difference in proliferation between 
3% and 40% (hyperoxia) oxygen saturation. 
 
However, CD8+ T-cells (Figure 3.5B) are cytotoxic and require a pathogen in order to be 
activated, whilst CD4+ T-cells are helper cells which stimulate other cells to carry out their 
function. Consequently, CD4+ T-cells proliferate more. 
Double positive (DP), CD4+CD8+ T-cells, (Figure 3.5 C) proliferate under 3% oxygen 
saturation 0.62-fold more than under 40% oxygen saturation 0.07-fold (ns). Double negative 
(DN) proliferated significantly (P<0.01) more under hyperoxia 8.5-fold vs. 3.2-fold under 
hypoxia (Figure 3.5D). 
 
B-lymphocytes  (Figure 3.5 E) and monocytes (Figure 3.5 F) proliferated as well, but also, 
like CD8+ cells, to a far lesser degree than CD4+ (1.09-fold for B-cells and 1.04-fold for 
monocytes, both in favour of 3% oxygen saturation). Interestingly, hyperoxia only affected 
proliferation of CD4+ T-cells, but not monocytes or B-lymphocytes. In summary, I found that 
hyperoxia suppressed CD4+ T-cell proliferation. 
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Figure 3.4. Proliferation of splenocytes depends on the level of oxygen 
saturation and the presence of telomerase (TERT) 
 
Splenocytes from Tert+/+ and Tert-/- mice were seeded at 2x106/well (volume = 
2ml/well) in a 24-well plate. Medium was changed and 1.5µg/ml IL-2 was added every 
2-3 days for all experiments. T lymphocytes were re-activated every 7 days (days 0, 7, 
14, and 21 if necessary) by adding CD3e/CD28-Biotin micro-beads at a 1:1 ratio 
(Miltenyi T-cell expansion kit). Cells were cultured either under 3% oxygen saturation 
or under 40% (hyperoxia) oxygen saturation. Growth curves were generated by 
counting a 10µl aliquot of cells in the Neubauer chamber. All values are displayed as 
mean±sem (n=4 Tert+/+ and n=3 Tert-/-). *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 
for comparison between 3% vs. 40% oxygen saturation using 2-way ANOVA. 												
0 2 5 7 10 12 15 17 20 22 25 28
0
20
40
60
80
days in culture
C
el
l c
ou
nt
 x
10
6 /
w
el
l
tert+/+ 3%
*
*
****
***
********
****tert
-/- 3%
tert-/- 40%
ns
tert+/+ 40%
****
	 112	
			
	
Figure 3.5. Long-term culture and growth curves of different splenocyte sub-
populations under different oxygen saturation levels with strong activation 
 
Wild-type splenocytes were seeded at 2x106 cells/ml in a 24-well plate. Cells were 
cultured over 14 days using anti-CD3 and anti-CD28 antibodies; 1.5µg/ml IL-2 was 
added and media was changed every 2-3 days, under 3% and 40% (hyperoxia) O2. At 
each time point of this experiment (0h, d3, d5, d7, d10, d14), cells were stained for 
CD45R, Cd11b, CD4 T-cells and CD8 T-cells to determine the proportions of each cell 
type in the sample. A: total CD4+ T-cells number/splenocytes, B: total CD8+ T-cell 
number/splenocytes, C: DP T-cells number/splenocytes, D: DN cells/splenocytes, E: 
total B-cells number/splenocytes, and F: total monocytes number/splenocytes. All 
values are displayed as mean±sem (n=3). *P<0.05, **P<0.01, ***P<0.001, 
****P<0.0001 for comparison between 3% vs. 40% oxygen saturation using 2-way 
ANOVA. 
 
 
 	
0 3 5 7 10 14
0.01
0.1
1
10
100
days in culture
C
el
l n
um
be
r x
10
6 /
m
l
tert+/+ 3%
tert+/+ 40%
**
ns
CD45R(B220)
E
0 3 5 7 10 14
0.01
0.1
1
10
100
days in culture
C
el
l n
um
be
r x
10
6 /
m
l
tert+/+ 3%
tert+/+ 40%
****
CD11b
F
0 3 5 7 10 14
0.01
0.1
1
10
days in culture
C
el
l n
um
be
r x
10
6 /
m
l tert
+/+ 3%
tert+/+ 40%
**
D
**
DN
0 3 5 7 10 14
0.001
0.01
0.1
1
10
days in culture
C
el
l n
um
be
r x
10
6 /
m
l tert
+/+ 3%
tert+/+ 40%
ns
C
DP
0 3 5 7 10 14
0.01
0.1
1
10
100
days in culture
C
el
l n
um
be
r x
10
6 /
m
l
tert+/+ 3%
tert+/+ 40% *
*** **** **
****
CD4+ T-cell
A
0 3 5 7 10 14
0.01
0.1
1
10
100
days in culture
C
el
l n
um
be
r x
10
6 /
m
l
tert+/+ 3%
tert+/+ 40%
ns
CD8+ T-cell
B
	 113	
3.2.3 Role of telomerase in CD4+ T-cell proliferation 
 
In this subchapter my aim was to understand the contribution of telomerase to proliferation of 
T-lymphocytes at under 3% and at 40% (hyperoxia) oxygen saturation.  
 
The previous experiment (Figure 3.5) suggested that the interaction between CD4+ T-cells, 
CD8+ T-cells, B-cells and monocytes plays an important role in cell proliferation and survival. 
This was particularly the case for B-cells and monocytes, which proliferate and survive 
similarly under both oxygen saturations (3% and 40%). This could be explained by the effect 
of cytokines, secreted by other splenocytes (Th2 cells secrete IL-4, which activate B-cells; 
Th1 cells secrete IL-2 and IFN-gamma, which activate monocytes. IFN-gamma also activates 
B-cells, and B-cells secrete TGF-beta and IL-4, activating Th1 cells and monocytes). 
 
I noticed that CD4+ T-cells proliferated more strongly than CD8+ T-cells in spite of 
similarities in cell receptors, activation and conditions. The reason for this difference might be 
that CD8+ T-cells respond less to T-cell receptor ligation compared to antigen-stimulation, 
however, the latter was not used in my experiment. In contrast, CD4+ T-cells can be activated 
by ligation of their CD3 and CD28 T-cell receptor and co-receptor. This raised the question 
how CD4+ T-cells would react under the same stimulation and oxygen concentration, 
provided they would be cultured on their own. To answer this question, the following 
experiment was undertaken. 
 
Splenocytes (Tert+/+ and Tert-/-) were expanded for 2 weeks under 3% oxygen saturation, as 
this yielded the highest proliferation rate, which also correlates to the highest telomerase 
activity. Cells were harvested on day 14, then purified through a magnetic separator. 2 x 
105/well CD4+ T-cells were cultured in a 96-well plate for 20 days under hypoxia (3% oxygen 
saturation) and hyperoxia (40% oxygen saturation). I found (Figure 3.6) that CD4+ (Tert+/+) 
T-cells proliferated strongly under 3% O2 culture conditions (P<0.0001), but not hyperoxic 
conditions (at day 20, cell numbers reached 3.5±0.11 x 106/well and 2.1±0.18 x 106/well 
respectively, from 2 x 105/well at day zero). 
 
To investigate the effect of TERT on CD4+ T-cell proliferation, TERT-/- mouse cells were 
used under the same conditions and treatment. As figure 3.6 shows, there was proliferation 
independent of telomerase for Tert-/- CD4+ T-cells from 2 x 105/well to 1.47 x 106/well and 
1.3 x 106/well at day 20 (ns) under 3% and 40% oxygen saturation. However, these increasing 
cell numbers were unaffected by 3% O2 or 40% (hyperoxia) O2, which was similar to whole 
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splenocytes TERT-/- (Figure 3.4). This result suggests that telomerase mainly plays a role in 
cell proliferation in either isolated CD4+ cells or whole splenocytes. I also noticed that the 
TERT+/+ CD4+ T-cells seemed to require interaction with other cells for proliferation, because 
all splenocytes (figure 3.4) increased in number under 40% oxygen saturation after day 10, 
compared to TERT-/- under both conditions (Tert+/+ 40% = 13.5 x 106/well, Tert-/- with 3% 
O2= 8.5 x 106/well, TERT-/- with 40% O2 = 7,97 x 106/well (ns) at day 10). 
 
The trend for cell numbers in this experiment at day 17 was: Tert+/+ with 40% O2 = 1.7 x 
106/well; Tert-/- with 3% O2 = 1.3 x 106/well; and Tert-/- with 40% O2 = 1.3 x 106/well. All are 
not significant except Tert+/+ with 40% O2 vs. Tert-/- with 40% O2 in which telomerase had a 
significant effect (P<0.05) on cell proliferation under hyperoxia (40% oxygen saturation). 
Furthermore, in Tert-/-, oxygen conditions had no effect on cell proliferation under 3% O2 = 
1.47 x 106/well and under 40% O2 = 1.3 x 106/well at day 20 compared to 2 x 105/well at day 
zero. 
 
After time and in the presence of telomerase, CD4+ T-cells may benefit from cytokines. 
Indeed, at day 20 there was a significant increase in cell numbers under 40% oxygen 
saturation (Tert+/+ 2.1 x 106/well compared to Tert-/- with 3% oxygen saturation 1.6 x 106/well 
(P<0.01)). I also noticed that by day 20, CD4+ T-cells increased from 2 x 105/well in the 
presence of Tert+/+ under 40% oxygen saturation = 2.1 x 106/well and Tert-/- under the same 
oxygen saturation 40% = 1.5 x 106/ well (P<0.0001). 
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Figure 3.6. The influence of TERT+/+ and oxidative stress on long-term culture 
and growth curve of CD4+ T-cells 
 
CD4+ T cells from either TERT+/+ or TERT-/- mice were seeded at 2x105 cells/well 
(volume = 200µl/well) in a 96-well plate. CD4+ T-cells were generated by 
immunomagnetic bead-isolation from splenocytes, which were cultured for 14 days 
with anti-CD3 and anti-CD28 antibodies. Medium was changed and 1.5µg/ml IL-2 was 
added every 2-3 days for all experiments. CD4+ T cells were activated every 7 days 
(days 0, 7, 14, and 21 if necessary) by adding CD3e/CD28-Biotin micro-beads at a 1:1 
ratio (Miltenyi T-cell expansion kit). Cells were cultured either under 3% or under 40% 
(hyperoxia) oxygen saturation. Growth curves were generated by counting a 10µl 
aliquot of cells in the Neubauer chamber. All values are displayed as mean±sem 
(n=3). ****P<0.0001 for comparison between 3% vs. 40% oxygen saturation using 2-
way ANOVA.  
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3.2.4 mTert-GFP+ (telomerase reporter) mice used to investigate the regulation of 
telomerase in lymphocytes 
 
3.2.4.1 Effect of oxidative stress on splenocyte proliferation from transgenic mTert-
GFP+ mice 
 
The mTert-GFP+ mice in this chapter were genotyped by another laboratory colleague, Dr. 
Gavin Richardson, IGM, Newcastle University. 
 
The aim was to investigate the regulation of telomerase in living cells as well as at a single 
cell level, based on the findings of previous experiments (3.3.4) in which telomerase plays an 
important role in cell proliferation. To establish the expression of the TERT gene in live cells 
mTert-GFP+ reporter mice were used. Splenocytes were expanded for 14 days. A single-cell 
suspension was purified from transgenic mTert-GFP+ and wild-type splenocytes. Finally, 
GFP+ expression was detected by flow cytometry and proliferation determined under different 
oxygen concentrations. 
 
Figure 3.7 shows that splenocytes with moderate activation of the mTert-GFP+ reporter also 
proliferate more under 3% O2 saturation than under 40% O2 saturation, from 2x106/well at 
day zero to 7.7±1.2x106/well and 5.3±0.4x106/well at day 14 (P<0.001) with O2 saturation 
having a significant effect (P<0.05). Regardless of the activation level, splenocyte 
proliferation was suppressed under oxidative stress, while strong activation correlated with a 
greater proliferation under both levels of O2 saturation. With strong activation (Figure 3.4), 
cells expanded 15-fold at day 14 (28-fold by the end of experiment, at day 28) compared to 4-
fold (at day 14) with moderate activation (in this experiment) under 3% O2 saturation. Also 
under 40% O2 saturation, I could see that cells were expanded about 11-fold at day 14 (and 
about 19-fold by the end of experiment, day 28) with strong stimulation (Figure 3.4) 
compared to about 3-fold at day 14 with moderate stimulation (Figure 3.7). 
 
3.2.4.2 Effect of oxidative stress on proliferation of subsets of transgenic mTert-GFP+ 
splenocytes 
 
As mentioned previously, interactions between different cells types within a splenocyte 
population seem to play a critical role in terms of proliferation based on various cytokines 
secreted by cells which also leads to the activation of other cell types. 
 
Figure 3.8A shows that the proliferation behaviour of CD4+ T-cells under moderate activation 
of the mTert-GFP+ is similar to the previous experiment (figure 3.5A) under strong activation. 
	 117	
CD4+ T-cells proliferated about 54-fold (P<0.0001) under 3% O2 saturation, from 
0.11±0.02x106/well to 6.13±1.47x106/well and, under 40% O2 saturation, about 35-fold 
(P<0.0001) from 0.11±0.02x106/well to 3.92±0.6x106/well at day 14 (Figure 3.8A). The 
difference between 3% O2 saturation and 40% O2 saturation was found to be significant at day 
14 (P<0.01). The significant changes between the two O2 saturations in cell proliferation 
numbers started from day 10 (P<0.05). At 3% O2 saturation (day 10), CD4+ T-cells reached 
5.5±0.8x106/well and at 40% O2 saturation, CD4+ T-cells reached 3.6±0.7x106/well. Also, the 
effect of O2 saturation was significant (P<0.05) between 3% and 40% at day 10. 
 
Compared to CD4+ T-cells, the cytotoxic CD8+ T-cells (both came from the same original T-
lymphocytes and both have the same receptors) showed the same behaviour under moderate 
activation (figure 3.8B) compared to strong stimulation (figure 3.5B). This may be due to the 
cytotoxic function of CD8+ T-cells requiring a pathogen to be activated more. However, 
figure 3.8B shows that at day 3 there was a significantly higher (P<0.0001) proliferation 
under 3% O2 saturation with 0.46±0.1x106/well compared to 0.1±0.04x106/well under 40% 
O2 saturation from 0.05±0.01x106/well at day zero. Also, with moderate stimulation, there 
was a significant (P<0.001) effect for O2 saturation between 3% and 40% (Figure 3.8B). 
 
Figure 3.8C shows the total GFP+ cell proliferation under 3% O2 saturation with 
0.36±0.14x106/well as significant (P<0.01) compared to 40% O2 saturation with 
0.07±0.04x106/well by day 14 from 0.04±0.015x106/well at day zero. The majority of 
proliferation happened at day 3 under 3% O2 saturation, during which cell numbers reached 
0.8±0.1x106/well compared to 0.15±0.04x106/well under 40% O2 saturation (P<0.0001). 
However, since we found that hyperoxia (40% O2 saturation) supressed telomerase activity 
(see figure 3.10) that might explain the lower cell proliferation under hyperoxia.  
 
There is no clear explanation for the differences in results of B-cell proliferation shown in 
figure 3.8D in this experiment compared to the previous experiment (Figure 3.5E). Here we 
can see that by the end of experiment, the B-cells had decreased to a lower level than at the 
beginning of the experiment. However, at day 5 there was a significantly (P<0.05) lower 
proliferation under 40% O2 saturation (0.92±0.33x106/well) compared to 3% O2 saturation 
(0.5±0.14x106/well) from (0.58±0.1x106/well at day zero). There was also a significant 
decrease in total cell number between the start of the experiment (0.58±0.1x106/well) and the 
end of the experiment (3% O2 saturation = 0.2±0.07x106/well; 40% O2 saturation = 
0.33±0.2x106/well). This may be related to the type of activation since B-cells require strong 
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activation as in the previous experiment (Figure 3.5E) in order to survive. The mouse 
genotype may have an effect on B-cells, which are from mTert-GFP+ mice (compared to wild-
type mice, figure 3.5E). There was no significant of O2 saturation on B-cell proliferation.   
 
What is surprising is that monocytes exhibited the same proliferation behaviour under 
moderate activation (shown in figure 3.8E) as they did under strong stimulation (Figure 3.5F). 
The influence of O2 saturation was not significant on monocyte proliferation. In addition, 
there was a slight trend for monocytes to proliferate (almost similarly) under both types of O2 
saturation (3% O2 saturation = 0.16±0.1x106/well and 40% O2 saturation = 
0.19±0.08x106/well, both from 0.11±0.007x106/well at day zero). In this case, there may have 
been some benefit yielded by cytokines secreted by other cells.  
 
3.2.4.3 Oxidative stress downregulates transgenic mTert-GFP+ expression in 
splenocytes 
 
The following experiment was created to explore how telomerase activity in a single live cell 
would be affected by oxidative stress. mTert-GFP+ mice were chosen on the basis of their 
telomerase reverse transcriptase, indicated by green fluorescent protein (GFP) (Breault, et al., 
2008). Furthermore, the expression of mouse telomerase reverse transcriptase is very close to 
telomerase activity in terms of regulation (Greenberg et al., 1998). GFP+ expression was 
measured against (wild-type) negative controls using a compensated FACSCanto II running 
FACSDiva software. 
 
Figure 3.9A shows that the total GFP+ cell proliferation under 3% O2 saturation with 
0.36±0.14x106/well was significantly different (P<0.01) compared to under 40% O2 saturation 
with 0.07±0.04x106/well by day 14, from 0.04±0.015x106/well at day zero. The majority of 
proliferation happened at day 3 under 3% O2 saturation. Cell numbers reached 
0.8±0.1x106/well, compared to 0.15±0.04x106/well under 40% O2 saturation with P<0.0001 at 
day3. However, we found (Figure 3.10) that 40% O2 saturation supressed telomerase activity, 
which might be the reason for the decrease in cell proliferation. 
 
To find out which subpopulation of GFP+ cells proliferated most, the reporter GFP+ cells were 
classified by FACSDiva software related to the majority population subset of splenocytes 
used in this study (CD4+, CD8+, CD11b and CD45R (B220)). 
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Figure 3.9B shows that GFP+CD4+ cells exhibit proliferation behaviour closer to the total 
GFP+ cells than the other cell populations shown in figures 3.9C, 3.9D, and 3.9E. A single 
cell expression percentage was generated based on the cell count per well at each time point. 
GFP+CD4+ cells proliferated from 0.016±0.008x106/well at day zero to 0.2±0.13x106/well 
under 3% O2 saturation and 0.051±0.05x106/well under 40% O2 saturation (ns). At day 10, 
cells had proliferated significantly (P<0.01) (0.3±0.1x106/well under 3% O2 saturation and 
0.02±0.006x106/well under 40% O2 saturation). The major proliferation took place at day 3 
(P<0.001). Cells reached 0.34± 0.05x106/well under 3% O2 saturation and 0.06±0.02x106/well 
under 40% O2 saturation. O2 saturation significantly affects telomerase expression. Figure 3.9 
shows GFP+CD4+ telomerase expression (P<0.01), GFP+CD8+ telomerase expression 
(P<0.01), GFP+B-cells+ telomerase expression (P<0.01) and GFP+monocytes+ (P<0.05). 
 
3.2.4.4 Oxidative stress represses telomerase activity in splenocytes 
 
By experimenting with mTert-GFP+ mice, we found that GFP+ expression disclosed 
information about telomerase presence at a single cell level. From this, we concluded that 
telomerase expression is diminished at 40% O2 saturation. Telomerase plays a crucial role in 
cell division and proliferation (Greenberg et al., 1999). To ensure that GFP+ expression in 
vivo correlates with telomerase activity, and also to find the effect of oxidative stress on 
telomerase activity, I expanded splenocytes for two weeks to assess the role of oxidative 
stress on telomerase activity during splenocyte proliferation. Telomerase activity was 
measured by TRAP-PCR ELISA as described in 2.2.10. Negative (Tert-/-) and positive 
controls (3T3 cells) were used (figure 3.10A). Figure 3.10B shows that under oxidative stress, 
telomerase activity diminished after day 5, whilst the maximum activity occurred at day 3, 
increasing by about 1.6-fold. Conversely, telomerase activity under 3% O2 saturation reached 
a significant (P<0.01) maximum activity at day 5, increasing by 3.9-fold vs. 1.4-fold under 
40% O2 saturation. Telomerase activity under hypoxia (3% O2) fluctuated after day 5 but 
remained high compared to zero hours and under hyperoxia (40% O2) until the end of the 
experiment at day 14. Telomerase activity under hypoxia (3% O2) was significantly (P<0.05) 
higher, increasing by 2.2-fold compared to 0.09-fold under oxidative stress (40% O2). There 
is a statistically significant (P<0.0001) difference between hypoxia (3% O2) and hyperoxia 
(40% O2). Time also played a significant (P<0.0001) role in terms of telomerase activity 
under hypoxia (3% O2). In conclusion, we can infer that oxidative stress is one factor that may 
decrease cell proliferation due to telomerase suppression. Furthermore, we can conclude that 
40% O2 saturation is an appropriate lab condition to model physiological oxidative stress. 
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Figure 3.7. Splenocytes from transgenic mTert-GFP+ grow better under 3% than 
40% oxygen saturation 
 
Splenocytes from transgenic mTert-GFP+ mice were seeded at 2x106/ml in a 24-well 
plate, and the plate was coated with anti CD3 and CD28 antibodies. Medium was 
changed and 1.5µg/ml IL-2 was added every 2-3 days for all experiments. Cells were 
cultured either under 3% or under 40% (hyperoxia) oxygen saturation for 14 days. All 
values are displayed as mean±sem (n=4). *P<0.05, ***P<0.001, ****P<0.0001 for 
comparison between 3% vs. 40% oxygen saturation using 2-way ANOVA.  
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Figure 3.8. Long-term growth curves of different lymphocyte subsets from 
transgenic mTert-GFP+ mice splenocytes under different oxygen saturation 
 
Splenocytes from mTert-GFP+ reporter mice were seeded at 2x106/ml in 24-well plates 
(coated by CD3 and CD28 antibodies overnight) for 14 days and on days 3, 5, 7, 10 
and 14. The cells were then cultured in 3% and 40% incubator oxygen saturation. 
Then, at each time point, expression of the GFP+ reporter relative to surface markers 
CD45R B220, CD11b, CD4+ and CD8+ was measured against wild-type and 
unstained) negative controls using a compensated FACSCanto II running FACSDiva 
software; 50,000 live events were analysed to determine the proportion of T-cell types. 
A: CD4+ T-cell number/splenocytes, B: CD8+ T-cell number/splenocytes, C: total 
GFP+ cell number/splenocytes, D: B-cell number/splenocytes, E: monocytes 
number/splenocytes. All values are displayed as mean±sem (n=4). * P<0.05, 
**P<0.01, *** P<0.001, **** P<0.0001 for comparison between 3% vs. 40% oxygen 
saturation using 2-way ANOVA. 
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Figure 3.9. Number of GFP+ cells in each splenocyte subset that express TERT 
gene from transgenic mTert-GFP+ mice 
 
Splenocytes from mTert-GFP+ reporter mice were seeded at 2x106/ml in 24-well 
plates (coated by CD3 and CD28 antibodies overnight) for 14 days and on days 3, 5, 
7, 10 and 14. The cells were then cultured in 3% and 40% incubator oxygen 
saturation. Then, at each time point, surface marker expression of genetically GFP 
relative to CD45R, CD11b, CD4+ and CD8+ was measured against negative controls 
using a compensated FACSCanto II running FACSDiva software; 50,000 live events 
were analysed to determine the proportion of T-cell types. A: total GFP+ cells number 
(splenocytes), B: total GFP+CD4+ cells number, C: total GFP+CD8+ cells number 
GFP+, D: total GFP+B-cell+ number, E: total GFP+monocytes+ number/ GFP+ cells. 
All values are displayed as mean±sem (n=4).  * P<0.05, ** P<0.01, *** P<0.001, 
****P<0.0001 for comparison between 3% vs. 40% oxygen saturation using 2-way 
ANOVA. 
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Figure 3.10. Telomerase activity in splenocytes from wild-type mice is higher 
under 3% than under 40% oxygen saturation 
 
Wild-type mice splenocytes were generated and then seeded at 2x106/ml in a 24-well 
plate at day 0, on plates coated overnight at 4°C with anti CD3 and CD28 antibodies. 
Medium was changed and 1.5µg/ml IL-2 was added every 2-3 days, under 3% and 40% 
oxygen saturation. Cells were harvested at the indicated time points (days 3, 5, 7, 10 
and 14), and cryopreserved at -80°C. TRAP-PCR was run with 500ng protein loaded for 
splenocytes and 100ng for 3T3 cells (positive control). A: controls, B: Telomerase 
activity under 3% and 40% O2 saturation. All values are displayed as mean±sem (n=5). 
* P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001 for comparison of 3% vs. 40% oxygen 
saturation using 2-way ANOVA. 
 
 	
Figure 3.11. Percentage of GFP+ cells from mTert-GFP+ mice that were cultured 
under different oxygen saturation, presented as a FACS dot plot 
 
Splenocytes from mTert-GFP+ reporter mice were seeded at 2x106/ml in 24-well plates 
(coated by CD3 and CD28 antibodies overnight) for 14 days. The cells were then 
cultured in 3% and 40% incubator oxygen saturation. Then, at each time point, on 
days 3, 5, 7, 10 and 14 surface marker expression of genetically GFP relative to 
CD45R (B220), CD11b, CD4+ and CD8+ was measured against negative controls 
using a compensated FACSCanto II running FACSDiva software; 50,000 live events 
were analysed to determine the percentage of GFP+ cells to all splenocytes. Red dots 
= GFP+ cells. (n=4) 
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3.2.5 Telomerase confers resistance to cell death in splenocytes 
 
In this final subchapter, I describe attempts to establish the role of telomerase or TERT in the 
ability of lymphocytes to resist cell death. Telomerase activation is linked with a range of 
processes, including immune cell activation, expansion of bone marrow blood cell progenitors 
and embryonic cell proliferation. Conversely, telomerase inhibition is associated with 
apoptosis, cellular senescence and degenerative diseases (Hahn et al., 1999; Mitchell et al., 
1999; Wyllie et al., 2000; Zhang et al., 1999). 
 
As in all previous experiments within this project, 50% of the medium (serum) was changed 
every 2 to 3 days. IL-2 and DMSO were also added when the medium was changed. These 
play a role in cell survival and proliferation. In order to analyse the effect of serum, IL-2 and 
DMSO starvation on telomerase activity and cell proliferation, 20% O2 saturation was used, 
which produced significant oxidative stress compared to 3% oxygen saturation (figure 3.12). 
Splenocytes (tert+/+ and tert-/-) were cultured in coated plates for 28 days, with no medium 
change or additions. To ensure the emerging environment had no effect, the oxidative stress 
level was measured between both genotypes (tert+/+ and tert-/-) and both conditions (medium 
change and no medium change) using dihydroethidium (DHE) fluorescence. 
 
Figure 3.13A shows that telomerase seems to play a critical role in cell survival, especially for 
CD4+ T-cells. The tert+/+ cell numbers were 2.2-fold greater than tert-/- (12.6±1.56x106/well 
vs. 5.65±1.1x106/well respectively) (P<0.01). For B-cells, the tert+/+ cell numbers were 1.8-
fold more than tert-/- (4.05±0.14x106/well vs. 2.27±0.44x106/well) (P<0.01). In monocytes, 
the tert+/+ cell numbers were 1.7-fold greater than tert-/- (1.7±0.06x106/well vs. 
1.01±0.11x106/well) (P<0.001). Furthermore, there was a positive trend in favour of tert+/+ 
cells compared to tert-/- (ns): in CD8+ T-cells (0.06±0.01x106/well vs. 0.04±0.01x106/well) 
and in DN (0.09±0.02x106/well vs. 0.04±0.02x106/well). We can conclude from this that 
telomerase not only leads to cell division and proliferation, or cell survival with normal 
nutrition, but also influences cell survival under starvation conditions. 
 
Figure 3.13B shows that there was no significant effect on oxidative stress level whether the 
medium was changed or not, nor when genotype tert+/+ under 20% oxygen saturation with 
medium change was used as 100% compared with other groups (Tert+/+ with no medium 
change, Tert-/- with medium change and Tert-/- with no medium change all under 20% O2).  
This also ensured that no effect came from potential physiological changes in the 
mitochondrial membrane, which can affect oxidative phosphorylation and hence ATP 
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generation by cells. In this instance, the JC-1 florescence ratio (FL3/FL1) was used to 
measure the mitochondrial membrane potential. Figure 3.13C shows no significant effect 
relating to either medium changes (or not) or genotype (tert+/+, tert-/-). Tert+/+ under 3% O2 
was used as 100% to compare with other groups (Tert+/+ with no medium change, Tert-/- with 
medium change and Tert-/- with no medium change all under 20% O2).  
 
		
Figure 3.12. Measurement of oxidative stress levels and mitochondrial 
membrane potential levels under 20% oxygen saturation. 
 
A, B. Splenocytes from either wild-type Tert+/+ or Tert-/- mice were seeded at 2x106/ml 
in a 24-well plate. Splenocytes were cultured for ≥ 20 days (n=4). Plates were coated 
with anti-CD3 and anti-CD28 antibodies.  Medium was changed and 1.5µg/ml IL-2 was 
added every 2-3 days for all experiments. Cells were cultured under 3% and 20% 
oxygen saturation. A. Oxidative stress levels were measured by dihydroethidium 
(DHE) fluorescence. B. Mitochondrial membrane potential levels measured by JC-1 
fluorescence ratio FL3/FL1. All values are displayed as mean±sem (n=4). *P<0.05 for 
comparison between oxygen saturation levels using 2-way ANOVA. 
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Figure 3.13. Telomerase positive cells survive better than telomerase negative 
cells under normoxia 
 
Splenocytes from Tert+/+ and Tert-/- mice were seeded at 10x106 cells/well in a 6-well 
plate (5ml/well). Cells were cultured over 28 days using anti-CD3 and anti-CD28 
antibodies. 1.5µg/ml IL-2 was added at the start time, after which no IL-2 was added or 
media changed during the 28 days. Cells were incubated under 20% O2. At the end of 
experiments (day 28): (A) splenocytes were stained with four colours, CD45R(B220), 
Cd11b, CD4+ and CD8+, to determine the proportions of each cell type in a sample. 
Also cell viability (bright field only) was measured using a Tali image-based cytometer 
(Invitrogen), with a Tali cellular analysis slide (20µl), splenocytes were stained with 
dead cell red and incubated one minute. (B) Tert+/+ vs. Tert-/- splenocytes oxidative 
stress levels were measured by dihydroethidium (DHE) fluorescence with and without 
medium change at day 28. (C) Tert+/+ vs. Tert-/- splenocytes mitochondrial membrane 
potential levels were measured by JC-1 fluorescence ratio with and without medium 
change at day 28. All values are displayed as mean±sem (n=3). ** P<0.01 for 
comparison between 3% vs. 20% oxygen saturation using 2-way ANOVA. 
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3.3 Discussion 
 
 
In this study, I used three different oxygen saturations; 3%, 20% and 40%. I found that under 
hypoxia (3% oxygen saturation) cells grew faster, lived longer and showed lower stress, 
compared to either 20% (normoxia) or 40% (hyperoxia) O2. This is in accordance with the 
finding of others who had shown improved growth and less damage under hypoxia compared 
to normoxia or hyperoxia in other cell systems and species (human and mouse cells) (Richter 
et al., 1972; von Zglinicki et al., 1995; Parrinello et al., 2003). 
One of the early studies on fetal tissues of mice and rat demonstrated that cell numbers 
increased under low oxygen percentage (1-3% O2) (Richter et al., 1972). The lifespan of 
human fibroblasts increased under 10% O2, compared to 20% O2 saturation (Packer and 
Fuehr, 1977). Mouse primary embryonic fibroblasts were cultured under 3% vs. 20% oxygen 
saturation for 28 days. Under 3% O2, the senescence effect that usually happens under 20% 
O2 after 28 days of culture was not apparent (Parrinello et al., 2003). In another study, 3% O2 
was used as hypoxia vs. 18% O2 as normoxia. The 3% O2 hypoxia induced cell proliferation 
and differentiation in rat mesangial cells, specialized cells around blood vessels in the kidneys 
(Sahai et al., 1997). 3% oxygen saturation also enhanced vascular cell proliferation compared 
to 21% oxygen saturation (Humar et al., 2002). According to Lopez-Barneo et al. (2001), the 
boundary between physiological and non-physiological hypoxia is blurred; any physiological 
response may be considered adaptive and can be either brought about by, or reversed by, 
induced hypoxia (3–5% O2). In a more recent review, Mckeown (2014) suggested a 2-6% 
range of oxygen saturation is likely to be deemed physiological hypoxia. She also suggested 
some definitions, for example: physoxia (physiological oxygen level) between 4-7.5% O2 and 
physiological hypoxia from 1-5% O2. Based on these, the 3% O2 saturation is in hypoxia 
range, not in physoxia range. Therefore, the term ‘hypoxia’ will refer to the 3% oxygen 
saturation used in this study. 
In this study, 40% O2 (hyperoxia) and 20% O2 (normoxia) significantly induced oxidative 
stress in splenocytes and CD4+ T-cells. It is known that normoxia induces oxidative stress in 
mouse primary cells and they are much more sensitive to oxidative stress than human cells 
(Parrinello et al., 2003). Here, it caused inflammation in mouse splenocytes under both 3% 
and 40% O2, but under hyperoxia, the inflammation level was stable at all time points and was 
at a significantly higher level compared to 3% O2. Inflammation levels declined from day 1 to 
day 3 by 7.5-fold (ns) under 3% O2. This finding is supported by a study on human 
fibroblasts, which concluded that 40% oxygen saturation decreased the proliferation of 
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fibroblasts and also decreased telomere length, suggesting that 40% O2 is a good model for 
senescence in human cells (von Zglinicki et al., 1995). 
 
Furthermore, a study on rats suggested that 40% O2 or higher for 24h or more enhanced 
oxidative stress by increasing the level of derivatives of reactive oxygen metabolites 
(dROMs) (Nagatomo et al., 2012). Oxidative stress was found to enhance atherogenesis in the 
vascular wall, which may lead to inflammation or myocardial infarction (Sorescu et al., 
2002). Chronic oxidative stress has been implicated in atherosclerotic plaques and endothelial 
dysfunction, which contributes to vascular inflammation (Guzik et al., 2006; Heitzer et al., 
2001). Moreover, the effect of oxidative stress on cell proliferation seems to be TERT-
dependent. T-lymphocytes from TERT-/- proliferated equally badly under both hypoxia and 
hyperoxia in comparison to T-lymphocytes from TERT+/+, which proliferated more under 
hypoxia than under hyperoxia. This finding aligned with previous studies which also 
demonstrated the vital role of telomerase in cell proliferation (Martin-Rivera et al., 1998), 
especially in lymphocytes (Buchkovich and Greider, 1996). From my results, analysis of 
both, mTert-GFP+/+ expression and telomerase activity, confirmed that oxidative stress under 
hyperoxia supressed telomerase activity. In long term cell culture, and without medium 
changes under normoxia (20% oxygen saturation), telomerase positive splenocytes survived 
about twice as well compared with Tert-/- and showed a significant (P<0.0001) proliferation 
increase and survival for CD4+ Tert+/+ (more than 10x106 compared with about 5x106 CD4+ 
Tert-/-) after 28 days in culture. 
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CHAPTER 4. Effect of MAPK inhibition/inhibitor (MAPKi) on 
splenocytes and CD4+ T-lymphocytes under chronic mild 
oxidative stress 
4.1 Introduction 
 
Previous studies have shown that telomerase activity and survival following TCR activation 
was enhanced by the inhibition of p38 MAPK signalling in CD4+ T-lymphocytes (Di Mitri et 
al, 2011). Furthermore, treatment of hypercholesterolaemic patients with a selective p38α/β 
Mitogen-activated protein kinase inhibitor (MAPKi) (losmapimod; GW856553) significantly 
improved endothelial dysfunction and vascular inflammation, making p38 a novel target for 
patients with cardiovascular disease (Cheriyan et al, 2011).  
 
MAPKi has been shown to reduce IFN-γ secretion in-vitro, causing less inflammation 
(Ranjbaran et al, 2007). Therefore MAPKp38 inhibition could stabilize  atherosclerotic 
plaque, decrease the atherogenic process itself (Melloni et al, 2012; Cheriyan et al, 2011), 
decrease myocardial apoptosis and improve post-ischaemic cardiac function (Ma et al, 1999). 
The aim for this experiment was to test whether inhibition of MAPK in CD4 T-cells affects 
proliferation in a telomerase-dependent way under culture conditions, with or without 
increased oxidative stress. 
 
4.2 Results 
 
4.2.1 Effect of MAPKi on IFN-gamma mRNA transcription under oxidative stress 
 	
I have shown in the previous chapter that oxidative stress induces transcription of IFN-gamma 
mRNA in splenocytes (Figure 3.3). IFN-gamma is known to suppress T-cell proliferation 
(Krenger et al., 1996). MAPKi has been shown to reduce IFN-gamma secretion in vitro, 
causing less inflammation (Sarov-Blat et al., 2010; Cheriyan et al., 2011). This experiment 
sought to find out the effect of MAPKi on IFN-gamma mRNA transcription under oxidative 
stress. Splenocytes were expanded and cultured for 3 days under hypoxia (3% O2) and 
hyperoxia (40% O2). One group was treated with (500nM/ml) MAPKi, the other remained as 
a control as described at (2.2.5). Figure 4.1 shows that the level of IFN-gamma in cells treated 
with 500nM/ml MAPKi was increased at day 1 and day 2, then at day 3 the level of IFN-
gamma transcription was almost the same as on day 3 under hypoxia (3% oxygen) saturation. 
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At day 3 under hyperoxia (40% oxygen saturation) the level of IFN-gamma mRNA transcript 
in cells treated with 500nM/ml MAPKi declined significantly (P<0.05); about 18-fold 
compared to the same cells not treated with MAPKi. At the same time point, there was a 
significant (P<0.05) difference between hypoxia and hyperoxia; about 15.3-fold, both 
untreated with MAPKi. Furthermore, there was no significant change (1.2-fold) in levels of 
IFN-gamma transcription between cells under hypoxia and hyperoxia treated with MAPKi. 
Based on this finding, I can conclude that 500nM MAPKi/ml seems to down-regulate IFN-
gamma production under oxidative stress, which could lead to decreased inflammation in 
vitro.   
 
 
 
 
 
Figure 4.1. MAPKi regulates transcription of IFN-gamma mRNA in splenocytes 
under oxidative stress. 
 
Splenocytes from wild-type (Tert+/+) mice were seeded at 2x106/ml in a 24-well plate. 
Splenocytes were cultured for 3 days. Plates were coated with anti-CD3 and anti-
CD28 antibodies. Control cells were grown on uncoated wells. Cells were cultured 
under 3% (hypoxia) and 40% (hyperoxia) oxygen saturation. All values are displayed 
as mean±sem (n=3). *P<0.05, for comparison between oxygen saturation levels using 
two-tailed unpaired t test.  			
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4.2.2 Effect of MAPK inhibition on splenocyte proliferation under oxidative stress 	
4.2.2.1 Effect of MAPK inhibition on lymphocyte proliferation under oxidative stress 		
I have shown in figure 3.4 that oxidative stress suppresses proliferation of splenocytes and 
CD4+ T-cells. With the next experiment, I wanted to find out the effect of p38 MAPKi on cell 
proliferation under oxidative stress. Splenocytes were expanded under both oxygen 
conditions, 3% and 40%, as described previously. Cells were treated with 500nM/ml p38 
MAPKi vs. control cells. Figure 4.2 shows that the positive effect of MAPKi on TERT+/+ 
splenocytes was comparable between 3% O2 (1.7-fold) and 40% O2 (1.4-fold) (ns), implying 
that oxygen saturation with MAPKi had no significant effect on splenocyte proliferation, 
which is the opposite of what was shown in the previous experiment (Figure 3.4). With 
MAPKi treatment, the suppressive effect of oxidative stress (40% O2 saturation) on 
splenocyte proliferation disappeared. This may be secondary to IFN-γ that was regulated by 
MAPKi under hyperoxia as seen in figure 4.1. There is no significant positive effect for 
MAPKi on TERT-/- splenocytes, but I could not detect any cell proliferation secondary to the 
MAPKi effect. Neither under 3% O2 nor under 40% did cell numbers change between day 2 
and day 28. In fact, comparing the effect of MAPKi between TERT+/+ vs. TERT-/- under the 
same oxygen conditions, I noticed that, under hypoxia the MAPKi has a significant (P<0.01) 
effect on TERT+/+ cell numbers (1.5-fold) vs. TERT-/- starting from day 15 and continuing to 
be significant until the end of experiment at day 28 (1.8-fold) in favour of TERT+/+ 
(P<0.0001). Under hyperoxia, the significant changes between TERT+/+ and TERT-/- from day 
12 onwards were 1.5-fold in favour of TERT+/+ (P<0.05) and continued until the end of 
experiment at day 28 (1.8-fold (P<0.0001)). 
 
Altogether, MAPKi seemed to counteract the oxidative stress produced by hyperoxia by 
decreasing the IFN-γ secreted by cells. Also, MAPKi enhances splenocyte proliferation both 
under hypoxia and under hyperoxia. The MAPKi effect is telomerase-dependent. 
 
 
4.2.2.2 Effect of MAPK inhibition on proliferation of lymphocyte subsets under 
oxidative stress 
 	
The majority of cell populations within splenocytes are CD4+ T-lymphocytes, CD8+ T-
lymphocytes, B-lymphocytes and monocytes, all of which serve different immunological 
roles and functions. Figure 4.2 shows that MAPKi enhances splenocyte proliferation under 
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both hypoxia and hyperoxia. The following experiment was established to discover which 
type of splenocyte subset proliferated more under hypoxia vs. hyperoxia when treated with 
MAPKi.  
 
Splenocytes were cultured under 3% and 40% oxygen saturation and both treated with 500nM 
MAPKi as described previously (2.2.5). Control samples without MAPKi were cultured under 
both oxygen conditions as a baseline to identify the impact of MAPKi on cells. Figure 4.3 
shows that all major splenocyte populations demonstrated the same effect on cell number 
under both oxygen saturations, which might suggest that MAPKi led to a neutralizing of the 
oxidative stress produced by hyperoxia. Furthermore, there were no significant changes in cell 
proliferation between hypoxia and hyperoxia (figures 4.3B-F) in CD8+ T-cells, DP, DN, B-
lymphocytes and monocytes, indicating that MAPKi plays a beneficial role with cells under 
oxidative stress. Figure 4.3A shows a significant effect of MAPKi between day 3 (first day of 
effect) and day 14 (final day of experiment), under both oxygen saturations (1.2-fold under 
hypoxia 3% O2 and 1.4-fold under hyperoxia 40% O2, P<0.05). This supports the conclusion 
that MAPKi keeps cells healthy under hyperoxia (40% O2), and neutralised the effect of IFN-
gamma secreted under oxidative stress. CD4+ T-cells demonstrated the most significant effect 
from MAPKi under both oxygen conditions. 
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Figure 4.2. Long-term culture and growth curve of splenocytes treated with 
500nM MAPKi under different oxygen saturations  
 
Splenocytes from Tert+/+ and Tert-/- mice were seeded at 2x106/well (volume = 
2ml/well) in a 24-well plate. Medium was changed, 500nM/ml MAPKi and 1.5µg/ml IL-2 
were added every 2-3 days for all experiments. T lymphocytes were activated every 7 
days (days 0, 7, 14, and 21 if necessary) by adding CD3e/CD28-Biotin micro-beads at 
a 1:1 ratio (Miltenyi T-cell expansion kit). Cells were cultured either under 3% 
(hypoxia) or under 40% (hyperoxia) oxygen saturation. Effect of MAPKi on cells 
number was calculated as relative to individual control for each group (without MAPKi). 
All values are displayed as mean±sem (Tert+/+ (3% n=4), (40% n=3), Tert-/- n=3)).  
**** P<0.0001 for comparison of 3% vs. 40% oxygen saturation using two-way 
ANOVA. 											
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Table	4.1.	Primary	cell	counts	(x106)	of	splenocyte	growth	curve	from	TERT+/+	mice	cultured	under	3%	oxygen	saturation.		
Days	in	
culture	
3% O2, control (x106)	 3% O2, 500nM MAPKi (x106)	
	 Mouse	
1	
Mouse	
2	
Mouse	
3	
Mouse	
4	
Mouse	
1	
Mouse	
2	
Mouse	
3	
Mouse	
4	
0	 2	 2	 2	 2	 2	 2	 2	 2	
2	 5.85	 5.35	 4.9	 5.14	 7.55	 6.93	 5.56	 6.87	
5	 10.55	 9.8	 8.75	 9.13	 14.5	 15.13	 13.76	 13.95	
7	 14.88	 13.13	 12.88	 13	 18.38	 17.19	 16.45	 16.93	
10	 23.28	 21.31	 18.12	 20.56	 37.75	 35.98	 29.25	 31.88	
12	 28.68	 25.5	 24.25	 25.17	 43.5	 43.41	 38	 40.85	
15	 32.75	 31.25	 27	 29.45	 56.88	 55.25	 45.51	 49.65	
17	 41.25	 40.88	 32.13	 35.1	 80.2	 75.1	 59.2	 65.54	
20	 45.68	 43.25	 35.08	 38.9	 93.63	 84.13	 69.98	 76.12	
22	 52.08	 48.12	 39.25	 44	 113.5	 99.5	 79.88	 87.11	
25	 63.41	 53.35	 46.85	 51.04	 128.4	 107.93	 88.1	 97.14	
28	 64.53	 56.12	 49.99	 52	 137.8	 124.05	 99.45	 108.1				
Table	4.2.	Primary	cell	counts	(x106)	of	splenocyte	growth	curve	from	TERT+/+	mice	cultured	under	40%	oxygen	saturation.		
Days	in	culture	 40% O2, control (x106)	 40% O2, 500nM MAPKi (x106)	
	 Mouse	1	 Mouse	2	 Mouse	3	 Mouse	1	 Mouse	2	 Mouse	3	
0	 2	 2	 2	 2	 2	 2	
2	 3.7	 3.61	 3.13	 4.91	 5.1	 4.6	
5	 5.13	 4.95	 4.58	 7.65	 7.13	 6.76	
7	 8.3	 8.11	 7.87	 10.5	 11.2	 9.42	
10	 14	 13.65	 12.92	 19.87	 17.25	 18.61	
12	 17.12	 16.74	 15.97	 26.75	 25.48	 27	
15	 21.73	 20.45	 21.1	 39.13	 34.23	 33.95	
17	 27.83	 25.52	 26.4	 50.7	 46.75	 41.13	
20	 30.25	 29.15	 28.25	 57.13	 51.8	 47.46	
22	 34.1	 34	 32.35	 62.88	 58.2	 55.13	
25	 36.25	 37.09	 35.15	 71.7	 65.02	 67.14	
28	 38.7	 39.11	 37.25	 78.22	 71.98	 73.72							
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Table	4.3.	Primary	cell	counts	(x106)	of	splenocyte	growth	curve	from	TERT-/-	mice	cultured	under	3%	oxygen	saturation.		
Days	in	culture	 3% O2, control (x106)	 3% O2, 500nM MAPKi (x106)	
	 Mouse	1	 Mouse	2	 Mouse	3	 Mouse	1	 Mouse	2	 Mouse	3	
0	 2	 2	 2	 2	 2	 2	
2	 2.74	 2.9	 3.7	 2.92	 4.1	 4.5	
5	 3.41	 3.45	 5.22	 3.57	 5.87	 6.54	
7	 4.69	 5.21	 8.75	 5.78	 7.2	 9.81	
10	 7.03	 7.3	 11.24	 9.75	 9.11	 13.85	
12	 10.45	 8.5	 13.25	 12.12	 11	 15.2	
15	 12.8	 11.3	 17.85	 14.79	 14.24	 18.74	
17	 14.44	 11.7	 19.85	 18.19	 16.87	 21.17	
20	 17.21	 13.4	 23.24	 20.1	 19.24	 25.75	
22	 18.54	 14.5	 25.5	 20.9	 22.5	 26.94	
25	 20.3	 15.87	 27.81	 23.24	 25.21	 29.22	
28	 22.1	 17.4	 29.21	 25.25	 26.7	 30.45				
Table	4.4.	Primary	cell	counts	(x106)	of	splenocyte	growth	curve	from	TERT-/-	mice	cultured	under	40%	oxygen	saturation.		
Days	in	culture	 40% O2, control (x106)	 40% O2, 500nM MAPKi (x106)	
	 Mouse	1	 Mouse	2	 Mouse	3	 Mouse	1	 Mouse	2	 Mouse	3	
0	 2	 2	 2	 2	 2	 2	
2	 2.45	 2.4	 3.21	 2.63	 2.7	 3.54	
5	 2.91	 2.8	 4.28	 4.04	 3.9	 4.91	
7	 4.64	 4.6	 7.9	 4.67	 4.91	 8.45	
10	 6.75	 6.7	 10.46	 6.8	 6.9	 10.95	
12	 8.71	 7	 12.25	 8.99	 7	 13.6	
15	 10.98	 10.05	 16.11	 11.57	 10.97	 16.96	
17	 11.5	 10.1	 17.28	 14	 11.3	 18.81	
20	 13.4	 12.25	 20.4	 17.16	 13	 22.87	
22	 15.5	 13.13	 23.87	 18.1	 14.45	 24.85	
25	 18.32	 14.4	 26.25	 19.21	 15.37	 27.15	
28	 20.6	 16.2	 27.2	 22.75	 16.95	 28.27							
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Figure 4.3. Long-term culture and growth curve of splenocyte subsets treated 
with 500nM MAPKi under different oxygen saturations. 
 
Wild-type splenocytes were seeded at 2x106 cells/ml in a 24-well plate. Cells were 
cultured over 14 days; 500nM MAPKi and 1.5µg/ml IL-2 were added, and medium 
was changed every 2-3 days, under 3% and 40% O2 saturation. Effect of MAPKi on 
cell number was calculated as relative to control. A: effect of MAPKi on CD4 T-cell 
number relative to control, B: effect of MAPKi on CD8 T-cell number relative to 
control, C: effect of MAPKi on DP T-cell number relative to control, D: effect of 
MAPKi on DN cells relative to control, E: effect of MAPKi on B-cell number relative to 
control, and F: effect of MAPKi on monocyte number relative to control. All values are 
displayed as mean±sem (n=3). * P<0.05 for comparison of 3% vs. 40% oxygen 
saturation using 2-way ANOVA. 
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4.2.3 Effect of MAPK inhibition on splenocyte telomerase expression (mTert-GFP+) 
and telomerase activity under oxidative stress 
 
4.2.3.1 Effect of MAPK inhibition on mTert-GFP+ reporter lymphocyte proliferation 
under oxidative stress 
 
The mTert-GFP+ mice in this chapter were genotyped by another laboratory colleague, Dr. 
Gavin Richardson, IGM, Newcastle University. 
 
The telomerase complex has various components, including the catalytic subunit, telomerase 
reverse transcriptase (TERT). TERT is distinct from other components in that it is 
transcriptionally regulated (Blackburn, 2005). According to Stewart et al. (2002), there is 
increasing evidence underlining the critical function of TERT in cell proliferation and 
differentiation. Ahmed et al. (2008) found that TERT also plays key roles in apoptosis and 
protection against oxidative stress, by entering mitochondria. Others have described a binding 
of TERT to mitochondrial DNA (Haendeler et al., 2009). There is a close correlation between 
mTert-GFP reporter expression and native mTert mRNA transcripts and telomerase activity in 
the tissue systems investigated	(Montogomery et al, 2011; Stadtfeld et al., 2008). 
 
As the expression of GFP+ cells driven by native mouse TERT promoter shows a high 
correlation with telomerase activity, I used splenocytes from mTert-GFP+ mice to test the 
expression of TERT when treated with MAPK inhibitor under hypoxia (3% O2) and 
hyperoxia (40% O2). Figure 4.4 shows a positive effect of MAPKi on mTert-GFP+ 
splenocytes proliferation at oxygen saturations of 3% and 40% respectively. However this 
effect was significant (P<0.01) under 3% O2 (1.3-fold), compared to 40% O2 at day 3. This 
increase continued, reaching a peak at day 10 (P<0.001) by 1.3-fold in favour of 3% vs. 40% 
O2 saturation at the same day. At day 14 (the end of experiment) there remained a significant 
(P<0.05) effect under hypoxia of a 1.2-fold increase compared to hyperoxia. The reason for 
the difference in significance between hypoxia and hyperoxia may be the type of cell 
activation (described at figure 2.5), as in this experiment moderate activation was used whilst 
strong activation was used in experiments (4.2.2.1 and 4.2.2.1). Alternatively, it may be 
related to a different mouse genotype. Altogether, the MAPKi had a positive effect under both 
hypoxia and hyperoxia in mTert-GFP+ splenocytes. 
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4.2.3.2 Effect of MAPK inhibition on proliferation of lymphocyte subsets from mTert-
GFP+ mice under oxidative stress 	
Splenocytes consist of T-lymphocytes, B-lymphocytes and monocytes as a majority 
population. I conducted this experiment to find out which lymphocyte subset has the greatest 
proliferation following MAPK inhibitor treatment under oxidative stress vs. hypoxia. Figure 
4.5A shows that the CD4+ T-cells benefited the most from MAPKi treatment under both 
oxygen saturation conditions, especially under hyperoxia, which was significant (P<0.05) 
from (no effect) day 3 (first day testing the MAPKi effect) to day 14 (end of experiment), 
increasing by 1.4-fold. Also, under hypoxia MAPKi had a significant positive effect on cell 
proliferation at day 3 (P<0.05) by 1.5-fold and day 7 (P<0.01) by 1.4-fold, compared to 
hyperoxia 40% O2. A positive effect was also observed on GFP+ expression under both 
oxygen saturation conditions that was non-significant (figure 4.5C); this supports the 
conclusion that the effect of MAPKi was telomerase-dependent. Figure 4.5B shows a positive 
trend of MAPKi on CD8+ T-cells under both hypoxia and hyperoxia (ns). B-cells (figure 
4.5D) and monocytes (figure 4.5E) showed a similar trend under both oxygen conditions, but 
by the end of the experiments (day 14) there was no effect of MAPKi on these cells under 3% 
O2, whereas the positive trend continued over the whole experiment under 40% O2. 
 
In conclusion, it seems that MAPK inhibitor treatment has a positive effect on cell 
proliferation under oxidative stress. This effect was present in splenocytes/CD4+ T-cells from 
mTert-GFP+ mice (different genotype), and the majority of proliferation is generated by CD4+ 
T-cells under both oxygen saturations. 
 
4.2.3.3 Effect of MAPK inhibition on telomerase activation in splenocytes under 
oxidative stress 
 
Inhibition of p38 MAPK activated the telomerase activity of CD4+ T-cells after TCR 
activation (Di Mitri et al., 2011). This experiment was conducted to evaluate the effect of 
MAPKi on telomerase activity in splenocytes under oxidative stress vs. hypoxia. Splenocytes 
were expanded under both 3% and 40% oxygen saturation as described at (2.2.5). Telomerase 
activity was quantified at different time points using TRAP ELISA as described at (2.2.11). 
 
Figure 4.6 shows a trend for a positive effect of MAPKi on telomerase activity under hypoxia 
which seems to be stable during the experiment. There is no clear explanation for the absence 
of any effect of MAPKi on telomerase activity under hyperoxia at the beginning of 
experiments (days 3, 5 and 7). By day 10 a positive effect was also observed under hyperoxia 
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(2.1-fold compared to telomerase activity at day zero). This positive trend continued until it 
became significant (P<0.05) at day 14 by 2.9-fold compared to hypoxia (3% O2) at day 14, 
and by 3.7-fold compared to telomerase activity at day zero (P<0.01). Compared to mTert-
GFP+ telomerase expression at figure 4.5C and to the splenocyte proliferation experiments 
under hypoxia and hyperoxia at figure 4.4, I noticed that the number of cells and also the 
telomerase expression in GFP+ cells under hyperoxia was less than under hypoxia, whilst the 
telomerase activity after time (days 10 and 14) under hyperoxia was higher than under 
hypoxia.  
 
This implies that under hyperoxia, even when the number of cells or expression of telomerase 
are lower, MAPKi maintains these low cell numbers, and expression of telomerase is more 
active under disadvantaged conditions of oxidative stress, to enable cell survival.   	 	
 
 
 
 
 
 
 
Figure 4.4. Long-term culture and growth curve of splenocytes from transgenic 
mTert-GFP+ mice treated with 500nM MAPKi under different oxygen saturations.  
 
Splenocytes from transgenic mTert-GFP+ mice were seeded at 2x106/ml in a 24-well 
plate were coated overnight at 4°C with anti CD3 and CD28 antibodies (prepared at 
1µl/ml PBS). Medium was changed, 1.5µg/ml IL-2 and 500nM MAPKi were added 
every 2-3 days for all experiments. Cells were cultured either under 3% (hypoxia) or 
under 40% (hyperoxia) oxygen saturation for 14 days. Effect of MAPKi on cell 
number was calculated as relative to control. All values are displayed as mean±sem 
(n=4). * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001 for comparison between 3% 
vs. 40% oxygen saturation using 2-way ANOVA. 	
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Figure 4.5. Long-term growth curve of T-cells from transgenic mTert-GFP+ 
mouse splenocytes treated with 500nM MAPKi under different oxygen 
saturations. 
 
Splenocytes from mTer-GFP+ reporter mice were seeded at 2x106/ml in 24-well plates 
coated with CD3 and CD28 antibodies overnight for 14 days. The cells were then 
cultured in incubators with 3% and 40% oxygen saturation. Medium was changed, 
1.5µg/ml IL-2 and 500nM MAPKi were added every 2-3 days for all experiments. Then, 
at each time point (days 3, 5, 7, 10 and 14), cells were harvested and surface marker 
expression of native GFP relative to CD45R, CD11b, CD4+ and CD8+ was measured 
against negative controls using a compensated FACSCanto II running FACSDiva 
software; 50,000 live events were analysed to determine the proportion of T-cell types. 
Effect of MAPKi on cells number was calculated as relative to control. A: effect of 
MAPKi on CD4 T-cells number relative to control, B: effect of MAPKi on CD8 T-cell 
number relative to control, C: effect of MAPKi on GFP cells number relative to control, 
D: effect of MAPKi on B-cell number relative to control, E: effect of MAPKi on 
monocytes number relative to control. All values are displayed as mean±sem (n=4). * 
P<0.05, ** P<0.01, **** P<0.0001 for comparison between 3% vs. 40% oxygen 
saturation using 2-way ANOVA. 			
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Figure 4.6. MAPKi treatment rescues telomerase activity in wild-type mice 
splenocytes treated under hyperoxia 
 
Splenocytes from wild-type mice were generated by seeding 2x106/ml in a 24-well 
plate at day 0, and plates were coated overnight at 4°C with anti CD3 and CD28 
antibodies. Medium was changed; 500nM MAPKi and 1.5µg/ml IL-2 were added every 
2-3 days, under 3% and 40% oxygen saturation. Cells were harvested at each time 
point (days 3, 5, 7, 10 and 14), then cells were cryopreserved at -80°C. TRAP-PCR 
was run with 500ng protein loaded and 100ng for 3T3 (positive control). Effect of 
MAPKi on telomerase activity was calculated relative to its control. All values are 
displayed as mean±sem (n=5). *P<0.05, ** P<0.01 for comparison of 3% vs. 40% 
oxygen saturation using 2-way ANOVA. 
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Table	4.5.	Primary	results	of	mouse	splenocyte	telomerase	activity	measured	by	TRAP-ELISA	(absorbance	450nM)		
	
Days	in	culture	 Mouse	1	 Mouse	2	 Mouse	3	 Mouse	4	 Mouse	5	
	 3% O2, control	
0h	 1.1	 0.125	 0	 0.5	 0.11	
d3	 0	 1.639	 0.862	 1.2	 1.15	
d5	 0.082	 0.684	 1.11	 0.015	 0.65	
d7	 1.87	 0.023	 1.323	 1.25	 0.6	
d10	 1.8	 0.245	 1.531	 1.09	 1.2	
d14	 0.44	 1.198	 0.142	 0.8	 1.37	
	 3% O2, 500nM MAPKi 
0h	 1.1 0.125 0 0.5 0.11 
d3	 1.198 1.679 0.731 1.2 1.35 
d5	 0.006 1.352 1.659 0.2 0.135 
d7	 1.943 0.643 1.33 1.25 0.95 
d10	 1.692 1.711 0.961 1.25 1.2 
d14	 1.761 1.756 0.345 0.065 1.085 
	 40% O2, control 
0h	 1.1	 0.125	 0	 0.5	 0.11	
d3	 0.153	 1.072	 0.095	 0.7	 0.93	
d5	 1.554	 1.375	 1.745	 1.15	 1.25	
d7	 0.569	 0.3	 0.171	 0.15	 0.07	
d10	 0.067	 0	 0.121	 0.14	 0.01	
d14	 0.032	 0.04	 0.11	 0	 0	
	 40% O2, 500nM MAPKi 
0h	 1.1	 0.125	 0	 0.5	 0.11	
d3	 0.073	 0.867	 0.003	 0.325	 1	
d5	 1.626	 1.021	 0.11	 0.71	 1.11	
d7	 0	 0.533	 0.111	 0	 0.4	
d10	 0	 0.12	 0.131	 0	 0.45	
d14	 0.319	 0.085	 0.033	 0.17	 0.072										
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4.2.4 Effect of MAPK inhibition on the proliferation of activated pure CD4+ T-cells 
under oxidative stress 
 
Splenocytes were expanded for 14 days as described at (2.2.7), then CD4+ T-cells were 
purified by immunomagnetic bead-isolation as described at (2.2.6), to find the effect of 
MAPK inhibitor on CD4+ T-cell proliferation under hyperoxia. Figure 4.7 shows that a 
significant (P<0.0001) positive effect of MAPKi on TERT+/+ CD4+ T-cell proliferation under 
hypoxia from day 5 (1.36-fold) until the end of the experiment at day 15 (1.56-fold), 
compared to hyperoxia. But under oxidative stress, MAPKi had a positive effect on CD4+ T-
cells similar to the positive effect of MAPKi on TERT-/- samples (under both oxygen 
saturation conditions). 
 
There was no effect of MAPKi on cell proliferation in TERT-/- CD4+ T-cells under hypoxia 
and hyperoxia. This suggests that the effect of MAPKi on TERT+/+ CD4+ T-cells under 
hyperoxia is not telomerase-dependent and may, due to the lack of cytokines secreted by other 
splenocytes, improve TERT+/+ CD4+ T-cells more strongly under oxidative stress and increase 
survival rates. 
 
Taking all this information together, I can conclude that the effect of MAPKi was telomerase-
dependent in the presence of other splenocytes in the subset (e.g. B-cells and monocytes) and 
that it interacted with its secretion (cytokines). 
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Figure 4.7. MAPKi improves proliferation of pure CD4+ T-cells under 3% oxygen 
in a TERT dependent manner 
 
CD4+ T cells from either Tert+/+ or Tert-/- mice were seeded at 2x105 cells/well (volume 
= 200µl/well) in a 96-well plate. CD4+ T-cells were generated by immunomagnetic 
bead-isolation from splenocytes, which were cultured for 14 days with anti-CD3 and 
anti-CD28 antibodies. Medium was changed, 500nM/ml MAPKi and 1.5µg/ml IL-2 
were added every 2-3 days for all experiments. T lymphocytes were activated every 7 
days (days 0, 7, 14, and 21 if necessary) by adding CD3e/CD28-Biotin micro-beads at 
a 1:1 ratio (Miltenyi T-cell expansion kit). Cells were cultured either under 3% 
(hypoxia) or under 40% (hyperoxia) oxygen saturation. Effect of MAPKi on cell 
numbers was calculated as relative to individual control (no MAPKi) for each group. All 
values are displayed as mean±sem (n=3). **** P<0.0001 for comparison of 3% vs. 
40% oxygen saturation using two-way ANOVA. 
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4.3 Discussion 	
As described in chapter 3, hyperoxia induced oxidative stress, which led to decreased T-cell 
proliferation, suppressed telomerase activity, and enhanced transcription of IFN-γ mRNA. In 
this chapter, splenocytes were treated with mitogen-activated protein kinase inhibitor 
(MAPKi) under oxidative stress (40% O2) as well as under hypoxia (3% O2). I found MAPKi 
significantly reduced IFN-γ levels under hyperoxia, indicating that MAPKi might resist or 
prevent the effect of oxidative stress on cell proliferation under hyperoxia. By day 3, the IFN-
γ levels were almost equal under both hypoxia and hyperoxia. This matches previous studies 
which found that MAPKi can reduce IFN-γ secretion in vitro, causing less inflammation 
(Sarov-Blat et al., 2010; Cheriyan et al., 2011). 
The second significant finding here is that lymphocytes from TERT+/+ mice proliferated 
almost equally under both hypoxia and hyperoxia when MAPKi was used. This suggests that 
the suppressive effect of oxidative stress on cell proliferation might be inhibited by MAPKi 
under hyperoxia. However, with TERT-/- mice, the positive effect of MAPKi was almost 
equal under both oxygen conditions and there was no change in proliferation pattern relative 
to the control group under either 3% or 40% oxygen saturation (figure 4.2 and figure 4.7). 
This suggests that the effect of MAPKi on cell proliferation required the presence of TERT. 
When I explored the effect of MAPKi on splenocyte subsets (when CD4+ T-cells are 
purified), I found a positive effect under both oxygen saturations, with no significant changes 
on cell proliferation numbers. This is contrary to the significant changes in splenocyte 
proliferation (chapter 3) when MAPKi was not present. The most apparent effect of MAPKi 
was generated by CD4+ T-cells under both hypoxia and hyperoxia. From this, we can 
conclude that MAPKi maintains splenocytes and CD4+ T-cell health under hyperoxic 
conditions might be through counteracting the effect of IFN-γ, which is produced under 
conditions of oxidative stress. MAPK inhibition enhanced CD4+ T-cell proliferation (figure 
4.7) only under hypoxia when using purified CD4+ T-cells.  
MAPK inhibition seems to exert a trend toward higher telomerase activity (figure 4.6) in the 
TRAP qPCR (ns). Under hyperoxia, MAPK inhibition enhanced telomerase activity by day 
10, showing significantly increased telomerase activity by day 14 (P<0.05). The proliferative 
effect of the MAPK inhibitor seems to be telomerase-dependent. Atherosclerotic plaques may 
be more stable under MAPKp38 inhibition, which would consequently slow down the 
atherogenesis, inhibit myocardial apoptosis and ultimately benefit post-ischaemic myocardial 
cardiac function (Ma et al., 1999). IFN-γ secretion has been shown to be reduced by p38 
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MAPKi, resulting in decreased inflammation in human coronary artery rings (Ranjbaran et al, 
2007), reduced myocardial apoptosis, and better post-ischaemic cardiac function (Ma et al, 
1999). CD4+ T-cell survival following TCR activation is greatly increased when p38 
signalling is inhibited, and telomerase activity was also enhanced in these cells (Di Mitri et 
al., 2011). When the p38 signalling pathway is blocked, both cell proliferation and telomerase 
activity are increased following human T-cell stimulation (Di Mitri et al., 2011). When p53 is 
activated, both senescence and DNA damage are increased as a result of oxidative stress (Liu 
and Xu, 2011). When DNA damage occurs, p38 MAPK is activated, which leads to pRb/p16 
and p53 pathway activation, both of which contribute to the progression of senescence 
(Passos et al., 2010; Freund et al., 2011; Iwasa et al., 2003). Following CD4+ T-cell 
stimulation, both telomerase activity and proliferation were seen to be increased (Di Mitri et 
al., 2011). Furthermore, it has been shown that p38 MAPK inhibition can increase 
mitochondrial mass, which leads to better mitochondrial function and possibly improved 
proliferation (Henson et al., 2014). 					
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CHAPTER 5. Effect of voluntary exercise on telomerase and 
regulatory T-lymphocytes in mice 
5.1 Introduction 
 
Good health is closely linked with regular physical exercise. In humans, aerobic exercise is 
associated with reduced cardiovascular risk (Tanasescu et al., 2002) and, in the presence of 
cardiovascular disease, with lower mortality rates (Jolliffe et al., 2001; Piepoli et al., 2014; 
Taylor et al., 2004). More broadly, a wide range of conditions including cancer (Juarranz et 
al., 2002), osteoporosis (Kemmler et al., 2004) and depression (Blumenthal et al., 1999) are 
positively affected by physical exercise. Furthermore, telomere length and telomerase activity 
increase in PBMNCs in sedentary middle-aged men after 3 months of exercise for telomerase 
activity, and after 4 months for telomere length (Melk et al., 2014). In a murine model, male 
wild-type (C57BL/6) mice had a significantly decreased body weight after 5 weeks of 
voluntary wheel running exercise compared to the sedentary male group mice. Decreasing 
body weight was not significant in female mice compared to the sedentary female group. In 
contrast, female mice ran faster and longer than male mice on the voluntary wheel running 
exercise. Furthermore, the absolute heart rate was significantly increased in the female group 
under exercise compared to the non-exercise female group. In the male exercising group, this 
increase was not significant (De Bono et al., 2006). 
 
Various complex diseases have been studied at a molecular level in genetically modified 
mouse models. In this chapter I employed apolipoprotein (ApoE) knockout mTert-GFP+ and 
other mouse genotypes, which have been used to study the effects of exercise on 
atherosclerosis (Okabe et al., 2006). It is known that atherosclerosis in ApoE-/- mice is caused 
by accumulation of fat inside the capillaries, when a high fat diet is consumed (Mahley, 1988; 
Piedrahita et al., 1992). Our combined ApoE-/-mTert-GFP+ mice were bred in our laboratory, 
to investigate telomerase activity and expression under different diet and exercise regimes. 
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5.2 Results 
 
5.2.1 Effect of voluntary wheel running exercise on C57BL/6 wild-type mice 
 
5.2.1.1 Variability and spatial pattern of speed and duration during voluntary wheel 
running exercise on C57BL/6 wild-type mice 	 	
As C57BL/6 strain mice are widely used in physiological and genetic mouse studies (De 
Bono et al., 2006; Mekada et al., 2009), I also used them in this experiment. Small groups 
were used initially, to test our computer system and the running facilities. These were created 
by Dr. Bill Chaudhry and modified from De Bono et al. (2006), as described at 2.2.15.	2 male 
and 2 female 8-week old C57BL/6 mice were individually provided with an angled wheel 
running exercise. After 3 weeks of voluntary wheel running, monitored by digital odometers 
activated by wheel rotation (Enduro 2), both genders had reached over 4 hours of exercise per 
day (Figure 5.1A).  
 
However, the female mice spent more time on the running wheel, especially in the second 
half of experimental period (days 13 to 22). Males peaked at 5 hours of exercise per day, 
while females reached up to 7 hours. There was a significant (2.1-fold, P<0.05) increase in 
terms of time spent running for the female group (from 3.1 hours to 6.5 hours at the end of 
exercise). The male group (P<0.05) increased their exercise by 1.3-fold, from 3.8 hours at the 
beginning of the experiment to 4.9 hours at the end of experiment. 
 
During the exercise period, female mice ran larger distances than the males (Figure 5.1B) 
especially in the second half of the experiment (females ran 18.3 km per 24 hours (P<0.0001), 
increasing by 5.2-fold, while males reached 13.4 km per 24 hours, increasing by 2.8-fold). 
 
The average running speed for both groups (Figure 5.1C) almost reached the same level 
during the exercise period, without significant changes between either of them. However, 
there were significant changes for individual groups between starting average speed and the 
end-point average speed (2.5-fold for the female group (P<0.0001) and 2.2-fold in the male 
group (P<0.0001)). 
 
Figure 5.1D shows the maximum speed at the upper 99.9th percentile of the interval 
histogram. By the end of exercising, the female mice reached 35±0.13 km/h and the males 
reached 25±2.2 km/h (P<0.0001) in 24 hours. 
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5.2.1.2 Diurnal pattern of TERT+/+ wild-type mice on voluntary wheel running 
exercise  	
Running activity was recorded continuously (in-second frames), which allowed analysis of 
individual diurnal exercise patterns. Both male and female mice ran almost exclusively during 
the dark time (Figure 5.2). However, the females’ average wheel rotation (speed) was higher 
per hour than male mice, especially at night (ns). From this, we can conclude that the 
computerised recording system of voluntary wheel running exercise is a good and sufficient 
measure to determine mouse activity at all times, including night time. Mice are a good model 
for voluntary wheel running exercise and have a nocturmal tendency. Female mice were more 
active than male mice. 
 
Figure 5.1. Daily running parameters for TERT+/+ wild-type mice:  
 
TERT+/+ wild-type mice were subjected to a voluntary wheel running exercise (using a 
computerized system to record and analyse individual wheel rotations) for 3 weeks. 2 
male and 2 female mice were used, both on normal diet. A: mean daily time (h) spent 
wheel running, defined as continuous exercise with a maximum interval between 
detected wheel rotations of 5 seconds. B: mean daily running distance (km) calculated 
by wheel circumference x the total of wheel rotations. C: mean daily average speed 
(km/h) calculated by the total distance run/total running time during each 24-hours 
period. D: mean daily maximum speed (km/h), the speed at the upper 99th percentile 
of wheel rotation speeds from all individual wheel rotation time intervals in a 24-hours 
period. All values are displayed as a standard deviation (SD). * P<0.05, **** P<0.0001 
for comparison of male group vs. female group using two-way ANOVA. 
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Figure 5.2 Diurnal patterns of average wheel rotations per hour for TERT+/+ wild-
type mice 
 
TERT+/+ wild-type (C57BL/6) mice on voluntary wheel running exercise for 3 weeks. 2 
male mice vs. 2 female mice, both on a normal diet. Number of wheel rotations per 
hour were averaged for each group. All values are displayed as a standard deviation 
(SD). No significant (ns) for comparison of male vs. female average wheel rotations 
using unpaired T-test, two-tailed. 
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5.2.2 Effect of voluntary wheel running exercise on TERT+/- (heterozygous) mice 
 
5.2.2.1 Variability and spatial pattern of speed and duration during voluntary wheel 
running exercise on TERT+/- (heterozygous) mice 	
The main goal for this chapter is to find the effect of exercise on telomerase activity and to 
further test our computerised recording system of voluntary wheel running exercise. This was 
conducted on TERT-heterozygous mice as these mice were available from Dr. Gabriele 
Saretzki’s lab, and also since using these it was possible to investigate the effect of 
heterozygous telomerase deficiency on mouse activity.  5 female TERT heterozygous mice 
were randomly entered into the study as the exercising group for 7 weeks, vs. 5 female TERT 
heterozygous mice randomly selected as the control group (no exercise). Both groups were on 
a normal diet and 7-9 months old. Figure 5.3A shows that these mice started at 2.5 hours 
exercise per day. It is very noticeable that the time spent exercising varied considerably from 
mouse to mouse and from day to day until they peaked at day 23 and spent about 6 hours 
exercising per day. Following this, the peak declined to a trough of 2.8 hours at day 34, which 
is still higher than the first day’s run. This decline came after about 3 weeks of increasing the 
duration of running. I suspcted that the mice required some recovery time for the second 
increasing running duration, which continued until the end of the study, reaching 4.54 hours 
of exercising during a 24-hour period. 	
Figure 5.3B shows the variation in distance covered during the experiment, which started 
from about 2.94 km per day, peaking at day 23 (15.2 km during 24 hours), then declining to a 
trough of 5.4km at day 34. Then after a prospective recovery stage, the distance covered 
increased until the end of experiment, reaching about 10.8 km. 	
Average speed (Figure 5.3C) reached 2.51 km/h (peak) at day 23, which started from 1.01 
km/h at day one and reached 2.43 km/h at the end of experiment. Maximum speed (Figure 
5.3D) almost reached 25 km/h on most days. However, it started from 18.6 km/h at day one 
and reached about 21.6 km/h by the final day. 
 
Together with the 7-9 month old mice, at some points mice might have needed some recovery 
time before starting to do more running. Furthermore, the computerised monitoring system 
generated clear data regarding the activity of individual mice. 
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5.2.2.2 Diurnal pattern of TERT+/- (heterozygous) mice on voluntary wheel running 
exercise 
 
Figure 5.4 shows the circadian pattern of wheel rotation during each hour per day. However, 
the mice do more voluntary activity at night time; this activity disappears during day time 
(light). The peak of average number of wheel rotations was at 3772.7 rotations per 24 hours. 
 
5.2.2.3 Effect of voluntary wheel running exercise on weight of TERT+/- 
(heterozygous) mice 
 
During the voluntary wheel running exercise, mice were weighed weekly, whilst the control 
group (no exercise) was only weighed at the beginning and end of the study. Both groups 
were on a normal diet. Figure 5.5 shows a significant (P<0.05) difference in body weight 
between the exercising group (26.24±2.4g) and the control group (28.84±0.87g) by the end of 
study. However, the exercising group showed a decrease in body weight, especially during the 
first two weeks of exercise. Body weight then increased, but not far from original weight 
(26.14±2.7g) vs. (26.24±2.4g) at the end of study (ns). There was a significant (P<0.05) 
weight increase for non-exercise mice (26.94±1.41g at the start vs. 28.84±0.87g at the end of 
study). Finally, after 7 weeks of voluntary wheel running, the exercise led to control weight in 
TERT+/- mice. 
 
5.2.2.4 Effect of voluntary wheel running exercise on splenocyte numbers in TERT+/- 
(heterozygous) mice 
 
After 7 weeks, both groups were dissected and splenocytes isolated. After washing, cells were 
counted using the Neubauer chamber as described under 2.2.2. Figure 5.6 shows a non-
significant trend for an increase in splenocyte numbers for the training group (28.1±1.2 x 106 
cells vs. 25.4±2 x 106 cells for the control group). Under voluntary wheel running exercise, no 
major changes in lymphocyte numbers were observed in spleens from TERT+/- mice. 
 
5.2.2.5 Effect of voluntary wheel running exercise on splenocyte subpopulations of 
TERT+/- (heterozygous) mice 
 
Splenocytes were phenotyped into the main populations by flow cytometer as described in 
2.2.9.2 There was a trend towards an increased percentage in favour of the training group for 
CD4+ T-cells (Figure 5.7A), 9.5±0.9% per spleen vs. 8.4±0.5% per spleen in the non-training 
group (ns) and for CD8+ T-cells (Figure 5.7B), 5.3±0.5% per spleen vs. 4.3±1.04% per spleen 
in the non-training group (ns). Furthermore, there were some trends in the percentage of 
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double positive (DP) T-cells (Figure 5.7C), double negative (DN) T-cells (Figure 5.7D), B-
cells (Figure 5.7E) and monocytes (Figure 5.7F) between both groups. Thus, in summary, 
there were no significant differences detected for any splenocyte subset under exercise 
compared to the non-exercise group. 
 
5.2.2.6 Effect of voluntary wheel running exercise on splenocyte regulatory T-cells of 
TERT+/- mice 
 
Immune function in mice was found to be enhanced by regular moderate physical activity, 
such as the wheel-running exercise. Previous studies showed that T-cell mediated immunity, 
Th1 response and NK cell activity were potentiated in response to exercise in both humans 
and animals (Sugiura et al., 2001; Davis et al., 2004; Murphy et al., 2004).  
 
The purpose of this experiment was to determine the effect of voluntary wheel running 
exercise on the percentage of regulatory T-cells in TERT+/- mice. Splenocytes from exercise 
trained mice were isolated and T-cell surface markers were stained and detected by FACS as 
described at 2.2.9. Figure 5.8A shows a trend towards an increase in percentage of 
CD4+FoxP3+ cells 2.4±0.4% per spleen for the exercise group vs. 2±0.4% per spleen for the 
non-exercise group. Figure 5.8B shows a trend for an increase in percentage of CD4+CD25+ 
in favour of the exercise group (0.35±0.04% per spleen vs. 0.33±0.03% per spleen in the non-
exercise group). The same trend is noticeable for the percentage of CD4+FoxP3+CD25+ 
(figure 5.8C), increasing by 0.94±0.06% per spleen vs. 0.89+-0.08% per spleen in the non-
exercise group. However, this trend disappeared for the percentage of CD4+FoxP3-CD25- 
12.1±0.98% per spleen vs. 12.1±0.49% per spleen for the non-exercise group (figure 5.8D). 
Thus, in summary, in these mice, there was no clear effect on regulatory T-cells (as they are 
healthy mice) and the benefit of running exercise may be converted to physiological muscle 
strength (this was observed for mice on exercise, but not measured here) and blood circulation 
improvement (Baltgalvis et al., 2012; Hayes and Williams, 1998). 
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Figure 5.3. Daily running parameters for TERT+/- (heterozygous) mice  
 
TERT+/- (heterozygous) mice were subjected to a voluntary wheel running exercise 
(using a computerized system to record and analyse individual wheel rotations) for 7 
weeks. 5 female mice on exercise with a normal diet. A: mean daily time (h) spent 
wheel running, defined as continuous exercise with a maximum interval between 
detected wheel rotations of 5 seconds. B: mean daily running distance (km) calculated 
by wheel circumference x the total of wheel rotations. C: mean daily average speed 
(km/h) calculated by the total distance run/total running time during each 24-hour 
period. D: mean daily maximum speed (km/h), the speed at the upper 99th percentile 
of wheel rotation speeds from all individual wheel rotation time intervals in a 24-hour 
period. All values are displayed as mean±sem. 
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Figure 5.4. Diurnal pattern of average wheel rotations per hour for TERT+/- 
(heterozygous) mice 
 
Heterozygous TERT+/- mice on voluntary wheel running exercise for 7 weeks. 5 
female mice on exercise, with a normal diet. Numbers of wheel rotations per hour were 
averaged for the group. 
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Figure 5.5. Body weight of TERT-heterozygous mice 
 
TERT+/- (heterozygous) mice on the voluntary wheel running exercise for 7 weeks. 5 
female mice on exercise vs. 5 female mice with no exercise, both on a normal diet. 
Body weight was measured for the exercising group each week, but only at the 
beginning and the end of study for control group. All values are displayed as 
mean±sem. * P<0.05 for comparison of body weight for the exercise group vs. no 
exercise group using paired t-test, two-tailed. 
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Figure 5.6. Splenocyte numbers of TERT+/- heterozygous mice with and without 
exercise 
 
TERT+/- (heterozygous) mice on voluntary wheel running exercise for 7 weeks. 5 
female mice on exercise vs. 5 female mice with no exercise, both on a normal diet. 
Cells were mixed with 1:1 0.4% Trypan blue solution and splenocyte numbers 
counted. All values are displayed as mean±sem. No significant (ns) for comparison of 
splenocyte numbers between exercising group vs. non-exercising group using 
unpaired t-test, two-tailed. 
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Figure 5.7. Percentage of splenocyte subsets of TERT+/- heterozygous mice 
with and without exercise. 
 
TERT+/- (heterozygous) mice on voluntary wheel running exercise for 7 weeks. 5 
female mice on exercise vs. 5 female mice with no exercise, both on a normal diet. 
Splenocytes were isolated by Ficoll-hypaque density gradient and cells were stained 
with the antibodies as described at 2.2.8. A: %CD4+ T-cells/splenocytes, B: %CD8+ 
T-cells/splenocytes, C: %DP T-cells/splenocytes, D: %DN T-cells/splenocytes, E: 
%B-cells/splenocytes and F: %Monocytes/splenocytes. All values are displayed as 
mean±sem. No significant (ns) for comparison of exercise group vs. non-exercise 
group using unpaired t-test, two-tailed. 
 
 
 
 
 
 
%
 C
D
8+
 T
-c
el
ls
 / 
sp
le
no
cy
te
s
Exercise Non exercise
0
2
4
6
8
ns
B	
%
D
P 
T-
ce
lls
/ s
pl
en
oc
yt
es
Exercise Non exercise
0.00
0.05
0.10
0.15 ns
C	
%
 D
N
 T
-c
el
ls
/s
pl
en
oc
yt
es
Exercise Non exercise
1.5
2.0
2.5
3.0 ns
D	
Exercise Non exercise
65
70
75
80
85
%
B
-c
el
ls
/s
pl
en
oc
yt
es
ns
E	
%
M
on
oc
yt
es
/s
pl
en
oc
yt
es
Exercise Non exercise
6
8
10
12
ns
F	
%
C
D
4+
 T
-c
el
ls
/ s
pl
en
oc
yt
es
Exercise Non exercise
6
7
8
9
10
11
12 ns
TERT-heterozygous mice
A	
	 159	
 
 
 
 
Figure 5.8. Percentage of regulatory T-cells in TERT+/- mice during exercise  
 
TERT+/- (heterozygous) mice on voluntary wheel running exercise for 7 weeks. 5 
female mice on exercise vs. 5 female mice without exercise, both on a normal diet. 
Cells were isolated by Ficoll-hypaque density gradient and cells were stained with 
beads as described at 2.2.14. A: percentage of CD4+FoxP3+ cells/splenocytes, B: 
percentage of CD4+CD25+/splenocytes, C: percentage of 
CD4+FoxP3+CD25+/splenocytes and D: percentage of CD4+FoxP3-CD25-/splenocytes. 
All values are displayed as mean±sem. No significant (ns) for comparison of exercise 
group vs. non-exercise group using unpaired t-test, two-tailed. 
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5.2.3 Effects of voluntary wheel running exercise on mTert-GFP+ mice 
 
5.2.3.1 Variability and spatial pattern of speed and duration during voluntary wheel 
running exercise on mTert-GFP+ mice 
 
The mTert-GFP+ mice in this sub-chapter were genotyped by another laboratory colleague, 
Dr. Karim Bennaceur, IGM, Newcastle University. 
 
mTert-GFP+ mice are genetically modified to contain a telomerase (mTERT) expression 
reporter. Therefore, in this experiment, 6 female mice were assigned to the voluntary wheel 
running exercise group vs. 6 female mice assigned to the control group (no exercise). Both 
groups were on a normal diet and were 2-3 months old. Performance varied between mice as 
well as from day to day. Figure 5.9A shows the time mice spent with running exercise, which 
started below 2 hours per day, then varied from 2-2½ hours per day. The distance travelled 
(Figure 5.9B) by these mice started at less than 2 km per 24 hours and reached up to 5 km per 
24 hours by the end of the experiment. The average speed (Figure 5.9C) started from about 1 
km/h at day one, reaching 1.75 km/h at the end of experiment. The maximum speed (Figure 
5.9D) for mTert-GFP+ mice started at around 35 km/h at the beginning of experiment and 
reached around 20 km/h by the end of the experiment. These mice spent a significant time 
exercising, but this was not what I expected based on the previous two groups. 
 
5.2.3.2 Diurnal pattern of mTert-GFP+ mice on voluntary wheel running exercise 
From wheel average rotation at figure 5.10, during the 5 weeks of exercising, the 6 female 
mice spent more time running during the night (in the dark). Maximum wheel rotation was at 
the beginning of the night, then gradually decreased until the lights were turned on. 
 
5.2.3.3 Effect of voluntary wheel running exercise on body weights of mTert-GFP+ 
mice 
After 5 weeks of voluntary wheel running exercise, the weight of mice under exercise 
decreased from 21.5±1.4g at the first two weeks to 20.7±0.9g. It then returned to the starting 
weight at week four (by 21.65±0.98g), then plateaued during the last two weeks of the 
experiment at 21.7±0.8g. On the other hand, the non-exercising group started from 21.5±0.5g 
then gradually increased (P<0.05), reaching 22.8±0.7g by the end of the experiment. In 
conclusion, exercising can lead to loss and control of weight. 
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5.2.3.4 Effect of voluntary wheel running exercise on splenocyte numbers in mTert-
GFP+ mice 
 
Cells were isolated from the spleen at the end of experiments by Ficoll-hypaque density 
gradient. Splenocytes were counted under the microscope using a Neubauer chamber 
(described at 2.2.2) for both exercising and non-exercising groups. There was no significant 
change in splenocyte numbers after exercising (28±0.9 x106/spleen) compared to the control 
group (26.6±2.3 x 106/spleen) by the end of the experiment. However, there is a trend towards 
increasing numbers for the exercising group. In contrast, there is a high variation in cell 
numbers from spleen to spleen in the control group (26.6±2.3 x 106/spleen) vs. a smaller 
variation (<0.99) for the exercising group. 
 
5.2.3.5 Effect of voluntary wheel running exercise on splenocyte subpopulations of 
mTert-GFP+ mice 
 
The aim of this experiment was to determine the effect of exercise on telomerase expression, 
as these mice have a telomerase reporter, as well as T-lymphocytes, B-lymphocytes and 
monocytes, which form the main splenocyte population. Cells were isolated from mice and 
stained with the respective antibodies as described under 2.2.8. For CD4+ T-cells (Figure 
5.13A) and CD8+ T-cells (Figure 5.13B), there were no significant changes under exercise 
compared to the control group. The same was noticed for GFP+ cells (Figure 5.13C); there 
was no significant change on TERT expression in GFP+ cells, just a trend toward increasing 
GFP+ cell numbers for the exercising group. However, a significant (P<0.05) response was 
observed for B-lymphocytes (Figure 5.13D) after the voluntary wheel running exercise 
(19.1±0.79 x 106/spleen) vs. (17.2±1.7 x 106/spleen) for the control group. B-cells may be 
differentiated into plasma cells, which produce antibodies and are released into the blood, or 
memory cells which remain in circulation for a long time and may respond to an antigen 
subsequently (Ozaki et al., 2004), so further investigation is required to find out which subset 
of B-cells responds to exercise. Monocytes (Figure 5.13E) also did not show any response to 
the running exercise. 
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Figure 5.9. Daily running parameters for mTert-GFP+ mice  
 
mTert-GFP+ mice were subjected to voluntary wheel running exercise (using a 
computerized system to record and analyse individual wheel rotations) for 5 weeks. 
6 female mice, exercising and on a normal diet. A: mean daily time (h) spent wheel 
running, defined as continuous exercise with a maximum interval between detected 
wheel rotations of 5 seconds. B: mean daily running distance (km) calculated by 
wheel circumference x the total of wheel rotations. C: mean daily average speed 
(km/h) calculated by the total distance run/total running time during each 24-hours 
period. D: mean daily maximum speed (km/h), the speed at the upper 99th 
percentile of wheel rotation speeds from all individual wheel rotation time intervals in 
a 24-hours period. All values are displayed as mean±sem. 
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Figure 5.10. Diurnal pattern of average wheel rotations per hour for mTert-GFP+ 
mice 
 
mTert-GFP+ mice on voluntary wheel running exercise for 5 weeks. 6 female mice  
exercising and on a normal diet. Numbers of wheel rotations per hour were averaged 
for the group.	
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Figure 5.11 Body weight of mTert-GFP+ mice with and without exercise 
 
mTert-GFP+ mice on the voluntary wheel running exercise for 5 weeks. 6 female mice 
on exercise vs. 6 female mice with no exercise, both on a normal diet. Weight was 
measured weekly for both groups. All values are displayed as mean±sem. * P<0.05 for 
comparison of exercise group vs. no exercise group using two-way ANOVA. 
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Figure 5.12. Number of splenocytes from mTert-GFP+ mice with and without 
exercise  
 
mTert-GFP+ mice on voluntary wheel running exercise for 5 weeks. 6 female mice on 
exercise vs. 6 female mice without exercise, both on a normal diet. Cells were mixed 
with 1:1 0.4% Trypan blue solution and splenocyte numbers counted. All values are 
displayed as mean±sem. (ns) no significant for comparison of exercising group vs. non 
exercising group using unpaired t-test, two-tailed. 
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Figure 5.13. Percentage of splenocyte subpopulations in mTert-GFP+ mice 
with and without exercise  
 
mTert-GFP+ mice on voluntary wheel running exercise for 5 weeks. 6 female mice 
on exercise vs. 6 female mice with no exercise, both on a normal diet. Cells were 
isolated by Ficoll-hypaque density gradient and stained with antibodies as 
described at 2.2.8. A: percentage of CD4+ T-cells/splenocytes, B: percentage of 
CD8 T-cells/splenocytes, C: percentage of GFP+ cells/splenocytes, D: percentage 
of B-cells/splenocytes and E: percentage of monocytes/splenocytes.  
All values are displayed as mean±sem. * P<0.05 for comparison of exercise group 
vs. non-exercise group using unpaired t-test, two-tailed. 
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5.2.4 Effect of voluntary wheel running exercise on ApoE-/-mTert-GFP+ mice 
 
5.2.4.1 Variability and spatial pattern of speed and duration during voluntary wheel 
running exercise on ApoE-/-mTert-GFP+ mice 
 
The mTert-GFP+ mice in this sub-chapter were genotyped by another laboratory colleague, 
Dr. Karim Bennaceur, whilst the ApoE-/- mice were genotyped by Natasha Curley, PhD 
student with Prof. Deborah Henderson and Dr. Bill Chaudhry’s team, IGM, Newcastle 
Univeristy. 
Mice body weight and calorie intake in this sub-chapter were recorded weekly by myself and 
by Natasha Curley, PhD student from Prof. Deborah Henderson and Dr. Bill Chaudhry’s 
team. The vascular phenotype of these mice and how it was affected by exercise will be 
studied by Prof. Deborah Henderson and Dr. Bill Chaudhry’s team (Natasha Curley, PhD 
student), IGM, Newcastle Univeristy. 
 
Apolipoprotein E (ApoE) is a protein-coding gene, from which the protein generated 
combines with fat to create a lipoprotein. ApoE is a very low density lipoprotein, involved in 
removing cholesterol from the bloodstream (Daniels et al., 2009). In 1992, the first line of 
ApoE-knockout mice was generated and these have since become the most used model for 
research on atherosclerosis. ApoE-knockout mice develop a high degree of atherosclerosis, 
rendering them ideal for research on the disease, and contributing towards vital new theories 
around atherosclerosis, namely that it is an inflammatory disease (Zhang et al., 1992; 
Williams et al., 2002; Knouff et al., 1999). Furthermore, atherosclerotic plaques were found 
to be stabilized in ApoE-/- mice after long term exercise (Pellegrin et al., 2009).  
 
Mouse telomerase reverse transcriptase (mTert)-GFP- transgenic mice (see chapters 3 and 4 
and others: Breault et al., 2008; Armstrong et al., 2000; Richardson et al., 2012) provide a 
model which can be used to determine TERT expression and presence in vivo and on a single 
cell level, which is thought to correlate well with its activity in several tissues (Breault et al., 
2008; Armstrong et al., 2000). As ApoE-/- mice provide a good model for lipid accumulation 
and plaque build up in atheroslcerosis development (Candido et al., 2002; Patel et al., 2001), 
we decided to generate a new mouse genotype: ApoE-/-mTert-GFP+, which can accumulate 
lipid (atherosclerosis) and report telomerase, through crosses between ApoE+/- (heterozygous) 
and mTert-GFP+ as described at 2.2.1.3. Ultimately, this would enable us to establish the role 
of telomerase specific to cells in atherosclerotic conditions. I had hypothesized that the 
exercise effects would increase the telomerase activity of lymphocytes. 
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ApoE-/-mTert-GFP+ mice were assigned to the voluntary wheel running exercise as two 
groups; one with a high fat diet (HFD) and another on normal diet (ND). Another two groups 
were assigned to no exercise (control group), one on a HFD and the other on ND. 
Furthermore, ApoE+/+mTert-GFP+ mice were used as a control group for (ApoE-/-). These 
mice had no exercise and again, one group was given a HFD and the other ND (table 5.1). 
 
Table 5.1. Groups of ApoE-/-mTert-GFP+ and ApoE+/+mTert-GFP+ mice 
 mTert-GFP+ 
Exercise No exercise 
ApoE-/- ApoE+/+ 
High fat diet n= 4 mice n= 4 mice n= 3 mice 
Normal diet n= 4 mice n= 4 mice n= 4 mice 
 
During 16 weeks of voluntary wheel running exercise, both HFD and ND groups reached up 
to 5 hours (Figure 5.14A) of running per 24 hours. However, there was a clear variation in 
exercise duration between mice and also from day to day. There was no significant change in 
time spent exercising between the two groups based on their diet, although there was a trend 
towards increased duration for the HFD group. Running duration gradually increased during 
the first 3 weeks for both groups. The HFD group started at about 2.2h per 24 hours, reaching 
up to 4.2h of running per 24 hours (P<0.0001) after 3 weeks. The ND group started at 2.2h, 
reaching up to 5.3h per 24 hours (P<0.0001). After this first peak for each group, the duration 
gradually fluctuated up and down until a second peak was reached at day 51. The HFD 
reached up to about 5.3h/24h (P<0.0001) and the ND about 5.2h/24h (P<0.0001). By the end 
of the experiment, mice in both groups spent about the same time running as when they 
started, around 2.2h/24h for each group. 
 
The distance moved (Figure 5.14B) during the first 3 weeks gradually increased, peaking at 
day 17, at 11.6 km/24h. The ND group started at 3.97 km/24h at day one (P<0.001), but the 
HFD group continued to increase until reaching its first peak at day 32, of 12.96 km/24h, up 
from about 3kh/24h at day one (P<0.001). After the first peak for each group there was a 
variation in distance moved between mice as well as from day to day, which may be related to 
the recovery period required before starting training again. It is clear that the HFD group ran 
the greater distance compared to the ND group at almost all time points in the second half of 
experiment, and this may be due to the higher energy in their diet. 
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Figure 5.14C shows that the average speed reached by the HFD group was greater than that of 
the ND group (ns). The HFD group almost reached 2.25 km/h at several time points, while the 
ND group reached only 1.75 km/h at the majority of time points. 
 
The maximum speed (Figure 5.14D) was almost equal for both groups until the last quarter of 
the experimental period, when a sudden drop was observed in the ND group for a few days, 
before returning to the maximum speed again.  
 
5.2.4.2 Diurnal pattern of ApoE-/-mTert-GFP+ mice on voluntary wheel running 
exercise 
 
According to the average wheel rotation for individual hours, it was obvious that the mice ran 
for longer and moved greater distances during night time when it was dark.  
However, ApoE-/-mTert-GFP+ mice in the HFD group performed more average wheel 
rotations (over 927.3±215.5/day vs. over 733.1±170/day for the ND group (P<0.01)).  
 
5.2.4.3 Effect of voluntary wheel running exercise on body weight of ApoE-/-mTert-
GFP+ mice 
 
During this experiment, mice in all groups were weighed, as was their food intake. The lowest 
body weights were recorded for the groups on exercise (Figures 5.3i and ii). As expected, all 
groups gained weight during the study as they started young, at 4 weeks old. Body weights 
increased significantly for all groups between day one and the last day (table 5.2). 
 
Table 5.2. Body weight of ApoE-/-mTert-GFP+ and ApoE+/+mTert-GFP+ mice 
Groups Exercise Diet  Average 1st weight Average end weight P value 
m
Te
rt-
G
FP
+  
A
po
E-
/-  YES HFD (i) 13.7±1.8 25.75±2.53 P<0.0001 ND (ii) 16.13±2.88 24±4.15 P<0.0001 
N
O
 
HFD (iii) 17.13±1.88 30.88±4.43 P<0.0001 
ND (iv) 17.37±1.83 28.18±1.58 P<0.0001 
ApoE+/+ HFD (v) 18.73±2.71 31.98±2.08 P<0.0001 
ND (vi) 15.48±1.33 29.38±2.34 P<0.0001 
 
Calorie intake was measured as ‘weight of food eaten multiplied with calorie intake of high 
fat diet’; (weight of food eaten = weight of food given – weight of food left; calorie intake of 
high fat diet is 4.5 kCal/g) to ensure any changes in weight were not due to poor nutrition, 
irrespective of exercise. Figure 5.16B shows that all groups had the same average food intake 
during the study, with no significant changes between them. There was a trend towards 
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increase in body weight for normal diet in the exercise ApoE-/-mTert-GFP+ group (ns).  Under 
exercise, there were no significant changes between groups (i and ii). In terms of food type, 
the HFD group gained more weight than the ND group (ns). There was a significant (P<0.05) 
change in weight between ND on exercise (ii) compared to the HFD non-exercise group (iii) 
for ApoE-/-mTert-GFP+ mice.  
 
ApoE protein binds to lipids to form lipoproteins. Its function is to package and carry 
cholesterol in the bloodstream, thereby playing a role in cholesterol level maintenance. Based 
on the results with exercise and an absence of ApoE, diet does not appear to cause any 
significant changes in our study (with exercise eat what you want). Furthermore, in the 
presence of ApoE, mice gain more weight than the exercising mice without ApoE, regardless 
of diet. 
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Figure 5.14. Daily running parameters for ApoE-/-mTert-GFP+ mice 
 
ApoE-/-mTert-GFP+ mice were subjected to a voluntary wheel running exercise (using 
a computerized system to record and analyse individual wheel rotations) for 16 
weeks. 4 mice on HFD vs. 4 mice on ND. A: mean daily time (h) spent wheel 
running, defined as continuous exercise with a maximum interval between detected 
wheel rotations of 5 seconds. B: mean daily running distance (km) calculated by 
wheel circumference x total of wheel rotations. C: mean daily average speed (km/h) 
calculated by the total distance run/total running time during each 24-hour period. D: 
mean daily maximum speed (km/h), the speed at the upper 99th percentile of wheel 
rotation speeds from all individual wheel rotation time intervals in a 24-hour period. 
All values are displayed as mean±sem. For comparison of HFD group vs. ND group 
using two-way ANOVA. 
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Figure 5.15 Diurnal pattern of average wheel rotations per hour for ApoE-/-
mTert-GFP+ mice 
 
ApoE-/-mTert-GFP+ mice on voluntary wheel running exercise for 16 weeks. 4 mice 
on high fat diet vs. 4 mice on normal diet. Number of wheel rotations per hour were 
averaged for each group. High fat diet (HFD) group ran further, especially in dark 
period. All values are displayed as mean±sem. ** P<0.01 for comparison of HFD vs. 
ND wheel average rotation using unpaired T-test, two-tailed. 
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Figure 5.16. Body weight and calorie intake for ApoE-/-mTert-GFP+ and 
ApoE+/+mTert-GFP+ mice on different diets with and without exercise 
 
ApoE-/-mTert-GFP+ mice on voluntary wheel running exercise for 16 weeks (4 mice on 
HFD (i) vs. 4 mice on ND (ii)), all vs. no exercise groups (4 mice on HFD (iii) vs. 4 
mice on ND (iv)), in addition to groups of ApoE+/+mTert-GFP+ mice (3 mice on HFD (v) 
vs. 4 mice on ND (vi)). A: Body weight was measured weekly for all groups. B: Calorie 
intake was measured for all groups. All values are displayed as mean±sem. * P<0.05, 
** P<0.01, *** P<0.001, **** P<0.0001 for comparison between HFD vs. ND and 
exercise vs. no exercise on ApoE-/-mTert-GFP+ mice using 2-way ANOVA multiple 
comparisons. Also, 2-way ANOVA multiple comparisons were used to compare 
between HFD vs. ND and ApoE-/-mTert-GFP+ vs. ApoE+/+mTert-GFP+ mice. 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
12
18
24
30
week
W
ei
gh
t (
g)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
0
50
100
150
200
weekC
al
or
ie
 in
ta
ke
 (4
.5
kC
al
/g
)
A	
B	
mTert-GFP+	
HFD on Ex's (ApoE-/-)
ND on Ex's (ApoE-/-)
HFD NO Ex's (ApoE-/-)
ND NO Ex's (ApoE-/-)
HFD NO Ex's (ApoE+/+)
ND NO Ex's (ApoE+/+)(vi)
(v)
(iv)
(iii)
(ii)
(i)
	 174	
 
5.2.4.4 Effect of voluntary wheel running on telomerase activity in ApoE-/- mTert-
GFP+ mice 
 
Telomerase reverse transcriptase (TERT) plays an important role in cell division. Also, 
PBMNCs telomere lengths significantly increased under moderate exercise (Ludlow et al., 
2008). Aerobic exercise reverses arterial inflammation with ageing in mice (Lesniewski et al, 
2011). In humans, telomere length and telomerase activity increases in PBMNCs in middle-
aged men with sedentary lifestyles after exercising for 4 months (Melk et al., 2014). This part 
of the experiment was designed to identify the effect of exercise on telomerase activity under 
either HFD or ND on modified genotype ApoE-/-mTert-GFP+ mice and also in ApoE+/+mTert-
GFP+ mice. 
 
Firstly, I compared diet and exercise in ApoE-/- mice (Figure 5.17 - purple section). Under 
exercise, HFD had a significant effect on telomerase activity 1.54±0.02 vs. 0.91±0.15 for ND 
group (P<0.05). Exercise induced significantly (P<0.001) higher telomerase activity than 
HFD without exercise in the same diet group (exercise = 1.54±0.02 vs. 0.4±0.18 = no 
exercise). HFD with exercise led to significantly (P<0.01) higher telomerase activity 
compared to the ND group without exercise (0.68±0.14). 
 
Secondly, I compared between ApoE-/- vs. ApoE+/+ mice on both diets but without exercise 
(Figure 5.17 - brown section). Under HFD without exercise, ApoE-/- mice had a trend towards 
higher telomerase activity than ApoE+/+ mice (ns). In general, the ApoE+/+ groups had a trend 
towards lower telomerase activity than ApoE-/- groups (ns).  
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Figure 5.17. Telomerase activity for ApoE-/-mTert-GFP+ and ApoE+/+mTert-GFP+ 
mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. Telomerase activity was measured for 
each mouse in each group. All values are displayed as mean±sem. * P<0.05, 
**P<0.01, *** P<0.001 for comparison between HFD vs. ND and exercise vs. no 
exercise on ApoE-/-mTert-GFP+ mice using 2-way ANOVA multiple comparisons 
(purple section). 2-way ANOVA multiple comparisons (brown section) were also used 
to compare between HFD vs. ND and ApoE-/-mTert-GFP+ vs. ApoE+/+mTert-GFP+ 
mice. The TRAP assay was performed by Dr. Gabriele Saretzki NU, ICaMB, using 
splenocyte pellets that I had prepared as described above. 
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5.2.4.5 Effect of voluntary wheel running on splenocyte numbers in ApoE-/- mTert-
GFP+ mice 
 
The purpose of the next experiment was to find out if there is any effect of exercise or diet on 
the number of splenocytes. Also, I wanted to find out whether there was an effect of diet type 
on splenocyte number in mice with a functioning ApoE+/+ gene. Splenocytes were counted 
using a Neubauer hemocytometer after being isolated by Ficoll-hypaque density gradient and 
washed as described at 2.2.2. 
 
In groups of ApoE-/-mTert-GFP+ mice (Figure 5.18 - purple section), there was no significant 
change in splenocyte numbers as a result of exercising. However, under HFD, splenocytes 
showed an increasing trend (42±2.16 x 106/spleen compared to the exercising group 
36.26±4.45 x 106/spleen (ns)). The same trend was found under ND; splenocyte numbers 
increased (36.35±1.44 x 106/spleen compared to the exercising group 32.6±5.8 x 106/spleen 
(ns)). 
 
In the non-exercise groups (Figure 5.18 - brown section), there was a significant (P<0.05) 
increase in splenocyte numbers (42±2.16) when ApoE was knocked out and under HFD, 
compared to the group on ND and in the presence of ApoE+/+. In summary, there was no 
significant change on splenocyte numbers for ApoE-/-mTert-GFP+ or ApoE-/-mTert-GFP+ mice 
under all conditions. 
 
5.2.4.6 Effect of voluntary wheel running on splenocyte B-cell numbers in ApoE-/- 
mTert-GFP+ mice 
 
The goal for this experiment was to find out whether exercise has an effect on mice under 
different diets regarding splenocyte sub-populations. To achieve this goal, cells were stained 
with 4 anibodies as described at 2.2.9, and subjected to flow cytometery. Surprisingly, the B-
cell population was affected the most under exercise (Figure 5.19 - purple section). Under 
exercise, B-cells significantly (P<0.001) decreased with ND (13.1±0.31 x 106/spleen 
compared to 20.16±0.82 x 106/spleen for the HFD group). B-cells in the exercise group on 
ND (13.1±0.31 x 106/spleen) decreased sgnificantly (P<0.0001) when compared to the no 
exercise group with HFD (22.7±1.18 x 106/spleen) and also when compared with the ND no 
exercise group 20.3±1.11 x 106/spleen (P<0.001). 
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When I compared the effect of the HFD without exercise on B-cell numbers in both ApoE-/- 
and ApoE+/+ (Figure 5.19 - brown section), there was no significant change in cell numbers. 
However, there was a trend towards increasing numbers between the same diet groups when 
comparing ApoE-/- with ApoE+/+. B-cell numbers were decreased under exercise with ND, 
suggesting that HFD increases B-cell numbers, while exercise counteracts this increase. 
 
5.2.4.7 Effect of voluntary wheel running on CD8+ T-cell numbers in ApoE-/- mTert-
GFP+ mice 
 
On T-lymphocyte levels, suprisingly, CD8+ T-cells significantly (P<0.05) decreased under 
exercise with HFD (0.95±0.14 x 106/spleen) compared to the non-exercising group on ND 
(2.48±0.39 x 106/spleen). However, there were no significant changes between the other 
groups. The main thing to notice here (Figure 5.20, compared with Figure 5.19) is that B-cell 
numbers increased under the running exercise with HFD compared to ND with exercise. 
However, CD8+ T-cell numbers decreased under the running exercise with HFD compared to 
ND with exercise. We noticed these opposing increases and decreases between B-cells and 
CD8+ T-cells in all groups, with some variation for ApoE-/-mTert-GFP+ mice. 
 
5.2.4.8 Effect of voluntary wheel running on GFP+B-cell numbers in ApoE-/- mTert-
GFP+ mice 
 
There was no significant change in the total number of GFP+ cell (Figure 5.22D) under all 
conditions, as these cells reflect telomerase-positive. However, total GFP+ cells have different 
subsets (GFP+CD4+, GFP+CD8+, GFP+B-cell and GFP+monocytes+), and figure 5.21 shows 
that GFP+B-cell number decreases significantly (P<0.05) (0.11±0.011 x 106/spleen in HFD 
with exercise, compared to ND without exercise (0.16±0.011 x 106/spleen)). B-cell with 
telomerase expression shows a significant (P<0.01) decrease in the exercising group 
(0.083±0.01 x 106/spleen), compared to the non-exercising group (0.16±0.011 x 106/spleen) 
both on ND. This significant (P<0.01) decrease was noticed when comparing the exercising 
group on ND (0.083±0.01 x 106/spleen) vs. the non-exercising group on HFD (0.15±0.015 x 
106/spleen). 
 
On the other hand, when comparing ApoE-/- (HFD vs. ND) vs. ApoE+/+ (HFD vs. ND), both 
non-exercising (Figure 5.21 - brown section), there were no significant changes between all 
groups except ApoE+/+ groups. There was a significant (P<0.05) decrease in GFP+B-cell 
numbers in ND without exercise (0.058±0.025 x 106/spleen), compared to HFD non-exercise 
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in the same genotype (ApoE+/+), of 0.363±0.17 x 106/spleen. Finally, the number of B-cells 
that express telomerase increased in ApoE-/- without exercise. Exercising seems to decrease 
the number of active telomerase-experessing B-cells under both types of diet, but more with 
ND. 
 
5.2.4.9 Effect of voluntary wheel running on other splenocyte subset numbers in 
ApoE-/- mTert-GFP+ mice 
 
Splenocytes include T-lymphocytes, B-lymphocytes and monocytes as a major population 
within the spleen. B-cells are shown in figure 5.19. T-lymphocytes also contain further 
subsets (CD4+, CD8+, DP and DN). In figure 5.20, CD8+ T-cells are displayed. Here, we can 
see the other T-lymphocyte subsets, CD4+ (Figure 5.22A), DP (Figure 5.22B) and DN (Figure 
5.22C). There were no significant changes between any of the groups under different exercise 
or diet conditions, and different genotypes have no effect on these cells. Figure 5.22D shows 
the total GFP+ cells, as these cells express active telomerase, but here also there was no 
significant change between all groups. Monocyte numbers (Figure 5.22E) show no significant 
changes under any effect for all groups.  
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Figure 5.18. Splenocyte numbers for ApoE-/-mTert-GFP+ and ApoE+/+mTert-GFP+ 
mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. Splenocytes were counted for each mouse 
in each group. All values are displayed as mean±sem. * P<0.05 for comparison 
between HFD vs. ND and exercise vs. no exercise on ApoE-/-mTert-GFP+ mice using 
2-way ANOVA multiple comparisons (purple section). 2-way ANOVA multiple 
comparisons (brown section) were also used to compare between HFD vs. ND and 
ApoE-/-mTert-GFP+ vs. ApoE+/+mTert-GFP+ mice. 
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Figure 5.19. B-cell (splenocytes) numbers for ApoE-/-mTert-GFP+ and 
ApoE+/+mTert-GFP+ mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks; 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. B-cell numbers were gated and counted 
for each mouse.  
All values are displayed as mean±sem. *** P<0.001, **** P<0.0001 for comparison 
between HFD vs. ND and exercise vs. no exercise on ApoE-/-mTert-GFP+ mice using 
2-way ANOVA multiple comparisons (purple section). 2-way ANOVA multiple 
comparisons (brown section) were also used to compare between HFD vs. ND and 
ApoE-/-mTert-GFP+ vs. ApoE+/+mTert-GFP+ mice. 
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Figure 5.20. CD8+ T-cell (splenocyte) numbers for ApoE-/-mTert-GFP+ and 
ApoE+/+mTert-GFP+ mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. CD8+ T-cell (spleen) numbers were 
counted for each mouse. All values are displayed as mean±sem. * P<0.05 for 
comparison between HFD vs. ND and exercise vs. no exercise on ApoE-/-mTert-GFP+ 
mice using 2-way ANOVA multiple comparisons (purple section). 2-way ANOVA 
multiple comparisons (brown section) were also used to compare between HFD vs. 
ND and ApoE-/-mTert-GFP+ vs. ApoE+/+mTert-GFP+ mice. 
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Figure 5.21. GFP+B-cell (splenocytes) numbers for ApoE-/-mTert-GFP+ and 
ApoE+/+mTert-GFP+ mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. GFP+B-cells from spleen number was 
counted for each mouse. All values are displayed as mean±sem. * P<0.05, ** P<0.01 
for comparison between HFD vs. ND and exercise vs. no exercise on ApoE-/-mTert-
GFP+ mice using 2-way ANOVA multiple comparisons (purple section). 2-way ANOVA 
multiple comparisons (brown section) were also used to compare between HFD vs. 
ND and ApoE-/-mTert-GFP+ vs. ApoE+/+mTert-GFP+ mice. 
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Figure 5.22. Number of other splenocyte subsets from ApoE-/-mTert-GFP+ and 
ApoE+/+mTert-GFP+ mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. A: CD4+ T-cell (spleen) number were 
counted for each mouse. B: DP T-cell (spleen) number. C: DN T-cell (spleen) number. 
D: GFP+ splenocyte number and E: Monocytes (spleen) number. All values are 
displayed as mean±sem. * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001 for 
comparison between HFD vs. ND and exercise vs. no exercise on ApoE-/-mTert-GFP+ 
mice using 2-way ANOVA multiple comparisons (purple section). 2-way ANOVA 
multiple comparisons (brown section) were also used to compare between HFD vs. 
ND and ApoE-/-mTert-GFP+ vs. ApoE+/+mTert-GFP+ mice. 
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5.2.4.10 Effect of voluntary wheel running on percentage of B-cells (thymocytes) in 
ApoE-/- mTert-GFP+ mice 
 
Bone marrow yields committed lymphoid progenitors, which make their way towards the 
thymus. During the early stage, committed T-cells do not express a T-cell Receptor (TCR) 
and these are deemed ‘double-negative thymocytes’ (DN; no CD4 or CD8) (Godfrey et al., 
1993). When these are successfully expressed (pre-TCR), cells proliferate extensively during 
the transition from DN4 to double-positive (DP). Cortical epithelial cells, which express 
MHC class I and II molecules, related to self-peptides, then interact with the 
TCR+CD4+CD8+ (DP) thymocytes (Robey et al., 1994; von Boehmer et al., 1989). T-
lymphocytes mature in the thymus, so we investigated the cell population in this organ to 
identify the effect of exercise, diet and genotype on T-cells. Thymocytes were isolated by 
Ficoll-hypaque density gradient. I also assumed the presence of a B-cell population in the 
thymus and cells were stained by CD45R (B220) together with other antibodies as described 
at 2.2.8. Thymic B-cells exist in small numbers in the thymus (Fehervari, 2013) and the sub-
population was gated and separated from the other population by flow cytometry. 
Surprisingly, there was an excess of B-lymphocytes in the thymus (Figure 5.23). Furthermore, 
there was a significant (P<0.05) decrease in B-cell percentage (Figure 5.23 - purple section) 
under training (1.25±0.25% per thymocyte compared to 5.25±0.85% per thymocyte, both on 
normal diet). On the other section (Figure 5.23 - brown section) there were no significant 
changes between all groups under all conditions on the percentage of B-cells at the thymus. 
 
5.2.4.11 Effect of voluntary wheel running on percentage of total GFP+ (thymocytes) in 
ApoE-/- mTert-GFP+ mice 
 
Green fluorescent protein (GFP+) positive cells correlate to cells that express the telomerase 
expression number at a cellular level. This expression indicates the percentage of telomerase 
present and of telomerase activity (Breault et al., 2008; Armstrong et al., 2000; Richardson et 
al., 2012). In this experiment, total GFP+ cell percentage was used as a read-out for 
telomerase protein expression, and we also sought to find the effect of exercise and other 
effects on both mouse genotypes on cell telomerase levels. Figure 5.24 (purple section) shows 
a significant (P<0.05) decrease in GFP+ percentage under exercise with HFD (0.798±0.22 % 
per thymus vs. 1.965±0.35 % per thymus for the non-exercising group with ND). 
 
When comparing the ApoE-/- vs. ApoE+/+ groups, both on the non-exercise program and fed 
with HFD vs. ND (figure 5.24 - brown section), there was no significant effect between all 
groups under all conditions. Surprisingly, in the spleen, the telomerase expression on B-cells 
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was significantly higher under exercise with HFD compared to ND with exercise. However, 
in the thymus (figure 5.24), the percentage of these cells was the lowest compared to all 
groups, except ND without exercise, in which both percentages were very similar (“ApoE-/-
mTert-GFP+” HFD exercise group = % 0.798±0.22 per thymus vs. “ApoE+/+mTert-GFP+” ND 
non-exercise group = % 0.76±0.31 per thymus). 
 
The percentage of total GFP+ expression in the thymus was very close to the CD8+ T-cell 
number at the spleen. From this, and because CD8+ T-cells are most commonly found in the 
thymus, the percentage of expression at the thymus matches the number of CD8+ T-cells. 
 
5.2.4.12 Effect of voluntary wheel running on percentage of CD4+ T-cells (thymocytes) 
in ApoE-/- mTert-GFP+ mice 
 
CD4+ T-cells mature and develop in the thymus. They are a subset of T-lymphocytes called T 
helper cells. This experiment was designed to ascertain whether exercise and diet have an 
effect on CD4+ T-cells in the thymus for both genotypes (ApoE-/-, and ApoE+/+) mTert-GFP+ 
mice. Figure 5.25 (purple section) shows that exercise with HFD does not change the 
percentage of CD4+ T-cells in the thymus 10±2.48% per vs. 7.5±0.5% for exercising group 
under ND (ns). Under the same diet without exercise, this trend became significant (P<0.05), 
but in favour of (ApoE-/-) ND no exercise (20±3.29% per thymocyte compared to (ApoE-/-) 
HFD no exercise, 10.5±1.5% per thymocyte). Furthermore, this increase in CD4+ T-cell 
percentage (20±3.29% per thymocyte) for group ApoE-/-mTert-GFP+ under ND without 
exercise was significant (P<0.01) compared to the exercising group with ND (7.5±0.5% per 
thymocyte). It was also significant (P<0.05) compared to the exercising group with HFD 
(10±2.48% per thymocyte). 
 
Figure 5.25 (brown section) shows that in ApoE+/+mTert-GFP+ mice (both groups without 
exercise), there was a trend towards an increase in CD4+ T-cells in favour of the ND group 
(9.25±0.25% vs. 7±2% for the HFD group, ns). When comparing these groups (ApoE+/+) with 
(ApoE-/-) no exercise, there was a significant (P<0.05) increase in CD4+ T-cell percentage in 
favour of ApoE-/-mTert-GFP+ on ND without exercise (20±3.29% per thymocyte compared to 
the same diet and no exercise, but ApoE+/+mTert-GFP+ mice, 9.25±0.25% per thymocyte). 
ApoE-/-mTert-GFP+ on ND without exercise (20±3.29% per thymocyte), the increasing 
percentage for CD4+ T-cells was significant (0.01) compared to ApoE+/+mTert-GFP+ group on 
HFD without exercise (7±2% per thymocyte). 
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5.2.4.13 Effect of voluntary wheel running on percentage of DP T-cells and other 
Thymocyte subsets in ApoE-/- mTert-GFP+ mice 
 
Double positive (DP) T-cells represent one stage of progress through the development of 
thymocytes. This phenotype follows DN (CD4-CD8-) cells and precedes the final mature T-
cells either CD4+CD8- or CD4-CD8+ (Li et al., 2007; Haynes et al., 2000). This experiment 
was designed to identify the effect of all variables in this study on the extent of DP T-cells in 
the thymus.  
 
Figure 5.26 (purple section) shows that there were no significant changes between all groups. 
However, under exercise, there was a trend towards increase in favour of the ND ApoE-/-
mTert-GFP+ group (73±3.9% per thymus vs. 65.75±7.9% per thymus for the HFD ApoE-/-
mTert-GFP+ group). Without exercise, the increasing percentage was in favour of HFD ApoE-
/-mTert-GFP+ (64.75±5.41% per thymus vs. 51.75±2.32% per thymus for the ND ApoE-/-
mTert-GFP+ no exercise group). 
 
On other hand, figure 5.26 (brown section) shows a significant (P<0.05) decrease of DP T-
cell percentage (51.75±2.32% per thymus, ND ApoE-/-mTert-GFP+ no exercise group 
compared to 71±2.1% per thymus, HFD ApoE+/+mTert-GFP+ no exercise group). Also, the 
ND ApoE-/-mTert-GFP+ no exercise group had a significant (P<0.05) decrease of DP T-cell 
percentage (51.75±2.32% per thymus vs. 68.75±3.47% per thymus, ND ApoE+/+mTert-GFP+ 
no exercise group). 
 
CD8+ T-cells (Figure 5.27A), DN T-cells (Figure 5.27B) and monocytes (Figure 5.27C) 
comprise the majority sub-population at the mouse thymus. However, these sub-populations 
showed no significant changes between cells under all conditions (exercise, diet and mouse 
genotype). 
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Figure 5.23 Percentage of B-cells in the thymus of ApoE-/-mTert-GFP+ and 
ApoE+/+mTert-GFP+ mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. Percentage of B-cell+ per thymocyte. All 
values are displayed as mean±sem. * P<0.05 for comparison between HFD vs. ND 
and exercise vs. no exercise on ApoE-/-mTert-GFP+/+ mice using 2-way ANOVA 
multiple comparisons (purple section). 2-way ANOVA multiple comparisons (brown 
section) were also used to compare between HFD vs. ND and ApoE-/-mTert-GFP+ vs. 
ApoE+/+mTert-GFP+ mice. 
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Figure 5.24. Percentage of total GFP+ cells in the thymus of ApoE-/-mTert-GFP+ 
and ApoE+/+mTert-GFP+ mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. Percentage of total GFP+ per thymocyte. 
All values are displayed as mean±sem. * P<0.05 for comparison between HFD vs. ND 
and exercise vs. no exercise on ApoE-/-mTert-GFP+ mice using 2-way ANOVA multiple 
comparisons (purple section). 2-way ANOVA multiple comparisons (brown section) 
were also used to compare between HFD vs. ND and ApoE-/-mTert-GFP+ vs. 
ApoE+/+mTert-GFP+ mice. 
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Figure 5.25. Percentage of CD4+ T-cells in the thymus of ApoE-/-mTert-GFP+ and 
ApoE+/+mTert-GFP+ mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. Percentage of CD4+ T-cell per thymocyte. 
All values are displayed as mean±sem. * P<0.05, ** P<0.01 for comparison between 
HFD vs. ND and exercise vs. no exercise on ApoE-/-mTert-GFP+ mice using 2-way 
ANOVA multiple comparisons (purple section). 2-way ANOVA multiple comparisons 
(brown section) were also used to compare between HFD vs. ND and ApoE-/-mTert-
GFP+ vs. ApoE+/+mTert-GFP+ mice. 
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Figure 5.26. Percentage of DP T-cells in the thymus of ApoE-/-mTert-GFP+ and 
ApoE+/+mTert-GFP+ mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. Percentage of DP T-cell per thymocyte. All 
values are displayed as mean±sem. * P<0.05 for comparison between HFD vs. ND 
and exercise vs. no exercise on ApoE-/-mTert-GFP+ mice using 2-way ANOVA multiple 
comparisons (purple section). 2-way ANOVA multiple comparisons (brown section) 
were also used to compare between HFD vs. ND and ApoE-/-mTert-GFP+ vs. 
ApoE+/+mTert-GFP+ mice. 
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Figure 5.27. Percentages of other thymocyte subsets of ApoE-/-mTert-GFP+ and 
ApoE+/+mTert-GFP+ mice on different diets with and without exercise 
 
2 groups of ApoE-/-mTert-GFP+ mice on the voluntary wheel running exercise for 16 
weeks, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE-/-mTert-GFP+ mice with no 
exercise, 4 mice on HFD vs. 4 mice on ND. 2 groups of ApoE+/+mTert-GFP+ with no 
exercise, 3 mice on HFD vs. 4 mice on ND. A: percentage of CD8+ T-cells per 
thymocyte, B: percentage of DN T-cells per thymocyte, C: percentage of monocytes 
per thymocyte. All values are displayed as mean±sem. No significant (ns) for 
comparison between HFD vs. ND and exercise vs. no exercise on ApoE-/-mTert-GFP+ 
mice using 2-way ANOVA multiple comparisons (purple section). 2-way ANOVA 
multiple comparisons (brown section) were also used to compare between HFD vs. 
ND and ApoE-/-mTert-GFP+ vs. ApoE+/+mTert-GFP+ mice. 
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5.3. Discussion 
 
This study confirmed that voluntary wheel running is a good model for investigating mouse 
exercise. The design gives mice the freedom to run as per their physiological need. Being 
voluntary, it also works at the molecular level, because it is non-stressful and therefore does 
not disrupt normal activity patterns. 4 different mouse genotypes were used: TERT+/+ 
(C57BL/6), TERT+/-, mTert-GFP+ and ApoE-/-mTert-GFP+. All exhibited almost the same 
diurnal activity. 
Weight and activity 
 
As expected, mouse bodyweight decreased after the running exercise, compared to the non-
exercise groups and this was significant in some cases. This finding supports previous studies 
(De Bono et al., 2006; Turner et al., 2005; Bernstein, 2003 and Allen et al., 2001). Female 
TERT+/+ mice were found to be more active and spent more time exercising compared to male 
mice. This was also found by De Bono et al. (2006). 
ApoE-/-mTert-GFP+ mice on a high fat diet (HFD) were more active in terms of both duration 
and distance, compared to mice of the same genotype on a normal diet (ND), both on 
voluntary exercise. These groups, on either HFD or ND gained less bodyweight in 
comparison to non-exercising HFD or ND groups. The average calorie intake by ApoE-/-
mTert-GFP+ mice on training with HFD was similar to ApoE-/-mTert-GFP+ mice without 
exercise either on HFD or ND. ApoE-/-mTert-GFP+ mice on training with ND consumed more 
calories compared to those on a HFD or those without exercise either on HFD or ND. This 
may be related either to ApoE deficiency, or because the opportunity to do more voluntary 
wheel exercise resulted in a loss of some bodyweight. Moreover, HFD mice may have been 
more active compared to ND mice because they had more energy. There was no significant 
change in the bodyweight for ApoE-/-mTert-GFP+ exercising mice for both HFD and ND. 
ApoE plays an important role in lipoprotein metabolism. Both chylomicrons and VLDL 
remnants (derived from diet and liver respectively) are cleared through a process that relies in 
part on ApoE. Studies by Mahley (1988) and Piedrahite et al. (1992) on ApoE deficient 
(ApoEKO) mice demonstrated for the first time a viable model for hyperlipidemia and 
atherosclerosis. The decrease in bodyweight after exercise was demonstrated by Pellegrin et 
al. (2009), who found that swimming exercise for 6 months led to significantly decreased 
bodyweight in ApoE-/- mice compared to a sedentary group. In addition, their data showed 
that 6 months of swimming exercise stabilized atherosclerosis progression (Pellegrin et al., 
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2009). However, other studies concluded that the exercise led to decreased atherosclerosis 
extension in ApoE-/- mice (Laufs et al., 2005; Pellegrin et al., 2009; Okabe et al., 2007). 
Lymphocyte ‘shifts’ 
Splenocyte numbers were measured in all groups and there was no significant trend towards 
increased cell numbers in the exercising groups. A range of other studies, using various 
designs, protocols, exercise regimes, species and tissues have found similar results in regard 
to immune cell levels following voluntary exercise (Woods et al., 2000; Woods et al., 2003; 
Hoffman-Goetz et al., 1992; Macneil and Hoffman-Goetz, 1993 and Jonsdottir et al., 1997). 
In conclusion, exercise does not seem to change splenocyte numbers. Interestingly, I found 
opposing increases and decreases between B-cell numbers and CD8+ T-cell numbers in all 
groups with some variation for ApoE-/-mTert-GFP+ mice. 
TERT heterozygous mice exhibited a trend toward increased CD4+ and CD8+ T-lymphocytes 
(ns) for the exercise group compared to the non-exercise group. However, the other 
subpopulations (double positive, double negative, B-cells and monocytes) seemed to decrease 
in cell numbers for the exercise group compared to the non-exercise group. A similar increase 
in T-lymphocytes was observed by Woods et al. (2003), who found that Balb/cByJNia mouse 
strains after 4 months of exercise provided a good model for immunology and cardiovascular 
research. Injecting BALB/c mice with mineral oil causes plasmocytoma production, which 
leads to monoclonal antibody production. In young mice, this caused, naïve and memory T-
lymphocyte production from splenocytes to return to normal. They also found the ratio of 
naïve to memory T-lymphocytes increased after exercise training in old mice, as exercise 
maintained absolute naïve T-cell numbers vs. memory T-cell numbers (Woods et al., 2003). 
The percentage of regulatory T-cells trended towards increasing (ns) compared to the non-
exercise group. This gave the impression that there was an effect on blood circulation, which 
allowed these cells to circulate and proliferate, leading to an increase in percentage. We used 
healthy mice and the benefit of the running exercise may convert to physiological muscle 
strength (this was observed but not measured). Because Tregs play an important role in 
activating or suppressing immune system function (Parsons et al., 2007; Akbari et al., 2003) 
and because the immune system functionality is normal for these mice, we did not find any 
significant changes between the exercising and control groups. 
 
mTert-GFP+ mice showed no significant changes in cell numbers for CD4+ and CD8+ T-cells, 
or in monocyte numbers between the exercising and non-exercising groups. I found a trend 
towards an increase in GFP+ cells expressing telomerase activity (ns). This may arise from 
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increased blood circulation due to exercise, which plays a role in cell proliferation and may 
improve telomerase function (expression). 
The trend towards increased splenocyte numbers favoured the non-exercise control group in 
the ApoE-/- mTert-GFP+ groups. This may be secondary to ApoE deficiency, which puts these 
mice under high risk of lipid accumulation and cardiovascular complications (Candido et al., 
2002; Patel et al., 2001). Also, the ApoE-/-mTert-GFP+ mice group on HFD with exercise 
expressed significantly lower numbers of GFP+B-cells+ compared to the non-exercise ND 
group, and trended towards decreased GFP+B-cell+ expression compared to the non-exercise 
HFD group. This may be related to the humoral immunity classification of Ig producing B-
cells (Berkowska et al., 2011). 
ApoE-/-mTert-GFP+ mice under exercise exhibited increased B-cell numbers in the HFD 
group and decreased B-cell numbers in the ND group. CD8+ T-cell numbers decrease in the 
HFD group and increased in the ND group. Similar trends were observed for ApoE-/-mTert-
GFP+ mice without exercise; the B-cell numbers increased for the HFD group and decreased 
in the ND group, whilst CD8+ T-cell numbers decreased for the HFD group and increased in 
the ND group. Ig production by B-cells pays a key role in humoral immunity. Conversely, 
CD8+ T-cells are cytotoxic and therefore contribute to the cellular immune response 
(Berkowska et al., 2011). Further study is required to establish the relationship between B-
cells and CD8+ T-cells in atherosclerosis. 
Intrestingly, I found a significant increase in B-cell numbers for the exercising group 
(19.1±0.79x106/spleen) vs. the control group (17.2±1.7x106/spleen). The increase of 
circulating B-cells was reported after sprinting exercise (Gray et al., 1993; Nieman, et al., 
1995). B-cells produce immunoglobulins (Ig) and play a role in humoral immunity 
(Berkowska et al., 2011). They differentiate into antibody- producing plasma cells or 
circulating memory cells (Ozaki et al., 2004). Further studies would be required to determine 
which type of B-cell responds to exercise. 
I found B-cells+ at the mouse thymus organ. This was also demonstrated by Fehervari (2013), 
who found a small population of thymic B-cells at the thymus. The percentage of total GFP+ 
expression in the thymus is very close to the CD8+ T-cell number at the spleen. From this, and 
because CD8+ T-cells are most commonly found in the thymus, this percentage of expression 
at the thymus matches the number of CD8+ T-cells. 
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Telomerase 
My study supports the idea that the effect of exercise on telomeres might be mediated in some 
way by telomerase and the TERT protein. Experiments using murine tissues have indicated 
that TERT may form part of a chromatin remodelling complex or act as a transcription factor 
(Park et al., 2009). These findings strongly support the idea that phenotype ageing can be 
inhibited in immune, vascular and cardiac cells, due to the connection between exercise and a 
supportive cellular environment which prevents telomere shortening. Furthermore, Ludlow et 
al. (2012) trained a CAST/Ei mice strain for 11 months on voluntary wheel running and found 
increased telomerase activity after exercise in mouse skeletal muscle. 
Telomerase is the enzyme that protects and elongates the telomeres at each chromosome end 
of the DNA. The effect of exercise on TERT expression and telomere-related proteins was 
determined by comparing TERT deficient mice with wild type mice (Werner et al., 2009; 
Werner et al., 2008). Both groups underwent the voluntary wheel running exercise and it was 
concluded that exercise had no effect on cell-cycle-checkpoint kinase 2 (Chk2), tumour 
suppressor protein p16, tumour suppressor protein p53 or telomere repeat binding factor 2 
(TRF2) for the TERT-/- group compared to the TERT+/+ group. In contrast, 3 weeks of running 
exercise significantly increased cardiac telomerase activity by more than twofold in wild type 
mice, as well as TERT expression in the heart compared to the sedentary group. In addition, 
cardiac telomere-stabilising proteins increased in wild-type mice doing voluntary exercise. 
P53, P16 and Chk2 mRNA expression was significantly reduced after 3 weeks of voluntary 
running compared to the control groups. In humans, telomerase activity in PBMNCs 
significantly increased by 2.5-fold in young athletes and by 1.8-fold in middle-aged athletes 
compared to sedentary individuals. Young participants exhibited non-significant changes in 
lymphocyte telomere lengths between athletes and untrained groups, but older people in the 
control group showed significant telomere shortening compared to the trained older group and 
younger groups either with or without training (Werner et al., 2009; Werner et al., 2008). 
mTert-GFP+ are telomerase reporter mice. There were no significant changes for telomerase 
expression in all GFP+ cells. 
I found that telomerase activity significantly increased in ApoE-/-mTert-GFP+ mice on 
exercise and HFD, compared to no exercise and ND. However, there was no significant 
change in the bodyweight for ApoE-/-mTert-GFP+ mice under exercise for both HFD and ND. 
I also demonstrated a significant effect on telomerase activity when ApoE-/- mTert-GFP+ mice 
on exercise were compared with the no exercise group, both on HFD. On exercise, telomerase 
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activity increased significantly (by 3.9-fold), indicating that ApoE-/-mTert-GFP+ mice without 
exercise may suffer from the HFD as they are ApoE deficient, whilst the ApoE-/-mTert-GFP+ 
mice on exercise benefit from exercise to reduce the lipids that may accumulate secondary to 
HFD and ApoE deficiency. ApoE-/- mice on HFD developed atherosclerosis (Meir and 
Leitersdorf, 2004). In contrast, aerobic exercise is able to reverse arterial inflammation with 
ageing in mice (Lesniewski et al, 2011). Human studies in leukocytes showed that decreased 
telomere length is associated with the development of atherosclerosis (Ogami et al., 2004; 
Benetos et al., 2004; Obana et al., 2003 and Samani et al., 2001). Thus, it is possible that by 
increasing telomerase activity during exercise, telomeres might become stabilised as shown 
by others previously (Melk et al., 2014). Thus one could expect one of the beneficial effects 
of exercise to be a delay in atherosclerosis. However, this was evident only under HFD in 
ApoE-/- mice. However, telomerase expression in B-cells in ApoE-/-mTert-GFP+ mice 
decreased significantly in cell numbers for the exercise group with ND compared to both 
groups (HFD and ND) without exercise. 
Finally, using the ApoE-/-mTert-GFP+ mouse model of atherosclerosis, we accelerate the 
effects of the disease by feeding these mice a high fat diet (HFD). Surprisingly, this treatment 
did not change telomerase activity in splenocytes. This contradicts the results from Gizard et 
al., (2011) who found increased vascular telomerase activity in a different mouse model 
(LDLR-/- mice) on a HFD. This discrepancy might be explained by either the different mouse 
models or the different cell type used to measure telomerase activity (Gizard et al., 2011). 
However, applying exercise to our ApoE-/-mTert-GFP+ mice under HFD resulted in increased 
telomerase activity in splenocytes, while a normal diet (ND) did not yield this effect (Chapter 
5). Exercise has been associated with improved cardiovascular health (Werner et al., 2008, 
2009; Sallam and Laher, 2016). The cardiovascular benefits of exercise have been frequently 
attributed to the reduction of many classical cardiovascular risk factors including blood lipid, 
inflammation and oxidative stress (Sallam and Laher, 2016). Oxidative stress and 
inflammation are also caused by HFD and I found in the in vitro experiments that hyperoxia 
inhibited splenocyte telomerase activity (Chapter 3). Atherosclerosis development is closely 
linked with oxidative stress and inflammation while exercise has been shown to decrease 
oxidative stress by upregulating the antioxidant defense and reducing inflammation markers 
including IFNγ  and TNFα (Sallam and Laher, 2016). Therefore, increased splenocyte 
telomerase activity during exercise may be linked to decreased oxidative stress and 
inflammation. However, we did not measure these parameters in the mouse model in order to 
draw direct conclusions. My data of increased telomerase activity after exercise (chapter 5), 
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correspond to those from Melk et al., (2014) who found longer telomeres increased 
telomerase activity after 3 months of exercise in human PBMNCs from middle-age sedentary 
males and those of Werner et al., (2009) who found increased telomerase activity and longer 
telomere length in PBMCs of athletes after exercise. The same group demonstrated on a 
mouse model that the beneficial effect of exercise on the decrease of senescence markers in 
vascular cells was dependent on the presence of telomerase since the effects were absent in 
TERT-/- mice (Werner et al., 2008). Taken together, all these results including our own 
findings of increased telomerase activity in ApoE-/-mTert-GFP+ mice during exercise and 
HFD compared to ApoE-/-mTert-GFP+ mice without exercise and on HFD suggest that 
telomerase activity may mediate the benefit of exercise on telomere length. However,	 the	underlying	mechanism	is	yet	to	be	investigated	in	more	detail. 
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CHAPTER 6. Effect of cardiac rehabilitation on telomerase 
activity and regulatory T-lymphocytes in patients following acute 
myocardial infarction 
6.1 Introduction 
 
Heart disease patients can benefit from being offered cardiac rehabilitation, which is a 
complex and tailored blend of lifestyle and nutritional education as well as a physical training 
programme (Wenger et al., 1995; Morris and Froelicher, 1991). Levels of telomerase activity 
directly affect telomere length, which is associated with oxidative stress and an increased risk 
of cardiac diseases (Epel et al., 2004; Epel et al., 2006; Demissie et al., 2006) and indeed, 
shortening of leukocyte telomeres has been implicated as a risk factor for myocardial 
infarction (MI) (Zee et al., 2009). Cardiovascular diseases are associated with low telomerase 
activity in PBMNCs (Epel et al., 2006). A study by Melk et al. (2014) found that healthy 
middle-aged men who had a previously sedentary lifestyle exhibited increased telomerase 
activity and telomere lengths following a three-month programme of physical activity. Naïve 
T-cells differentiate into separate subpopulations when stimulated by antigens and cytokines. 
These subpopulations include T-helper (Th) cells and CD4+CD25+FOXP3+ regulatory (Treg) 
T-cells. 5-10% of all peripheral CD4+ cells are Tregs and these are critical to the maintenance 
and induction processes involved in immune homeostasis (Chen et al., 2003; Fontenot et al., 
2003). Tregs also govern target T-cells and antigen presenting cells (APCs), which inhibit T-
cell proliferation and cytokine expression by secreting inhibitory cytokines, including 
transforming growth factor beta (TGF-β) and IL-10. These have an immunosuppressant effect 
(Sakaguchi, 2005) and also suppress atherosclerosis (Robertson et al., 2003; Mallat et al., 
2001). Telomere maintenance is influenced at a molecular level by TERT mRNA up-
regulation (Codd et al., 2013). miRNAs are regulated through physical exercise and this in 
turn influences the expression of the genes which control telomere homeostasis (Chilton et al., 
2014). This sheds some light on the relationships between exercise, telomere length in 
PBMNCs and health improvement (Chilton et al., 2014). 
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6.2 Results 
 
6.2.1 Accelerometer-based physiological response to cardiac rehabilitation 
 
6.2.1.1 Effect of cardiac exercise rehabilitation on patients’ weight and BMI 	
In my study, average weight of the 19 patients who participated was 84±3.7 kg and it was 
81.8±3.1 kg for the 8 patients who attended the post-cardiac exercise rehabilitation test 
(Figure 6.1A). However, when the comparison was performed for the 8 patients who attended 
pre- and post-exercise tests, a non-significant trend toward decrease was noticed in favour of 
post-cardiac rehabilitation (84±3.7 kg vs. 86.5±4.7 kg for pre-cardiac exercise rehabilitation) 
(Figure 6.1B). Figure 6.1C shows that the BMI result from all 19 patients who participated in 
the pre-rehabilitation test and those 8 patients who participated in the post-rehabilitation test. 
There was no significant decrease in BMI after the cardiac exercise rehabilitation programme 
among the 8 patients who underwent both pre- and post-cardiac exercise rehabilitation tests 
(Figure 6.1D). 
 
6.2.1.2 Effect of cardiac rehabilitation on daily physical activity 	
The accelerometer data were extracted by Dr. Sarah Charman, MoveLab, Newcastle 
University, using accelerometers that I had prepared and collected from patients. Data were 
analysed by me. 
 
An accelerometer is a movement sensor which objectively measures the intensity of both 
physical activity and the relaxation period (Jakovljevic et al., 2014). This device has been 
used in various forms since 1920 as a measurement of acceleration (Walter, 2007). The 
GENEActiv monitor was worn by our patients at the wrist of the non-dominant hand for 7 
days, as previously described by Jakovljevic et al. (2014) for 24 hours per day. The device 
was used to time the participants’ pre-cardiac exercise rehabilitation programme, followed by 
their post-cardiac exercise rehabilitation programme, as described at (2.2.17). Figure 6.2A 
shows the average daily physical activity measured in acceleration (mg), (mg is 1000 gal, gal 
is galileo = 1cm/sec2), 1which was 5.3±0.9mg for the pre-rehabilitation patients (14 
individuals) and 23.8±2.6mg for the post-rehabilitation patients (7 individuals). The 
significant (P<0.05) increase in intensity of acceleration movement was noticed when the 
comparison applied only to the 6 patients who underwent both pre- and post-cardiac exercise 
rehabilitation testing (Figure 6.2B). I found the intensity was 26±1.6mg for post-exercise 
group vs. 15.5±1mg for pre-exercise group. The cardiac exercise rehabilitation programme 
can therefore lead to improvement of daily activity. 
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6.2.1.3 Time spent per day in moderate to vigorous physical activity (MVPA)		
Studies have shown that after cardiac rehabilitation, the capacity and duration of exercise was 
improved (Tyni-Lenne et al., 1998; Cheetham et al., 2002). Time spent on exercise is one 
parameter that can indicate improvement levels. I measured the time patients spent each day 
doing MVPA, as shown in figure 6.3A. The 14 patients at the pre-rehabilitation stage spent 
35.3±5 min/day and the 7 patients after the cardiac rehabilitation programme spent 91.9±15.2 
min/day. A significant (P<0.05) increase in time spent on daily MVPA was found with the 6 
patients (Figure 6.3B) who engaged in both pre- and post-rehabilitation testing (35.6±5.8 
min/day before exercise rehabilitation, compared to 104±10.8 min/day after the exercise 
rehabilitation programme).  
 
6.2.1.4 Daily physical activity as acceleration distribution	
 
The daily activity for patients was measured as acceleration distribution and this was divided 
into units of 50mg intensity for pre- and post-exercise programmes. The activity distribution 
was different from patient to patient during the day-night period. This intensity was averaged 
for all monitoring over 7 days. Figure 6.4 shows the results from the groups of 14 patients 
pre-rehabilitation and 7 patients post-rehabilitation, whilst figure 6.5 shows the comparison 
between 6 patients who underwent the test pre- and post-rehabilitation after MI. In figure 6.4, 
most of the daytime was spent with low intensity (0-50mg) activity - about 1320±10.2 
min/day for the pre-rehabilitation group and 1222±28.2 min/day for the post-rehabilitation 
group. This means that the post-rehabilitation group spent more time on moderate and 
vigorous activity per day. After the rehabilitation programme, the patients started to spend 
about 83.6±14.9 min/day on moderate activity, with an intensity of 50-150mg and 54.4±6.8 
min/day before rehabilitation with about half an hour difference per day. Conversely, the 
patients who spent 18.1±3.3 min/day on vigorous activity had an intensity of 150-250mg and 
4.6±0.7 min/day for before the exercise program, with about 13.5 min/day spent on vigorous 
activity. 
 
When only the 6 patients who underwent both tests (pre- and post-) were considered (figure 
6.5), I noticed that before cardiac rehabilitation, these patients spent significantly (P<0.05) 
more time in low intensity activity 0-50mg by 1320±11.7 min/day vs. 1196±13.2 min/day for 
the same patients after cardiac rehabilitation. The moderate (50-150mg) daily activity for 
these 6 patients was increased significantly (P<0.001) from 54.3±9.8 min/day for pre-
rehabilitation vs. 95.8±14.3 min/day for the same patients after exercise rehabilitation. The 
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time spent on vigorous (150-250mg) activity for the same patients was significantly 
(P<0.001) increased to 20.6±3.3 min/day post-cardiac exercise rehabilitation from 4.5±1 
min/day pre-cardiac exercise rehabilitation. It seems clear that after cardiac rehabilitation, 
physical activity was increased and the intensity of exercise was significantly increased. 
 	
		
Figure 6.1. Cardiac patients’ weight and BMI pre- and post-cardiac exercise 
rehabilitation. 
 
Weight (kg) and BMI (kg/m2) were measured before and after cardiac exercise 
rehabilitation. A: Weight (kg) for all patients involved in the study, B: Weight (kg) for 8 
patients involved in both pre- and post- examination, C: BMI (kg/m2) for all patients 
involved in the study, D: BMI (kg/m2) for 8 patients involved in both Pre- and Post- 
examination. All values are displayed as mean±sem. (ns) not significant for 
comparison between Pre- and Post-cardiac exercise rehabilitation using a two-tailed 
paired t-test for B, D. 								
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Figure 6.2. Acceleration for cardiac patients pre- and post-cardiac exercise 
rehabilitation 
 
The wrist accelerometer was used to determine the daily physical activity by 
acceleration. A: The comparison between all patients with valid data for 24h/7days. 14 
patients pre-cardiac exercise rehabilitation vs. 7 patients post- cardiac exercise 
rehabilitation. B: The comparison between the patients with valid data for 24h/7days 
attending both tests. 6 patients pre- and post-cardiac exercise rehabilitation. All values 
are displayed as mean±sem. *P<0.05 for comparison between pre- and post-cardiac 
exercise rehabilitation using a two-tailed paired t-test for B. 
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Figure 6.3. Time spent per day in moderate to vigorous physical activity 
(MVPA) for pre- and post-cardiac exercise rehabilitation. 
 
A: The comparison between all patients with valid data for 24h/7days. 14 patients 
pre-cardiac exercise rehabilitation vs. 7 patients post-cardiac exercise rehabilitation. 
B: The comparison between the patients with valid data for 24h/7days attending both 
tests, 6 patients pre- and post-cardiac exercise rehabilitation. All values are displayed 
as mean±sem. *P<0.05, **P<0.01 for comparison between pre- and post-cardiac 
exercise rehabilitation using a two-tailed unpaired t-test for A and a paired t-test for 
B. 
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Figure 6.4. Acceleration distribution of time spent in 50 mg units-intensity for 
pre- and post-cardiac exercise rehabilitation.		
All daily activity for each patient was recorded and divided into 50mg units (intensity) 
for 24h/7 days. In each 50mg unit, the average for all patients/7days was calculated 
for 14 patients pre-cardiac exercise rehabilitation and 7 patients post-cardiac exercise 
rehabilitation. All values are displayed as mean±sem.	
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Figure 6.5. Acceleration distribution of time spent in 50 mg units-intensity for 
pre- and post-cardiac exercise rehabilitation.		
All daily activity for each patient was recorded and divided into 50mg units (intensity) 
for 24h/7 days. In each 50mg unit, the average for all patients/7days was calculated 
for 6 patients pre-cardiac exercise rehabilitation and 6 patients post-cardiac exercise 
rehabilitation. All values are displayed as mean±sem. *P<0.05 for comparison between 
pre- and post-cardiac exercise rehabilitation using a two-tailed paired t-test.	
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6.2.2 Effect of cardiac rehabilitation on lymphocyte subsets 
	
6.2.2.1 Effect of cardiac rehabilitation on T-lymphocytes 	
All 19 patients in this chapter were recruited and blood taken for pre-cardiac rehabilitation 
stage by Marilena Giannoudi, post graduated medical student, Newcastle University, whilst 
the blood were taken for post-cardiac rehabilitation by Dr. Suzanne Cormack, IGM, 
Newcastle University. 
Lymphocytes Th1 and Th17/Th1 significantly increase in peripheral blood after myocardial 
infarction (Cheng et al., 2008; Methe et al., 2005 and Zhao et al., 2011). The circulating 
frequency of CD4+ T-cells increases in patients with established atherosclerosis or with high 
risk factors of cardiovascular diseases (Dumitriu et al., 2009). In mouse models, γδ T-cells, αβ 
CD4+ T-cells, NK T-cells and B-cells were detected in the myocardium after myocardial 
infarction, and γδ T-cells remain present for days afterwards (Yan et al., 2012; Yan et al., 
2013). To find the effect of cardiac exercise rehabilitation on T-lymphocytes, PBMNCs were 
24h after primary percutaneous coronary intervention (PPCI) and also after the cardiac 
rehabilitation exercise program described at (2.2.20). Figure 6.6A shows the absolute T-cell 
numbers after cardiac rehabilitation (1241±143 cells/µl) and (1764±258 cells/µl) for all 
patients in the pre-rehabilitation group. This decrease in total T-lymphocytes was significant 
(P=0.03) in comparison to the 8 patients tested before (2174±578 cells/µl) and after 
(1241±143 cells/µl) rehabilitation (Figure 6.6B). However, this significance disappeared 
when I applied the sensitivity analysis (omitting the single outlier) P=0.08.  
 
6.2.2.2 Effect of cardiac rehabilitation on CD4+ and CD8+ T-lymphocytes 	
Figure 6.7A illustrates the CD4+ T-cell levels when all participants were considered, 
910±119.2 cells/µl compared to 1261±192.9 cells/µl for the pre-rehabilitation group. 
However, when comparing only patients who underwent blood sampling before and after 
cardiac rehabilitation, 8 patients, (Figure 6.7B), this decrease in CD4+ T-cell numbers was 
significantly (P=0.02) in favour of the post-rehabilitation group by 910±119.2 cells/µl vs. 
1610±429.7 cells/µl for pre-rehabilitation exercise group. Furthermore, this significance of 
CD4+ T-cells remained even after I applied the sensitivity analysis (omitting the single 
outlier) P=0.02). Figure 6.7C shows the CD8+ T-cell numbers pre-cardiac rehabilitation 
(491.2±72.9 cells/µl) and after cardiac exercise rehabilitation (287.6±57.5 cells/µl). Figure 
6.7D shows a non-significant trend towards decreased CD8+ T-cell numbers post-cardiac 
exercise (287.6±57.5 cells/µl vs. 552.4±144.1 cells/µl) for the same patients before the 
rehabilitation programme. 
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Double positive (DP) T-cell numbers, figure 6.8A illustrates the DP T-cell numbers from all 
patients who participated in this study, with an average of (28.2±9.2 cells/µl) before the 
exercise programme and (23.5±14.7 cells/µl) after the exercise programme. When a 
comparison was performed for the patients who had taken part in both pre- and post-
rehabilitation (Figure 6.8B), there was a significant (P<0.05) decrease in DP T-cell numbers 
in favour of the post-cardiac rehabilitation programme (23.5±14.7 cells/µl compared to 
38.4±22.2 cells/µl for the pre-cardiac rehabilitation programme). Figures 6.8C and 6.8D 
compare the ratio of CD4+/CD8+ T-cells between pre- and post-cardiac exercise rehabilitation 
programmes, showing no change was noticed between these. 
In conclusion, the rehabilitation exercise programme had a positive effect in decreasing T-
lymphocytes and their subsets after myocardial infarction. These cells are ordinarily 
increasingly recruited to the affected myocardium (Methe et al., 2005; Zhao et al., 2011). 
 
6.2.2.3 Effect of cardiac rehabilitation on other lymphocyte subsets 
 
Figures 6.6-6.8 illustrates the effect of cardiac exercise rehabilitation on T-lymphocytes and 
their subsets. This experiment was performed to discover to what extent the other lymphocyte 
subsets were affected by exercise. Figure 6.9A shows all lymphocyte subsets (T-cells, B-cells 
and NK-cells) for all patients. There was a decrease in all lymphocyte numbers after exercise 
(1771±215.9 cells/µl) and (2319±339.6 cells/µl) before exercise programme. When compared 
with the 8 patients who took part in pre- and post-rehabilitation blood tests (Figure 6.9B), the 
same non-significant decrease by 1771±215.9 cells/µl after the exercise programme compared 
to 2883±770.4 cells/µl for before exercise program. Figure 6.9C shows that the B-lymphocyte 
numbers for all participants in the pre-rehabilitation group (347.3±72.4 cells/µl) and 
(262.4±53 cells/µl) for post-cardiac rehabilitation. The non-significant decrease in B-cell 
numbers was noticed only when compared with the 8 pre- and post-exercise program patients 
(figure 6.9D). Natural Killer (NK) lymphocyte numbers are illustrated as an average of 
173.7±22.5 cells/µl for the pre-rehabilitation group and 260.1±46.8 cells/µl for the post- 
cardiac rehabilitation (figure 6.9E). A non-significant increase was noticed for the 8 patients 
(Figure 6.9F) pre-rehabilitation 260.1±46.8 cells/µl compared to 230.8±44.3 cells/µl for 
before exercise program. 
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Figure 6.6. Total T-lymphocyte absolute numbers pre- and post-cardiac exercise 
rehabilitation 	
PBMNCs TruCount using FACSCanto II software was applied to determine the 
absolute number for each cell population. A: Total T-cell number/µl for all patients 
involved in the study, B: Total T-cell number/µl for 8 patients involved in both Pre- and 
Post-examination. All values are displayed as mean±sem. *P<0.05 for comparison 
between pre- and post-cardiac exercise rehabilitation using a two-tailed paired t-test 
for B. 
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Figure 6.7. Absolute numbers of CD4+ and CD8+ T-lymphocytes pre- and post-
cardiac exercise rehabilitation 	
PBMNCs TruCount using FACSCanto II software was applied to determine the 
absolute numbers for each cell population. A: CD4+ T-cell numbers/µl for all patients 
involved in the study, B: CD4+ T-cell numbers/µl for 8 patients involved in both Pre- 
and Post-examination, C: CD8+ T-cell numbers/µl for all patients involved in the 
study, D: CD8+ T-cell numbers/µl for 8 patients involved in both Pre- and Post-
examination. All values are displayed as mean±sem. *P<0.05 for comparison 
between pre- and post-cardiac exercise rehabilitation using a two-tailed paired t-test 
for B, D. 
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Figure 6.8. DP T-lymphocytes absolute number and CD4+/CD8+ T-cells ratio pre- 
and post-cardiac exercise rehabilitation 	
PBMNCs TruCount using FACSCanto II software was applied to determine the 
absolute number for each cell population. A: DP T-cell numbers/µl for all patients 
involved in the study, B: DP T-cell numbers/µl for 8 patients involved in both Pre- and 
Post-examination, C: CD4+/CD8+ T-cell ratio for all patients involved in the study and 
D: CD4+/CD8+ T-cell ratio for 8 patients involved in both Pre- and Post-examination. 
All values are displayed as mean±sem. *P<0.05 for comparison between pre- and 
post-cardiac exercise rehabilitation using a two-tailed paired t-test for B, D. 
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Figure 6.9. Absolute numbers of other lymphocyte types pre- and post-cardiac 
exercise rehabilitation 	
PBMNCs TruCount using FACSCanto II software was applied to determine the 
absolute number for each cell population. A: All lymphocyte numbers/µl for all 
patients involved in the study, B: All lymphocyte numbers/µl for 8 patients involved in 
both Pre- and Post-examination, C: B-cell numbers/µl for all patients involved in the 
study, D: B-cell numbers/µl for 8 patients involved in both Pre- and Post-examination, 
E: NK-cell numbers/µl for all patients involved in the study, F: NK-cell numbers/µl for 
8 patients involved in both Pre- and Post-examination. All values are displayed as 
mean±sem. (ns) not significant for comparison between pre- and post-cardiac 
exercise rehabilitation using a two-tailed paired t-test for B, D, F. 
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6.2.3. Effect of cardiac rehabilitation on regulatory T-cells 
 
Stimulation by antigens and cytokines differentiates naïve T-cells into distinct 
subpopulations, which include: T-helper (Th) cells as well as CD4+CD25+FOXP3+ regulatory 
T (Treg) cells. Tregs play a key role in immune homeostasis and tolerance, including 
maintenance and induction, and make up 5-10% of all peripheral CD4+ cells (Chen et al., 
2003; Fontenot; 2003). Antigen presenting cells (APCs) and target T-cells are regulated 
through Tregs, which consequently inhibit both cytokine production and T-cell proliferation. 
Tregs secrete transforming growth factor (TGF)-β, IL-10 and other inhibitory cytokines, 
which suppress the immune system (Sakaguchi, 2005) and also atherosclerosis (Robertson et 
al., 2003; Mallat et al., 2001). Patients with ST-segment elevation MI were found to have 
higher levels of Tregs circulating in their bloodstream (Ammirati et al., 2010).  
 
To investigate the effect of exercise rehabilitation on regulatory T-cells in patients with MI, 
Tregs were quantified pre- and post-cardiac exercise rehabilitation using flow cytometry 
(described at 2.2.19). Figure 6.10A shows the percentage of Tregs with high CD25 expression 
for all patients who participated in the study (the percentage of Tregs after exercise at 
0.22±0.1% and 1.5±0.2% before exercise). A significant (P<0.01) decrease was noted for the 
8 patient results post-rehabilitation 0.2±0.1% compared to 1.4±0.4% pre-rehabilitation (figure 
6.10B). At low CD25+ expression for all patients (Figure 6.10C), Treg percentage was 
4.2±0.6% before cardiac rehabilitation and 0.7±0.2% after cardiac rehabilitation. For the 8 
patients the decrease in Treg percentage was significant (P<0.001) post-cardiac exercise 
rehabilitation (Figure 6.10D) (0.7±0.2% vs. 4.5±1% for pre-cardiac rehabilitation). Figure 
6.10E shows that CD4+/FoxP3+ without any expression for CD25+ cells (CD4+/CD25-
/FoxP3+), was 3.7±0.8% for all patients who participated in the pre-exercise programme and 
0.5±0.1% of the post-exercise programme. A study has shown FoxP3 expression in 
CD4+CD25- T-cells (Khattri et al., 2003). Figure 6.10F compares Treg cells with negative 
CD25+ cells for the 8 patients who had the pre- and post- test. A significant decrease in the 
percentage of Tregs was noticed in favour of post-rehabilitation patients (0.5±0.1% compared 
to 3.5±1% for pre-rehabilitation patients). 
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Figure 6.10. Percentage of regulatory T-cells pre- and post-cardiac exercise 
rehabilitation 	
The percentage of regulatory T-cells from PBMNCs was measured using 
FACSCanto II. A: Percentage of Treg expression with high expression of CD25 for 
all patients, B: Percentage of Treg expression with high expression of CD25 for the 
8 patients involved in both Pre- and Post-examination, C: Percentage of Treg 
expression with low expression of CD25 for all patients, D: Percentage of Treg 
expression with low expression of CD25 for the 8 patients involved in both Pre- and 
Post-examination, E: Percentage of Treg expression with non-CD25 expression for 
all patients, F: Percentage of Treg expression with non-CD25 expression for the 8 
patients involved in both pre- and post-examination. All values are displayed as 
mean±sem. **P<0.01, ***P<0.001, ****P<0.0001 for comparison between Pre- and 
Post-cardiac exercise rehabilitation using a two-tailed paired t-test for B, D, F. 
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Figure 6.11. Illustration of the detection and gating of the two levels of CD25+ 
expression  	
Gating of CD25+ expression. A: High CD25+ expression. B: Low CD25+ expression. 
C: No CD25+ expression (negative). 
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6.2.4 Effect of cardiac rehabilitation on telomerase activity and telomere length 
	
6.2.4.1 Effect of cardiac rehabilitation on telomerase activity 	
Low telomerase activity in PBMNCs has been found to be related to cardiovascular diseases 
(Epel et al., 2006). Telomerase activity and telomere length among PBMNCs increased after 3 
months of physical activity in healthy middle-aged men with a sedentary lifestyle (Melk et al., 
2014). This experiment was designed to find the effect of cardiac exercise rehabilitation on 
telomerase activity for patients following acute MI. PBMNCs were measured after 24 hours 
of catheterization and following the cardiac rehabilitation programme. Telomerase actvity 
was measured by TRAP ELISA as described at 2.2.11. Figure 6.12A shows the difference in 
telomerase activity before and after cardiac exercise in all 19 patients and in the 8 patients 
who attended the post-cardiac rehabilitation test. There is no significant difference in 
telomerase activity before and after cardiac exercise when compared with the 8 patients who 
attended both the pre- and post-rehabilitation tests (figure 6.12B). 
 
6.2.4.2 Effect of cardiac rehabilitation on telomere length 
 
Telomeres are found at the end of chromosomes and plays an important role in cell division 
(Hayflick, 1965). Telomeres shorten with each cell division until their length reaches a critical 
level and the cell stops replicating (Benetos et al., 2001). Telomere length and telomerase 
activity have been shown to contribute to cardiac diseases and oxidative stress (Epel et al., 
2004; Epel et al., 2006; Demissie et al., 2006). This study was conducted to find the effect of 
cardiac exercise rehabilitation on telomere length in acute MI patients. Telomere length was 
measured, as described at 2.2.21. Figure 6.13A shows the telomerere length results for pre-
cardiac exercise rehabilitation, with a TS ratio of 0.6147±0.044 for all 19 patients and post-
cardiac exercise rehabilitation with a ratio of 0.6125±0.07 for 8 patients. Telomere length 
apparently trends toward increase for pre-cardiac exercise rehabilitation (0.6638±0.043 vs. 
0.6125±0.07 for post-cardiac exercise rehabilitation (ns)) when compared with the 8 patients 
who did both pre- and post- tests (Figure 6.13B).  
 
Figure 6.14A shows that in all 19 patients, cells with shorter telomeres exhibited higher 
telomerase activity during the pre-rehabilitation exercise. Currently, very little is known about 
this correlation, but it is believed that it demonstrates that telomerase activity is required to 
prevent telomere shortening. The signalling mechanism between short telomeres and 
telomerase also remains unknown, although the involvement of TERRA mechanisms, or 
ATM or TRF1 signalling has been suggested (Redon et al., 2010, Tong et al., 2015). 
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However, figure 6.14B indicates that following rehabilitation exercise, this relationship might 
be reversed; patients with longer telomeres exhibited higher telomerase activity. These 
findings were also observed in patients who did both the pre-rehabilitation and post-
rehabilitation tests (n=8), as seen in figures 6.14C. 
 
From these findings, we can conclude that rehabilitation exercise might be able to invert the 
negative correlation between telomere length and telomerase activity. However, a much larger 
sample size is required to confirm this suggestion. 
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Figure 6.12. Telomerase activity in PBMNCs for MI patients pre- and post-cardiac 
exercise rehabilitation 	
Telomerase activity was measured for MI patients both pre- and post-cardiac 
exercise rehabilitation. All values are displayed as mean±sem. (ns) not significant for 
comparison between pre- and post-cardiac exercise rehabilitation using a two-tailed 
paired t-test for B. 
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Figure 6.13. Telomere length in PBMNCs for MI patients pre- and post-cardiac 
exercise rehabilitation. 	
Telomere length was measured as ratio of the telomere length to the single copy 
gene. All values are displayed as mean±sem. (ns) not significant for comparison 
between pre- and post-cardiac exercise rehabilitation using a two-tailed paired t-test 
for B. 
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Patients with low telomerase activity were not able to maintain telomere length, while those 
with high or medium telomerase activity were able to maintain or even elongate their 
telomere length. 
 
 
 
 
Figure 6.14. Relationship between telomere length (TL) and telomerase activity 
(TA) in PBMNCs for MI patients with pre- and post-cardiac exercise rehabilitation. 
 
A: Relationship between TA and TL for 19 patients who underwent the pre-cardiac 
exercise rehabilitation test. B: Relationship between TA and TL for 8 patients who 
underwent the post-cardiac exercise rehabilitation test. C: Relationship between TA 
and TL for 8 patients who underwent the pre-cardiac exercise rehabilitation test. 
Correlation was performed by Dr. G. Saretzki using SIGMA Plot. 
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6.3. Discussion 
 
Acute myocardial infarction (AMI) patients who underwent cardiac rehabilitation exhibited a 
non-significant trend toward decreased body weight and BMI (measured as weight/height2). 
Figure 6.1A shows that body weight increased after cardiac rehabilitation. This was because 
the pre-rehabilitation group included female patients. Our result was not significant in term of 
decreased body weight after 12 weeks of cardiac exercise rehabilitation, but it does 
correspond to results from Kraemer et al. (1997), who studied 31 healthy participants either 
with or without specific exercise training programmes for 12 weeks and observed a 
significant decrease in body weight after 6 weeks of exercise. Additionally, they found a 
significant reduction in high-density lipoprotein cholesterol (HDL-C) levels in both groups 
without exercise (hypocaloric low-fat diet group, and high diet group), whilst low-density 
lipoprotein cholesterol (LDL-C) levels reduced in the exercise group (Kraemer et al., 1997). 
Several studies recognized that high LDL-C levels were associated with increased MI risk, 
and this risk was decreased with high HDL-C levels (Duffy et al., 2012; Sniderman et al., 
2012; Murphy et al., 2009, Smith et al., 2006). Furthermore, Leon and Sanchez’s (2001) 
review of 51 studies involving a total of 4700 participants found that physical training for 
more than 12 weeks yielded increased HDL-C levels and decreased LDL-C and triglyceride 
levels (Leon and Sanchez, 2001). This confirms work by Stefanick et al., 1998, which stated 
that physical exercise leads to decreased LDL-C levels and increased HDL-C levels. 
In this study, the post-cardiac rehabilitation test was conducted with patients 6-9 months after 
MI, which had included 3 months of cardiac exercise rehabilitation. Physical exercise 
improved daily physical activity, confirming the findings of a study by Luszczynska and 
Sutton (2006), which found continued exercise 8 months after MI to be a major predictor of 
physical activity compared to a non-continuous exercise group. Following cardiac 
rehabilitation, patients usually maintain the exercise regime so as not to relapse through lack 
of exercise (Sullum et al., 2000; Scholz et al., 2005). The authors referred to this patient 
maintenance as ‘self-efficacy’. This was noticed in our study as well, as patients reported that 
they were still training on the rehabilitation programme. In our study, I found that time spent 
doing moderate to vigorous physical activity increased by 2.6-fold after cardiac exercise 
rehabilitation (P=0.0074). These findings were demonstrated by other studies; that exercise 
rehabilitation leads to improved daily activity for cardiac patients (Tyni-Lenna et al., 1998) 
and improves both their capacity to exercise and their cardiac output (Cheetham et al., 2002). 
In our study (figures 6.4 and 6.5), patients spent less time in low intensity daily activity (0-
50mg) including sleep and relaxation, after cardiac exercise rehabilitation this. Some of this 
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time was spent in high acceleration movement, whilst some of it averaged as moderate to 
vigorous (daily) physical activity. 
T-lymphocytes in this study decreased after cardiac exercise rehabilitation. This was 
significant for the patients who underwent blood sampling before and after cardiac 
rehabilitation, however, in my results when I applied the sensitivity analysis the decrease of 
T-lymphocytes was no longer significant. In contrast, I still found a significant decrease in 
CD4+ T-cells (which remained after the sensitivity analysis), but not in CD8+ T-cells after 
exercise rehabilitation. Moreover, this was also detected in the double positive population of 
CD4+CD8+ T-cells. This significant decrease in CD4+ T-cell numbers had a positive effect on 
patient health following cardiac exercise rehabilitation. The circulating frequency of CD4+ T-
cells increases in patients with established atherosclerosis or with high cardiovascular disease 
risk factors (Dumitriu et al., 2009). Lymphocytes Th1 and Th17/Th1 significantly increase in 
peripheral blood after MI (Cheng et al., 2008; Methe et al., 2005 and Zhao et al., 2011). In 
mouse models, γδ T-cells, αβ CD4+ T-cells, NK T-cells and B-cells were detected in the 
myocardium after MI, and γδ T-cells remain present for days thereafter (Yan et al., 2012; Yan 
et al., 2013). The trend toward decreased B-cells is close to the T-cells pattern. However, 
natural-killer (NK) cells showed a trend towards an increase after cardiac exercise 
rehabilitation (ns). This result is consistent with a study performed to characterize  NK cell 
activity in relation to AMI, which found significantly decreased baseline NK cell activity on 
days 1, 3, 7 and14, and at 6-weeks among AMI patients compared to a control group 
(Klarlund et al., 1987). It was found that NK cell activity could be increased by using 
interferon, interleukin and indomethacin, although it was never completely restored to its 
original levels (Klarlund et al., 1987). NK cells exhibit the greatest lymphocyte subset 
increase in activity among all lymphocyte subsets, of up to 200% above resting levels, for 
high intensity, brief duration exercise (Nielsen et al., 1996) and longer duration exercise 
(Mackinnon et al., 1988). These increases in cell activity are observed during, or immediately 
following the exercise activity, and return to resting levels in the hours and days following the 
exercise (Berk et al., 1990; Mackinnon et al., 1988; Shek et al., 1995). A positive correlation 
has been found between NK cell levels and exercise intensity (Nieman, et al., 1993 and Tvede 
et al., 1993). 
My results also demonstrated a significant reduction in Treg percentages at PBMNCs. As we 
found earlier in this study, CD4+ T-cells decreased significantly in pre- and post-cardiac 
exercise rehabilitation. Tregs are a subset of CD4+ and their decrease was confirmed by the 
CD4+ T-cell results. Treg cell numbers were increased and recruited to infarct area in 
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experimental MI mice, leading to a decrease in the inflammation which may occur after MI, 
helping to improve function and remodel the infarct area (Dobaczewski et al., 2010; Sharir et 
al., 2014; Saxena et al., 2014). A review study by Hofmann and Frantz (2015) demonstrated 
that inflammation is one complication of MI. Tregs were increased post MI, as anti-
inflammatory cells may improve healing (Hofmann and Frantz, 2015). Based on this, and our 
results showing a decline in Tregs after cardiac rehabilitation, overall it may suggest that there 
was no inflammation - or at least the inflammation level decreased, which led to decreased 
Tregs. Also, cardiac function appeared to stabilize in MI mice, as increased Tregs play a role 
in preventing cardiac dysfunction (Tang et al., 2012). Tregs secrete transforming growth 
factor beta (TGF-β), IL-10 and other inhibitory cytokines, which suppress the immune system 
(reviewed in Sakaguchi, 2005) and also atherosclerosis (Robertson et al., 2003; Mallat et al., 
2001). Patients with ST-segment elevation MI were found to have higher levels of circulatory 
Tregs (Ammirati et al., 2010). Our results showed that Treg cell expression significantly 
decreased with high CD25+ expression, low CD25+ expression and with no CD25+ expression 
(Khattri et al., 2003). This finding supports the idea that Tregs play a key role in immune 
homeostasis and tolerance, including maintenance and induction. They make up 5-10% of all 
peripheral CD4+ cells (Chen et al., 2003; Fontenot et al., 2003). Antigen presenting cells 
(APCs) and target T-cells are regulated through Tregs, which consequently inhibits both 
cytokine production and T-cell proliferation (reviewed in Sakaguchi, 2005). 
My study showed that there were no significant changes either on telomere length or 
telomerase activity for patients between pre- and post-cardiac exercise rehabilitation. There 
was a non-significant trend towards an increase in telomerase activity for 8 vs. 8 patients after 
cardiac rehabilitation and this matched a study which demonstrated that low telomerase 
activity and telomere length is a risk factor of cardiovascular diseases (Epel et al., 2006). Our 
study conducted on MI patients may have required a longer time to notice a significant 
improvement in telomere length. The study by Melk et al. (2014) concluded that telomerase 
activity and telomere length among PBMNCs increased after 3 months of physical activity in 
healthy middle-aged men with a sedentary lifestyle.  
MY study found a positive correlation between telomere length and telomerase activity. 
Patients exhibiting low telomerase activity also exhibited shorter telomeres, whilst patients 
whose telomerase activity was medium or high exhibited the ability to maintain or even 
extend their telomeres. Telomere length and telomerase activity contributes to cardiac 
diseases and oxidative stress (Epel et al., 2004; Epel et al., 2006; Demissie et al., 2006). 	
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CHAPTER 7. GENERAL DISCUSSION 	
7.1 Telomerase regulation under hyperoxia and hypoxia in vitro 
 
Firstly I established an in vitro model of oxidative stress and inflammation condition by 
culturing lymphocytes and monocytes under hyperoxic conditions. My results showed that 
hyperoxia (40% O2 saturation) and normoxia (20% O2 saturation) induced oxidative stress 
(measured with DHE in a flow cytometer) in mouse splenocytes and CD4+ T-cells from both 
TERT+/+ and TERT-/- mice respectively, compared with hypoxia (3% O2 saturation). I also 
found that hyperoxia induced a persistantly high IFN-gamma production in cultured mouse 
splenocytes, whereas under hypoxia, IFN-gamma production decreased from day one to day 
three. The main finding was the decrease of T-cell proliferation under hyperoxic conditions, 
which was dependent on the presence of TERT and telomerase activity. A study by von 
Zglinicki et al. (1995) showed that the proliferation of human fibroblasts under hyperoxic 
conditions was reduced compared to normoxia. This decrease in proliferation correlated to an 
accelerated telomere shortening caused by single strand damage in the telomerase due to 
increased oxidative stress under hyperoxia (von Zglinicki et al., 1995). It was also noted that 
hyperoxia can cause telomeres to reduce to lengths similar to that found in senescence. 
Consequently, hyperoxic conditions may also be used as a model for senescence. 
Furthermore, both the ageing process and hyperoxia cause increased generation of 
intracellular oxygen free radicals (Gille and Joenje, 1992; Sohal and Brunk, 1992; Shigenaga 
et al., 1994). Single-strand breaks and other DNA damage are mediated by the presence of 
free radicals, even under normoxic conditions (Fraga et al., 1990). The p53-dependent cell 
cycle exit pathway has been shown to rely on DNA strand breaks (Nelson and Kastan, 1994) 
and the same pathway has been found to mediate proliferation inhibition during senescence 
(Shay et al., 1993; Bond et al., 1994, Passos et al., 2010). 
My study observed the effect of oxidative stress on both telomerase activity and cell 
proliferation, proposing two potential mechanisms, for the decrease in proliferation in cells 
that have telomerase activity. Telomere maintenance is affected by oxidative stress in two 
ways: 1) DNA damage is induced in telomerase negative fibroblasts, resulting in increased 
telomere shortening (Petersen et al., 1998); 2) oxidative stress causes telomerase to be 
exported from nuclei to mitochondria (Ahmed et al., 2008; Haendeler et al., 2009), thus 
preventing it from maintaining telomeres in the nucleus in hTERT over-expressing fibroblasts 
(Ahmed et al., 2008). However, nothing is known about this mechanism in lymphocytes. 
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My study found that hyperoxia decreased telomerase activity, however, it is not known 
whether telomerase/TERT was exported out of the nucleus. A study by Santos et al. (2004) 
has demonstrated that the TERT sequence contains a mitochondrial localisation signal which 
causes TERT to localise at mitochondrial sites. Furthermore, exclusion from the nucleus of 
both ectopically overexpressed TERT, as well as endogenous TERT in endoithlial cells, has 
been shown to be stress dependent (Haendeler et al., 2004) and is therefore not solely due to 
overexpression itself. The large nucleus to cytoplasm ratio found in lymphocytes mekes it 
technically difficult to analyse the exclusion of telomerase from the nucleus. Furthermore, 
studies by Akiyama (2003) and Kawauchi (2005) have shown Akt phosphorylation on serine 
227 of the TERT protein to induce telomerase activity. T-cell (CD8+) senescence causes this 
phosphorylation to decline (Plunkett et al., 2007), suggesting that oxidative stress may be 
involved in reduced telomerase activity by reducing the activity of Akt responsible for this 
telomerase activating phosphorylation. Proving this hypothesis would however require further 
study. 
Under hypoxia, it has been observed that cells grow more quickly, live longer and exhibit 
fewer stress indicators (Richter et al., 1972; Packer and Fuehr, 1977; Parrinello et al., 2003). 
The cells in my study were mouse splenocytes and T-cells, and in accordance with findings 
from Parrinello at al. (2003), these showed signs of significant oxidative stress under 
conditions of normoxia and hyperoxia.  Inflammation levels, reflected by IFN-γ production at 
the RNA level, were higher under hyperoxia. A study by von Zglinicki et al. (1995) showed 
that 40% oxygen saturation led to senescence after human fibroblast proliferation was 
suppressed and telomere length decreased. Our study confirmed decreased splenocyte and 
lymphocyte proliferation at 40% O2. Telomere length was not analysed in mouse models in 
my study because the incubation times under hyperoxia were very short and the telomeres in 
mouse cells are very long. However, our group did use the flow-FISH technique to find that 
telomere length changed in TERC knockout splenocytes in comparison with wild-type litter-
mates (Bennaceur et al., 2014; Al-Ajmi et al., 2014). The study on mouse ageing by Hewitt et 
al. (2012) suggests that telomere damage as a potential cause of cell senescence and ageing 
may also implicate telomere influence in decreased proliferation. 
Hyperoxia (40% O2 saturation) is a model for inducing oxidative stress, which may lead to a 
number of health outcomes in different cell types. These include; atherogenesis in vascular 
walls, which is linked to inflammation or an enhanced risk of myocardial infarction (Sorescu 
et al., 2002); the formation of atherosclerotic plaques; and endothelial dysfunction, which also 
leads to inflammation (Guzik et al., 2006; Heitzer et al., 2001).  
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Telomerase plays a critical role in cell proliferation. In our study, the absence of TERT was 
found to diminish the effects of oxidative stress, with TERT-/- T-lymphocytes exhibiting the 
same low proliferation levels under both hypoxia and hyperoxia. My study also found that 
mTert-GFP+ expression and telomerase activity in splenocytes were suppressed under 
hyperoxia and that telomerase expression was significantly higher under conditions of 
hypoxia. I speculate that hyperoxia might enhance IFN-γ mRNA transcription and 
inflammation in general (Kudo et al., 2012, González-Muniesa et al., 2015), which leads to 
suppressed T-cell proliferation and decreased mTert-GFP+ expression under 40% O2. Our 
group has demonstrated that decreased telomerase activity in unstimulated PBMCs is caused 
by increased inflammation in patients with acute cardiovascular infarction (acute stemi), but 
further study is required to confirm a direct causal relationship (Bennaceur et al., 2014). 
7.2 Effects of mitogen-activated protein kinases inhibition (MAPKi) on 
telomerase under oxidative stress 
In my results MAPK inhibition down-regulated IFN-gamma production under oxidative stress 
at the same level under hypoxia by day 3. Splenocyte proliferation increased equally under 
hypoxia and hyperoxia. This may be related to decreased inflammation in vitro, as IFN-
gamma is a pro-inflammatory cytokine (Prasanna et al., 2010), and IFN-gamma is produced 
as a key proatherogenic cytokine expressed in arterial plaques (Frostegård et al., 1999). This 
is secondary to the fact that IFN-gamma reduces CD8 T-lymphocyte generation, largely 
during the immune response to foreign antigens, by limiting proliferation of IL-2 producing 
CD4+ T cells. As suggested by Hidalgo et al. (2005), a feedback loop is generated, in which 
IFN-gamma is produced by effectors to inhibit production of IL-2. In turn, this suppresses the 
production of CD8+ T cells. 
Sarov-Blat et al. (2010) and Cheriyan et al. (2011) found that IFN-γ secretion in vitro was 
reduced by the presence of MAPKi, resulting in less inflammation. Studies on IFN-γ secretion 
from human atherosclerotic coronary artery rings cultured with IL-12/IL-18 yielded decreased 
production of IFN-γ after treatment with MAPKi, including reduced inflammation (Ranjbaran 
et al, 2007). 
My results showed that the effect of MAPKi seemed to be telomerase-dependent, as there was 
no increase in proliferation in TERT-/- mice splenocytes under either oxygen saturation when 
cells were treated with MAPK inhibitor compared to untreated cells. Furthermore, telomerase 
expression, reflected by the percentage of GFP+ cells from mTert-GFP+ mice increased when 
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these cells were treated with the MAPK inhibitor, and was diminished when cells were 
cultured under hyperoxia without MAPK inhibitor treatment.  
The study of MAPK inhibition under hyperoxia found telomerase activity increased by day 
10, and this became significant by day 14 (2.9-fold, P<0.05), in comparison to hypoxia. 
MAPKi therefore seems to be dependent on both TERT and also interaction between cells. 
The same proliferation pattern was observed in purified CD4+ T-cells from both TERT+/+ and 
TERT-/- under hyperoxia. Under MAPKi treatment, no proliferation was observed in either 
hypoxic or hyperoxic conditions. Cell proliferation was seen to be the same for all splenocyte 
subsets and TERT+/+ when treated with MAPKi in both hypoxic and hyperoxic conditions 
(1.4-fold and 1.6-fold respectively at day 28 compared to day 2). This improvement in cell 
proliferation, telomerase (TERT) expression and telomerase activity may relate to the 
blocking of the p38 signalling pathway, which was found to lead to increased cell 
proliferation and increased telomerase activity after stimulation in human T-cells (Di Mitri et 
al., 2011). 
p38 MAPK signalling plays a key role in senescence and in pro-inflammatory cytokine 
production by T-cells, including: IL-1β, TNF-α, and IL-6 (Iwasa et al., 2003; Rincón and 
Pedraza-Alva, 2003; Zarubin and Han, 2005). The p38 pathway is also involved in the 
response to oxidative stress induced by mild hyperoxia, which inhibits fibroblast proliferation 
and in addition activates p53, which shortens telomeres. As stated earlier, hyperoxic 
conditions in vitro may be used as a model for senescence (von Zglinicki et al., 1995). My 
data demonstrated that hyperoxic conditions led to decreased T-cell proliferation, which is 
linked to reduced telomerase expression and activity. This association can be partially 
reversed by blocking the p38 pathway under oxidative stress. This result is a confirmation of 
findings by A. Akbar’s group (Di Mitri et al., 2011, Henson et al., 2015). 
DNA damage activates p38 MAPK, which plays an important role in senescence induction by 
activating the pRb/p16 and p21/p53 pathways (Freund et al., 2011; Iwasa et al., 2003; Passos 
et al., 2010). Increased telomerase activity and proliferation were noticed after CD4+ T-cells 
were stimulated (Di Mitri et al., 2011). A study showed that inhibition of p38 MAPK 
improves mitochondrial function with increasing mitochondrial mass, which, it has been 
suggested, may improve proliferation (Passos et al., 2010; Henson et al., 2014). 
Mouse CD4+ T-cells exhibit separate pathways for IL-12/IL-18 and TCR signalling. The 
former depends on p38 MAPK activation, whilst the latter relies on calcineurin activity (Yang 
et al., 2001). Studies in organ culture have shown that inhibition of p38 MAPK has a greater 
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effect on stabilizing and limiting the atherosclerotic human coronary artery rings than 
rapamycin, which is an mTOR (mammalian target of rapamycin) inhibitor. These findings are 
echoed in experiments on the inhibition of IFN-γ production via IL-12. IFN-γ secretion has 
been shown to be reduced by p38 MAPKi, resulting in decreased inflammation in human 
coronary artery rings cultured with IL-12/IL-18 (Kusaba et al., 2005; Ranjbaran et al., 2007).	
7.3 Voluntary wheel running exercise increases telomerase activity in 
splenocytes in mice 
In this part of my thesis, I subjected mice from different genetic backgrounds to voluntary 
wheel running exercise. As expected, mice were mainly exercising during night-time. Our 
computerised voluntary wheel running system proved to be a reliable monitor of exercise 
activity in mouse models. My study’s most important finding was that splenocytes from 
ApoE-/-mTert-GFP+ mice on high fat diet (HFD) and exercise showed increased telomerase 
activity by 3.9-fold (P<0.001) in comparison to cells from the non-exercising group. 
Telomerase activity increased by 1.7-fold (P<0.05) for the HFD exercise group compared to 
the normal diet (ND) exercise group. Thus, there seems to be an interaction between diet, 
exercise and telomerase activity. However, the underlying mechanisms are still unknown. 
In theory, the possibility of an unspecific silencing of GFP reporter exists. However, I do not 
think it occurred in my experiment because the amount of GFP+ cells in the growth-curve 
(Figure 3.8C – page 121) measuring the mTERT transcription is identical to the telomerase 
activity measured by TRAP-ELISA (Figure 3.10 – page 123). This means that the 
downregulation of the mTERT promoter in the GFP+ cells from the transgenic mice shows 
the same as the decrease in telomerase activity measured by TRAP assay. Furthermore, within 
the GFP+ population, the number of GFP+CD4+ cells (Figure 3.9B – page 122) shows a 
growth-curve almost identical to the two previous results. Thus, most of the changes (less 
mTERT transcription and less telomerase activity) are mainly due to the downregulation of 
these 2 parameters in CD4+ cells. Consequently, I did not observe any unspecific decrease of 
the reporter, but rather a specific change due to transcriptional changes of the mTERT 
promoter. 
ApoE-/-mTert-GFP+ mice on HFD and exercise showed a 1.5-fold (P<0.001) increase in B-
cells in comparison to ND. A similar pattern was seen with the ND exercise group in 
comparison to both the HFD and ND non-exercise groups (1.7-fold with P<0.0001 and 1.6-
fold with P<0.001 respectively). 
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Telomerase activity was increased in splenocytes by exercise. However, we do not know 
whether this increase contributes to the enhanced cell division rates in ApoE-/-mTert-GFP+ 
mice. We also speculate that these parameters might contribute to the slowing of 
atherosclerotic plaque development. Other animal models have shown that atherosclerosis can 
be slowed to a large extent by voluntary exercise in ApoE-/- under HFD (Fukao et al., 2010). 
These authors show reduction in white adipose tissue weight and improved endothelial 
function as possible mechanisms. In general, exercise can reduce inflammation (Petersen and 
Pedersen, 2005; Ringeis et al., 2015). It has been shown that a TNF-α independent pathway 
enables muscle cells to produce IL-6 during exercise, which causes other anti-inflammatory 
cytokines (e.g. IL-1ra and IL-10) to enter the blood circulation. Similarly, TNF-α, a pro-
inflammatory cytokine, is inhibited by exercise (Petersen and Pedersen, 2005). 
It has been suggested by Moustardas et al. (2014) that reduction in atherosclerotic plaque size 
is connected with matrix-metalloproteinases and their inhibitors, MMP/TIMP, and in 
particular, their balance following exercise. Proteolytic enzyme inhibition and infiltration of 
inflammatory cells into the plaque are suggested as a mechanism by which plaque 
development might be reduced. Further to this, the plaque could be stabilised by combined 
exercise and statin treatment (Moustardas et al., 2014). 
A study by Cardinot et al. (2016) found that atherosclerotic plaques could be modified via 
exercise in mice, resulting in a more stable phenotype. Both the preventative and therapeutic 
exercise protocols caused the collagen content of plaques to increase, and the preventative 
protocol also caused fat content to decrease. The precise causal mechanism for this is not yet 
established, but a number of processes were implicated. For example, increased collagen 
deposition is caused by reduced CD40 expression (Cardinot et al., 2016). Regular exercise is 
widely considered by clinical researchers to induce an anti-inflammatory response, protecting 
against atherosclerosis (Szostak and Laurant, 2011; Petersen and Pedersen, 2005), and 
experimental models have yielded similar results. Exercise appears to reduce the 
inflammatory response in various areas, including the hypothalamus (Moreira et al., 2013; Yi 
et al., 2012), adipose tissue (Medeiros et al., 2011; Ringseis et al., 2015), aortic valve 
(Matsumoto et al., 2010) and even within the atherosclerotic plaque (Matsumoto et al., 2013). 
In vitro results from our study confirmed that inflammation (IFN-gamma production) 
suppressed splenocyte and T-lymphocyte proliferation, as well as telomerase activity under 
hyperoxia (40% oxygen saturation), whilst cells proliferated more with activated telomerase 
activity when treated with a MAPK inhibitor under the same oxygen conditions. 
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Telomere repeat binding factor (TRF2) expression is increased by exercise in wild-type mice, 
and this was shown to prevent doxorubicin-induced cardiac apoptosis (Werner et al., 2008). 
The effect was not observed in TERT-/- mice, however. From this, we can infer that when 
telomerase is not present, telomere-stabilising proteins are inhibited and cardiac apoptosis 
increases. 
Splenocyte numbers did not increase significantly among the exercising groups. Other studies 
also found this, including Woods et al. (2000, 2003), Hoffman-Goetz et al. (1992), Macneil 
and Hoffman-Goetz (1993) and Jonsdottir et al. (1997). Woods et al. (2003) concluded that 4 
months of aerobic exercise on a treadmill was the ideal duration, allowing manipulation and 
quantification of the intensity and duration of exercise. (Our study also measured intensity 
and duration of exercise). However, they found that the percentage of CD4+ and CD8+ splenic 
T-cells was unchanged by exercise compared to the control group, although the number of 
splenocytes in the spleen had decreased significantly after exercise. The non-exercising ApoE-
/-mTert-GFP+ control groups exhibited an increase in splenocyte numbers, and it is thought 
this may be connected with ApoE deficiency, which is linked to lipid accumulation and 
cardiovascular complications (Zhang et al., 1992; Williams et al., 2002; Knouff et al., 1999). 
 
A non-significant increase in numbers of CD4+ and CD8+ T-lymphocytes was observed in the 
exercised TERT heterozygous group. Other subpopulations however (DP, DN, B-cells and 
monocytes) decreased in the exercise group. Woods et al. (2003) found T-lymphocyte 
numbers, in 2 year old specific pathogen-free (SPF) inbred male Balb/cByJ mice increased 
following 4 months of exercise, enabling restoration of their levels to those of young mice. 
Older mice exhibited increased numbers of naïve (as opposed to memory) T-lymphocytes 
after exercise. Furthermore, regulatory T-cells were seen in my study to increase following 
exercise, suggesting that increased blood circulation might have enhanced the proliferation of 
these cells. I observed increased physiological muscle strength in our exercised mice (not 
measured). In spite of the important role played by Tregs in immune activation or 
suppression, our mice were healthy, and to my best knowledge had normal immune function. 
No significant difference was observed between the exercise and non-exercise groups. 
 
No significant difference was observed in CD4+, CD8+ T-cell or monocyte numbers in mTert-
GFP+ mice between exercise and non-exercise groups. I did, however, observe a trend (ns) 
towards increased telomerase activity in GFP+ cells for the exercise group, possibly due to 
higher blood circulation levels. Other studies indicate that exercise had no effect on cell-
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cycle-checkpoint kinase 2 (Chk2), tumour suppressor protein p16, tumour suppressor protein 
p53, or telomere repeat binding factor 2 TRF2 for TERT-/- mice compared to TERT+/+ after 21 
days of short-term voluntary running exercise (Werner et al., 2008, 2009). Telomerase 
protects and elongates telomeres at each chromosome end, and therefore the effect of exercise 
on telomerase activity is of great importance. Our findings, combined with previous studies 
(Werner et al., 2008, 2009), add credibility to the idea that telomerase might mediate the 
effect of exercise on telomeres. Findings by Park et al. (2009) suggest that TERT may act as a 
transcription factor or may be a component within a chromatin remodelling complex. 
Consequently, there is a possible connection between exercise and a supportive cellular 
environment for immune, vascular and cardiac cells, which could be significant in preventing 
oxidative stress and its complications. A study by Ludlow et al. (2012), which found 
increased telomerase activity in skeletal muscle of CAST/Ei (wild-derived short telomere) 
mice after 11 months of voluntary exercise, shows that exercise might have a positive effect 
on telomerase activity. Telomeres exhibited reduced shortening in the liver and cardiac tissues 
of mice who underwent exercise. These findings correspond to my experiments, in which I 
analysed telomerase activity (but not telomerase lengths) in splenocytes. In both studies, 
telomerase activity was maintained after exercise, which suggests that exercise might have a 
positive effect on telomere length. 
The mTert-GFP+ exercise group exhibited significantly increased B-cell numbers after 
exercise compared to the control group. Supporting results from human studies were reported 
by Gray et al. (1993) who found the percentage of plasma cells (effector B-cells) significantly 
increased post interval exercise in young trained men. B-cells serve many functions, including 
immunoglobulin (Ig) production and humoral immunity (Berkowska et al., 2011), 
differentiating into antibody-producing plasma cells, or circulating memory cells (Ozaki et al., 
2004).  
Diet was critical to our murine study. A high fat diet enabled ApoE-/-mTert-GFP+ mice to run 
further and for longer. The exercising mice also gained less body weight on HFD compared to 
non-exercising mice on HFD, in spite of having a similar average calorie intake. Exercising 
ApoE-/-mTert-GFP+ mice on a normal diet consumed more calories than other ApoE-/-mTert-
GFP+ groups on average. Whilst his may be connected to the loss in body weight, it could 
also be associated with ApoE deficiency. As expected, HFD mice had more energy and were 
therefore more active. Pellegrin et al. (2009) found that not only did exercise (swimming) 
cause decreased body weight in ApoE-/- mice, but that it also stabilised the progression of 
atherosclerosis. This is supported by a number of other studies (Laufs et al., 2005; Pellegrin et 
al., 2007 and Okabe et al., 2006). Laufs et al., (2005) used male wild-type and ApoE-/- mice 
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on a voluntary wheel running exercise for 6 weeks, and a control group from each genotype 
randomly. They found that oxidative stress was increased in aortic tissue for the wild-type 
control group compared to the wild-type exercise group. Importantly, his finding implicates 
that exercise decreases oxidative stress which could, in accordance with my in vitro findings 
that oxidative stress decreases telomerase activity, that the latter was increased by exercise via 
a decrease in oxidative stress. Following 6 weeks on a HFD, the control group of ApoE-/- 
mice exhibited atherosclerotic lesions in the aortic root and ascending aorta. Conversely, the 
exercising group did not exhibit such lesions. A twofold increase in vascular superoxide 
levels was found in HFD ApoE-/- mice with no exercise compared to HFD wild-type mice 
with no exercise (Laufs et al., 2005).  
Pellegrin et al., (2007) divided male ApoE-/- mice on HFD for 9 weeks into two groups. One 
group underwent a swimming exercise for 9 weeks, and one group was a control. The 
swimming group was found to have significantly fewer atherosclerotic lesions in the aortic 
roots compared to the control group.  
Okabe et al. (2006) forced 6-week old ApoE-/- mice to undertake swimming exercise in a 
warm water bath (37°C) for 20min/day, 3 times/week for 2 months. A second group 
undertook the exercise for 4 months. Each of these two groups had its own (non-exercising) 
control. It was concluded that both exercise periods decreased the development of 
experimental atherosclerosis in ApoE-/- mice compared to the non-exercising groups. It was 
also suggested that exercise may increase the level of plasma oxidized fatty acids in mice on 
HFD, and further upregulate the endothelial isoform of nitric oxide synthase. 
 
ApoE-/-mTert-GFP+ mice on exercise and HFD exhibited increased telomerase activity in 
splenocytes, but there was no significant change in body weight for either this group or the 
ND group, compared to non-exercise groups. HFD-fed mice exhibited increased telomerase 
activity with exercise, indicating that the HFD combined with exercise has a significant effect 
on increasing telomerase activity. This suggests that the ApoE-/-mTert-GFP+ mice might 
benefit from exercise to reduce the lipids that accumulate as a result of the HFD and the ApoE 
deficiency. Meir and Leitersdorf (2004) found that ApoE-/- mice on HFD developed 
atherosclerosis, and a subsequent study, by Lesniewski et al. (2011) showed that aerobic 
exercise reversed arterial inflammation with ageing. Human leukocyte studies have associated 
shorter telomeres with the onset of atherosclerosis (Ogami et al., 2004; Benetos et al., 2004; 
Obana et al., 2003 and Samani et al., 2001). Exercise might lead to increased telomerase 
activity and consequently maintained telomere length. However I did not measure telomere 
length in my study involving mice, in view of their known long lengths. 
	 232	
No significant changes were found in TERT expression in all GFP+ cells isolated from mTert-
GFP+ mice. However, the number of telomerase-positive lymphocytes among peripheral 
blood mononuclear cells was found to decrease with age (Bennaceur et al., 2014), which 
could be a consequence of lesser proliferation among immune cells. In my results, TERT 
expression was determined on a single cell level, whilst telomerase activity was measured 
from a cell pellet in our experiments. Telomerase activity increased in ApoE-/-mTert-GFP+ 
mice on exercise with HFD. However, in the mTert-GFP+ mice experiment, no significant 
effect of exercise was observed on TERT expression. Despite the fact that GFP+ cells only 
report TERT expression, a number of other mechanisms are known to regulate telomerase 
activity, such as post-transcriptional TERT modification. In lymphocytes, telomerase activity 
is regulated by Akt phosphorylation of TERT on serine 227 (Akiyama et al., 2003 and 2004). 
Akt expression and phosphorylation can be increased by exercise, resulting in decreased 
apoptosis and improved cardiac function (Zhang et al., 2007). Conversely, using a PI3K 
kinase inhibitor reversed these beneficial effects, revealing some insights and opening up 
potential for further investigation into the connection between cardiac function and exercise 
(Zhang et al., 2007). From this, it can be speculated that telomerase activity might be 
upregulated during exercise due to increased Akt activity. 
B-cell number in ApoE-/-mTert-GFP+ mice decreased significantly for the ND exercise group 
in comparison with the ND and HFD no-exercise groups. ApoE deficient mice on HFD also 
expressed fewer GFP+B-cells (mTert-GFP+B-cells expression) in comparison with the ND 
and HFD non-exercise groups. This is thought to be connected with Ig-producing B-cells’ 
humoral immunity function (effector B-cells) (Berkowska et al., 2011). However, a human 
study conducted on young male athletes demonstrated that the concentration of effector B-
cells increased in PBMNCs after exercise (Gray et al., 1993). B-cell numbers increased in 
both ND and HFD without exercise, and may lead to accelerated atherosclerosis in ApoE-/-. Ig 
production plays a vital role in humoral immunity and our study showed opposing increases 
and decreases between B-cells and CD8+ T-cells in all ApoE-/-mTert-GFP+ groups. B-cells 
were also found in the mouse thymuses. The relationship between B-cells and CD8+ cells is, 
to my knowledge, not established, and requires further investigation. 
 
 
 
 
	 233	
7.4 Cardiac exercise rehabilitation reduces Tregs in PBMNCs after 
myocardial infarction (MI) in humans 
 
Acute myocardial infarction (AMI) patients who had undergone cardiac rehabilitation showed 
reduced regulatory T-cell percentages at PBMNCs by 6.8-fold (P<0.001). There may be an 
association here with decreased inflammation levels that increased after AMI, and Tregs 
recruitment and proliferation at the infarct site. Although my study found no significant effect 
of exercise in human patients on telomerase activity, I hesitate to draw firm conclusions on 
this issue in view of the low sample number involved. Whilst the sample number is an 
obvious limitation, the study may nevertheless be of value as a pilot study for larger 
experiments.  
Patients with AMI who performed a programme of cardiac rehabilitation generally exhibit a 
trend towards decrease in body weight and BMI. Kraemer et al. (1997), in their study of 31 
healthy patients on a 12-week exercise training programme, found significantly reduced body 
weight after 6 weeks, as well as significantly reduced HDL-C levels in the non-exercise 
groups (with both a LFD and HFD). The opposite was found for LDL-C, which was reduced 
with exercise. The benefits of exercise are therefore obvious regarding cardiovascular risk, as 
LDL-C is associated with a high risk of MI (Duffy et al., 2012; Sniderman et al., 2012; 
Murphy et al., 2009 and Smith et al., 2006). A review of 51 studies on physical training 
across 4700 participants (18 to 80 years old men) who successfully completed their exercise 
programme (about 60% of all participants) found that the exercise programme increased 
HDL-C levels and decreased LDL-C and triglyceride levels (Leon and Sanchez, 2001). 
My study investigated the effects of 6-9 months of post-cardiac rehabilitation in 8 MI 
patients, which included 3 months of physical training exercise. It was found that the exercise 
component increased the likelihood of patients being physically active 8 months following MI 
(Luszczynska and Sutton, 2006). The exercise regime is usually maintained to prevent 
relapse, which has been referred to as ‘self-efficacy’. Self-efficacy was observed in our study, 
which found that the time spent doing moderate to vigorous physical activity increased by 
2.6-fold after cardiac exercise rehabilitation. My study found that patients often spent less 
time doing low intensity activity and more time doing moderate to vigorous daily activity and 
had more time for recovery. 
Our study also measured T-lymphocytes both before and after cardiac rehabilitation, finding a 
significant decrease for patients who underwent cardiac exercise rehabilitation, but when 
sensitivity analysis was applied (omitting the single outlier) the decrease of T-lymphocytes 
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after cardiac rehabilitation was not significant. More specifically, I found CD4+ T-cells 
decreased significantly also with sensitivity analysis (omitting the single outlier), but not 
CD8+ T-cells. This yields a benefit to the patient’s health, as a higher frequency of CD4+ T-
cells is associated with higher atherosclerosis or cardiovascular disease risk factors (Dumitriu 
et al., 2009). Other studies found that Th1 and Th17/Th1 lymphocytes increased significantly 
following MI (Cheng et al., 2008; Methe et al., 2005 and Zhao et al., 2011). In mice, γδ T-
cells, αβ CD4+ T-cells, NK T-cells and B-cells were detected in the myocardium following 
MI. Furthermore, γδ T-cells can remain in the peripheral blood for many days (Yan et al., 
2012, 2013).  
Cardiac exercise rehabilitation also caused a trend towards increase in numbers of NK cells 
compared to pre cardiac exercise rehabilitation in my study. Klarlund et al. (1987) found that 
interferon, interleukin and indomethacin could increase NK cell activity, but never quite 
restore it to pre-AMI levels. High intensity exercise was found to increase the amount of NK 
cells among lymphocyte subsets by up to 200% (Nielsen et al., 1996; Mackinnon et al., 1988), 
but these levels returned to normal within a few hours of the exercise. Exercise intensity and 
NK cell levels are positively correlated (Nieman et al., 1993; Tvede et al., 1993). 
 
As mentioned earlier, we found a significant decrease in CD4+ T-cells following cardiac 
exercise rehabilitation. This was also indicative of a drop in Treg percentages. In murine 
models, when Treg numbers increase, inflammation following MI was found to decrease, 
which benefits the recovery of the infarct area through remodelling, as Tregs play a role in 
suppressing inflammation (Dobaczewski et al., 2010; Sharir et al., 2014; Saxena et al., 2014). 
Inflammation is a complication associated with MI, so if this is reduced, then recovery 
outcomes improve (Hofmann and Frantz, 2015). The decrease in Tregs found in our 
experiments could be due to decreased inflammation. Tang et al. (2012) also found a negative 
correlation between increased Treg numbers and cardiac dysfunction. This was due to the 
secretion of TGF-beta, IL-10 and other inhibitory cytokines, which suppressed the immune 
system (reviewed in Sakaguchi, 2005) and also suppressed atherosclerosis (Robertson et al., 
2003; Mallat et al., 2001). A study by Ammirati et al. (2010) found increased Treg levels in 
ST-elevated MI patients, and I found that high CD25 expression, low CD25 expression, and 
no CD25 expression (Khattri et al. 2003), caused a significant decrease in Treg cell 
expression after cardiac exercise rehabilitation. Tregs make up 5-10% of all peripheral CD4+ 
cells, and the above findings emphasise the critical role they play in immune homeostasis, 
tolerance, maintenance and induction. A review by Sakaguchi (2005) emphasised that Tregs 
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also have a role in regulating APCs and target T-cells, inhibiting cytokine production and T-
cell proliferation. 
 
I found no significant changes in telomerase activity or telomere length between pre- and 
post-cardiac exercise rehabilitation patients in our study. However, our study found a trend 
towards increased telomerase activity in some patients following cardiac rehabilitation, 
suggesting that exercise has a beneficial effect on telomerase activity. This confirms findings 
by Melk et al. (2014), as well as studies by Werner et al. (2008 and 2009), which suggested 
that telomerase activity may reflect the benefit of exercise on telomere length. This is 
confirmed in our own findings of increased telomerase activity in ApoE-/-mTert-GFP+ mice 
during exercise and HFD compared to ApoE-/-mTert-GFP+ mice without exercise and on 
HFD. 
 
A study by Epel et al. (2006) established a link between telomerase activity, telomere length 
and cardiovascular disease, but did so without using an exercise program. Their study found a 
correlation between low telomerase activity and risk factors for cardiovascular disease 
(CVD). These include: an unhealthy lipid profile, high glucose levels during fasting, high 
systolic blood pressure, increased adipose in the abdomen, composite Metabolic Syndrome 
variable and of course, smoking. However, a correlation with telomere length was only found 
with increased catecholamine and cortisol levels. The authors proposed that low levels of 
telomerase in leukocytes may indicate potential risk of CVD and might potentially cause 
decreased telomere length. My research may require more time and a greater number of 
patients to establish any significant changes in telomerase activity and increase in telomere 
length. Melk et al. (2014) found that 6 months of physical exercise could increase telomere 
length and telomerase activity even at earlier time points in PBMNCs among healthy but 
previously sedentary middle-aged men. 
My study found a trend for a positive correlation between telomerase activity and telomere 
length. Telomere length is maintained, and can even be increased, among patients who exhibit 
medium or high telomerase activity (Melk et al., 2014). Cardiac diseases and oxidative stress 
are heavily influenced by telomerase activity and telomere length (Epel et al., 2006; Demissie 
et al., 2006; Ludlow et al 2012; Werner et al., 2008 and 2009). 
 
 
 
	 236	
7.5 Limitations of my study 
 
My study of GFP positive lymphocytes (chapters 3,4 and 5) may be prone to the following 
limitations: 
The mTERT-GFP+ reporter system only detects changes in mTERT expression levels. 
However, it is not known if telomerase activity will also increase as a result of transcriptional 
TERT activation. In general, it is known that telomerase activity is regulated on many 
different levels and transcriptional control of TERT is only one of these. Nevertheless, 
changes in transcription levels have often been reported as resulting in changes in telomerase 
activity (Breault et al., 2008). However, in my study we used the mTERT-GFP+ reporter cells 
as an additional method of measuring telomerase activity directly using the TRAP assay. In 
page/chapter we showed that there was a positive correlation between the TRAP assay results 
of telomerase activity in saplenocytes and the GFP expression level in splenocytes from 
mTert-GFP+ mice. 
 
In the mouse study, unavailability of the mouse ApoE-/-mTert-/- genotype made it impossible 
to establish how much the presence of TERT contributed to the effects of exercise and diet. 
Unfortunately, I made an error in the cryopreservation of the ApoE-/-mTert-GFP+ mouse 
serum, and consequently these samples could not be used to establish lipid accumulation 
levels and the extent to which the exercise and diet contributed to lipid accumulation in the 
presence and absence of the ApoE gene. 
I realised late in the study that 20% oxygen saturation would be a more useful saturation to 
determine the effects of oxidative stress on splenocytes and CD4+ T-cells, especially with 
MAPKi. 
 
In the human study, patient numbers were low for many reasons. For example, some patients’ 
conditions did not fit my inclusion criteria; some patients left the study or did not use the 
accelerometer correctly; and some patients were unable to attend the post-cardiac 
rehabilitation test. In addition, I was not able to involve a control group (healthy participants) 
due to time limitations. 
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7.6 Future experiments: 
 
Given the time and opportunity, I would like to find out: 
 
1. The effect of MAPK inhibition on splenocytes under 20% oxygen saturation. Also, I 
would like to establish the effect of MAPK inhibition on splenocytes expanded under 
40% oxygen saturation for at least two weeks without MAPK inhibitor treatment. 
Following transfer to 3% oxygen saturation some cells would be treated with MAPK 
inhibitor, whilst others would not. This might establish possible effects of MAPK 
inhibition on splenocytes under oxidative stress and inflammation conditions (taken 
from 40% O2 in the previous two weeks), and would also find the extent to which 
oxygen saturation itself contributes to decrease the IFN-gamma and oxidative stress. 
2. It would be interesting to analyse how oxidative stress decreases telomerase activity 
and whether it is directly regulated by decreased Akt activity. Likewise, it would be 
interesting to analyse whether TERT is also excluded from the nucleus in lymphocytes 
by using immuno-fluorescence staining of TERT and/or Western blot analysis after 
cell fractionation. 
3. I would like to explore the extent to which telomerase might be affected by exercise 
and diet in ApoE-/-Tert-/- and ApoE+/+Tert-/- mice. 
4. In the human study, I would have liked to increase the number of MI patients to get a 
higher power and statistical significances for the potential effects of exercise on 
telomerase activity and telomere length. 
5. I would be interested to use a control group of healthy participants, some of whom 
would be assessed for exercise and others not, in parallel with MI patients undergoing 
the rehabilitation programme, to ascertain how Tregs, B-cells and CD8 T-cells 
respond to exercise in different groups. 
6. I would like to isolate (pre- and post-rehabilitation) B-cells and CD8+ T-cells from MI 
patients and from healthy (with and without exercise) groups, to study these cells’ 
behaviour under different oxygen saturations. 	 	
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